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SUMMARY 
 
Single ventricle heart defects, where systemic and pulmonary venous returns mix 
in the single functional ventricle, represent the most complex form of congenital heart 
defect, affecting 2 babies per 1000 live births. Surgical repairs, termed “Fontan Repairs,” 
reroute the systemic venous return directly to the pulmonary arteries, thus preventing 
venous return mixing and restoring normal oxygenation saturation levels. Unfortunately, 
these repairs are only palliative and Fontan patients are subjected to a multitude of 
chronic complications. It has long been suspected that hemodynamics play a role in 
determining patient outcome. However, the number of anatomical and functional 
variables that come into play and the inability to conduct large scale clinical evaluations, 
due to too small a patient population, has hindered decisive progress and there is still not 
a good understanding of the optimal care strategies on a patient-by-patient basis.  
Over the past decades, image-guided computational fluid dynamics (CFD) has 
arisen as an attractive option to accurately model such complex biomedical phenomena, 
providing a high degree of freedom regarding the geometry and flow conditions to be 
simulated, and carrying the potential to be automated for large sample size studies. 
Despite these theoretical advantages, few CFD studies have been able to account for the 
complexity of patient-specific anatomies and in vivo pulsatile flows.  
In this thesis, we develop an unstructured Cartesian immersed-boundary flow 
solver allowing for high resolution, time-accurate simulations in arbitrarily complex 
geometries, at low computational costs. Combining the proposed and validated CFD 
solver with an interactive virtual-surgery environment, we present an image-based 
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surgical planning framework that: a) allows for in depth analysis of the pre-operative in 
vivo hemodynamics; b) enables surgeons to determine the optimum surgical scenario 
prior to the operation. This framework is first applied to retrospectively investigate the in 
vivo pulsatile hemodynamics of different Fontan repair techniques, and quantitatively 
compare their efficiency. We then report the prospective surgical planning investigations 
conducted for six failing Fontan patients with an interrupted inferior vena cava and 
azygous continuation. In addition to a direct benefit to the patients under consideration, 
the knowledge derived from these surgical planning studies will also have a larger impact 
for the clinical management of Fontan patients as they shed light onto the impact of caval 
offset, vessel flaring and other design parameters upon the Fontan hemodynamics 
depending on the underlying patient anatomy. These results provide useful surgical 
guidelines for each anatomical template, which could benefit the global surgical 
community, including centers that do not have access to patient-specific surgical planning 
interfaces. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Single Ventricle Heart Defects and Surgical Repairs 
Single ventricle congenital heart defects (SHVD) affect about 2 babies per 1000 
live births. In these patients, the oxygenated blood coming from the lungs and the 
deoxygenated blood coming back from the rest of the body mix in the single ventricle 
leading to acute hypoxia and death if left untreated. The concept of a total right 
ventricular bypass, first introduced by Fontan and Baudet in 1971 [1], is a palliative 
surgical procedure aimed at separating the systemic and pulmonary circulations thereby 
eliminating venous blood mixing. In its current form the Fontan procedure is performed 
in three stages, ultimately resulting in what is called a total cavopulmonary connection 
(TCPC) where the inferior (IVC) and superior (SVC) vena cavae are anastomosed 
directly onto the pulmonary arteries (PAs) thus bypassing the right side of the heart and 
preventing cyanotic blood mixing in the single ventricle. 
 
1.2 Long-Term Complications 
Since its inception, modifications of the Fontan procedure have steadily improved 
surgical outcomes, reducing the post-operative mortality to the level of simpler 
congenital heart disease repairs. However, the marked improvement in surgical outcome 
is balanced by the numerous and serious long-term complications encountered by the 
Fontan patients, including congestive heart failure, progressive ventricular dysfunction, 
- 2  - 
atrial arrhythmias, atrioventricular valve regurgitation, pulmonary arteriovenous 
malformation (PAVMs), diminished exercise capacity, protein losing enteropathy (PLE), 
somatic growth retardation, thrombotic complications, and poor neurodevelopmental 
outcomes [2-4]..  
 
1.3 Impact of theTCPC on the Long-Term Patient Outcome 
While the etiology of these complications is multi-factorial, the hemodynamics of 
the TCPC determined by its design and surgical construction have a predominant impact 
on the patient outcomes. Elevated TCPC resistances have been shown to limit cardiac 
output and exercise capacity. Orientation and relative position of the IVC and SVC at the 
center of the connection have a predominant impact upon the distribution of blood flow 
and nutrients to the lungs, which will in turn dictate whether a patient is prone to PAVMs 
or not. Flow disturbances within the TCPC construct increase energy dissipation and may 
yield unphysiologic fluid stresses on blood elements, ultimately resulting in thrombus 
formation. Optimization of the TCPC hemodynamics via its design is thus a critical step 
towards alleviating the long term complications observed in SVHD patients and 
improving long-term clinical outcome.  
 
1.4 Optimization of the TCPC Hemodynamics 
Several options have been discussed in literature regarding the optimal TCPC 
implementation, suggesting the inclusion of IVC-SVC offset [5], vessel curvature[6], 
flaring of the anastomosis site [7, 8], or the use of Y-shaped IVC grafts [9, 10]. However, 
with the refinement of the clinical and bioengineering investigation methods, it has now 
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become clear that the anatomical variability between patients calls for a patient-specific 
optimization of the TCPC design and hemodynamics. Virtual-reality simulators that 
reproduce the surgical gesture, coupled with physics-driven computational fluid 
dynamics (CFD) solvers, offer a unique platform for surgeons to pre-operatively optimize 
their surgical procedure on a patient-specific basis. Nonetheless, such patient-specific 
surgical planning approach still requires significant technical innovations on both the 
virtual modeling and CFD fronts, and its feasibility within clinically practical resources 
and time-frame has yet to be demonstrated. 
 
1.5 Numerical Modeling Challenges 
From the CFD end in particular, a major challenge stems from the complexity of 
the in vivo anatomies, and the number of parameters to be modeled. In vivo flows 
typically take place in multi-connected, tortuous vessels, with moving walls, pulsatile 
inflows, and feature non-Newtonian behavior and a host of flow regimes ranging from 
laminar to transient and fully-developed turbulence. Modification of the patient’s 
anatomy during surgery not only affects the local hemodynamics but also often results in 
remodeling of peripheral organs, which in turn impacts the inflow and outflow boundary 
conditions of the domain under consideration. Surgical planning CFD simulations thus 
have to call upon number of simplifications, which ought to be carefully reviewed in 
order to assess the relevance of the predicted performances and determine the parameters 
that may or may not be disregarded in favor of faster simulations and increased number 
of tested virtual-surgery options. In the TCPC realm, simulations have commonly 
assumed one or several of the following: simplified geometries, rigid walls and steady 
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inflow/outflow conditions. While idealized geometries obviously cannot account for the 
diversity of the in vivo anatomies the impact of the other parameters is less clear. 
Preliminary studies have modeled uniformly elastic walls [11] and pulsatile inflow 
conditions [12, 13], pointing to the latter as having a larger impact upon the predicted 
TCPC performance. However, the question as to whether modeling pulsatile inflows is 
critical for the comparative performance of different surgical options remains open.  
 
1.6 Objective of this Thesis Work 
This thesis thus seeks to develop a fully-validated numerical flow solver that will 
allow for pulsatile 3D flow simulations in patient-specific TCPCs to quantify the impact 
of pulsatility across different TCPC options, and that could be used to conduct patient-
specific surgical planning studies within clinical timeframe and resources.  
 
1.7 Summary of Results 
In the first specific aim, we devise a novel unstructured Cartesian immersed-
boundary approach to tackle the geometrical intricacies of in vivo cardiovascular 
anatomies, and accurately capture the unsteadiness of associated blood flows. The 
accuracy and computational efficiency of the proposed numerical approach is 
demsontrated by carrying out systematic mesh refinement studies for several internal 
flow problems ranging in complexity from flow in a 90 degree pipe bend to flow in 
patient-specific TCPC anatomies, and comparing our results to experimental 
measurements obtained in the same geometries under both steady and pulsatile inflow 
conditions. 
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This numerical framework is then applied in a two-pronged approach, classified 
in two independent specific aims: (Aim 2) to probe the pulsatile in vivo TCPC 
hemodynamics and understand the impact of pulsatility on the predicted efficiency 
metrics; and (Aim 3) to establish of a novel surgical planning approach based on 
hemodynamic performance and demonstrate its potential benefits to treat patients with 
complex SVHDs. Finally, by reviewing the experience gained during the patient-specific 
pulsatile and surgical planning investigations, we seek to derive surgical guidelines for 
specific anatomical templates, thus expanding the clinical and patient community that 
may benefit from this study.  
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CHAPTER 2 
BACKGROUND AND SIGNIFICANCE 
 
This chapter provides a brief background on the physiology of the normal heart 
before focusing on congenital single ventricle heart defects. The efforts made to improve 
the outcome of patients born with such defects are then discussed in details laying the 
ground for the current study.  
 
2.1 Normal Cardiovascular System 
Blood is a major means of transportation for the nutrients and wastes that travel to 
and from our tissues. It is pumped through our entire body by the heart and perfuses each 
single tissue through a complex network of arteries, capillaries and veins, called the 
cardiovascular circulation. This cardiovascular circulation can be subdivided into two 
primary circuits: the pulmonary and systemic circulations (Figure 2-1). The pulmonary 
circuit describes the blood pathway going from the right side of the heart to the lungs and 
back to the left side heart, while the systemic circulation transports the blood between the 
heart and the remainder of the body. 
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Figure 2-1: Schematic of the two primary circuits of the human blood circulation. The 
pulmonary circuit drives the blood from the heart to the lungs and back to the heart while 
the systemic circulation transports the blood to and from the rest of the body. RA and 
RV: Right atrium and right ventricle. LA and LV: Left atrium and ventricle. (Image 
courtesy: [1]) 
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In a normal physiology as shown in Figure 2-2, the blood through the systemic 
circuit is driven by the left side of the heart while the blood through the pulmonary circuit 
is driven by the right side. The septum separates the right and left sides creating two 
distinct pumps that function in series (Figure 2-3, left panel). Each side of the heart 
consists of two chambers, an atrium and a ventricle. This four-chambered structure of the 
heart is essential to its function. The ventricles provide the pumping force while the atria 
provide the buffer volume needed to receive the continuous blood flow returning from 
the body or the lungs. In addition to these four chambers, four valves control the inlet and 
outlet of both ventricles to prevent blood flow reversal and ensure the efficiency of the 
ventricular contraction. When the left ventricle (LV) contracts during systole, the 
increase in ventricular pressure closes the bileaflet mitral valve and forces the trileaflet 
aortic valve open. Consequently, the blood that was present in the left ventricle before 
systolic contraction flows from the left ventricle through the open aortic valve into the 
aorta then to the rest of the body. As pressure builds up in the aorta and decreases in the 
left ventricle, the aortic valve closes. Meanwhile, the blood returning from the lungs 
through the pulmonary veins is stored in the left atrium (LA). Left atrium pressure 
increases and the mitral valve reopens. Blood then flows from the left atrium through the 
mitral valve into the left ventricle during diastole. 
Similarly, the systemic blood coming back from the body flows through the 
inferior vena cava (IVC) and superior vena cava (SVC) into the right atrium (RA). It then 
passes through the tricuspid valve into the right ventricle (RV) from where it is 
discharged through the trileaflet pulmonary valve into the pulmonary circulation towards 
the lungs for gas exchange. 
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Figure 2-2: Schematic of a normal heart. (Image courtesy: [2]) 
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2.2 Congenital Heart Defects (CHDs) 
Congenital heart defects (CHDs) describe all abnormalities of the heart’s structure 
that are present at birth. These may involve defects in the heart muscle, in the heart 
valves, or in the great arteries and veins that are directly connected to the heart. CHDs 
arise from faulty embryogenesis between the third and eighth week of gestation, when all 
the major cardiovascular structures develop, normally going from a simple straight tube 
to a complex four-chambered heart. Over 40 different forms of CHDs have been 
reported, ranging from asymptomatic malformations to complex life-threatening defects 
[3]. The most prevalent forms of CHDs are listed in Table 2-1. The incidence of children 
born with one or a combination of such defects is about 8 in every 1,000 live births in the 
United States, making CHDs the most common type of birth defect [4].  
 
 
Table 2-1: Frequencies of congenital heart defects [5] 
CHD % of all CHD 
Ventricular Septal Defects (VSD) 33 
Patent Ductus Arteriosus (PDA) 10 
Pulmonary Stenosis (VS) 10 
Tetralogy of Fallot 9 
Aortic Stenosis (AS) 8 
Coarctation of the Aorta 5 
Atrial Septal Defect (ASD) 5 
Transposition of the Great Arteries 5 
Atrioventricular Septal Defect 4 
Truncus Arteriosus 1 
Tricuspid Atresia 1 
Total Pulmonary Venous Connection (TPVC) 1 
Others 8 
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Most CHDs are cyanotic in nature, meaning that the heart’s ability to pump blood 
and deliver oxygen to the different tissues in the body is compromised. Typical clinical 
symptoms include labored breathing, fast heart rate, and a cool and clammy skin. More 
severe forms may lead to higher degrees of cyanosis with the skin, lips and nailbeds 
taking a bluish color. Little is known about the cause of most CHDs, and to date, there is 
no known prevention or cure for any of these diseases. More than half of the children 
born with a CHD will require at least one invasive surgery in their lifetime [3]. Yet, with 
the progresses in diagnosis and treatment, most of these CHDs can be treated with an 
excellent prognosis. Unfortunately, the short and long-term prognosis for the more 
complex forms of CHDs drastically falls behind that statistic, maintaining CHDs as the 
number one cause of all infant deaths in the United States, and the number one cause of 
birth defect related death worldwide [3].  
 
2.3 Single Ventricle Heart Defects (SVHD) 
Particularly challenging from a clinical and surgical standpoint are the defects (or 
combination of defects) observed in about 25% of the CHD patients, which effectively 
lead to a single-ventricle anatomy and physiology. These defects, which are commonly 
grouped under the term of single ventricle heart defects (SVHD), result in a 
cardiovascular configuration where the heart no longer functions as two separate right 
and left pumps but rather as a single one driving blood to both pulmonary and systemic 
circuits (Figure 2-3). The ability of the single ventricle to drive blood to both body and 
lungs depends on the presence of shunts or septal defects allowing for a communication 
between the pulmonary and systemic circuits. However, these pulmonary to systemic 
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connections also lead to a significant amount of mixing between the oxygenated and 
deoxygenated blood causing SVHD patients to be severely cyanotic and for most cases to 
require surgical interventions within the first years of life. These defects constitute the 
most complex forms of CHD and mortality rates are quite high despite significant 
progress in patient treatment and management. 
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Figure 2-3: Schematic showing the human blood circulation in a single ventricle 
physiology (right panel) as opposed to the normal physiology (left panel).  
 
 
The most prevalent forms of CHDs leading to a SV anatomy include hypoplastic 
left or right heart syndrome, tricuspid or mitral valve atresia, transposition of the great 
arteries, and a double inlet ventricle. These often occur with other concomitant defects. 
The tetralogie of Fallot, for example, describes the concurrent presence of a ventricular 
septal defect, overriding aorta, pulmonary outflow track obstruction and right ventricular 
hypertrophy. Atrioventricular canal defects or double outlet right ventricle may also lead 
to a SV anatomy when complicated by an underdeveloped ventricle. While all SVHD 
yield to common symptoms, such as increased cyanosis, it is important to realize that the 
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underlying anatomy can drastically differ from patient to patient. The structure of the 
single ventricle may resemble the normal left or the normal right ventricle, or neither. 
Surrounding vascular structures may be affected or not. All of these considerations will 
not only impact the ease with which a surgeon may perform the necessary repairs but also 
impact the long-term prognosis of these patients. The following sections thus review 
different forms of SVHD, with a special focus on some of the most complex forms, 
which are typically where advances in biomedical research are the most needed. 
 
2.3.1 Tricuspid Atresia and Hypoplastic Right Heart Syndrome 
Tricuspid atresia accounts for 1-2% of all CHDs [6]. In these patients, the 
tricuspid valve, which lies between the right atrium and right ventricle, is either inexistent 
or closed with the three leaflets sealed into a single structure (Figure 2-4). The occlusion 
of the blood pathway between the right atrium and right ventricle typically results in an 
underdeveloped right ventricle, and single functional left ventricle. Survival right after 
birth depends on the presence of other compensatory defects allowing the blood to bypass 
the malfunctioning right ventricle. This is illustrated in Figure 2-4 where the systemic 
blood flows from the right to the left atrium through an atrial septal defect. A ventricular 
septal defect then allows a portion of the mixed oxygenated and de-oxygenated blood to 
flow back into the right ventricle and pulmonary circulation.  
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Figure 2-4: Extreme case of tricuspid atresia where the tricuspid valve is inexistent. As a 
result of the inexistent atrio-to-ventricular flow the right ventricle is hypoplastic, leading 
to a case of SVHD. Atrial and ventricular septal defects allow the left ventricle to pump 
to both pulmonary and systemic circuits. (Image courtesy: [6]) 
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2.3.2 Hypoplastic Left Heart Syndrome 
Hypoplastic left heart syndrome (HLHS) is one of the most severe forms of single 
ventricle disease. In this defect, the left side of the heart, including the ventricle, mitral 
and aortic valves and the aortic root, is under developed. In severe cases of HLHS, the 
left ventricle is unable to pump blood and survival at birth depends on the existence of 
other compensatory defects. Such a situation is well illustrated in Figure 2-5. As the left 
ventricle is unable to fulfill its pumping action, the oxygenated blood returning from the 
lungs flows from the left atria to the right through an atrial septal defect. A patent ductus 
arteriosus, shunting the pulmonary arteries to the descending aorta, then allows a portion 
of the blood pumped by the right ventricle to flow into the systemic circulation.  
One of the most detrimental aspects of HLHS compared to other forms of SHVD 
is that the right ventricle is in charge of pumping blood to the high resistance systemic 
circuit. In a normal biventricular anatomy, this role is imparted to the left ventricle, which 
is strong and muscular, while the right ventricle is optimized for the low resistance 
pulmonary circuit. This makes HLHS the most debilitating form of SHVD, with 100% 
mortality rate within the first year of birth if left untreated [7]. 
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Figure 2-5: Hypoplastic Left Heart Syndrome (HLHS) associated with an atrial septal 
defect and a patent ductus arteriosus. (Image courtesy: [2]) 
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2.3.3 SVHD Combined with Heterotaxy Syndrome 
Heterotaxy syndromes, or situs ambiguous, are rare CHDs, where the 
configuration of the thoracic and abdominal organs is indeterminate. Though heterotaxy 
patients actually span the whole spectrum of organ orientations, heterotaxy syndromes 
tend to fall into two primary subtypes, namely (1) right atrial isomerism, or asplenia 
syndrome, and (2) left atrial isomerism, or polysplenia syndrome. In right atrial 
isomerism, the visceral structures tend to resemble the normal right side. The two atrial 
appendages have the morphologic features of a right atrium (broad-based triangular 
shape). There usually are two sinus nodes and absence of coronary sinus. The liver is 
midline, the spleen absent, and both lungs have 3 lobes. The descending aorta and IVC 
are on the same side of the spine. On the opposite, in left atrial isomerism, the visceral 
structures tend to resemble the normal left side. The two atrial appendages have the long, 
tubular appearance with a narrow neck that is typical of the left atrium, and the sinus 
node may be absent. Patients typically feature two-lobed lungs on both sides, and 
multiple spleens. Left isomerism is also typically associated with abnormal systemic 
venous connections. Interruption of the IVC with azygous continuation to the SVC is 
reported in most cases [8], and more than half of the patients feature persistent left 
superior vena cava (LSVC). 
Both types of isomerisms are almost always associated with complex intra-cardiac 
CHDs [9]. In a retrospective study on 163 patients with left isomerism, Gilljam and 
colleagues [8] report that only 22 of them had normal intra-cardiac structures while 141 
had concomitant intra-cardiac CHDs, including atrial septal defects (n=135), ventricular 
septal defects (n=111), and hypoplastic left or right ventricle (n=70). Survival rates at 10 
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years ranged from approximately 80% for the 22 patients with normal intra-cardiac 
structures down to 40% for patients with concomitant SVHD. As a result of the large 
number of cardiovascular and gastro-intestinal abnormalities, SVHD combined with 
heterotaxy syndromes represent one of the most challenging forms of SVHD to manage. 
 
2.4 Surgical SHVD Repairs 
2.4.1 Historical Perspective on SVHD Repairs 
Without surgical intervention, survival of SVHD patients once depended on the 
presence of defects such as a septal defect or a patent ductus arteriosus (Figure 2-4) 
allowing for the single ventricle to pump blood to both systemic and pulmonary circuits.  
The first surgical repairs attempted on SVHD patients stemmed from that very 
observation. Noticing that Tetralogy of Fallot patients with a concomitant patent ductus 
arteriosus lived longer than those without, Taussig, Blalock and Thomas developed in 
1945 a surgical shunt procedure that mimicked the effect of the patent ductus by 
connecting the subclavian artery to the PAs [10]. However, despite the increased 
pulmonary blood flow through the shunt, arterial oxygen saturation levels remained low 
due to blood mixing in the single-ventricle. Furthermore, placing the systemic and 
pulmonary circulations in parallel subjected the single ventricle to a chronic volume 
overload, ultimately leading to congestive heart failure.  
The advent of the Fontan operation in 1971 [11] brought about a revolution in the 
management of SVHD. The procedure as it was originally described by Fontan and 
Baudet consisted in a complete bypass of the right side of the heart achieved by 
constructing two independent SVC-to-RPA and IVC-to-LPA tracks (Figure 2-6). The 
- 19  - 
IVC-to-LPA track resulted from the direct anastomosis of the right atrium onto the RPA 
with two homograft valves placed right upstream and downstream (2a and 2c in Figure 
2-6) of the right atrium to prevent flow reversal in the IVC due to gravity and to the 
regular contraction of the right atrium.  
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Figure 2-6: Schematic of the five major steps of the Fontan procedure [11]. ASD = Atrial 
Septal Defect, MPA = Main Pulmonary Artery.  
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The principle of a complete bypass of the right side of the heart as a result of the 
Fontan procedure achieved a number of salutary transformations to the SV anatomy 
(Figure 2-7). It separated the systemic and pulmonary circuits, relieved the volume 
overloaded ventricle and abolished blood mixing, which in turn ostensibly improved 
arterial oxygen saturation. On the other hand, the surgical implementation described by 
Fontan and Baudet yielded  number of drawbacks: first, the insertion of the valve 
homografts obstructed the low-pressure IVC-to-LPA circulation [12]; then, the separation 
of the IVC-to-LPA and SVC-to-RPA tracks did not allow for any adaptation of the 
LPA/RPA blood flow ratio, leading to serious complications if one of the lungs became  
obstructed; and finally, all nutrients and hepatic factors coming through the IVC were 
excluded from the RPA, yielding pulmonary arteriovenous malformation (PAVMs) in the 
right lung [13-15].  
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Figure 2-7: Schematic showing net result of the Fontan procedure on the cardiovascular 
circuit. The total right heart bypass restores the separation of the systemic and pulmonary 
circuits as in the normal physiology. The single ventricle acts as the left ventricle while 
the right side is replaced by the passive Fontan connection.  
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In 1973, Kreutzer et al. [16] described a valveless atrio-pulmonary (AP) 
connection as an alternative to the Fontan connection. Both SVC and IVC were left in 
their native configuration, connected to the right atrium. The bypass was simply achieved 
by an end-to-end anatomosis of the right atrial appendage onto the main pulmonary artery 
(Figure 2-8). This procedure had the advantages of redistributing the hepatic fluid to both 
lungs and splitting the pulmonary blood flow depending upon the needs and resistance of 
either lung. Furthermore, just as in the Fontan procedure, the preservation of the entire 
atrial appendage was meant to take advantage of the small but non negligible atrial 
contractions to help drive the flow from the IVC to the PAs.  
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Figure 2-8: Schematic representation of the three main approaches that have been used to 
bypass the right side of the heart for SVHD repairs. The surgically created connections 
are colored in blue, while the white arrows depict in a simplistic fashion the global blood 
flow pathway.  
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Although the AP connection was quickly endorsed and has had widespread use in 
many centers, the long-term follow-up indicated that patients with an AP-connection 
developed supraventricular arrhytmias, right atrial thrombus, exercise intolerance and 
other symptoms associated with low cardiac output [17-20]. These complications were 
usually related to a markedly dilated right atrium appendage, which was suspected to be 
due to the increased pressure load imposed on the atrium [21]. This atrial dilatation was 
in turn associated with stagnant flows along the dilated right side of the atrium and 
turbulent flows elsewhere in the AP connection (Figure 2-8), resulting in significant fluid 
energy dissipation [21]. 
In 1988, De Leval et al. proposed the total cavopulmonary connection (TCPC) as 
an alternative to the AP procedure that would no longer make use of the entire atrial 
chamber [22]. The TCPC was performed by the direct anastomosis of the SVC to the 
superior wall of the RPA, followed by the creation of a tunnel through the right atrium 
connecting the IVC to the inferior wall of the RPA (Figure 2-8, right most panel). They 
demonstrated that such a geometry led to fewer flow disturbances and lower fluid energy 
losses than the AP connection, and hypothesized that these energy savings would more 
than compensate the loss of atrial pumping capabilities. This hypothesis was later 
corroborated by retrospective clinical studies that reported a more favorable course 
during the postoperative period, lower mortality rates and improved outcomes for patients 
with a TCPC compared to patients with an AP connection [23-25].  
In summary, in an effort to reduce post-operative mortality, improve long-term 
outcomes and broaden the patient population eligible for single-ventricle repairs, the right 
heart bypass procedure originally proposed by Fontan and Baudet [11] has considerably 
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evolved in the past decades. Since the mid-90’s, the TCPC has become the procedure of 
choice for SVHD repairs. It is now performed in multiple stages, allowing the heart, 
lungs and peripheral vasculatures to progressively adapt to the post-operative physiology. 
It is worthwhile noting that even though the original Fontan procedure is no longer in use, 
clinicians still commonly refer to SVHD repairs as the “Fontan procedure”. In the 
remainder of this thesis, “Fontan procedure” will thus be used as a generic term for 
SVHD repairs, while “Fontan patients” will refer to SHVD patients eligible for these 
repairs. Specific denomination (TCPC, AP) will be used when the differentiation between 
the different surgical techniques plays a key role.  
 
2.4.2 Current Approach to SVHD Repairs: The Staged Total CavoPulmonary 
Connection (TCPC)  
A complete right heart bypass is almost impossible to complete at birth. The 
pulmonary vascular resistance is high, and the vessel sizes are too small for a successful 
cavopulmonary connection. The three-stage TCPC approach (Figure 2-9) allows the body 
to gradually adapt to substantially different hemodynamic conditions.  The aims of the 
different stages are as follows: 
a) Stage 1: Achieve unrestricted flow from the heart to the aorta and ensure at 
least a minimal blood flow to the lungs 
b) Stage 2: Improve the lung perfusion and begin the separation of systemic and 
pulmonary circulations 
c) Stage 3: Complete the separation of systemic and pulmonary circulations. 
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Staging the operations has markedly improved surgical outcomes and allowed the TCPC 
surgery to be applied to a larger range of SVHD patients [26]. It is now an integral part of 
the methodology for SVHD repairs. 
The first stage is not required for all SVHD patients, but only for those featuring 
an obstructed systemic or pulmonary pathway. Its objective is to establish a viable 
circulation, allowing neonates to survive until they are eligible for the actual SVHD 
repairs performed at a minimum of 4 months of age in stages 2 and 3. This first 
intervention is completed in the first days or weeks after birth using the Norwood 
procedure [27], which entails the placement of a systemic-to-pulmonary shunt (such as 
the Blalock-Taussig BT shunt) to increase pulmonary blood flow in patients with blocked 
pulmonary pathway. In children with HLHS, stage 1 also includes the enlargement of the 
hypoplastic aortic arch to restore a proper systemic ventricular outflow (Figure 2-9). 
The right heart bypass itself is performed in stages 2 and 3 (Figure 2-9). The 2nd 
stage is typically performed between 4 and 12 months of age. The native patent ductus 
arteriosus or surgically created systemic-to-pulmonary shunt is removed, and the superior 
venous return is diverted to the lungs by creating a direct SVC-to-PA anastomosis. This 
superior cavopulmonary connection is the first step toward the complete separation of the 
systemic and pulmonary circulations. It alleviates the ventricular overload imposed by the 
systemic-to-pulmonary shunt, visibly reduces cyanosis via a more efficient lung 
perfusion [28], and gives the heart some time to adapt to the increase in systemic 
resistance [29]. The full separation of the systemic and pulmonary pathways is completed 
in Stage 3 with an IVC-to-PA anastomosis (Figure 2-9). This final stage is performed 
anywhere between 1 and 5 years of age. 
- 25  - 
Hypoplastic
Aorta BT-shunt
Aortic arch 
augmentation
Native Heart with SVHD: 
Example of an HLHS
Stage 1: 
Norwood procedure
Patent Ductus
Arteriosus
SVC
IVC
LPA
RPA
SVC
IVC
LPA
RPA
Stage 2: 
Superior Cavopulmonary Connection
Stage 3: 
Total Cavopulmonary Connection
SVC to
RPA 
anastomosis
Shunt 
closure
SVC
IVC
LPA
RPA
Construct 
routing 
the IVC to 
the PAs
IVC to
RPA 
anastomosis
SVC
IVC
LPA
RPA
 
 
  
Figure 2-9: Cartoon depicting the different stages of the TCPC procedure as applied to a 
SVHD patient born with a hypoplastic left heart syndrome. (Images inspired by [30]) 
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2.4.3 Degrees of Freedom in the TCPC Procedure 
Although surgeons agree on the staged TCPC as being the procedure of choice for 
Fontan repairs, number of controversies exist about the exact surgical procedure to follow 
for each one of the stages, the type of material to use, and the age at which each one of 
these interventions should be performed.  
The 2nd stage for example, is typically performed using either a bidirectional 
Glenn (BDG) or a Hemi-Fontan (HF) connection (Figure 2-10). Although no clear 
clinical benefit exists of choosing one procedure over the other, the geometry and 
hemodynamics of the HF and BDG connections are clearly different. In the BDG 
procedure, the SVC is disconnected from the atrium and sutured to the RPA in an end-to-
side anastomosis, resulting in a T-shaped connection with a flow stagnation point where 
the SVC flow hits the inferior aspect of the RPA (Figure 2-10(a)). In an HF connection, 
on the other hand, the SVC remains in its native configuration and it is the right atrial 
appendage that is connected to the PAs. A patch is inserted into the right atrium to 
redirect the SVC flow towards the PAs. The SVC flow typically forms a large 
recirculation in the atrial appendage, prior to flowing into the PAs (Figure 2-10(b)). 
 
SVC
LPARPA
RA
(a) Bidirectional Glenn (b) Hemi-Fontan
 
Figure 2-10: The two different approaches typically used to perform the SVC-to-PA 
anastomosis in the 2nd stage of the TCPC procedure: a) Bidirectional Glenn; b) Hemi-
Fontan (Image courtesy: [31]). The black arrows depict the global blood flow pathway.  
- 27  - 
Similarly, the 3rd stage is mostly done in one of two ways: by constructing an 
intra-atrial tunnel or using an extra-cardiac connection (Figure 2-11). Intra-atrial tunnels 
[22] entail the construction of an independent flow pathway going through the right 
atrium and directing the lower systemic venous return from the IVC up to the superior 
aspect of the atrial appendage. This construction makes use of the atrial wall on one side 
and an artificial graft on the other. Intra-atrial tunnels offer the non-negligible advantage 
of allowing the IVC baffle to grow with the patient. On the other hand, their construction 
requires opening the right atrium, which carries the risk of disrupting the cardiac 
electrophysiology and inducing arrhythmias. In addition, they often result in bulgy IVC 
conduits which have been associated with extensive recirculations, flow disturbances, and 
energy dissipation [32, 33]. 
 
 
 
Intra-Atrial TCPC 
SVC
IVC
LPA
Artificial Graft IVC-to-MPA 
Tunnel constructed 
in the right atrium
Extra-cardiac graft IVC”pulled” to the 
MPA
Extra-cardiac TCPC
 
Figure 2-11: Different options available to perform the IVC-to-pulmonary anastomosis in 
stage 3. (Images inspired by [30]) 
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In contrast to intra-atrial procedures, extra-cardiac approaches [34] do not go 
through the atrium, but rather use a complete artificial vessel graft (of typically 20 to 24 
mm in diameter) to route the IVC around the heart all the way to the PAs (Figure 2-11). 
As such, extra-cardiac options require fewer suture lines, no incision in the atrial wall, 
less or no time on the heart-lung machine, and result in almost cylindrical IVC conduits 
associated with smoother blood flow circulation with limited flow disturbance [35]. 
However, these advantages are  somewhat balanced by the fact that extra-cardiac 
conduits are typically constructed using artificial vessel grafts (made of Goretex, or 
Dacron) which do not provide any growth potential and have been associated with 
conduit stenosis and throboembolism [34, 36, 37]. Direct IVC-to-MPA connections 
(where the extra-cardiac conduit is constructed by direct end-to-end anastomosis of the 
IVC to the MPA) have been used as a way to combine the advantages of extra-cardiac 
conduits with the benefits of using autologous tissues (growth potential and limited 
thrombogenicity). But such an option requires a particular arrangement of the MPA and 
IVC and cannot be generalized to all patients. Yalcinbas et al. [38] report of the 
construction of an extra-cardiac conduit using an autologous pericardium flap with 
positive short-term outcome (30 months). Longer follow-up data are still needed to assess 
the robustness of the method.  
Some institutions have also advocated in favor of punching a temporary 
fenestration (or hole) between the IVC conduit and the right atrium to give the heart more 
time to adapt to the post-operative flow conditions [39]. Including a fenestration in the 
IVC conduit was demonstrated to lower the systemic venous pressures as well as to 
improve ventricular filling, consequently leading to improved cardiac output and overall 
- 29  - 
oxygen delivery [39, 40]. Lemler et al. [41] added that fenestration at the time of the 
Fontan surgery improved short term outcome in standard-risk patients, with a 41% 
decrease in the hospitalization duration immediately after surgery, and 67% fewer 
additional procedures in the postoperative period than for patients without a fenestration. 
However, while some institutions advocate systematic fenestration, others argue that it 
should be used more selectively, balancing the potential benefits against the risks and 
costs of the additional intervention needed to close the fenestration [40]. 
Finally, the age at which each stage should be completed is still under debate. The 
mean age at the time of TCPC completion and the mean interval of time separating two 
consecutive surgeries have significantly decreased over the past decade. While some see 
this as a beneficial trend [42] that has reduced most of the major complications, others 
recommend caution pointing out that suture lines significantly limit vessel growth and 
that vessel size is a major factor for hemodynamic efficiency [43]. 
In summary, while the TCPC is now accepted as the procedure of choice for 
SVHD repairs, there are quite a few open-ended questions as to its exact implementation. 
The geometry of the final surgically created TCPC, the timing of the stages, and the 
material to use are as many parameters over which surgeons have at least some degree of 
control. Performing a Hemi-Fontan in the 2nd stage followed by an intra-atrial procedure 
in the 3rd stage for example, will result in a drastically different geometry than a BDG 
followed by an extra-cardiac connection. Similarly, the age at which each of these stages 
is performed will impact vessel diameters. The different geometries resulting from each 
of these surgical choices will in turn entail different flow features and hemodynamics, but 
the question as to which is better is still highly controversial.  
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2.5 Long-Term Complications in SVHD Patients after Fontan Repairs 
Modifications to the original Fontan procedure, as well as the improvement in 
patient management and care, have steadily improved surgical outcomes, bringing the 
post-operative survival rates up to the level of simpler congenital heart repairs [44-46]. 
However, while most institutions now report 95% post-operative survival rates, the 10-
year survival rate drops to 60-80% [47-49]. The fact is that the Fontan procedure results 
in a non-physiologic cardiovascular configuration where the single ventricle has to pump 
blood through both the systemic and pulmonary vascular beds in series (Figure 2-7). The 
single ventricle experiences an increased afterload (including both systemic and 
pulmonary vascular resistances) and decreased preload (ventricular filling). In addition, 
there is a significant increase in central venous pressure due to the lack of pressure step-
up typically provided by the right ventricle [50]. 
In the early post-operative stages, the sudden increase in central venous pressure 
may lead to ascites, pleural effusions, decreased pulmonary compliance and increased 
pulmonary vascular resistance. If no remedial action can be taken, then the only real 
option is to take down the TCPC connection and leave the circulation with a superior 
cavopulmonary anastomosis [51].  
Late failure is typically associated with some of the chronic problems that are a 
consequence of the abnormal Fontan circulation. Progressive ventricular dysfunction, 
atrial arrhythmias, atrioventricular valve regurgitation, pulmonary arteriovenous 
malformations (PAVMs), diminished exercise capacity, protein losing enteropathy (PLE), 
somatic growth retardation, thrombotic complications, and poor neurodevelopmental 
outcomes [47] are some of the most commonly reported complications. In their autopsy 
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review, Kiaffas and colleagues [52] identified congestive heart failure (82% of all 
deaths), arrythmias (12%) and central venous system dysfunction (6%) as the leading 
causes for mortality. PLE is reported with a low incidence ranging from 1.5 to 11%, but a 
50% mortality rate was reported 5-years from the time of diagnosis [53]. A review of 592 
patients showed evidence of thrombus formation in 9% of patients at a mean follow-up 
time of 22 months [54]. 
There are two key components to the Fontan circulation, the single pumping 
ventricle on the one hand and the vascular resistances and compliances on the other. 
Focusing on the ventricular side, Kirklin et al [55] found ventricular hypertrophy to be a 
significant risk factor for death. They reported that the survival rate of patients with 
diminished qualitative ventricular function was only 35% compared to 70% with normal 
or hyperdynamic function. Senzaki and colleagues argued that increased afterload, 
decreased preload, and abnormal ventricular-vascular coupling contribute to the 
decreased cardiac reserve and function in patients with a Fontan circulation [56]. 
However, this mechanism does not entirely explain the differences in survival and 
outcome observed among patients receiving sensibly similar procedures. Altmann and 
colleagues [57] found the native right ventricle function to be the best predictor for 
operative survival for SVHD patients born with HLHS. Sundareswaran et al. 
demonstrated that native single right ventricles has a significantly lower power output 
capacity than native single left ventricles [58]. Accordingly, while the chronic pressure 
overloaded condition of the single ventricle in a Fontan circulation makes it susceptible 
for ventricular dysfunction and heart failure, the failure rate is further conditioned by the 
native configuration and function of the ventricle. 
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The vascular resistance imposed by the systemic, TCPC and pulmonary circuits in 
series is another key component of the abnormal Fontan circulation. Clinical studies have 
shown that, unlike healthy individuals, Fontan patients only respond to exercise by 
increasing their heart rate, while the stroke volume, which is typically limited by the pre-
load, remains approximately constant [56, 59]. On the other hand, PLE and liver 
dysfunction have been correlated with the high central venous pressures observed in 
Fontan patients [60, 61]. While seemingly independent, both of these observations stem 
from the fact that, in the absence of a right pumping chamber, pressure difference 
between the IVC and the left atrium is the only force left to drive blood through the 
TCPC and lungs. Therefore, the higher the vascular resistance downstream of the liver, 
the higher the pressure difference required to achieve a given cardiac output. This 
observation falls back to Guyton’s isolated venous theory [62, 63], which states that the 
cardiac output in single ventricle patients is highly sensitive to the vascular resistance 
downstream of the venous compliance. Even though Guyton’s theory focused on the 
effect of pulmonary vascular resistance (PVR), the vascular segment of interest in 
practice includes both the TCPC and lungs, both of which lie in series downstream of the 
venous compliance. Accordingly, elevated PVR or TCPC resistance would both result in 
increased central venous pressures, which have been associated with PLE, and decreased 
maximum cardiac output, which will limit the patient’s exercise capacity. 
Vasodilating agents [64] have been utilized successfully to lower PVR. However, 
in Fontan patients all blood flow has to first travel through the TCPC, such that if the 
effective resistance of the connection is high, improvements in PVR alone may be 
insufficient to improve preload and cardiac output, especially under the increased 
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demands of exercise or other high output states (e.g., illness, pregnancy).  The importance 
of designing the TCPC so as to minimize its resistance was further emphasized by 
Sundareswaran et al. [65]. Using a combination of in vivo Phase Contrast MRI (PC MRI) 
measurements, CFD results and lumped parameter modeling, the authors established that 
1) the TCPC resistances in these patients ranged from 0.1 Wood units (WU) to 1.08WU, 
with a mean of 0.39+/-0.26 WU, which is non-negligible in front of the PVR (mean of 
1.96+/-0.80 WU); 2) there was a negative correlation between the TCPC resistance and 
the resting cardiac output and a positive correlation between the TCPC resistance and the 
central venous pressure; and 3) these behaviors were exacerbated under exercise 
conditions where the TCPC with the highest resistance (1.08 WU) only allowed for a 
20.5% increase in cardiac output at 150 beats/min vs. a 50% increase for the TCPC with 
the lowest resistance, and a 119% increase in the normal biventricular model. This study 
is an agreement with previous clinical findings, but more importantly it demonstrates that 
the variations in TCPC designs observed across Fontan patients translates into variations 
in TCPC resistances that can significantly impact the resting hemodynamics and exercise 
capacity of these patients. This thus brings forth the question as to how to optimize the 
design of the TCPC so as to minimize its hemodynamic resistance. 
Another major complication that results in Fontan failure and is in part affected 
by the TCPC design is progressive cyanosis due to the development of unilateral PAVMS 
[66-70].  PAVMs are intrapulmonary shunts, connecting the pulmonary arteries directly 
to the pulmonary veins, thus allowing the de-oxygenated blood from the systemic 
circulation to return to the left atrium without flowing through the gas exchange units. 
The primary consequence of PAVMS is decreased oxygen saturation. Furthermore, the 
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intrapulmonary shunts lead to a drop in pulmonary vascular resistance, which tends to 
direct more flow to the diseased lung creating a positive feedback loop of increasing 
cyanosis. Although the underlying mechanism leading to PAVMs is unknown, studies 
have shown that liver derived factors present in the hepatic venous blood prevent their 
formation [14, 67, 69, 70]. Therefore, an unbalanced hepatic flow distribution to the left 
and right lungs due to an inadequate design of the IVC-to-PA conduit during the 3rd stage 
of the TCPC surgery could potentially lead to PAVMs. Clinically, once the extent of 
PAVMs is such that oxygen saturation is critically low, the only palliative option is to re-
operate and re-orient the IVC conduit to achieve a better hepatic flow distribution [14, 
71-74].  However, although several palliative options have been discussed in the 
literature such as the use of a bifurcated extra-cardiac IVC conduit or drainage of the 
hepatic vein to the persistent azygous vein [72], there is no solution to date that results in 
the adequate hepatic flow distribution for the cardiovascular configuration of each 
specific patient.  
In summary, while the reasons for Fontan failure are no doubt multi-factorial, a 
number of the aforementioned complications may be related to the geometric design of 
the TCPC, would it be via the resulting hemodynamic TCPC resistance or the resulting 
distribution of blood flow and hepatic nutrients to the lungs. Accordingly, in this study, 
we chose to focus our attention on the TCPC and its design optimization with respect to 
key hemodynamic metrics, including energy dissipation, hemodynamic resistance, and 
the distribution of the cardiac output and hepatic flow to the two lungs.  
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2.6 In vivo Investigations of the TCPC Hemodynamics 
The above clinical follow-up studies not only demonstrate the morbidity and 
decreased functional status of Fontan patients but clearly emphasize the need for 
improvements in the surgical procedure. Consequently, number of studies have sought to 
assess the geometrical characteristics of the different options used to perform the TCPC 
surgery and characterize their impact on the TCPC hemodynamics, the single ventricle 
performance, and the overall patient outcome. Magnetic resonance imaging (MRI) has 
emerged as an attractive non-invasive imaging technology to assess TCPC 
hemodynamics in vivo as it allows for the acquisition of both anatomy and flow, and is 
harmless to the patient thus allowing for frequent repeated scans if needed. With the 
advents of image segmentation, interpolation, surface fitting and visualization methods, 
raw magnitude and phase contrast MRI techniques can be used to reconstruct the 3D in 
vivo anatomies and velocity fields, respectively. 
MRI has in particular been used by Dr Yoganathan’s laboratory at the Georgia 
Institute of Technology to constitute a large database of Fontan anatomies and flows, 
which now includes data for over 250 patients recruited at the Children’s Healthcare of 
Atlanta (CHOA), the Children’s Hospital of Philadelphia (CHOP), the Children’s 
Hospital Boston (CHB). This wealth of in vivo data has provided a unique opportunity to 
look at the geometrical characteristics of a wide range of TCPC implementations (Figure 
2-12). As can readily be anticipated from the diversity of the anatomies displayed in 
Figure 2-12, it is highly unlikely that there would be one single surgical implementation 
that will be optimal for all patients. Variations in the geometry of the completed TCPCs 
depend on the surgical options retained at each one of the TCPC stages (e.g. intra-atrial  
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Figure 2-12: Representative sample of in vivo TCPC anatomies from the GeorgiaTech 
MRI database. (a) and (b) show the geometries that may result from different surgical 
procedures (intra-atrial and extra-cardiac TCPC), while (c) and (d) highlight the different 
native anatomical configurations. 
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vs. extra-cardiac) as well as on the native patient anatomy (e.g. presence of a single or 
bilateral SVC, normal or interrupted IVC, heterotaxy syndrome). 
The first study to quantitatively compare TCPC geometries was conducted by 
Krishnankutty et al. [75]. The analysis process involved the reconstruction of 26 TCPC 
geometries (13 intra-atrials and 13 extra-cardiacs), the extraction of the TCPC skeleton 
(or vessel axes), and finally the systematic quantification of the vessel cross-sectional 
area, vessel curvature, and IVC-SVC offsets. Intra-atrial options were found to have 
significantly higher area variations than extra-cardiacs, due to the more irregular 
geometry of intra-atrial baffles when compared to the smooth extra-cardiac grafts. In 
addition, that study demonstrated that irrespective of the TCPC option, patients born with 
HLHS were at higher risk of LPA narrowing than those without HLHS. This was 
attributed to the aortic arch reconstruction done in stage 1 for HLHS patients, during 
which surgeons tend to oversize the aortic arch, which in turn compresses the LPA and 
prevents its growth. This study was the first to benchmark the anatomic variability of 
patient specific TCPCs. Such a quantitative geometric characterization is a critical step to 
correlate hemodynamic performances with geometric features.  
Focusing on the Fontan flow characteristics, Fogel et al. [76] used phase contrast 
MRI (PC MRI) to measure the IVC and SVC flow rates in ten SVHD patients with an 
intra-atrial TCPC (1.8+0.3 years old). By superimposing a pre-saturation pulse on the 
IVC and the SVC selectively, the authors were able to assess the portion of inferior and 
superior venous returns that was directed to the LPA and RPA. Distributions of blood to 
each lung were almost equal for all patients (RPA/LPA blood=0.94+/-0.11), but the LPA 
received a significantly larger amount of IVC blood (67 +/- 12%) than the RPA [76].  
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Hjortdal et al. used real-time PC MRI to assess the impact of respiration on the 
TCPC flow rates [77]. They demonstrated that inspiration facilitated IVC flow under 
resting conditions, increasing it to 2.99+1.25 L/min/m2 during inspiration versus 
0.83+0.44 L/min/m2 during expiration. SVC flow was not significantly affected by the 
respiratory cycle, and under exercise conditions, the peripheral muscular pump seemed to 
have more influence than respiration on the Fontan circulation. 
Be’eri et al. used ECG-gated 3D PC MRI to compare the flow dynamics of five 
AP and five TCPC connections at multiple time points across the cardiac cycle [78]. The 
authors selected the orientation of their PC MRI acquisition plane slice so as to include 
the caval, atrial, and pulmonary components of the Fontan pathway. This study is one of 
the few studies looking at the velocity fields within the Fontan construct and not only at 
its inlets and outlets (in cross-sections of the IVC, SVC, LPA and RPA). This may in part 
be attributed to the prohibitively long PC MRI acquisition time, which have been a 
limiting factor for adult applications and pose an even greater challenge in pediatrics, 
where it is difficult to keep infants and young children still for extended periods of time. 
Interpolation methods [79, 80] are thus gaining interest as a mean to reduce the 
acquisition time by limiting the number of acquisition plane required, while still 
providing an appropriate representation of the blood flow field. The continuous 
representation of the 3D time-dependent blood flow fields opens avenues to the in vivo 
assessment of surrogate markers for TCPC efficiency such as the distribution of hepatic 
flow to the lungs [80, 81]. Metrics such as energy dissipation should still be handled with 
caution as PC MRI cannot resolve all length scale, features high noise levels in the 
vicinity of the vessel walls, and is often associated with signal loss in regions of high 
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flow disturbances. In vitro experiments and numerical modeling have arisen as attractive 
means to complement these in vivo measurements for in depth hemodynamic analyses.  
 
2.7 Experimental and Computational Modeling of the TCPC Hemodynamics 
Since the first in vitro experiment done by de Leval et al. that demonstrated the 
superiority of the TCPC over AP connection [22], parametric in vitro and computational 
fluid dynamics (CFD) studies aimed at better understanding the TCPC hemodynamics 
have flourished. Early in vitro or numerical studies investigated the impact of 
independent geometric parameters on the overall efficiency of highly simplified TCPC 
geometries with steady flows and rigid walls. In these studies, the simplified TCPCs 
typically consisted of four cylindrical vessels with varying curvature, diameter, or 
connection offset (see Figure 2-13).  
 
 
 Diameter      Offset           Angle       Curvature  
Figure 2-13: Examples of isolated parameters that could define the TCPC geometry (here 
focused on the variation of the IVC design).  
 
 
Using such idealized models in vitro, Sharma et al. [82] demonstrated that the 
power dissipated across the connection was significantly reduced when the IVC and SVC 
were not directly facing each other but rather were offset by 1.0 or 1.5 caval diameters. 
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Using a similar idealized in vitro setting, Gerdes et al. [83] demonstrated that if the IVC 
baffle was curved such that IVC and SVC flows did not collide, the energy dissipation 
would be reduced as well. The emphasis set by these studies on the design of the IVC 
anastomosis was somewhat balanced by DeGroff et al. [43] who argued that vessel 
diameter was the main determinant of TCPC energy efficiency, while other parameters, 
such as caval offset, only played a secondary role. Their argument was supported by an in 
vitro analysis of models with varying caval offset and two sets of vessel dimensions. The 
numerical study of Ryu et al. [84], which compared the performance of idealized TCPCs 
with straight or curved PAs and with different SVC diameters, reached the same 
conclusion, pointing to the vessel dimensions as being the primary factor for energy 
dissipation. The authors also emphasize that oversimplification of the TCPC geometry 
may bias the conclusions reached by in vitro or numerical parametric studies. 
An interesting study to understand the mechanisms of energy dissipation in the 
TCPC is the combined experimental and numerical investigation of Khunatorn et al. [85]. 
In an effort to understand why their numerical results predicted lower power losses in the 
idealized no-offset TCPC than the earlier in vitro measurements of Sharma et al. [82], 
Khunatorn et al. conducted an in depth analysis of the in vitro and CFD flow fields. They 
pointed to secondary flow structures in the PAs as an important source of dissipation. 
Also, while in their simulations the collision of the IVC and SVC streams yielded a stable 
saddle point, experimental measurements revealed flow instabilities at the collision site. 
The authors inferred that these flow instabilities could further enhance the secondary 
structures downstream in a fashion similar to what is illustrated in Figure 2-14. 
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Figure 2-14: Experimental dye flow visualization in an idealized no-offset TCPC at 50/50 
LPA/RPA flow split. (a): Dye injected through the SVC. (b): Dye injected through the 
IVC. (Image courtesy: [33]) 
 
 
Heading towards more comprehensive modeling, recent experimental and 
computational work has included patient-specific anatomies [33, 86-94]. These studies 
revealed higher levels of flow disturbances (Figure 2-15) and energy dissipation than in 
the earlier idealized geometries, as well as a large inter-patient variability. The in vitro 
power losses reported by de Zélicourt et al. for one extra-cardiac [89] and one intra-atrial 
[33] patient specific TCPC were, respectively, 5 and 70 times higher than those 
previously reported by Sharma et al. [82] for their idealized one-diameter offset TCPC. 
The authors pointed to the smaller vessel dimensions as well as the irregular shape of the 
in vivo connections as the main explanation for the high levels of energy dissipation. The 
argument was supported by a set of parametric studies in idealized geometries, which 
progressively incorporated the features of the in vivo intra-atrial TCPC [95]. Reduction in 
vessel dimensions increased dissipation, which was even further increased when the 
central connection area was enlarged to mimick the bulgy IVC intra-atrial tunnel. The 
sudden expansion of the IVC and SVC into the central connection area favored the 
development of flow recirculation and instabilities, which turned into an intense and 
chaotic mixing in the patient-specific intra-atrial case (Figure 2-15).  
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Figure 2-15: In vitro dye flow visualization of a patient-specific intra-atrial TCPC [95]. 
The experiments were conducted with constant inflow rates. The instantaneous time-
series demonstrates how the flow instabilities due to the IVC and SVC flow collision 
develop into an intense and chaotic mixing at the center of the connection. (1) to (5): dye 
injected in the IVC; (6) to (10): dye injected in the SVC.  
 
 
Whitehead et al. conducted a larger sample size CFD study of 10 patient-specific 
TCPCs [92]. Simulations were conducted under the resting, mild and heavy exercise 
conditions. The results re-emphasize the fact that there in vivo configurations span a large 
range of power losses, especially under exercise conditions. Seeking to identify the main 
determinants of energy dissipation in patient-specific geometries, Dasi et al. [96] 
compiled the experimental and numerical power losses obtained across 22 patient-
specific anatomies, and confronted them to geometrical metrics obtained from 
skeletonisation. Results showed that, irrespective of the connection type, the minimum 
PA cross-sectional area was the strongest correlate for normalized energy dissipation rate 
(R2-value of 0.898 and P<0.0002), setting the emphasis on the need to i) avoid LPA 
constriction in stage 1 and ii) dilate any stenosed vessel in later stages. Refining their 
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analysis further, the same authors [97] derived a simple analytical form of energy 
dissipation rate which includes the effect of cardiac output, flow split, body surface area, 
Reynolds number, and pulmonary artery size, and leaves two parameters to be adjusted. 
The excellent fit provided by this analytical expression re-iterates the fact that the vessel 
dimensions at the time of TCPC completion play a key role in the magnitude of the 
TCPC power losses. In that study, the impact of other geometrical parameters, such as 
vessel curvature, caval offset, bulginess of the IVC conduit, is accounted for in the two 
parameters to be fit. 
Based on the above studies, Soerensen and colleagues suggested the use a 
bifurcated graft, or Optiflo connection, to avoid blood mixing at the center of the 
connection, reduce secondary flow structures in the PAs, and ultimately minimize energy 
dissipation [98]. Proof of concept was provided both experimentally and numerically in 
highly simplified geometries, revealing energy dissipation levels 50% lower than in any 
other idealized configuration. The potential benefits of such a bifurcated graft over 
traditional non-bifurcated ones was further demonstrated in a patient-specific scenario by 
Mardsen et al. [99]. Using CFD to predict the power losses, the authors reported 
decreased energy dissipation when splitting the IVC into a Y-shape connection. Both 
groups also put forth the fact that the bifurcated graft offered an easy control on the blood 
flow and hepatic factor distribution to the lungs. This last point is of major interest to 
prevent the formation of PAVMs, but was somewhat balanced by the recent patient-
specific study CFD by Sundareswaran et al. [81], where the designed Y-shaped graft 
failed to achieve a balanced hepatic flow distribution to the lungs. Such a contradiction in 
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patient-specific applications is not surprising given the wide range of anatomical 
configurations, but highlights the need for patient-specific modeling.  
 
2.8 Towards Patient-Specific Surgical Planning 
Merely looking at the range of anatomical configurations observed in vivo, it is 
apparent that there is not one procedure that would be optimally suited for all Fontan 
patients. Furthermore, optimizing the TCPC geometry for both minimum energy 
dissipation and balanced hepatic flow distribution, for example, can lead to contradictory 
surgical guidelines making the clinical decision more complex rather than helping it. An 
alternate approach is to take advantage of the advances in clinical imaging, image 
processing, and numerical methods to perform parametric studies such as the ones listed 
in Section 2.7 but on a patient-specific basis, thus identifying the optimal surgical 
strategy for each individual patient. A major milestone for patient-specific optimization 
and surgical planning is the ability to modify the pre-operative anatomy and model the 
different post-operative configurations. Early studies have typically employed 
commercially available computer aided design (CAD) tools to manually modify 
geometries and generate only a few alternate post-operative options [88, 89]. Such 
processes are cumbersome and depend on the skill of the operator, especially when 
applied to complex anatomies. Two main approaches have thus been derived to achieve 
anatomy modification: (1) parametric representation and modification of the anatomy, (2) 
advanced anatomy editing tools, with a special focus on easing the human-computer 
interaction. 
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The first category of tools includes work such as the one conducted by Mardsen et 
al. [100], which does not reproduce the surgery per se but is directly focused towards 
automated shape optimization. Each patient-specific geometry is decomposed into a finite 
set of parameters, which can then be varied to generate different post-operative 
anatomies. In their first report for instance, Mardsen et al. [100] sought to optimize the 
design of an end-to-side anastomoses for bypass surgery. This study used an idealized 
vessel representation, where the geometry of the end-to-side anastomosis was 
characterized by three parameters: vessel diameter, graft diameter, and connection angle. 
Parametric variation of the graft angle and diameter, and automatic generation of the 
corresponding 3D geometry allowed the authors to conduct an automated optimization of 
the anatomosis design. The difficulty to generalize such an approach for the systematic 
investigation of all the options available to the surgeon (including extra-cardiac, intra-
atrial and bifurcated Y-grafts for example) lies in the parametric decomposition of 
complex shapes. In addition, ensuring that the final designs fall within what is surgically 
feasible (i.e. no main vessel compression or appropriate vessel wrapping around the heart 
in the case of extra-cardiac options) may represent a challenge in itself.  
The second category of tools addresses these difficulties by trying to reproduce 
the internal patient anatomy and surgical gesture. These may be related to virtual 
sculpture and make use of the progresses in geometrical handling, image rendering, and 
human-computer interactions. Pekkan and Rossignac [101] reported a preliminary 
virtual-surgery framework for cardiovascular surgeries. This virtual surgery interface is 
exemplified in Figure 2-16 for the performance of a 3rd stage, extra-cardiac TCPC 
connection. The patient anatomy was reconstructed from MRI, providing a 3D 
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representation of the vessels involved in the TCPC surgery (IVC, SVC, LPA, and RPA) 
and surrounding anatomical structures(such as the heart and great vessels), which 
constrain the surgeon’s degrees of freedom. Using two haptic trackers, one in each hand, 
the user/surgeon may directly interact with the geometry, here placing and deforming an 
artificial graft to complete the TCPC. Similar frameworks have been developed for 
applications other than cardiovascular. O’Leary et al. [102] report of an interface with 
sensitive feedback to mimic bone surgery. Virtual-reality surgical simulators are also 
gaining interest as training and evaluation tools for surgical trainees [103, 104]. The 
realism of these virtual surgery environments and the relevance of the surgical options 
designed therein depend on the extent to which the surrounding structures are represented 
in the interface, as well as on the realism with which the surgeon may perform a 
procedure. Contrary to the framework proposed by Marsden et al. [100], these virtual 
surgery environments are user intensive and do not easily lend themselves to systematic 
optimization procedures. On the other hand, these tools more easily allow for novel 
surgical procedures to be designed and tested on realistic patient-specific anatomies 
rather than simplified representations.   
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Figure 2-16: Virtual surgery environment [101]: Patient TCPC (shown in dark red) and 
surrounding anatomical structures, such as the heart and great vessels (shown in blue), 
have been reconstructed from MRI and loaded into the virtual-surgical interface. Using 
two haptic trackers, one in each hand, the user/surgeon may directly interact with the 
geometry, here placing and deforming an artificial graft (light transparent red) to 
complete the TCPC. 
 
 
Coupled with robust CFD solvers, environments such as the ones developed by 
Marsden et al. [100] or Pekkan et al. [101] provide a unique opportunity for surgeons to 
1) visualize the patient anatomy prior to entering the operating room, 2) envision multiple 
surgical options, 3) assess the hemodynamics of each option, and finally 4) identify the 
best surgical scenario (balancing energy dissipation, flow distribution and surgical 
feasibility) on a patient-specific basis. Such a patient-specific surgical planning approach 
is especially attractive for diseases such as SVHD, where the small patient population and 
the diversity of the underlying anatomies make it difficult to draw general guidelines 
based on clinical studies alone. 
 
- 48  - 
2.9 Computational Fluid Dynamics Modeling of the TCPC: Current Status 
and Limitations 
As was highlighted in the previous sections, computational fluid dynamic (CFD) 
has arisen as an attractive option to model complex biomedical flow patterns, 
complement clinical in vivo data to further the understanding of disease mechanisms, or 
provide patient-specific surgical recommendations. CFD methods provide distinct 
advantages over other forms of investigation: a high degree of freedom regarding the 
geometry and conditions to be simulated, a full 3D representation of the flow field to a 
level of details that cannot be achieved in vivo nor in vitro, the possibility to be 
automated for large sample size studies, and finally the potential to be coupled with 
virtual surgery environments to investigate novel surgical options and optimize the TCPC 
procedure on a patient-by-patient basis. However, despite these exciting prospects, it is 
important to keep in mind that any modeling approach carries simplifications and 
limitations, which should be carefully assessed prior to drawing any clinical conclusions. 
Most of the studies listed in Section 2.7 called upon one or several of the following 
assumptions: simplification of the geometry, rigid walls, constant flow rates at the inlets, 
constant flow rate or pressure at the outlets, and no feedback mechanism between the 
local TCPC hemodynamics and the global cardiovascular function. On the other hand, 
developing a fully-coupled multi-scale model of the whole circulation, including realistic 
TCPC geometry, wall material properties, detailed fluid mechanics of the TCPC, 
downstream pulmonary vascular resistance and a closed-loop adaptive model of the 
whole cardiovascular circuit, if at all feasible, will most likely yield a highly complex 
numerical scheme, increase convergence times, and ultimately hinder clinical 
- 49  - 
applicability. The ultimate objective of an investigative numerical flow solver is not so 
much to capture all in vivo intricacies but rather to yield results of clinical relevance 
within a clinically acceptable timeframe. This section thus reviews the numerical 
investigations of the TCPC hemodynamics, with a special emphasis on the selected 
modeling assumptions and their relative impact on the predicted performance of different 
TCPC options.  
 
2.9.1 Vessel Wall Motion 
Orlando et al. looked into the impact of wall compliance on the hemodynamics of 
an idealized, uniformly elastic TCPC [105]. They reported a 10% increase in power 
losses when compared to the same simulations conducted using rigid walls. This 
variation is of small magnitude in front of the variations in power losses that have been 
observed when altering the interaction of the IVC and SVC streams. Sharma et al. [82] 
for example, already reported a 50% increase in power loss between an idealized 
geometry with and without caval offset. De Zélicourt et al. found a 5 fold increase in 
power loss when allowing the instabilities arising from the IVC and SVC collisions to 
develop, still in an idealized setting, and up to a 70 fold increase when compared to an 
anatomical connection of similar dimensions [33, 95]. The rigid wall assumption may 
thus appear as a reasonable first order assumption in front of other geometrical 
modifications.  
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2.9.2 Flow Pulsatility 
Due to the absence of a right ventricle, neglecting flow pulsatility in the TCPC 
was assumed to be an acceptable assumption by most investigators. Yet, pulsatility in 
both IVC and SVC has been reported clinically in Fontan patients [106, 107] such that 
the validity of this assumption is questionable. The first pulsatile experiment was 
described by DeGroff et al. [108], who modeled generic IVC and SVC flow waveforms 
in a set of idealized TCPCs with varying caval offsets. Comparison to steady flow 
simulations revealed an increase in power loss under pulsatile conditions for all tested 
geometries. Pulsatility led to a 67% increase in the average power loss for the 1 diameter 
offset model, while this increase was of only 25% in the no-offset model. As a result, 
under pulsatile conditions, including a 1 diameter offset only yielded a 3% reduction in 
power loss compared to not having any offset, whereas steady flow results had predicted 
a 28% reduction. The lower sensibility of the no-offset model to the pulsatile flow 
disturbances could be attributed to the fact that the absence of caval offset already led to 
significant levels of instability even with constant inflow rates.  
Marsden et al. [90] confirmed that flow pulsatility increased the energy 
dissipation measured in patient-specific geometries. In that study, the authors made use of 
two patient specific geometries and patient specific flow curves when available. The 
impact of lower limb exercise was modeled by increasing the heart rate and mean IVC 
flow rate. Results revealed a significant decrease in energy efficiency (defined as the ratio 
of the outlet power to the inlet power) under pulsatile conditions for both models and 
under all simulated exercise levels. 
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Both of these studies demonstrated a significant impact of pulsatility on energy 
efficiency, thus raising the question of whether this would alter the relative performance 
of different TCPC options. The idealized results of DeGroff et al. [108] hint towards the 
fact that intra-atrial options, which host important levels of instabilities even with steady 
inflows, might be less sensitive to pulsatile disturbances than extra-cardiac options. On 
the other hand, analysis of the in vivo IVC and SVC flow curves of 62 patients from the 
Georgia tech database (Table 2-2) revealed that the IVC pulsatility levels are on average 
3.2 times higher for intra-atrial TCPCs compared to extra-cardiac options, which would 
hint towards a higher impact of pulsatility in intra-atrial options. In order to gain a better 
insight into the intra-atrial and extra-cardiac TCPC hemodynamics, there is thus a need 
for a detailed study accounting for differences in patient-specific anatomy and pulsatility 
between intra-atrial and extra-cardiac options. 
 
Table 2-2: Mean pulsatility indices obtained 62 patients selected from the GeorgiaTech 
patient database  
Vessel IVC  (in intra-atrials) 
IVC  
(in extra-cardiacs) SVC 
Pulsatility 2.00 + 2.70 0.62 + 0.21 0.82 + 0.56 
 
 
2.9.3 Impact of the Surrounding Structures  
The most straightforward way of specifying the boundary conditions is to impose 
the inlet and outlet flow rates based on the measured in vivo data, typically obtained from 
PC MRI. These measured flow data are ideal for reproducing the in vivo state, but pose 
some problems when simulating exercise conditions or altering the geometry. Indeed, 
reorienting the IVC baffle or dilating an LPA stenosis could alter the flow distribution to 
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the lungs, such that results obtained using the in vivo flow rates may be an erroneous 
representation of what would happen after modifying the TCPC. Similarly, a 
modification in TCPC geometry will most likely alter its hemodynamic resistance, which 
will in turn impact the cardiac output achieved by the single ventricle [65]. 
Multi-scale approaches, coupling detailed 3D CFD investigations of the TCPC to 
lower order representation of the rest of the cardiovascular system, are currently under 
development to model the regulation of the outlet flows by the downstream pulmonary 
vasculature, as well as the impact of the TCPC upon the rest of the cardiovascular 
system. Marsden et al. [90] for example prescribed a resistance value to represent the 
impact of the downstream pulmonary vasculature upon the LPA and RPA outflows. The 
adequate pulmonary resistance was obtained by fitting the outflow pressures to in vivo 
measurements. Seeking to circumvent the need for these patient specific pressure data, 
which can only be obtained by invasive catheterization, Clipp et al. [109, 110] suggested 
using 1D finite element analysis to model blood flow in arterioles large enough to be 
captured by MRI and imposing an organ specific impedance boundary condition using 
parameterized fractal trees. Extending the domain even further, lumped parameter models 
have been used, though not in synergy with 3D CFD, to represent the entire 
cardiovascular circuit at minimal computational costs [65, 111]. Here again, these models 
require number of in vivo pressure and flow data to fit each one of the organ-specific 
parameters, which can be difficult to obtain. 
In addition to the need for additional patient specific data to fit the different model 
parameters, extending the simulation domain brings forth one major consideration: 
increasing the model complexity does not necessarily add to the accuracy if the number 
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of unknown increases. Is a coupled CFD-lumped parameter model more accurate if 
generic parameters have been used to fit the vascular compliances? Can the lumped-
parameter model predict the post-operative remodeling of the lung and vasculature? Is the 
gain in accuracy worth the added computational cost? Consider for example a Fontan 
patient with unilateral PAVMs in the left lung. Due to the venous to pulmonary shunts 
present in his left lung, this patient will present a far lower PVR on the left side than on 
the right. The objective of a surgical planning study would thus be to rebalance the 
hepatic flow distribution, hoping to revert the left PAVMs. This would in turn increase 
left lung resistance, making the pre-operative model no longer valid. Similarly, venous 
compliance and resistance is known to vary acutely after the Fontan surgery, such that 
lumped parameters fit to the pre-operative state may not adequately represent the 
cardiovascular adaptation even in the acute stage. One approach to overcome this 
problem would be to develop evolutionary models of the vasculature, such that the 
pulmonary vascular resistance (PVR) would vary depending on the amount of nutrients 
distributed to each lung for example. Development of such a model however would 
require a large amount of clinical data for both parameter fitting and model validation, 
which are not available to date.  
An alternate approach is to characterize the TCPC efficiency of the different 
surgical options over a wide range of flow conditions [33, 88], thereby providing the 
necessary information to the engineers and clinicians to try and predict the temporal 
adaptation of the lungs and flow splits. Similarly, depending on the objective of the 
study, decoupled CFD and lumped-parameter simulations may represent a viable and 
more efficient strategy to explore a broad range of “what if” scenarios in a short clinical 
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time-frame. As an example, Whitehead et al. [92] used 3D CFD simulations to 
characterize the resistance of different geometries. Sundareswaran et al. [65] then 
conducted an independent lumped-parameter study to predict the exercise performance of 
a patient with these TCPC resistances. Similarly, Pekkan et al. [111] made use of CFD-
derived TCPC resistances and subsequent lumped-parameter modeling to test the benefit 
of a ventricular assist device depending on the patient’s TCPC resistance.  
 
2.9.4 Solver Accuracy and Need for Validation 
Finally, the notion that CFD is a mature technology that can be applied 
indiscriminately to model any flow physics is becoming de facto in the biomedical field. 
In reality, CFD is an intricate and continuously evolving science that necessitates a close 
synergy and integration between modeling efforts and in vitro experimentation to guide 
model development and validation. This is of particular importance when dealing with 
biomedical engineering flows since they exhibit a host of unique modeling challenges 
and difficulties. Such flows take place in complex, multi-connected domains with 
compliant walls and flexible immersed boundaries and are dominated, among others, by 
pulsatile effects, three-dimensional separation and vortex formation, regions of flow 
reversal, periodic transition to turbulence and laminarization. In spite of these enormous 
complexities, which pose a formidable challenge to even the most advanced CFD tools 
available today, only a few of the TCPC studies include an adequate CFD validation. A 
typical counter-example is the study by Khunatorn et al. [112] that found caval offset to 
be detrimental from a power loss point of view, contrary to the experimental findings by 
Sharma et al. in the same geometry [82]. Khunatorn et al. [85] later demonstrated out that 
- 55  - 
their numerical approach failed to capture the flow instabilities at the center of the 
connection and secondary flow structures in the PAs, which could explain discrepancies 
even in global efficiency measures such as energy dissipation rates. Pekkan et al. pointed 
out that overall 2nd order accuracy was a requirement to capture patient-specific TCPC 
flow structures, even when considering time-averaged flow fields [87]. The limitations of 
CFD tools for TCPC simulations have been documented on many occasions [85, 87, 113-
115], and all of these studies reinforce the need for high-resolution numerical schemes, 
comprehensive experimental validation, and careful application [115]. 
 
2.10 Summary and Significance of the Proposed Approach 
Previous experimental, numerical and in vivo studies have all underscored the 
high sensitivity of the TCPC efficiency, and thus the patient outcome, to the TCPC 
geometrical design. However, despite a large number of available bioengineering studies, 
there is still a lack of clear guidelines for the clinical community to best design the TCPC 
connection during surgery. With the recent convergence of high-resolution medical 
imaging and processing methods, and the development of virtual surgery environments 
where the surgeon can reproduce the gestures he would do in the operating room and 
modify a virtual anatomy, numerical methods present the unique opportunity to provide 
individualized surgical planning for each incoming patient. As promising though these 
new technologies may seem, their application in the TCPC realm is still sparse and the 
clinical relevance of the existing CFD studies remains limited by either too large a 
number of simplifications, or too small a number of patient cases to draw relevant 
surgical guidelines. In addition, there is a continuing need for a careful assessment of the 
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different modeling assumptions, in order to assess the parameters that may or may not be 
disregarded in favor of faster simulations and increased number of tested options. Finally, 
it is worthwhile to highlight that while CFD is generally perceived as a well-established 
and reliable technology, it is in reality a constantly evolving science, calling for thorough 
validation at each development stages. 
The approach proposed in this thesis thus seeks to develop a fully-validated 
numerical flow solver that will allow for pulsatile 3D flow simulations in patient-specific 
TCPCs to quantify the impact of pulsatility across different TCPC options, and that could 
be used to conduct patient-specific surgical planning studies within clinical timeframe 
and resources. To this end, our numerical approach will be designed to capture the 
intricacies of in vivo anatomies with high accuracy but minimum user-interaction, while 
the flow solver will ensure overall second order spatial and temporal accuracy to resolve 
the instabilities and secondary flow structures reported in patient-specific anatomies.  
All developments will be validated against controlled in vitro experiments to 
ensure accuracy. Patient-specific pulsatile simulations will be conducted using in vivo 
anatomies and flow curves reconstructed from MRI and PC MRI data available from the 
Georgia Tech Fontan patient database. To quantify the effect of pulsatility on the TCPC 
efficiency, each pulsatile simulation will be accompanied by a constant inflow counter-
part, conducted using the same in vivo anatomy but the mean vessel flow rate rather than 
in vivo flow curve. Comparison between the performance metrics obtained under steady 
and pulsatile conditions will for the first time quantify the relative impact of flow 
pulsatility across in patient specific geometries across different TCPC templates.  
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In addition, the proposed numerical solver will fill in a crucial gap in the array of 
tools needed for the completion of a surgical planning tool, allowing surgeons to not only 
virtually perform multiple different surgical options within a virtual-reality simulator, but 
also compare their hemodynamic efficiency to best plan the TCPC surgeries for each 
patient. Application and benefits of such an integrated surgical planning will be 
demonstrated on patients featuring an interrupted IVC with azygous continuation, who 
represent a particularly challenging clinical scenario. The different surgical options to be 
investigated will be developed in close synergy with the surgeon in charge of the patient. 
As this subgroup of patient is especially prone to PAVMs, emphasis will be set on 
equally distributing the cardiac output and the hepatic nutrients to the left and right lung. 
Secondary optimization metrics will include minimizing the pressure drops and energy 
dissipation. In addition to a direct benefit to the patient under consideration, this study 
will also have a larger impact for the clinical management of SVHD patients with an 
interrupted IVC. First, the systematic review of the various geometries investigated for 
each surgical planning case will allow for a better definition of the different “anatomical 
templates” (e.g. interrupted IVC combined with a single SVC or bilateral SVCs, 
classification based on the relative position of the azygous and inominate vein). Then, it 
will shed light onto the impact of caval offset, vessel flaring and other design parameters 
upon TCPC hemodynamics depending on the underlying patient anatomy. These results 
will provide useful surgical guidelines for each anatomical template, which could benefit 
the global surgical community, including centers that do not have access to patient-
specific surgical planning interfaces. 
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CHAPTER 3 
NUMERICAL BACKGROUND 
 
The approach proposed in this thesis seeks to develop a fully-validated numerical 
flow solver that will allow for pulsatile 3D flow simulations in patient-specific total 
cavopulmonary connections (TCPC), and that could be used to conduct patient-specific 
surgical planning studies within clinical timeframe and resources. For the purpose of this 
study, blood will be assumed to be an incompressible Newtonian fluid, which is a fair 
assumption in large vessels, and the motion of the TCPC walls will be neglected. The 
main challenges to be addressed are to define a numerical approach that 1) accurately 
captures the unsteady dynamics of in vivo blood flows, and 2) allows for the fine 
discretization of arbitrarily complex in vivo structures with minimum user interaction. 
The following sections will thus review the computational fluid dynamics (CFD) 
approaches that have been developed to tackle incompressible Newtonian flows, and the 
options available to capture the geometrical intricacies of in vivo geometries. 
 
3.1  A Brief Review of Incompressible Newtonian Fluid Dynamic 
Prior to dwelling into the different modeling options of incompressible Newtonian 
fluids, this section provides a brief overview of the governing equations of 
incompressible fluid motion. The motion of a fluid is governed by the conservation laws 
of mass and momentum. These equations, called the Navier-Stokes equations, can be 
expressed in their integral form by: 
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where nr  represents the outward normal from the closed surface S enclosing the arbitrary 
volume V, ( )t,ρ xr  is the fluid density at a given location ( xr ) and instant in time (t), 
( )t,xu rr  the velocity. ( )tP ,xr  and ( )t,xT r  represent the normal and anisotropic components 
of the stress tensor acting on the surface of the fluid element. For fluid applications, 
( )tP ,xr  thus describes the pressure field, while ( )t,xT r  describes the effect of the viscous 
forces. ( )t,xF r
r
 the force per unit mass due to any external field. Equation II-1 simply 
states that the change in mass within a given volume V is equal to the mass of fluid 
entering and exiting that same volume. Equation 2-2 is an application of Newton’s 2nd 
law to a continuum rather than to a solid object. It states that the acceleration of a volume 
of fluid V (left hand side of Equation 2-2) is equal to the sum of the forces acting on this 
element of fluid (right hand side).  
 
The above system of equations contains too many unknowns to be solved directly 
and modeling assumptions ought to be made in order for the system to have a solution. In 
our particular case, blood in large vessels is considered to be an incompressible 
Newtonian fluid and all external body forces will be neglected. These assumptions yield 
the following simplifications: 
(1) As the flow is incompressible, the density, ρ , is constant and uniform.  
 ( ) ρρ =t,xr   (3-3) 
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(2) Then, the shear stresses tensor, ( )t,xT r ,  of a Newtonian fluid is symmetric 
and proportional to the shear strains, ( )t,xE r : 
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3
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where μ is the viscosity of the fluid, I is the is the 3x3 identity matrix  
(3) Finally, neglecting all body forces yields:  
 0
rr
=Fρ  (3-5) 
With all these assumptions combined, Equations 2-1 and 2-2 simplify into the following 
integral form of the incompressible Navier-Stokes equations: 
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The above integral form is ideal for finite volume formulations, which assess the 
force balance over each computational grid cell. Alternatively, finite difference 
approaches, which establish the force balance at every grid node, will find the discrete 
reformulation of the above equations more useful. These may be obtained by applying the 
Gauss–Ostrogradsky theorem to Equations 2-6 and 2-7. This theorem states that the flux 
of a vector field through a surface S is equal to its integral over the enclosed volume V, 
allowing all quantities to be expressed as volume integrals. As the continuity and 
momentum relations hold for any volume V, it can be deduced that these relationship 
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hold in any point, yielding the following form for the discrete incompressible Navier-
Stokes equations:   
 ( ) 0=∇ ur  (3-8) 
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3.2  Numerical Methods for Incompressible Newtonian Flows 
Several numerical schemes have been developed for the simulation of both steady 
and unsteady incompressible flows. Approaches differ in the way they handle (i) the 
temporal discretization and time advancement procedure, and (ii) the spatial 
discretization, both of which are addressed in the following sub-sections.  
 
3.2.1 Temporal Discretization 
The specificity of the incompressible Newtonian equations is the absence of an 
evolutionary equation for pressure that would establish an explicit relationship between 
the temporal derivative of pressure tP ∂∂  and other spatial derivatives. A direct 
consequence is that with the Navier-Stokes equations formulated as in Equations 2-6 
through 2-9, the pressure field cannot be calculated by an explicit time-advancement 
procedure as is used in compressible applications. Nevertheless, velocity and pressure are 
tightly inter-related, and their synchronization is a compulsory requirement for both the 
continuity and the momentum equations to be satisfied. The following sections give a 
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detailed review of the two main approaches that have been derived to enforce this 
pressure-velocity coupling, namely: 1) the artificial compressibility (AC) method, and 2) 
fractional step pressure projection (FSPP) method.  
3.2.1.1 Artificial Compressibility Methods 
The AC method for steady incompressible flow simulations was first proposed by 
Chorin [116]. This method builds on a simple physical observation: in incompressible 
fluid, information is transmitted from one side of the fluid to the other at infinite speed. 
This poses an inherent modeling difficulty as numerical schemes cannot replicate infinite 
propagation speed. The basic idea of the AC approach is thus to perform pseudo-
iterations within each physical time step, allowing the information to be propagated at 
finite speed in the pseudo-time domain. The Navier-Stokes equations with that 
formulation can be written as follows:  
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where t is the physical time, τ  the pseudo time and the constant c0 is equivalent to the 
speed of sound in the artificially compressible fluid. The superscript n denotes the flow 
and pressure values after the nth physical time-step, while superscripts *l+1 and *l denote 
the flow and pressure values at the pseudo-time steps l and l+1. This formulation restores 
the elliptic character of the compressible equations, so that any of the time-marching 
approaches developed for compressible flows can be applied here. The above equations 
are iterated in pseudo-time until equilibrium is reached for every physical time-step. 
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Consequently, linearization errors in physical time can be driven to machine zero and the 
governing equations can be satisfied at the next physical time level. The method therefore 
has the same order of accuracy for velocity and pressure as that of the discretization of 
the momentum equations. However, as stated above, equilibrium needs to be reached at 
every physical time-step. This implies that the entire right hand side of Equation 2-11 
needs to be evaluated at every pseudo-iteration until convergence, considerably 
increasing the CPU time per physical time step.  
3.2.1.2 Fractional Step Pressure Projection Methods 
The fractional step method, which was first introduced by Harlow and Welch 
[117], is perhaps the most widely used approach for incompressible flows. The basic idea 
consists of breaking down the complex Navier-Stokes equations into simpler steps for 
which efficient time integration procedures can more readily be designed. It typically 
proceeds into two steps: First an intermediate velocity field *ur  is computed using the 
momentum equation only, i.e. without enforcing the continuity equation. Then, since 
*ur doesn’t satisfy the continuity equation, and thus is not divergence free, a second step 
is performed to correct *ur and produce a divergence free field 1+nur .   
Boundary conditions are the major problem of FSPP approaches. Applying 
physical boundary conditions onto the intermediate velocity field, which has no true 
physical meaning, brings down the overall scheme accuracy. FSPP approaches that 
neglect pressure for the first step have been shown to be limited to 1st order temporal 
accuracy unless very specific boundary conditions are applied [118]. Far more accurate 
results may be obtained by retaining the best known estimate for pressure in the 1st step 
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and applying a correction on both velocity and pressures in the second. This approach 
corresponds to the P2 class of FSPP in [118] and proceeds as follows:  
(1) Intermediate velocity step: Considering for simplicity a fully explicit time stepping 
algorithm, the momentum equation for the intermediate velocity in P2 class methods 
reads as: 
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Note that the pressure field P corresponds to the known pressure field at time step n.  
(2) Correction step: The terms omitted from the momentum equation in the first step are 
then solved together with the continuity equation:  
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The incremental pressure Pδ  is obtained using the divergence-free property of the 
velocity field 1+nur  . Taking the divergence of Equation 2-13 and using the fact that the 
velocity field 1+nur  is divergence free, we obtain the Poisson equation for the incremental 
pressure Pδ :  
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Once Pδ is know, the velocity un+1 and pressure Pn+1 fields at time n+1 can be obtained 
using the expressions given in Equations 2-13.  
 
Since, in the P2 class of FSPP, the intermediate velocity satisfies the full 
momentum equation, physical boundary conditions can be used on the intermediate 
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velocity field. The resulting accuracy is of at least second order when using the physical 
boundary conditions on the intermediate pressure and velocity fields [119] and can be 
increased even further when using carefully designed boundary methods such as the one 
proposed by Kim and Moin [120]. While AC methods could yield higher degree of 
accuracy, this benefit is in practice balanced by the drastically faster computational speed 
of FSPP approaches. Ge and Sotiropoulos [121], for example, used a Krylov subspace 
method, namely the restarted Generalized Minimal Residual Method (GMRES) solver, 
enhanced with a multigrid preconditioner to solve the Poisson equation. The authors 
report excellent computational performances, and successfully capture the pulsatile blood 
flow dynamics through a bileaflet heart valve, testifying for the robustness of the method. 
Such a FSPP approach combines both efficiency and 2nd order temporal accuracy, and 
thus constitutes an attractive alternative to the AC method. 
 
3.2.2 Spatial Discretization 
Accuracy, stability, and ease of implementation should be carefully considered 
when choosing among different spatial discretization schemes. The most straightforward 
way to compute 1st and 2nd spatial derivatives is to employ centered differences on a 
collocated grid (where pressure and velocity information are stored at the same location). 
Using the artificial compressibility approach for the time-integration for example, central 
difference operators would yield the following expression for the continuity and 
momentum equations on the one-dimensional uniform grid shown in Figure 3-1: 
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Pi-1 , ui-1 Pi , ui Pi+1 , ui+1
Δx Δx  
Figure 3-1: Schematic representation of a collocated one dimensional uniform grid. 
Pressure and velocity values are stored at the same location. 
 
 
Unfortunately, Equations 2-16 and 2-17 lead to two types of instabilities: 1) 
oscillations in the velocity fields at high Reynolds numbers and 2) oscillations in the 
pressure field. The instabilities in the velocity fields are the same as that encountered 
when solving advection-dominated transport equations or boundary layer equations, and 
are due to the symmetric nature of the velocity differentiation stencils. The unphysical 
amplifications of small perturbations in the velocity field can be cured by explicitly 
introducing an artificial dissipation, or using more dissipative difference operators (such 
as upwind schemes) to the same effect.  
The oscillations in the pressure field find their origin in the combined use of 
collocated grids and symmetric difference operators. With such a layout, the temporal 
evolution of the pressure Pi depends on ui+1 and ui-1, which in turn depend on Pi-2, Pi and 
Pi+2. The pressure values on the odd and even grid lines thus evolve without a direct 
interaction and may reach a solution independently of one another, leading to what is 
known as the check-board effect. This issue may be circumvented by either introducing 
an artificial damping term that will smooth the pressure field and stabilize the solution, or 
using staggered grids. In the latter option, pressure values are stored at the cell centers 
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while velocities are stored at the cell faces (see Figure 3-2). Using this alternating pattern, 
the partially discretized continuity and momentum equations become: 
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Figure 3-2: Schematic representation of a one dimensional uniform staggered grid 
arrangement. Velocity values are stored on the cell surface, while pressure values are 
stored at the cell center. 
 
 
A limitation of staggered grid arrangement is the difficulty to synchronize the 
velocity and pressure boundary conditions prescribed at the node and half-node 
respectively. The hybrid staggered/non-staggered grid arrangement presented by 
Gilmanov et al. [122] represents an elegant alternative to the problem. The Navier-Stokes 
equations are solved using the staggered grid arrangement for stability, while the 
boundary conditions are prescribed on the non-staggered grid layout. This simple 
reformulation simplifies the implementation of the solution reconstruction algorithm near 
complex immersed bodies and was shown to increase the accuracy on the vicinity of the 
boundary.  
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3.2.3  Summary of the CFD Schemes for Incompressible Flows 
In summary, the approach retained for this thesis will build on the methods 
developed by Gilmanov et al. [122] and Ge et al. [123]. The spatial discretization scheme 
will be based on the hybrid staggered/non-staggered arrangement proposed by Gilmanov 
et al. [122], which combines the stability of staggered grid layouts and the simplicity and 
accuracy of non-staggered grids for the prescription of the boundary conditions. The 
convective terms will be further discretized using an upwind difference operator to avoid 
to the development of velocity instabilities. Finally, the solver will incorporate the FSPP 
approach developed by Ge et al. [123] for its computational expedience. With all these 
tools at hand the main question to be answered is that of the actual discretization of the 
computational domain. Irrespective of the numerical scheme retained, the generation of a 
finely resolved computational mesh of the in vivo TCPCs is primordial for the accuracy 
of the predicted hemodynamics. Identifying the best strategy to capture the in vivo 
geometries will be the object of the following sections. 
 
3.3  Numerical Simulations in Arbitrarily Complex Geometries 
A major challenge for the numerical simulation of in vivo cardiovascular flows 
stems from the difficulty to generate computational meshes that properly describe the 
complexity of real-life anatomies. Unstructured grids with finite-volume or finite-element 
methods provide a natural choice for tackling such problems and have been used with a 
great deal of success [124-126]. Such methods, however, typically involve higher 
computational overhead than finite-difference or finite-volume methods on structured 
grids. Structured curvilinear body-fitted meshes have also been used but generally need 
- 69  - 
to be used in conjunction with domain decomposition methods, such as overset Chimera 
grids [87].  Even when domain decomposition is employed, the generation of good 
quality composite, boundary-conforming meshes could be cumbersome and time 
consuming for realistic anatomies [87].  
Non-boundary conforming immersed-boundary (IB) approaches have recently 
attracted considerable attention for the simulation of flows around complex bodies as 
they circumvent the difficulty of the body-fitted volume mesh generation. The complex 
geometry is immersed in a background Eulerian grid (Figure 3-3), which will be used to 
solve the Navier-Stokes equations. Due to the ease with which they can handle complex, 
moving boundaries, IB methods have been applied to a wide range of problem types 
ranging from relatively simple flows past cylinders, [122, 127] to flows past swimming 
animals and organisms, [122, 128]. A review of the different methods used for problems 
with liquid-solid boundaries is offered by Mittal et al. [129].  
 
 
 
Figure 3-3: Surface mesh of a TCPC (in red) immersed in a background Eulerian grid (in 
blue). 
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The quality of the interface tracking and the enforcement of the boundary 
conditions are two key factors for the overall accuracy of IB methods. In our applications, 
the TCPC walls will be assumed to be rigid such that tracking of the vessel deformation 
is of no relevance. On the other hand, enforcement of the boundary conditions, namely of 
the no-slip boundary conditions along the TCPC walls, should be carefully implemented. 
Three dominant approaches have been discussed in literature, namely cut-cell methods 
[130-132], diffuse immersed-boundary methods [133, 134], and sharp interface 
immersed-boundary methods [121, 122]. 
Cut-cell methods modify the shape of the computational cells cut by the body to 
adapt to the exact geometry of the immersed boundary (Figure 2-4) and generate a 
Cartesian albeit boundary-conforming mesh. Using proper interpolation strategies, the 
flow variables can be computed on the resulting irregular cell interfaces according to the 
boundary conditions on the body. A difficulty encountered in the implementation of cut-
cell methods arises from the large number of possible geometrical configurations for the 
interfacial cells, which calls for a large number of special cases when implementing the 
boundary conditions. Furthermore, in complex geometries, the unavoidable generation of 
 
 
Immersed body
Interfacial cell
Fluid cell
 
Figure 3-4: Cut-cell approach. Interfacial trapezoidal cells allow the mesh to conform 
to the shape of the immersed geometry. To avoid having cells of small dimensions, 
interfacial cells merge with the closest fluid cells. 
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interface cells with very small volume adversely impacts the conservation and stability 
properties of the solver. Special treatments are thus also required during the mesh 
generation step to merge small cells with their closest neighbors [131].  
Contrary to the cut-cell approach, diffuse and sharp-interface immersed boundary 
methods do not modify the geometry of the Cartesian to conform to the immersed body. 
In diffuse immersed-boundary methods the Navier-Stokes equations are solved on the 
entire embedding Eulerian grid. The action of the immersed boundary is transmitted to 
the fluid through an additional source term in the momentum equations. This technique 
has successfully been applied by Peskin et al. to model the action of a beating heart and 
the associated intra-cardiac hemodynamics [133, 135]. The cardiac muscle fibers were 
modeled as a set of elements linked by springs. To avoid numerical instabilities, a delta 
function was then used to distribute the external forcing of these muscle fibers over 3 to 4 
fluid nodes in the vicinity of the boundary. The need for such force distribution poses an 
inherent limitation to the accuracy of these methods, smearing the location of the 
immersed boundary over a few grid cells and calling for high resolution grids in order to 
properly capture the solid-fluid interfaces. 
Sharp interface immersed-boundary (SIIB) approaches [136, 137] seek to address 
that limitation by circumventing the need for discrete force stencils. Similarly to cut-cell 
approaches the immersed-boundary is treated as a sharp-interface. However, rather than 
modifying the Eulerian grid cells in the vicinity of the boundary to apply the boundary 
conditions exactly at the immersed boundary location, SIIB methods use an interpolation 
strategy to impose the boundary conditions on the fluid elements closest to the boundary. 
The embedding Cartesian grid is differentiated into three element categories: the 
- 72  - 
elements that fall outside of the fluid domain, the fluid elements that are in the immediate 
vicinity of a boundary (IB elements) and the fluid elements that fall strictly inside the 
fluid domain (fluid elements). The Navier-Stokes equations are solved on the fluid 
elements without adding any external forcing from the immersed-boundary. The action of 
the immersed-boundary is accounted for at the IB-elements, whose pressure and 
velocities are reconstructed by interpolation between the closest immersed-boundary and 
fluid elements (Figure 3-5). The interpolation procedure is key in the overall SIIB 
accuracy. Using the quadratic interpolation method exemplified in Figure 3-5, Gilmanov 
et al. demonstrated that SIIB methods could easily yield overall second order accuracy 
[122]. Taking advantage of their combined ease of implementation and accuracy, 
researchers have used SIIB methods for a wide range of problem types ranging from 
relatively simple flows past cylinders [122, 127], to flows past swimming animals and 
organisms [122, 128], blood flow past the leaflets of a mechanical prosthetic heart valve 
[121], and even flows around a walking human [138]. 
 
 
 
Figure 3-5: Reconstruction of the solution at a boundary node (b) by interpolating 
between the closest immersed-boundary element (a) and closest fluid element (c) along 
the local normal to the immersed-boundary. (Image courtesy: [122]) 
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Going back to the modeling of the in vivo TCPC anatomies, IB methods seem 
ideally suited to capture the intricacies of the in vivo anatomies without requiring a 
tedious mesh generation. SIIB methods, in particular, offer a promising route both in 
terms of implementation simplicity and spatial accuracy. However, with the exception of 
the pioneering work by Peskin and McQueen, who used the classical diffused-interface 
IB formulation [134, 139], and the more recent SIIB study of Yokoi et al. [140], the use 
of IB methods in simulating complex anatomical blood flows is not as wide-spread as one 
would anticipate given the ease with which such methods can handle arbitrarily complex 
geometries.  
One possible explanation for the scarcity of applications of IB methods to 
anatomical flows lies in the manner in which such methods handle the Cartesian grid 
nodes that are not part of the flow domain (i.e. the nodes that reside outside of the fluid in 
the solid side of a fluid/solid interface). The common practice is to retain such non-fluid 
grid nodes in the grid structure but blank them out of the computation, sacrificing the 
added memory and computational overhead due to the unused non-fluid nodes for the 
sake of the overall algorithmic simplicity. Such approach is reasonable when dealing with 
external flow problems around bodies that only represent a small fraction of the 
background Eulerian computational box. But a drastically different situation can be 
encountered in biomedical problems, when IB methods are applied to simulate internal 
flow problems. Let us consider for example a 90 degree curved pipe immersed into a 
uniform Cartesian grid as shown in Figure 3-6. Despite the simple geometry under 
consideration, it is evident that most of the Cartesian grid nodes actually reside outside of 
the pipe, with no more than 15% of the nodes located within the fluid domain. 
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Figure 3-6: 90o curved pipe immersed in a Cartesian grid 
 
 
This situation will only be exacerbated when one attempts to model arbitrarily 
complex, multi-connected anatomical TCPC geometries with an IB methodology. As 
illustrated in Figure 3-7, the ratio of fluid nodes to Cartesian grid nodes does not exceed 
10%, and can drop to as low as 1-5% for more tortuous geometries. A clear example of 
this shortcoming can be found in the recent work of Yokoi et al. [140] who employed a 
SIIB approach to simulate blood flow in a very complex cerebral aneurism anatomy 
immersed in a Cartesian grid with 160×50×75 nodes. Yokoi et al. did not provide any 
information about the number of nodes lying in the interior of the aneurysm model but 
given the complexity of their geometry the vast majority of the Cartesian nodes must 
have resided in the exterior of the flow domain and thus unnecessarily burdened the 
computation. Furthermore, Yokoi et al did not carry out any grid sensitivity studies as 
they reported results for only one mesh. Therefore, the feasibility of carrying out grid 
convergence studies for complex anatomical geometries using a SIIB approach has yet to 
be demonstrated.  
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Figure 3-7: Patient-specific TCPC geometry immersed in a uniform Cartesian mesh. The 
curvature of the vessels involved leads to a large number of unused non-fluid nodes 
around the structure of interest while only a small portion of the nodes (6%) lie within the 
fluid domain, inside the vessels. IVC and (L or R) SVC: inferior and (left or right) 
superior venae cavae. AZ: azygous vein. LPA and RPA: left and right pulmonary arteries.  
 
 
3.4  Optimizing the Data Structure of SIIB Methods 
As discussed above, the main challenge confronting SIIB methods when applied 
to flows in complex, cardiovascular anatomies lies in the excessive memory overhead 
added by the unused Cartesian grid nodes. In addition SIIB methods are especially 
sensitive to the mesh refinement in the vicinity of the immersed surface, due to the 
velocity reconstruction performed at the boundary nodes. This calls for even finer meshes 
in these boundary regions in order to maintain the overall scheme accuracy. The need for 
different levels of refinement in different regions of space is not specific to SIIB methods 
and there is a large core of literature dedicated to the definition of efficient data structures 
to achieve high spatial resolution in localized regions of space.  
Block-structured grids (or multi-block methods) [141] present an attractive option 
to minimize the overhead imposed by the non-fluid nodes. In such methods, the geometry 
is embedded in several overlapping Cartesian blocks such that each block offers a better 
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fit to a section of the immersed body, thus, reducing the number of unwanted non-fluid 
nodes. However, for such an implementation to be optimal careful attention should be 
paid to the definition of the blocks. This is far from being straightforward in complex 
anatomical geometries such as the TCPC geometries shown in Figure 3-7.  
Adaptive mesh refinement (AMR) approaches represent another class of methods 
which seeks to achieve the desired spatial accuracy by embedding the geometry in series 
of progressively refined grids, providing finer spatial sampling only where needed 
(Figure 3-8). The basic principle is to define a refinement metrics, such as the velocity 
gradient or vorticity magnitude, allowing the mesh to be automatically adapted to best 
capture the flow fields. If the refinement metrics is larger than a preset number, the mesh 
is refined further. On the opposite, if it is below another preset threshold, the mesh may 
be coarsened without lowering the overall simulation accuracy. In the context of SIIB 
methods, AMR has successfully been applied by Collela et al. [142-144] and Peskin et al. 
[135, 145] as a mean to maintain the overall scheme accuracy by increasing the 
resolution in the vicinity of the immersed fluid/solid interface. In both studies, the mesh 
was refined by patches (Figure 3-8) and a structured grid structure was retained for all 
refinement levels. Such data structure provides undoubtful advantages for the 
implementation of the gradient, divergence and Laplacian operators needed to solve the 
governing Navier-Stokes equations, and allows for an easy correspondence between the 
different mesh levels at the coarse/fine interfaces. On the other hand, the final data 
structure retains some dependence on the embedding Cartesian grid size for each one of 
the refinement levels, which hinders its applicability to internal flow simulations. 
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Figure 3-8: Properly-nested locally-refined Cartesian grid. Coarse/fine interfaces are 
indicated by bold lines. (Image courtesy: [135]) 
 
 
Octree methods have also been used as a more versatile form of AMR [146], 
allowing for mesh refinement in individual mesh cells rather than in patches and using 
hierarchical tree structures to store mesh connectivity. The mesh is typically represented 
starting with a single embedding grid cell that further subdivides until the desired spatial 
accuracy is achieved. Octree approaches effectively reduce the memory footprint of the 
data structure but typically result in complicated data structures with relatively slow 
access and construction times. In an effort to improve data access rates within discrete 
stencils, Khokhlov et al. [146] suggested the use of a fully-threaded tree structure. In 
addition to the parent/children relationship, direct neighborhood information is stored for 
each mesh refinement level, thus allowing for faster horizontal spanning of the 
hierarchical tree. Along the same lines Losasso et al. [147] recommended using a 
uniform block structured grid at the coarsest level, as opposed to a single cell, and 
defining each grid cell as an octree of its own.  
Nielsen et al. [148] argued that even with an implementation such as that 
proposed by Losasso et al. [147], the memory footprint still showed some dependency on 
- 78  - 
the dimensions of the embedding grid. The authors present an interesting alternative 
where all the Cartesian grid cells that fall outside of the domain of interest are effectively 
dropped out of the data structure, thus, resulting in a Cartesian albeit unstructured data 
structure. Unstructured meshes (using tetrahedral or hexagonal elements) have commonly 
been used in the literature. The particularity of the approach proposed by Nielsen et al. 
[148] lies in the definition of an efficient recursive mapping scheme that restores grid 
connectivity information, ensures a constant data access time to all points and minimizes 
data storage. Such data structure is very attractive for TCPC applications, allowing for all 
non-fluid nodes to be disregarded, while retaining an efficient access to neighboring flow 
and pressure information. In the study by Nielsen et al., strong emphasis was set on 
minimizing data storage as the algorithm was mainly meant to be applied to track 
surfaces (which are one dimension smaller than the embedding Cartesian grid). This 
problem is less stringent for our applications, since in vivo TCPC geometries still occupy 
1-10% of the Cartesian grid. As a result, our implementation could afford a slightly more 
memory-intensive mapping scheme, in favor of a faster, direct data access rate. 
 
3.5  Approach Retained and Contribution 
This thesis seeks to develop an accurate numerical method that will allow for 
pulsatile flow simulations in in vivo cardiovascular geometries. SIIB methods seem 
ideally suited for that purpose as they can handle geometries of arbitrary complexity, 
while retaining the accuracy and ease of implementation of Cartesian methods. However, 
as was highlighted in this chapter, their application to internal flows has been hindered by 
the memory overhead imposed by the non-fluid nodes, which impose an unnecessary 
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burden to the computations and limits the spatial accuracy achievable within practical 
time-frame and computational resources. Making use of an unstructured Cartesian grid 
formulation, the approach developed in this thesis seeks to extend the application range 
of SIIB methods, and demonstrate their potential for carrying detailed high-resolution 
simulations in arbitrarily complex anatomical geometries. In particular, the proposed 
approach builds on the structured SIIB formulation developed by Sotiropoulos and 
coworkers [121, 122] for external flows around moving bodies. This SIIB method is 
recast using an unstructured Cartesian representation similar to that of Nielsen et al. 
[148], wherein all grid nodes falling outside of the flow domain will be eliminated from 
the computational domain. However, instead of the recursive formulation described by 
Nielsen et al. to establish the grid connectivity [148], we take advantage of the bijective 
mapping that exists between the unstructured fluid grid and the underlying structured 
Cartesian grid. This alternate formulation, though less memory efficient, allows for direct 
data access thus addressing one of the major limitations of unstructured formulations.  
Each numerical development is validated against detailed controlled in vitro 
experiments. To demonstrate the benefits of our approach, the re-formulated SIIB scheme 
is applied to carry out systematic grid refinement studies for internal flow problems 
ranging in complexity from a curved pipe to real-life, patient-specific TCPC geometries. 
The developed numerical solver is then applied to probe the impact of pulsatile inflow 
conditions upon the hemodynamic performance of different TCPC geometries. Finally, 
we demonstrate how such a versatile unstructured SIIB approach could benefit the 
clinical community, allowing for the performance of patient-specific surgical planning 
studies within a clinically practical timeframe.  
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CHAPTER 4 
HYPOTHESIS AND SPECIFIC AIMS 
 
The introduction of a complete right heart bypass procedure [11] brought in a 
revolution in the management and care of children born with single ventricle heart 
defects (SVHD). Over the years this procedure has evolved from the original single-stage 
Fontan surgery to the multi-stage total cavopulmonary connection (TCPC) procedure, in 
which the superior vena cava (SVC) and the inferior vena cava (IVC) are directly 
connected to the pulmonary arteries bypassing the right side of the heart. Despite marked 
improvements in overall survival, these patients still present with numerous severe long-
term complications such as ventricular dysfunction, pulmonary arteriovenous 
malformation (PAVMs), diminished exercise capacity, protein losing enteropathy (PLE), 
and thrombotic complications [47, 149, 150]. While the etiology of these complications is 
multi-factorial, the hemodynamics of the TCPC determined by its design and surgical 
construction have a predominant impact on the patient outcomes. Elevated TCPC 
resistances have been shown to limit cardiac output and exercise capacity. Orientation 
and relative position of the IVC and SVC at the center of the connection have a 
predominant impact upon the distribution of blood flow and nutrients to the lungs, which 
will in turn dictate whether a patient is prone to PAVMs or not. Flow disturbances within 
the TCPC construct increase energy dissipation and may yield unphysiologic fluid 
stresses on blood elements, ultimately resulting in thrombus formation. Optimization of 
the TCPC hemodynamics via its design is thus a critical step towards alleviating the long 
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term complications observed in SVHD patients and improving long-term clinical 
outcome.  
Several options have been discussed in literature regarding the optimal TCPC 
implementation, suggesting the inclusion of IVC-SVC offset [82], vessel curvature[84], 
flaring of the anastomosis site [83, 151], or the use of Y-shaped IVC grafts [99, 152]. 
However, with the refinement of the clinical and bioengineering investigation methods, it 
has now become clear that the anatomical variability between patients calls for a patient-
specific optimization of the TCPC design and hemodynamics. Virtual surgery interfaces 
coupled with physics-driven computational fluid dynamics (CFD) solvers offer a unique 
platform for surgeons to pre-operatively optimize the surgical procedure on a patient-by-
patient basis. Nonetheless, such patient-specific surgical planning still requires significant 
technical innovations on both the virtual modeling and CFD fronts, and its feasibility 
within clinically practical resources and time-frame has yet to be demonstrated. 
From the CFD end in particular, a major challenge stems from the complexity of 
the in vivo anatomies, and the number of parameters to be modeled. In vivo flows 
typically take place in multi-connected, tortuous vessels, with moving walls, pulsatile 
inflows, and feature non-Newtonian behavior and a host of flow regimes ranging from 
laminar to transient and fully-developed turbulence. Modification of the patient’s 
anatomy during surgery not only affects the local hemodynamics but also often results in 
remodeling of peripheral organs, which in turn impacts the inflow and outflow boundary 
conditions of the domain under consideration. Surgical planning CFD simulations thus 
have to call upon number of simplifications, which ought to be carefully reviewed in 
order to assess the relevance of the predicted performances and determine the parameters 
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that may or may not be disregarded in favor of faster simulations and increased number 
of tested virtual-surgery options. In the TCPC realm, simulations have commonly 
assumed one or several of the following: simplified geometries, rigid walls and steady 
inflow/outflow conditions. While idealized geometries obviously cannot account for the 
diversity of the in vivo anatomies the impact of the other parameters is less clear. 
Preliminary studies have modeled uniformly elastic walls [105] and pulsatile inflow 
conditions [90, 108], pointing to the latter as having a larger impact upon the predicted 
TCPC performance. However, the question as to whether modeling pulsatile inflows is 
critical for the comparative performance of different surgical options remains open. This 
question is especially relevant when comparing extra-cardiac and intra-atrial approaches, 
which host very different levels of instabilities and mixing even under non-pulsatile 
conditions. 
 Accordingly, the hypothesis of this thesis is two folds: we first hypothesize that 
immersed-boundary CFD methods are ideally suited to conduct patient-specific 
surgical planning within a clinical setting, and then that a thorough understanding of 
the in vivo pulsatile hemodynamics of intra-atrial and extra-cardiac options is a critical 
step towards more refined post-operative modeling. These hypotheses will be addressed 
in three steps: 
1) Tailor existing immersed boundary methods to achieve high resolution simulations at 
low computational costs in arbitrarily complex geometries, under both steady and 
pulsatile conditions 
2) Investigate the pulsatile hemodynamics of extra-cardiac and intra-atrial TCPCs using 
in vivo anatomies and flow curves 
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3) Conduct pre-operative surgical planning studies for SVHD patients with an 
interrupted IVC 
The structure followed for each of these specific aims is detailed in the subsequent 
paragraphs.  
 
Specific Aim 1. Achieve high resolution simulations at low computational costs in 
arbitrarily complex geometries by optimizing the data structure of sharp-interface, 
immersed boundary (SIIB) methods. The main challenges to be addressed in this 
specific aim are to define a numerical approach that 1) allows for the fine discretization 
of arbitrarily complex in vivo structures with minimum user interaction; 2) accurately 
captures the unsteady dynamics of in vivo flows. To this end, the approach retained builds 
upon an existing sharp interface immersed boundary (SIIB) method [122, 123], whose 
accuracy has previously been demonstrated for external flow applications around a 
swimming fish [122] or around a moving heart valve leaflet [153-156]. SIIB approaches 
are ideally suited for our application as they circumvent the mesh generation difficulties: 
the complex geometry is immersed in a background Cartesian grid, and the Navier-
Stokes equations are solved only for the Cartesian grid nodes that fall within the fluid 
domain. However, in the context of the TCPC these approaches face the challenge that 
most of the Cartesian grid nodes fall outside of the flow domain. These “non-fluid” nodes 
impose an unnecessary memory and computational overhead without enhancing the 
numerical resolution in the region of interest, and ultimately limit the maximum 
achievable accuracy. To remedy this situation, we will recast the original structured SIIB 
formulations into an unstructured Cartesian grid layout, which will solely retain the fluid 
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Cartesian nodes and drop all non-fluid nodes, and take advantage of the bijective 
mapping that exists between the unstructured fluid grid and the underlying structured 
Cartesian grid to prescribe the unstructured connectivity. 
The efficiency of our method will be demonstrated by carrying out systematic 
mesh refinement studies for several internal flow problems ranging in complexity from 
flow in a 90 degree pipe bend to flow in patient-specific TCPC anatomies. Accuracy will 
be assessed by comparing the computed flow fields to experimental measurements 
obtained in the same geometries under both steady and pulsatile inflow conditions. 
 
Specific Aim 2. Investigate the effect of pulsatility in intra-atrial and extra-cardiac 
patient-specific TCPCs. The objective of this aim is to gain insights into the pulsatile in 
vivo TCPC hemodynamics, assess whether neglecting pulsatility affects the predicted 
performance ranking of different options, and if so determine whether pulsatility should 
be accounted for in all options or only in intra-atrial ones. To achieve this specific aim, 
extra-cardiac and intra-atrial patients will be selected from the Georgia Tech Fontan 
database of magnetic resonance images (MRI) based on the availability of anatomical 
reconstruction, inflow/outflow flow curves, and 3D in vivo flow reconstruction [80]. 
Simulations will be conducted using the patient-specific geometries and flow curves, with 
rigid boundaries. Comparison with controlled in vitro experiments under the same 
conditions will testify for the accuracy of the flow solver, while comparison to the 
reconstructed in vivo flow fields will test for the validity of the modeling assumptions, 
namely rigid wall and prescribed flow boundary conditions. Finally, to quantify the effect 
of pulsatility on the TCPC efficiency, each pulsatile simulation will be accompanied by a 
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constant inflow counter-part, conducted using the same in vivo anatomy but with the 
mean vessel flow rate rather than in vivo flow curve. Comparing the flow structures, 
pressure drops, power losses and hepatic flow distribution predicted by the steady inflow 
simulations to those obtained by averaging the pulsatile simulations over a cardiac cycle 
will for the first time quantify the relative impact of flow pulsatility in patient specific 
geometries across different TCPC templates. This knowledge will then determine 
whether efforts should be placed in designing statistical models of the flow pulsatility in 
virtual-surgery options to further refine post-operative modeling. 
 
Specific Aim 3. To pre-operatively determine the TCPC geometry that will 
optimize hepatic flow distribution and energy dissipation for patients featuring an 
interrupted IVC with azygous continuation. One of the most challenging SVHD 
subgroups from a clinical and surgical prospective is SVHD patients featuring an 
interrupted IVC with azygous continuation. Clinical studies [67, 69] report an especially 
high incidence of unilateral PAVMs in these patients, due to a mal-distribution of the 
hepatic nutrients through the TCPC to the diseased lung. The fact is that, in these 
patients, the distribution of hepatic flow to the lungs is even more sensitive to the design 
of the TCPC than in patients without interrupted IVC, while the large number of 
anatomical and flow abnormalities make it even more difficult for surgeons to identify 
the best-suited surgical approach based on anatomical observations alone. This is the 
exact setting where fluid dynamics and associated flow distributions could make or break 
the surgery, and virtual surgical planning make a significant clinical impact.  
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The feasibility of such a surgical approach will be demonstrated by the combined 
use of the virtual surgery interface developed by Dr Jarek Rossignac and the flow solver 
presented in SA1. The pre-operative anatomy and flows will be obtained from magnetic 
resonance images. Virtual surgeries will be designed within the virtual surgery interface 
in close synergy with the surgeon assigned to the patient. CFD simulations will then be 
conducted on each designed option to predict the associated hemodynamics performance. 
Emphasis will be set on optimizing the TCPC design for an even distribution of blood 
flow and hepatic nutrients to the left and right lungs. Secondary optimization metrics will 
include power losses and pressure drops across the connection. Whenever such 
information will be available, the recommended option will be compared to the one 
actually performed in vivo, and predicted performance will be contrasted to clinical 
follow-up data.  
In addition to a direct benefit to the patient under consideration, this study will 
also have a larger impact for the clinical management of SVHD patients with an 
interrupted IVC. First, the systematic review of the various geometries investigated for 
each surgical planning case will allow for a better definition of the different “anatomical 
templates” (e.g. interrupted IVC combined with a single SVC or bilateral SVCs, 
classification based on the relative position of the azygous and inominate vein). Then, it 
will shed light onto the impact of caval offset, vessel flaring and other design parameters 
upon TCPC hemodynamics depending on the underlying patient anatomy. These results 
will provide useful surgical guidelines for each anatomical template, which could benefit 
the global surgical community, including centers that do not have access to patient-
specific surgical planning interfaces. 
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CHAPTER 5 
STUDY DESIGN AND PROTOCOLS 
 
In this chapter, we describe the methods and protocols used for the two arms of 
our study, namely the investigation of the pulsatile hemodynamics of the total 
cavopulmonary connection (TCPC), and the pre-operative surgical planning studies. We 
first present the overall study design of these two investigations, followed by a 
description of each technical milestone, from patient data acquisition, to numerical 
modeling and extraction of the clinically relevant metrics. The mathematical formulation 
of the computational fluid dynamic (CFD) solver developed for these studies is addressed 
separately in Chapter 6.  
 
5.1 Study Design and Methodology Overview 
Prior to delving into the different methodologies used, it is important to recall the 
goals of the pulsatile and surgical planning studies and outline the overall processes 
required to achieve them. The study design of the pulsatile study is illustrated in Figure 
5-1. This study investigates the impact of pulsatility on the hemodynamics of different of 
TCPC connection types. To this end, we compare the hemodynamics obtained using the 
pulsatile in vivo flow curves to the ones obtained using the mean in vivo flow rates in a 
controlled idealized TCPC representation first, and then for three patients having each 
undergone a different TCPC procedure. The comparison of the pulsatile and non-pulsatile 
results for the same patient will demonstrate whether pulsatility has strong impact on the 
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clinical end-points for that patient, whereas the comparison across the four different 
patients will highlight whether some procedures are more sensitive to pulsatility than 
others. We will also compare the pulsatile CFD results to the 3D in vivo flow fields 
obtained from magnetic resonance imaging (MRI). This last comparison will provide 
preliminary insights into the impact of some of our numerical modeling assumptions, 
notably neglecting wall motion, upon the range of validity of our simulations.  
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CFD using mean vessel 
flow rates
•Can the TCPC hemodynamics and efficiency be 
characterized using the mean vessel flow rates?
•Are some TCPCs more sensitive to pulsatility than 
others? 
Patients with different TCPCs (n=3)
MRI and PC MRI acquisition
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CFD using in vivo flow 
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In vivo pulsatile flow 
fields from PC MRI
Flow fields and efficiency 
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running average 
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Comparison
•Strength and limitations of PC MRI 
and CFD for in vivo flow 
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Figure 5-1: Study design of the pulsatile investigations. The gray boxes depict steps that 
were performed by collaborators, while the blue boxes highlight the core of our work.  
 
 
The surgical planning study makes use of the image processing tools developed in 
our laboratory and of the flow solver developed in this thesis, to help surgeons identify 
the best-suited TCPC implementation on a patient-by-patient basis. The overall 
framework is presented in Figure 5-2. The first step is the acquisition of clinical images 
(preferably MRI) to obtain the patient’s pre-operative anatomy and flow rates. The pre-
operative anatomy is loaded into a virtual surgery interface, where the user or surgeon 
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can virtually perform multiple different surgical procedures and compare their 
hemodynamic performance, as predicted by the in-house CFD solver developed in the 
course of the present thesis. This patient-specific surgical planning framework is applied 
to six patients who were referred for the completion or redo of the final stage of the 
TCPC, i.e. to connect the hepatic veins to the pulmonary arteries. A subset of the surgical 
planning patients (4 out of 6) already had a completed TCPC at the time of referral, but 
suffered from severe complications due to an improper TCPC design in the first round. 
For these four patients, an additional set of simulations was conducted prior to the 
surgical planning to investigate the hemodynamics of the failing connection, and use that 
knowledge to guide the design of possible corrective procedures in the subsequent steps.  
 
 
Patients referred for completion/redo 
of the 3rd stage TCPC (n=6)
Performance Comparison
Clinical Imaging (MRI & PC MRI, or CT)
•Identify the best performing option for each patient
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surgical guidelines
CFD CFD CFD CFD
Unsteady, non-pulsatile CFD
Pre-operative assessment
Virtual Surgery:
Generation of multiple alternate 
TCPC options
 
Figure 5-2: Study design of the surgical planning investigations. The gray boxes depict 
steps that were performed by collaborators, while the blue boxes highlight the core of our 
work.  
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Finally, by reviewing the results obtained across all six patients, we draw general 
guidelines and identify cases for which individualized surgical planning remains the only 
recommendable approach. 
Although seeking to answer different questions, both the pulsatile and surgical 
planning investigations use the same array of tools and methods, including: clinical 
image acquisition, image processing to extract the in vivo anatomies and flows, computer 
aided design (CAD) to manipulate the in vivo geometries, image-based numerical 
modeling, and finally extraction of the clinically relevant metrics. The general 
organization of each one of these steps is best illustrated by the flow chart shown in 
Figure 5-3. Similarly to the color-scheme used in Figure 5-1, the work conducted by our 
collaborators, namely the clinical imaging and image processing, is shown in gray to be 
differentiated from our contribution. Each point is addressed in turn in the following 
sections. We first describe our patient selection criteria, followed by a brief background 
on the clinical imaging modalities used. We then detail every technical step, lumped into 
five main categories: (1) the handling of the anatomies would they be patient-specific or 
virtual surgical options, (2) the extraction of the vessel flow curves and mean flow rates, 
(3) the reconstruction of the 3D in vivo flow fields (for the pulsatile study only), (4) the 
set-up of the CFD simulations, and (5) the extraction of the clinically relevant metrics.  
 
5.2 Patient Selection 
The four patients recruited as part of the pulsatile study were retrospectively 
selected from the Georgia Tech database of Fontan patients. These patients were 
recruited based on the availability of the following three sets of in vivo information: a) 
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3D reconstruction of the TCPC geometry, b) flow curves through each one of the TCPC 
vessels, and c) 3D reconstruction of the in vivo velocity fields. For the surgical planning 
study, the patients were enrolled on a surgical-need basis. In an effort to address as large 
a patient population as possible, the enrollment criteria for these patients were less 
stringent than for the pulsatile study, and only the 3D reconstruction of the pre-operative 
anatomy and mean vessel flow rates were required. 
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Figure 5-3: Methodology overview. The gray boxes depict steps that were performed by 
collaborators, while the blue boxes highlight the core of our work.  
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5.3 Imaging Modalities Used 
Magnetic resonance imaging (MRI) was the clinical imaging modality of choice 
for this study, as it has the unique ability to non-invasively provide both anatomical and 
velocity measurements. MRI uses a powerful magnetic field to align the nuclear 
magnetization of the free-precessing hydrogen protons, typically found in water inside 
the body. Radio frequency (RF) fields are used to systematically alter the alignment of 
this magnetization, causing the hydrogen nuclei to produce a rotating magnetic field 
detectable by the scanner. This signal can be manipulated by additional magnetic fields to 
build up enough information to construct an image of the body. 
Anatomical MR images provide a density map of the free-precessing hydrogen 
protons. Cardiovascular applications typically make use of a True-FISP sequence (true 
fast imaging with steady state precession), an example of which is provided in Figure 5-4. 
True-FISP sequences are encoded such that high proton densities (such as blood) appear 
in white, whereas lower densities (such as the pulmonary airways or soft tissues) appear 
in black. This sequence thus optimizes the contrast between the blood stream and the 
surrounding structures, which is ideally suited for the reconstruction of the TCPC blood 
vessels needed for our applications. Furthermore, True-FISP MRI is fast and relatively 
motion insensitive, which makes it a reliable technique, even in patients who have 
difficulties holding their breath as is often the case in young subjects such as the Fontan 
patients.  
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airways
Blood in the heart
Lipidic layer
 
Figure 5-4: Example of a True-FISP anatomical MRI of the heart in a four chamber view. 
The heart, blood vessels and the lipidic layer under the skin, all of which are rich in 
water, appear in white, whereas the pulmonary airways appear in black. 
 
 
Beyond anatomical features, MRI can also non-invasively quantify blood 
velocities. The basic principle is to subject the free-precessing hydrogens protons to two 
consecutive magnetic gradient pulses of opposite signs, Gx and -Gx. For static protons, the 
two pulses will cancel out. However, for protons moving at a velocity Vx in the direction 
of the magnetic gradient, this will translate into a phase shift, xφ , in the measured signal. 
This phase shift is directly proportional to the velocity of the protons, and can be 
expressed as: 
 xxx VG ⋅=
22 τγφ  (5-1) 
where γ is the gyromagnetic ratio of protons, and τ is the length of the magnetic gradient 
pulse Gx. The image created as a result of these phase shifts constitute what is called a 
phase-contrast MRI (PC MRI) acquisition. 3D velocity vectors can be obtained by 
performing three consecutive PC MRI acquisitions encoded for three orthogonal spatial 
directions, as exemplified in Figure 5-5. The velocities in each direction can be recovered 
from the pixel intensity by a simple linear transformation, the white pixels corresponding 
to the maximum positive velocity along the encoding direction, the black pixels the 
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maximum negative velocity, and the gray pixels a zero velocity. The signal in the 
pulmonary airways and surrounding atmosphere is characterized by salt-and-pepper 
noise. 
 
Blood 
flowing
Salt &pepper 
noise in the:
•athmosphere
•lungs
Foot-Head Left-Right Anterior Posterior
 
Figure 5-5: Example of a 3D PC MRI acquisition. All three images are acquired in the 
same plane, but with the velocity encoded in three orthogonal directions, namely in the 
Foot-Head, Left-Right, and Anterior-Posterior directions.  
 
 
A drawback of MRI is that it requires the exposition of the patient to a strong 
magnetic field. While this is not harmful per se, it is totally counter-indicated if the 
patient has metallic implants, such as coils or pacer wires. Two of the patients enrolled in 
the surgical planning study featured such devices and were imaged using X-ray computed 
tomography (CT). Similarly to the anatomical MRI images, CT images capture the blood 
stream with a pixel intensity different from those of the surrounding organs. Similar 
image processing techniques can thus be applied to both types of images to extract the 
anatomical information. However, CT does not allow for velocity measurements. As will 
be discussed in the corresponding results section (Chapter 9), flow conditions for these 
two patients were obtained from invasive catheterization measurements, or from mean 
flow values in patients of similar age and weight when no other measurement was 
available. 
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5.4 Preparation of the In Vivo and Surgical Planning Anatomies 
This section details the processes leading from the anatomical images to a surface 
mesh readily usable in the CFD simulations.  
 
5.4.1 Imaging Protocol 
A stack of anatomical (MRI or CT) images was acquired in the axial direction 
spanning the entire thorax (Figure 5-6). The anatomical images were acquired at a single 
time-point in the cardiac cycle, providing a static representation of the TCPC geometry, 
with a typical in-plane resolution of 0.5 to 1 mm per pixel and a slice thickness of 3 to 5 
mm. Depending on the size of the patient 40 to 50 True-FISP MRI images and 100 to 150 
CT images were required to cover the thorax, spanning from the confluence of the 
hepatic veins into the inferior vena cava (IVC) to the top of the aortic arch.  
 
 
Sample acquisitionAcquisition location
Axial Anatomical Images
Top of the aortic arch
Confluence of the hepatic 
veins and IVC
True-
FISP
MRI
CT
3 to 5
0.75 to 1.5
1
40-50
True-FISP 
MRI X-ray CT
100-150Number of slices
0.5Slice Thickness (mm)
0.5Pixel size (mm)
1Number of time points
Acquisition Parameters
 
Figure 5-6: Anatomical acquisition protocol. The location of the acquisition planes is 
shown by the black lines overlaid on the TCPC and heart. 
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5.4.2 Reconstruction of the TCPC Geometry 
The 3D geometry of the TCPC is reconstructed from the anatomical images, using 
a methodology previously developed in our laboratory [157, 158] and illustrated in 
Figure 5-7. Since the in-plane resolution of the MRI or CT images is typically three to 
five times finer than the out-of-plane resolution due to MRI constraints, these images are 
first interpolated to an isotropic voxel size in order to improve the overall accuracy of the 
anatomical reconstruction[157]. This interpolation is achieved using the adaptive control 
grid interpolation technique developed by Frakes and co-workers[157]. The TCPC flow 
domain is then interactively segmented in each one of the interpolated slices using a 
bouncing ball algorithm[158] (Figure 5-7 a). The segmented contours are finally 
imported into Raindrop Geomagic Studio 9.0 (Geomagic Inc., NC, USA) and a surface is 
fitted to the contours to create a 3D reconstruction of the geometry (Figure 5-7 b and c).  
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Figure 5-7: Main steps for the reconstruction of a TCPC anatomy from a stack of axial 
MRI, performed using a combination of in-house interpolation and segmentation 
software and Geomagic Studio 9.0 (Geomagic Inc., NC, USA) for the surface fit. 
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5.4.3 Surface Finish: Smoothing and Creation of Planar Vessel Cross-
Sections 
The reconstructed anatomies typically feature number of surface irregularities, 
which stem from slight deviations in the MRI segmentation process but are not 
representative of what is seen in vivo. In regard of the upcoming CFD simulations, it 
should also be ensured that all surface elements follow the same orientation, with their 
normal pointing towards the vessel lumen. Accordingly, after their reconstruction the 
TCPC anatomies are imported into a CAD software, Geomagic Studio 9.0 (Geomagic 
Inc., NC, USA), for further smoothing and post-processing. The main surface processing 
steps are illustrated in Figure 5-8. Surface irregularities are smoothed out using the “sand-
paper” option offered by the software. The element orientation can be readily visualized 
in Geomagic Studio, as elements pointing towards the vessel lumen should appear in 
blue, while inverted elements should appear in yellow. Inverted elements are deleted and 
the holes filled based on the surface curvature. Finally, the prescription of the CFD flow 
boundary conditions at each inlet and outlet requires planar vessel cross-sections. These 
vessel cross-sectional cuts are created by intersecting the TCPC surface with a plane 
oriented perpendicularly to the vessel axis. For consistency across datasets, the inlet and 
outlet cross-sections are systematically taken at the following locations: 
- Just downstream of the confluence between the hepatic veins and the IVC 
- Just downstream of the confluence between the innominate vein and the SVC 
- And just upstream of the point where the LPA and RPA branch into smaller vessels 
For the surgical planning options, these cuts are taken on the pre-operative anatomy, prior 
to any virtual surgery modifications, so as to ensure that all the options designed for a 
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given patient considered the same vessel configurations. A detailed protocol for the 
surface processing steps performed in Geomagic Studio 9.0 (Geomagic Inc., NC, USA) is 
provided in Appendix A.1. 
 
 
Surface from MRI 
reconstruction
Cleaned surface
Planar Cross-section
Fit surface patches and 
export surface as .igs
 
Figure 5-8: Surface finish operations performed in Geomagic Studio 9.0 (Geomagic Inc., 
NC, USA): (a) TCPC surface as obtained from PC MRI, (b) after surface smoothing, (c) 
after the creation of planar inlet/outlet cross sections. 
 
 
5.4.4 Creation of Virtual Surgical Options 
A major milestone for the planning of surgical procedures is the ability to modify 
the pre-operative anatomy and design different post-operative configurations. Studies 
limited to only a few cases have typically employed commercially available CAD tools to 
manually modify geometries[88, 89]. Such processes are cumbersome and depend on the 
skill of the operator, especially when applied to complex anatomies. In this thesis, we 
thus used the virtual-surgery interface developed by Rossignac and co-workers[159-162] 
to easily design a large number of options for each patient.  This interface makes use of 
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the recent advances in 3D geometrical morphing, image rendering and human-computer 
interaction to provide an environment where the user can easily interact with the 
reconstructed anatomy.  
Performance of a virtual surgery within that interface is illustrated in Figure 5-9. 
For surgical planning applications, the anatomical reconstruction procedure described in 
Section 5.4.2 is not only applied to the TCPC (shown in red in Figure 5-9) but also to the 
surrounding cardiovascular structures, such as the heart, aorta and pulmonary veins 
(shown in blue in Figure 5-9), to better represent the constraints faced by the surgeon. 
The semi-transparent tube features an artificial extra-cardiac graft to be placed. Using 
two 3D magnetic trackers, one each hand, the user can precisely set the graft in place and 
deform it to follow the curvature of the heart and avoid the surrounding vessels.  
 
 
 
Figure 5-9: Performance of a virtual surgery within the interface developed by Rossignac 
and co-workers [101, 161]. The vessels involved in the TCPC (shown in red) and 
surrounding anatomical structures, such as the heart and great vessels (shown in blue), 
have been reconstructed from MRI and loaded into the virtual-surgical interface (A). 
Using two haptic trackers, one in each hand, the user/surgeon may directly interact with 
the geometry, here placing and deforming an artificial graft to complete the TCPC (B). 
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The above interface allows for the fast design of a large number of possible grafts, 
varying the point of connection, degree of curvature, using intra-atrial or extra-cardiac 
approaches, or even bifurcated Y-shaped grafts. However, in its current state, that 
interface does not allow for the thus-created graft variations to be stitched to the patient’s 
anatomy. All stitching or cutting operations are thus performed off-line using the 
Geomagic Studio 9.0 (Geomagic Inc., NC, USA), as illustrated in Figure 5-10. The in 
vivo anatomy and virtual graft are first united using the Boolean operation toolkit. The 
anastomosis site is then smoothed to better represent what would be seen in vivo. For 
patients who had a completed TCPC but required a new baffle to be designed, the 
original baffle was deleted and the two ends filled based on the vessel curvature. 
 
 
“Clean” anatomy Take down the
pre-operative IVC graft
Boolean union
Alternate graft designed in the 
surgical planning interface
Create smooth 
connection sites
 
Figure 5-10: Stitching and cutting operations performed in Geomagic Studio 9.0 
(Geomagic Inc., NC, USA)  
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5.4.5 Surface Mesh Generation for CFD  
Having prepared the in vivo or surgical planning geometries, the final step 
consists in discretizing the TCPC with an unstructured triangular surface mesh to be 
imported into the CFD flow solver. This is achieved using the commercial meshing 
software Gambit 2.4 (ANSYS Inc., PA, USA). To increase the stability of the CFD 
simulations, the pulmonary arteries are extended by approximately 5 vessel diameters, 
allowing the swirling pulmonary flows to reattach prior to reaching the outlet of the 
domain. Similarly, the inlets are extended by approximately one diameter to avoid any 
spurious effect of the boundary condition prescription on the flow dynamics within the 
connection itself. The extended geometry is discretized with an unstructured triangular 
surface mesh using a typical resolution of 1 to 1.5 mm. The surface mesh is exported 
using the FIDAP file format, which is readily usable by the CFD flow solver. A detailed 
protocol for the surface mesh generation is provided in Appendix A.2. This step 
completes the anatomy preparation section. 
 
 
Import .igs from 
Geomagic
Extend inlet/outlet 
vessels
Unstructured triangular 
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Figure 5-11: Vessel extension and surface meshing in Gambit 2.4 (ANSYS Inc., PA, 
USA). 
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5.5 Vessel Flow Rates 
After meshing the in vivo or surgical planning anatomies, the second requirement 
for patient-specific simulations is to obtain the patient-specific flow conditions. Here, we 
detail the imaging modality and acquisition protocol used to measure the TCPC flow 
rates in vivo, and the subsequent image processing and analysis required to extract the 
necessary information. 
 
5.5.1 Imaging Protocol 
In order to provide flow boundary conditions at each inlet and outlet of the TCPC, 
one PC MRI slice was acquired across each one of the TCPC vessels. The slices were 
oriented normally to the vessel axis, and only the through-plane velocity was captured 
(Figure 5-12). For consistency across patients, the PC MRI cross-sections were acquired: 
- Just downstream of the confluence between the hepatic veins and the IVC 
- Just downstream of the confluence between the innominate vein and the SVC 
- And just upstream of the point where the LPA and RPA branch into smaller vessels 
 
 
Through-Plane PC MRI for flow boundary conditions
4 to 6 
(depending on 
anatomy)
Number of 
slices
3 to 6 mmSlice Thickness
0.7to 1.5 mmPixel size
20 to 30Number of time points
Acquisition Parameters Sample acquisitionAcquisition locations
 
Figure 5-12: PC MRI acquisition protocol for the vessel flow rate characterization. The 
location of the acquisition planes is shown by the black lines overlaid on the TCPC.  
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For each cross-sectional slice, data were acquired at 20 to 30 evenly-spaced time points 
in the cardiac cycle depending on the heart rate of the patient (a slower heart rate 
allowing for more acquisitions than a fast one).  
 
5.5.2 Extraction of the TCPC Vessel Flow Rates 
The pixel intensity in each one of the through-plane PC MRI acquisitions is 
linearly proportional to the through-plane velocity component, so that the velocity field 
within a region of interest can be quantified with a simple linear transformation. The key 
is to properly isolate the vessel cross-section of interest, namely one of the TCPC inflows 
or outflows. This segmentation is performed using the approach developed by 
Sundareswaran et al. [163], which combines gradient flow, parametric active contours to 
identify the vessel borders and an adaptive median filtering to remove the spurious noise 
vectors close to the vessel walls. Once the vessel is segmented, the vessel flow rate is 
simply obtained by integrating the out-of-plane velocity component over the cross-
section. The process is iterated over the 20 to 30 acquisition time points, yielding a 
characteristic flow curve for each vessel, as exemplified in Figure 5-13. For the non-
pulsatile simulations, these flow curves were then averaged over the cardiac cycle, 
yielding a single mean flow rate value per vessel. 
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Figure 5-13: Example of the inflow and outflow curves as computed from PC MRI. The 
black lines depict the sum of the inflow or outflow rates.  
 
 
5.5.3 Flow Corrections for the CFD Boundary Conditions 
As can be observed from Figure 5-13, the sum of the incoming flow rates as 
computed from PC MRI was generally not equal to the sum of the outgoing flows 
through the left and right pulmonary arteries. This might be attributed to the small  
dimensions of the pulmonary arteries, which leads to a larger error in the PC MRI 
measurements. Irrespective of the underlying reason for this discrepancy, the flow 
conditions to be prescribed in the CFD simulations should ensure a global mass 
conservation. Accordingly, the in vivo PC MRI measurements are corrected as follows. 
Assuming the incoming flow rates to be more accurate, the flow conditions at the TCPC 
inlets are prescribed using the in vivo flow measurements. The outflow boundary 
conditions on the other hand are prescribed using the in vivo LPA/RPA flow ratios. 
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The resulting flow conditions for non-pulsatile simulations will thus read as 
follows: 
 MRIPCI
CFD
I QQ =  (5-2) 
 ∑
∈
⋅
+
=
nflowiI
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IMRIPC
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where IQ  denotes the mean flow rate through the inlet I, RPAQ and LPAQ indicate the 
mean flow rates through the RPA and LPA outlets, respectively, the PC MRI superscript 
denotes the values obtained from the PC MRI measurements and the CFD superscript 
denotes the values used for the CFD boundary conditions. 
The same approach is propagated to the pulsatile simulations, where the in vivo 
flow curves are prescribed at the inlets, while the time varying in vivo flow ratios are 
used at the outlets. An additional step is, however, required to more finely discretize the 
flow rate and flow ratio curves than the 20 to 30 time points provided by the PC MRI 
measurements. These curves were thus first decomposed into a Fourier series of sine 
waves, from which the signal could be reconstructed with a higher temporal resolution.  
 
5.6 In Vivo 3D TCPC Velocity Fields 
With the recent progresses in acquisition and post-processing techniques, PC MRI 
now constitutes an attractive approach to characterize the in vivo velocity fields on a full 
volumetric dataset (and not only in a few acquisition slices). All four patients retained for 
the pulsatile investigation were selected based on the availability of reconstructed 3D in 
vivo velocity fields, to compare the CFD predictions and in vivo measurements. The 
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subsequent sections briefly describe the acquisition parameters and velocity 
reconstruction.  
 
5.6.1 Imaging Protocol 
Compared to anatomical MRI, PC MRI requires a long acquisition time, which 
limits its application for detailed hemodynamic investigations, especially in young or 
diseased subjects who may not be able to stay in the magnet for the necessary amount of 
time. Accordingly, for the velocity reconstructions, the 3D PC MRI slices were acquired 
in the coronal direction, allowing the entire TCPC to be covered with 6 to 10 slices rather 
than the 40-50 axial slices used for the anatomical acquisition. The slice orientation and 
typical acquisition parameters are given in Figure 5-14. It might be noted that the spatial 
resolution in every direction is two to three times coarser than in the anatomical MRIs. 
 
 
Coronal, 3D PC MRI to reconstruct the 3D in vivo flow fields
5 to 10Number of slices
3 to 6 mmSlice Thickness
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Acquisition Parameters Sample acquisitionAcquisition locations
 
Figure 5-14: PC MRI acquisition protocol for the reconstruction of the 3D in vivo 
velocity fields. 
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5.6.2 Reconstruction of the 3D Velocity Fields 
Obviously, characterizing the TCPC with only a limited number of slices comes 
at the cost of spatial resolution. In order to visualize the detailed in vivo 3D flow 
structures, the coronal PC MRI measurements were thus interpolated to an isotropic 
voxel size of 1 to 2mm. Scalar interpolation methods, where each velocity component is 
interpolated individually, do not perform well on 3D PC MRI data-sets and are especially 
sensitive to the high levels of noise present in the vicinity of the vessel walls. The 
divergence-free interpolation developed by Sundareswaran et al. [80] takes advantage of 
the incompressible properties of blood to interpolate all three velocity components in 
conjunction. In addition, Sundareswaran et al. [80] impose a no-slip boundary condition 
along the vessel walls, which constrains the velocities to be null at the vessel boundaries 
and efficiently filters the noise in the vicinity of the walls. Recursively applying this 
divergence-free interpolation to the 20 to 30 acquisition time points yields a time-
dependent representation of the 3D in vivo velocity fields. For the four patients selected 
for the pulsatile study, the time-dependent velocity reconstructions were readily available 
as per the work of Sundareswaran and Haggerty.  
 
5.7 CFD Simulations 
With the surface meshes of the in vivo or surgical planning anatomies created in 
Section 5.4 and the patient-specific flow conditions obtained from Section 5.5, detailed 
hemodynamic evaluations can now be performed using the flow solver developed as part 
of the first specific aim of this thesis. For the clarity of our presentation, the mathematical 
formulation of the solver is addressed separately in Chapter 6, and only the set-up of the 
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CFD simulations is treated in this section. Detailed instructions regarding the input 
parameter prescription are provided in Appendix A.3 and Appendix B. 
 
5.7.1 Non-Dimensionalization 
In our solver formulation, we solve the incompressible Newtonian Navier-Stokes 
equation in their non-dimensional form, using one of the TCPC inlets as the reference for 
normalization. Assuming that the vessel of reference is the inferior vena cava (IVC), the 
velocities are normalized by the mean velocity at the IVC inlet, IVCU , and the distances 
by the equivalent IVC diameter, IVCD , defined as πIVCIVC AD 2= , where IVCA  is the 
area of the IVC inlet cross-section. Time is normalized by the characteristic time scale 
defined as IVCIVC UD , and pressure by 
2
IVCUρ , where -3mkg 1060 ⋅=ρ is the density of 
blood. Finally, we define the characteristic Reynolds number to be 
( ) μρ IVCIVC DU ⋅=Re , where -1-1 smkg 3.71 ⋅⋅=μ  is the viscosity of blood.  
 
5.7.2 Volume Mesh Generation 
Resolution of the Navier-Stokes equations requires both a robust flow solver, and 
an adequate discretization of the fluid domain. This last point constitutes a major 
challenge for in vivo applications due to the difficulty to generate computational volume 
meshes that can adequately describe the complexity of real-life anatomies. Unstructured 
grids provide a natural choice for tackling such problems and have been used with a great 
deal of success [124-126], but typically involve higher computational overhead than 
structured grids. Structured curvilinear body-fitted meshes have also been used for this 
purpose but in conjunction with overset Chimera grids [87]. Even when domain 
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decomposition is employed, the generation of good quality, composite, boundary-
conforming meshes could be cumbersome and time consuming for realistic anatomies 
[87]. The formulation retained for this thesis effectively addresses these difficulties using 
an immersed-boundary approach. The Navier-Stokes equations are solved on a structured 
Cartesian grid, which can easily be generated, and the location of the TCPC vessel wall is 
carefully tracked to appropriately prescribe the boundary conditions. 
Accordingly, provided with the unstructured surface meshes generated in Section 
5.4, the only parameters required to generate the volume mesh are 1) the characteristic 
distance used to normalize the TCPC geometry, and 2) the non-dimensional spatial 
resolution for each one of the Cartesian grid directions. The spatial resolution used in this 
thesis typically was of 0.02 DIVC, but finer grids were employed in cases were severe 
vessel stenoses were present, for example. A detailed mesh refinement study supporting 
this parameter setting is provided in Chapter 7. 
 
5.7.3 Boundary Conditions 
Flow boundary conditions are prescribed using the corrected time-averaged flow 
rates or corrected flow curves from Section 5.5. Since all computations are conducted in 
non-dimensional form, caution should be paid to appropriately normalize the vessel flow 
rates and cardiac cycle duration. All flow simulations reported in this thesis use one of 
two types of inlet velocity profiles: 1) a flat velocity profile where the velocity is uniform 
across the inlet cross-section; or 2) a parabolic velocity profile based on the equivalent 
hydraulic diameter of the inlet under consideration. The velocity profile at the outflows is 
extrapolated from the fluid domain and rescaled to enforce global mass conservation. 
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Finally, the immersed TCPC vessel wall is treated as a rigid, no-slip wall. Details on the 
formulation of these boundary conditions may be found in Chapter 6, Section 6.2. 
 
5.7.4 Convergence Criteria 
For all simulations, convergence at each time-step is ensured by constraining the 
mean divergence to reduce by 3 orders of magnitude or more, and the maximum non-
dimensional divergence to fall below 0.001. Non-pulsatile flow simulations are iterated 
until convergence of the running average, which is assessed by tracking the pressure and 
velocity time histories at selected points within the computational domain. These trackers 
are typically set at the center of the connection and within the pulmonary outflow tracks. 
Pulsatile simulations are iterated over a minimum of 3 cardiac cycles. The first cardiac is 
systematically discarded as it does not account for the unsteady effects imparted by the 
earlier cycles. 
 
5.8 Clinical Metrics Extraction 
As highlighted in the clinical background (Section 1.5), the postulated pathways 
through which a given TCPC impacts the long-term outcome of a patient include: 
- the pressure drops across the connection, which in turn impact the pressure levels in 
the gastro-intestinal track, higher pressures being correlated with a higher risk for 
protein losing enteropathy 
- the power lost across the connection, which increases the workload imposed on the 
single ventricle by an equal amount 
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- and the distribution of the hepatic nutrients to the left and right lung, which condition 
their development, a low supply in hepatic nutrients being correlated with the 
development of pulmonary arterio-venous malformations. 
The above metrics will thus be the central focus of our analyses. When deemed 
necessary, qualitative visualization of the flow structures or pressure drops will also be 
provided in order to elucidate the mechanisms leading to an increased energy dissipation, 
or a given hepatic flow distribution. Unless otherwise specified in the corresponding 
chapters, all non-pulsatile flow fields, pressures or hepatic flow distributions shown in 
this thesis are obtained using the converged running average, while the pulsatile results 
correspond to the instantaneous flow fields. Extraction of the velocity and pressure fields, 
power loss calculation, and hepatic flow distribution quantification are addressed in turns 
in each one of the following subsections.  
 
5.8.1 Extraction of the Flow and Pressure Fields 
The first step for all subsequent post-processing is to remove the vessel 
extensions, which were solely added for computational purposes but do not correspond to 
any in vivo structures. This is achieved using an in-house code that reads in the 
unstructured Cartesian grid used for the computations and a triangular surface mesh of 
the TCPC geometry without extensions created in Gambit 2.4 (ANSYS Inc., PA, USA). 
All points falling outside of the domain delimited by the surface mesh without extension 
are discarded. Distances, velocities and pressures are re-dimensionalized to cm, cm/s and 
mmHg units providing clinically meaningful information, and written into an ASCII file 
format to be read by any visualization software. All visualizations performed herein used 
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Tecplot 360 (Tecplot Inc., WA, USA). Finally, velocities and pressure are averaged over 
each inlet and outlet of the TCPC domain with no extensions, providing the pressure 
drops and velocity values needed for the power loss calculations.  
 
5.8.2 Power Loss Calculations 
The power losses, E& , across the TCPC are computed using the following control 
volume expression 
 ( ) ( ) ( )∫ ⋅⎟⎠
⎞
⎜
⎝
⎛ +=
S
dSnxuxuxPE rrrrrr& 2
2
1 ρ  (5-5) 
 
Where 1060=ρ  kg/m3 is the density of blood, P is the static pressure, ur  is the velocity 
vector, S is the TCPC surface, including inlets and outlets, dS is the surface element, and 
nr  is the inward surface normal. The instantaneous and mean power losses are computed 
the in-house code depicted above during the removal of the vessel extensions, avoiding 
the need to perform additional integrations. 
 
5.8.3 Hepatic Flow Distribution Quantification 
Quantification of the hepatic flow distribution to the left and right lung first 
requires the knowledge of the path followed by these nutrients. For the purpose of this 
study, all diffusion effects are neglected and the hepatic nutrients are considered as 
weightless point particles, passively advected by the flow. The method used to compute 
the particle pathways differ depending upon whether the particles are tracked through a 
single flow field, as is the case for the non-pulsatile simulations, or through successive 
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instantaneous flow fields, as in the pulsatile simulations. Those two methods are 
described in turn below. 
5.8.3.1 Hepatic Flow Distribution in Non-Pulsatile Simulations 
For the quantification of the hepatic flow distribution on the converged running 
average, one to two thousand particles are uniformly seeded over a cross-section of the 
hepatic veins and the corresponding streamtraces are generated using Tecplot 360 
(Tecplot Inc., WA, USA). These streamtraces serve separate the particles into two 
groups: RPAHep→Ω , which regroups all particles exiting through the RPA, and LPAHep→Ω  
for the particles exiting through the LPA. The amount of hepatic flow going to the RPA 
and LPA, RPAHepQ →  and LPAHepQ → , respectively, is then quantified as: 
 ∑
→Ω∈
→ =
RPAHepp
ppRPAHep dAuQ
0  (5-6) 
 ∑
→Ω∈
→ =
LPAHepp
ppLPAHep dAuQ
0  (5-7) 
where 0pu  the velocity of the particle p at its seeding point and pdA  is the area 
represented by that particle. Since the particles are uniformly seeded NpAdAp =
 
where 
A is the cross-sectional area of the hepatic or IVC inlet, and Np is the number of particles 
seeded over that cross-section. In the subsequent chapters, hepatic flow distribution is 
typically expressed as the percentage of hepatic flow going to each lung, obtained as: 
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5.8.3.2 Particle Tracking and Pulsatile Hepatic Flow Distribution 
For the pulsatile simulations, the particle pathways were computed using an in-
house particle tracking code. Since the hepatic nutrients are considered as weightless 
passively advected particles, their velocity is equal to that of the surrounding fluid and 
their displacement is governed by the following equation: 
 ( )nnP
t
n
P txu
t
x
n
,rr
r
=
∂
∂
 (5-10) 
where nPx
r  denotes the spatial location a particle P at the instant nt , and ( )nnP txu ,rr  is the 
fluid velocity obtained from the CFD simulations at the point nPx
r  and instant nt . The 
main components of the particle tracking algorithm are thus a spatial and temporal 
interpolation scheme to reconstruct ( )nnP txu ,rr  from the available CFD results, and a time-
integration scheme to advance the particle position in time. 
The temporal interpolation is performed using a second-order accurate linear 
formulation given by: 
 ( ) ( ) ( ) ( ) ( )
12
2112 ,,,
TT
TxuTtTxutTtxu
nn
n
−
⋅−+⋅−
=
rrrr
rr
 (5-11) 
where nt  is the time point at which the information is needed, and 1T  and 2T  are the two 
closest instants where CFD results were obtained, verifying 21 TtT
n ≤≤ .  
The spatial interpolation is performed using a third order-accurate parabolic 
scheme, applied in turn in each spatial direction. To simplify our explanations, let us 
consider a one-dimensional problem, with one velocity component u and one spatial 
direction x as exemplified in Figure 5-15. Let Px  be the x coordinate of the particle P for 
which u is needed. Let i be the index of the computational grid cell containing Px . Since 
- 115  - 
all the simulations reported in this thesis are conducted on uniform Cartesian grids, the 
index i can simply be obtained by ( ) 1min +Δ−= xxxi P , where minx  is the x coordinate of 
the first Cartesian grid cell center, and xΔ  is the grid spacing in the x direction.  
 
x
1−ix ix 1+ixxP
P
1−iu iu 1+iuuP
 
Figure 5-15: One dimensional example of the interpolation stencil for the third-order 
accurate spatial interpolation used in the particle tracking algorithm. 
 
 
Knowing the velocity at the grid closest grid cell center, ( ) ii uxu = , we can 
express ( )Pxu  as follows: 
  ( ) ∫ ∂
∂
+=
P
ix
x
iP dxx
uuxu  (5-12) 
Equation 4-12 is approximated with a centered Riemann integral as: 
 ( ) ( )iP
xx
iP xxx
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−⋅
∂
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−
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 (5-13) 
where the first derivative xu ∂∂  is evaluated at the mid-point between ix  and Px . Using 
the same approach as in Equation 4-8, this derivative can be further expressed as: 
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 (5-14) 
u is assumed to follow a locally parabolic profile, such that the second derivative 
22 xu ∂∂  is constant across our interpolation stencil, and can be evaluated in xi. All 
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required spatial derivatives are evaluated using a second order-accurate central scheme, 
as follows:  
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Combining Equations 4-13 through 4-16 we obtain the following expression for ( )Pxu : 
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Finally, the time integration is performed using an approximate 4th order accurate 
Runge-Kutta scheme as follows: 
 ( ) ( )nnPnPP txutxx ,2
1 rrrr ⋅
Δ
+=  (5-18) 
 ( ) ( )( )nPnPP txutxx ,2
12 rrrr ⋅
Δ
+=  (5-19) 
 ( ) ( )( )nPnPP txutxx ,23 rrrr ⋅Δ+=  (5-20) 
 ( ) ( )( ) ( )( ) ( )( ){ }nPnPnPnnPnPnP txutxutxutxutxx ,,2,2,6
3211 rrrrrrrrrr +⋅+⋅+⋅
Δ
+=+  (5-21) 
where each one of the velocity values are reconstructed using the above temporal and 
spatial interpolation schemes. For the sake of computational speed, the temporal 
interpolation is only performed once at the beginning of the time integration, in ntt = . 
One to two thousand particles are released at the inlet cross-section of the hepatic 
veins, at 200 evenly spaced time points per cardiac cycle. These particles are advected 
through the pulsatile TCPC flow fields using the above described particle tracking 
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algorithm. Similarly to the non-pulsatile approach the particles are then classified into 
two groups depending on the pulmonary artery through which they exit. The final hepatic 
flow distribution is quantified as: 
 
LPAHepRPAHep
RPAHep
RPA NN
N
HFD
→→
→
+
=  (5-22) 
 
LPAHepRPAHep
LPAHep
LPA NN
N
HFD
→→
→
+
=  (5-23) 
where RPAHepN →  and LPAHepN →  are the number of particles exiting through the RPA and 
LPA, respectively. 
This concludes the description of the methods and protocols used in this thesis to 
numerically simulate blood flow in patient-specific TCPC anatomies and extract the 
clinically-relevant efficiency metrics, ultimately allowing us to identify the most 
performing option(s) during the surgical planning investigations, and understand the 
impact of neglecting or including pulsatility on the accuracy of our predictions. 
 
- 118  - 
CHAPTER 6 
NUMERICAL METHODS 
 
In this chapter, we present the numerical methods used to simulate flows within  
complex cardiovascular anatomies. The formulation employed is an extension of the 
methodology developed by Sotiropoulos and co-workers [123, 164], which has been 
successfully applied to flow simulations around swimming fishes, and through 
mechanical heart valves under pulsatile flow conditions. This formulation is here recast 
onto a hybrid structured/unstructured layout to best tackle internal flows within arbitrarily 
complex cardiovascular structures. This chapter is organized as follows: First, we restate 
the governing equations and present the flow solver formulation retained for their discrete 
integration. Next, we describe the structured sharp-interface immersed-boundary method 
and, last, the hybrid structured/unstructured formulation developed to optimize the 
computational efficiency of immersed-boundary methods for internal flow applications. 
The chapter closes with a few remarks on code parallelization. 
 
6.1 Solver Formulation 
6.1.1 Governing Equations for Incompressible Newtonian Flows 
For the purpose of this study, blood will be assumed to be an incompressible 
Newtonian fluid, which is a fair assumption in large vessels. Under these assumptions, 
blood motion is governed by the unsteady, incompressible, Newtonian Navier-Stokes 
equations. Using a vectorial notation these equations may be expressed as follows: 
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 ( ) 0=∇ ur  (6-1) 
 
( ) ( ) ( ) ( )( )
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⎫
⎩
⎨
⎧ ∇+∇∇+⋅∇−−∇=
∂
∂ Tp
t
uuuuu rrrr
r
Re
1
 (6-2) 
where ur  is the three-dimensional velocity vector, p is the pressure, t is time, Re the 
Reynolds number and ∇  is the spatial derivative operator. It should be noted that the 
above equations depict the Navier-Stokes equations in their non-dimensional form. The 
characteristic scales of the problem were chosen to be the equivalent IVC diameter, 
IVCD ( πIVCIVC AD 2= , with IVCA  the area of the IVC inlet cross-section) and the mean 
velocity at the IVC inlet, IVCU . In addition, the density and molecular viscosity of blood 
were assumed constant, given by -3mkg 1060 ⋅=ρ  and -1-1 smkg 3.71 ⋅⋅=μ , respectively. 
  
6.1.2 Variable Layout & Notations 
To simplify the presentation of the temporal and spatial discretizations used in our 
flow solver, we will first present the layout adopted to store the pressure and velocity 
variables and the notations used in the subsequent sections.  
As discussed in details in the numerical background (Section 1.2.2), the 
straightforward implementation of a three-point central difference scheme on top of a 
non-staggered grid (where pressure and velocities are both stored at the cell centers) may 
lead to non-physical pressure oscillations, the well-known odd-even decoupling problem. 
This problem can be effectively resolved using a staggered storage of the flow variables, 
where the velocity components are stored at the cell interfaces while the pressure is 
stored at the cell centers. Such staggered arrangement, originally proposed by Harlow and 
Welch in 1965 [165], removes the pressure oscillations without the requirement for  
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special treatments on the pressure field or for the addition of artificial dissipation terms to 
stabilize the computations. However, as the pressure and each one of the velocity 
components are stored in different locations, adequate prescription of the boundary 
conditions is a stringent problem for staggered grid approaches. Based on these 
observations, Gilmanov and Sotiropoulos [164, 166] developed a hybrid staggered/non-
staggered grid approach, which combines the versatility and convenience of 
implementation of the non-staggered grids with the stability and accuracy of staggered 
mesh approaches. This hybrid formulation has been successfully applied to a wide range 
of flow simulations, such as flows around fishes and planktonic copepod, or blood flow 
through artificial heart valves [123, 164, 166, 167].  
Given the successful simulations of complex flows achieved using the 
staggered/non-staggered arrangement of the variables [123, 164, 166, 167], the numerical 
methodology developed and employed in this thesis builds upon this algorithm. To help 
the discussion, Figure 6-1 demonstrates the data storage locations using this hybrid layout 
for one Cartesian grid cell. For the remainder of this method section, integer indices, such 
as ( )kji ,,  in Figure 6-1, will denote the cell centers. In counterpart, half integer indices, 
such as ( )kji ,,21+ , ( )kji ,21, +  and ( )21,, +kji  in Figure 6-1, will denote the centers 
of cell surfaces in each one of the grid directions.  
Similarly to a staggered grid arrangement, the pressure p is stored at the cell 
center, while the velocity components { }( )3,2,1with ∈mum  are stored at the surface 
centers. In addition to the staggered variables, the hybrid arrangement also makes use of 
non-staggered velocities { }( )3,2,1with ∈mvm  to ease the computation of the governing 
equations and the prescription of the boundary conditions. Away from the boundaries, 
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these non-staggered velocities are reconstructed from the surface-centered velocities with 
a QUICK interpolation scheme, as exemplified below for the 1v  velocity component: 
 ( )
( ) ( ) ( )
8
63 ,,231,,211,,211
,,1
kjikjikji
kji
uuu
v ++−
−⋅+⋅
=  (6-3) 
 
 
u1(i+1/2,j,k)
p(i,j,k) v1(i,j,k)
v2(i,j,k)
u2(i,j+1/2,k)
u3(i,j,k+1/2)
Pressure at the 
cell center
Velocities at the 
surface center
Interpolated 
velocities at the 
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Non-Staggered 
Layout
v3(i,j,k)
 
Figure 6-1: Schematic representation of a hybrid staggered/non-staggered layout. The 
light gray lines are provided as a mere visual help, to help localize the centers of the cell 
surface. 
 
 
 
6.1.3 Temporal Discretization - Fractional-Step Formulation 
The governing equations are integrated in time using a fractional-step method, 
which comprises two steps: a prediction step, where the momentum equations are solved 
without enforcing continuity; and a correction step, which enforces the divergence free 
constraint and advances both pressure and velocities in time.  
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1- Prediction step: In the prediction step, we solve the momentum equations (Equation 5-
2) using a second-order accurate backward Euler scheme for the time derivative and a 
semi-implicit formulation for the right hand side of the equation. The partially discretized 
momentum equation reads as follows: 
 ( ) ( ) ( ) ( )( )
⎭
⎬
⎫
⎩
⎨
⎧ ∇+∇∇+⋅∇−−∇=+−
Δ
− Tnnn p
t
****1*
Re
143
2
1 uuuuuuu rrrrrrr  (6-4)  
where nur and 1−nur  are the velocity field at time step n and n-1, and *ur  describes 
intermediate non-divergence free velocity field. Note that *ur satisfies the momentum 
equation with the pressure pn and not pn+1.  
2- Correction step: The intermediate field *ur  is in general not divergence free, so that in 
the second step, a correction is applied to produce a velocity field 1+nur  that satisfies both 
the divergence free constraint and the momentum equations expressed with pn+1. These 
conditions may be formulated as follows:  
 ( ) 01 =∇ +nur  (6-5) 
 ( ) ( ) ( ) ( )( )
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Δ
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t
****111
Re
143
2
1 uuuuuuu rrrrrrr  (6-6)  
 
By subtracting Equation 5-4 to Equation 5-6, we obtain the following equation for the 
incremental pressure, nn ppp −= +1δ : 
 ( ) ( )puu
t
n δ−∇=−
Δ
+ *1
2
3 rr
 (6-7) 
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Taking the divergence of Equation 5-7 and applying the fact that the divergence of 1+nur  
is zero, we obtain the Poisson equation for the incremental pressure:  
 ( ) ( )*2
2
3 u
t
p r∇
Δ
=∇ δ  (6-8) 
Having solved Equation 5-8 for Pδ , 1+nur  and 1+np  can be simply obtained as: 
 ppp nn δ+=+1  (6-9) 
 ( )ptuun δ∇Δ−=+
3
2*1 rr  (6-10) 
 
6.1.4 Resolution of the Prediction Step 
Given the temporal discretization described above, the key point for the prediction 
step is the computation of the convective, viscous and pressure terms at the surface 
centers for the resolution of the three momentum equations. It is important to recall here 
that all variables are stored on a hybrid staggered/non-staggered layout, where p  and vr  
depict the collocated pressure and velocity variables, while ur  depicts the velocities at the 
surface centers. For the sake of simplicity, the momentum equations given in 4-2 will be 
recast as follows: 
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where ( )urmConv and ( )u
r
mVisc  with 3,2,1=m  denote the three components of the 
convective and viscous terms. These relate to the convective and viscous fluxes, mCF
r
 and 
m
VF
r
 ( 3,2,1=m ), as follows: 
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where the fluxes at the surface centers of each control volume are expressed as: 
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 (6-17) 
As can be seen from the above equations, using a purely staggered grid would 
require the evaluation of the viscous and convective terms on the three different control 
volumes (centered on each one of the surface centers), which can quickly burden the 
speed of the numerical simulations. The staggered hybrid/non-hybrid approach 
circumvents that difficulty by first evaluating the viscous and convective terms at the cell 
centers and then reconstructing them at each one of the surface centers. The method 
employed for the flux calculations and their derivatives are treated in the following 
subsections. 
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6.1.4.1 Evaluation of the Viscous Fluxes  
The viscous fluxes through each one of the cell interfaces are evaluated with a 
second-order accurate central difference scheme applied to the cell-centered velocity 
values, vr . Let us consider the viscous flux ( )kjiVF ,,21
1
+  that is applied on the 2x - 3x  
interface centered on the point ( )kji ,,21+ : 
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The evaluation of ( )kjiVF ,,21
1
+  requires the evaluation of the derivatives of all three 
velocity components in the direction normal to the interface (i.e. along 1x ), and the 
derivatives of the 1u  velocity component along the two directions tangential to the 
interface (i.e. along 2x  and 3x ). The derivatives normal to the interface are evaluated 
using a second-order accurate central difference scheme as follows: 
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 with 3,2,1=m  (6-19) 
The derivatives in the two tangential directions are first evaluated in ( )kji ,,  and 
( )kji ,,1+  using a central difference, and then interpolated in ( )kji ,,21+ :  
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The viscous fluxes are only evaluated on valid cell interfaces, i.e. at cell interfaces 
such that both ( )kji ,,  and ( )kji ,,1+  fall within the fluid domain. Accordingly, the 
normal derivatives given by Equation 5-19 are always defined. On the other hand, the 
tangential derivatives given by Equations 5-20 and 5-21 use a larger stencil, and special 
cases may arise in the vicinity of the immersed boundary where some of the required 
cell-centers do not belong to the fluid domain. In such case, the differential stencil is 
modified from a three-point central difference to a differential stencil biased towards the 
fluid domain, as illustrated in Figure 6-2 for a 2D grid layout. Accounting for these 
special cases, Equation 5-20 reads as follows: 
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Figure 6-2: Stencil used for the evaluation of the tangential derivatives required for the 
viscous flux calculations, exemplified on a 2D Cartesian grid. 
 
 
6.1.4.2 Evaluation of the Convective Fluxes  
Similarly to the viscous fluxes, the computation of the convective fluxes through 
each one of the cell interfaces is conducted using the reconstructed cell-centered 
velocities, vr . To increase the stability of the momentum equations, the convective fluxes 
at the surface centers are approximated using a second-order accurate upwind-biased 
QUICK scheme expressed as: 
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where the forward flux ( ) ( )
+
+
+
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and the backward flux ( ) ( )
−
+
−
+ kjikjiu ,,21,,21 U
r
 is evaluated as: 
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Similarly to the viscous fluxes, convective fluxes are only evaluated on valid cell 
interfaces, i.e. at cell interfaces such that both ( )kji ,,  and ( )kji ,,1+  fall within the fluid 
domain. In cases where ( )kji ,,1−  or ( )kji ,,2+  fall outside of the forward and 
backward flux evaluations revert to first order as:  
 ( ) ( )kjikji ,,,,21 vU
rr
=++  (6-28) 
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6.1.4.3 Evaluation of the Flux Derivatives  
From the above surface-centered fluxes, mCF
r
 and mVF
r
 ( 3,2,1=m ), the convective and 
viscous terms can be directly obtained at the cell centers using central differencing:  
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The surface-centered viscous and convective terms are then reconstructed from 
the above cell-centered values using a QUICK interpolation scheme applied in each one 
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of the grid dimensions. The expression for the viscous and convective flux derivatives in 
( )kji ,,21+  thus reads as: 
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Finally, since the pressure is stored at the cell centers, the pressure gradient is 
directly obtained at the surface centers by applying a central differencing as follows: 
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Having discretized the pressure, convective and viscous terms at each one of the 
surface centers, ur can readily be advanced in time, yielding the intermediate non 
divergence free velocity field, *ur .  
 
 
6.1.5 Resolution of the Pressure-Correction Step 
The overall efficiency of a fractional step method largely depends on the approach 
adopted to solve the Poisson equation in the correction step (Equation 5-8). All spatial 
derivatives are discretized using central differencing, and Equation 5-8 in its discrete 
form reads as follows: 
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The above system may be re-written as BA =⋅ϕ , where A  is the discrete 3D 
Laplacian operator, B  can be computed from the intermediate velocity field *ur , and ϕ  is 
the solution vector containing the incremental pressure values for each grid cell. If one 
seeks to solve the Poisson equation in simple coordinates, such as a rectangular structured 
Cartesian grid for example, then A  is a sparse symmetric matrix and the solution can be 
efficiently obtained through direct solvers [168, 169]. However, as will be detailed later 
in this chapter, the domain considered for our applications is limited to the Cartesian grid 
cells inside the fluid domain, resulting in an effectively unstructured grid. With such 
data-structure, the discrete 3D Laplacian operator, A, is still sparse (with at most 7 non-
zero elements per row), but no-longer symmetric. Iterative methods thus represent the 
only feasible alternative to solve the discrete Poisson equation in our unstructured grid 
system.  
The mathematical description of the different iterative methods available to date 
is beyond the scope of this thesis and the interested reader is referred to [170] for a 
detailed review on iterative approaches to linear and non-linear systems of equations. 
Briefly, rather than computing A-1, the exact inverse of the matrix A, and solving ϕ  as 
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bA 1−=ϕ , iterative methods seek to devise a linear operator S that approximates A-1 and 
iterate the solution vector  ϕ  until convergence. The iterative procedure proceeds as: 
 nnn rS ⋅+=+ ϕϕ 1   (6-36) 
where nϕ is the solution vector computed at the nth iteration, and nn Abr ϕ−=  is the 
corresponding residual. The system is iterated until rn is smaller than a set convergence 
criterion. The difference between alternate iterative methods resides in the approach 
retained to construct the approximate inverse operator S. 
The most efficient iterative solvers available today include Krylov subspace 
methods, such as the flexible general minimal residual (FGMRES) [171] and stabilized 
bi-conjugate gradient (BiCGSTAB) [172] formulations, and multi-grid methods, where 
the equation is first solved on a coarse grid and then refined onto a finer grid level. An 
additional option is to pre-condition the solution by first using a fast iterative method to 
formulate an initial guess, and then using a higher accuracy scheme to refine the solution. 
Combining the above approaches, Ge and Sotiropoulos [123] demonstrated that using a 
multigrid-preconditioned FGMRES method to solve the Poisson equation yielded a 
robust and computationally efficient fractional step formulation.  
Accordingly, in this work, we employ an FGMRES solver with a cell-centered 
multi-grid preconditioner to solve the Poisson equation. To better explain the multi-grid 
procedure, let us denote by 1+l  the Cartesian grid on which the Navier-Stokes are 
solved, and by l  a coarser grid level, embedded in grid 1+l . The grid for the coarser 
level l  is generated by coarsening the level 1+l  by a factor two in each direction. This 
process is illustrated in Figure 6-3 for a two-dimensional Cartesian grid. 
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Fine Grid, Level 1+l Coarse Grid, Level l
Superimposed 
Fine and Coarse Grids
Cell center on the fine grid Cell center on the coarse grid
 
Figure 6-3: Two embedded grid levels 
 
 
We then define two multi-linear interpolation operators, ll →+1R and 1+→llR , which 
will be used to interpolate variables from the finer level 1+l  onto the coarser level l , 
and reciprocally to restrict variables from l  to 1+l  (see Appendix C for implementation 
details). With these notations in mind, the iterative procedure at level 1+l  reads as: 
 ( ) nnn rA 111111 +−++++ ⋅+= llll ϕϕ   (6-37) 
and may be recast as follows: 
 ( ) nnn rRAR 1111111 +→+−+→+++ ⋅⋅⋅+= llllllll ϕϕ  (6-38) 
where 111 +→+→+= llllll RARA  is the Jacobian matrix restricted to the level l . If we now 
define lS  as the solution procedure used to approximate 
1−
lA  on the level l , the Poisson 
equation can be solved as: 
 { }{ }nnn rRSR 111111 +→++→+++ ⋅+= llllllll ϕϕ  (6-39) 
 
- 133  - 
The solution at the fine grid level 1+l  can be obtained by solving the equation at the 
level l , which is less computationally expensive than on the finer grid 1+l , and then 
interpolating the coarse solution onto level 1+l . A two level multi-grid procedure will 
thus proceed as follows: 
1. Solve the equation on the fine grid as bS ⋅= ++ 1
0
1 llϕ , to obtain the initial 
residual: 0 1
0
1 ++ −= lll ϕAbr  
2. Restrict the residual from the finer to the coarser level: 0 11
0
+→+= llll rRr  
3. Solve the equation on the coarser level: 0lll rS ⋅=Δϕ  
4. Interpolate the solution lϕΔ  from the coarser to the finer level and update the 
solution at the finer level: lllll ϕϕϕ Δ⋅+= +→++ 1
0
1
1
1 R  
5. Compute the corresponding residual and solve the equation at the finer level 
one more time to smoothen the interpolated solution. 
 
As illustrated in Figure 6-4, the same process is repeated recursively when more than two 
levels are employed. It may be noted that the Poisson equation is solved after each 
interpolation or restriction to smoothen the reconstructed fields. The key to an efficient 
multi-grid implementation is thus to use fast iterative methods to smoothen the finer 
levels (levels 1 to 3 in Figure 6-4), and a high accuracy scheme to solve the Poisson 
equation on the coarsest level (level 0 in Figure 6-4). To this end, we employ a Block 
Jacobi decomposition for the finer levels, and the FGMRES method at the coarsest level.  
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Restrict residual
Interpolate solution
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Bijacobi
(1)
Bijacobi
(1)
Bijacobi
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FGMRES
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Bijacobi
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(2)
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(2) (4)
(4)
(4)
Resolution Procedure
 
Figure 6-4: Schematic representation of the multi-grid solution procedure with four grid 
levels. Numbers in parenthesis refer to the itemized list given above. The iterative 
procedures used for each “Solve” step are provided in red. 
 
 
In summary, our Poisson solver combines an FGMRES method with a multi-grid 
preconditioner. The solution procedure is characterized by the following parameters:  
1. multiple embedded grid levels, which are iteratively coarsened by a factor two in all 
directions  
2. tri-linear restriction and interpolation operators between two consecutive grid levels 
3. discrete 3D Laplacian operators, lA , for each grid levels, which are constructed at the 
first time step, and stored in memory for improved computational speed in the 
subsequent time iterations 
4. solution procedures lS at each grid level, which use the FGMRES method to solve the 
Poisson equation at the coarsest level and a Block Jacobi decomposition to serve as 
a smoother at the finer levels.  
This Poisson solver was implemented using the Krylov Subspace libraries offered by 
PETSC [173, 174], where the FGMRES and multi-grid methods were readily available. 
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The interested reader is thus referred to the PETSC manual [174] for more details on the 
implementation of these iterative solvers.  
 
6.2 Sharp Interface Immersed-Boundary Method  
The fractional step method described above is implemented together with the 
sharp interface immersed-boundary approach of Gilmanov and Sotiropoulos [164]. This 
approach distinguishes itself from other immersed boundary implementations in the 
treatment of the Cartesian nodes closest to the immersed boundary. In this section, we 
thus first present the classification of the Cartesian grid nodes, depending on their 
location with respect to the immersed boundary, followed by a detailed description of the 
boundary condition prescription.  
6.2.1 Node Classification 
The surface of the immersed boundary, here the TCPC vessel wall, is discretized 
with an unstructured triangular mesh and immersed in a background Cartesian grid. With 
reference to Figure 6-5, the cells of the Cartesian grid are sorted as follows: 1) external 
cells that are outside of the fluid domain; 2) immersed boundary (IB) cells that are 
located in the interior of the flow domain but in the immediate vicinity of the immersed 
boundary; and 3) fluid cells that are located strictly inside the fluid domain. In the flow 
solver presented above, the Navier-Stokes equations are discretized and solved on the 
fluid cells only, with boundary conditions prescribed at the IB cell centers. Only the cell-
centered velocity components need to be reconstructed at these IB cell centers because 
the hybrid staggered/non-staggered grid approach of Gilmanov and Sotiropoulos [164] 
eliminates the need for explicitly specifying boundary conditions for the pressure. 
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Figure 6-5: Schematic representation of a 2D immersed-boundary layout. The fluid 
domain is immersed in a background Cartesian grid. The Cartesian grid cells are sorted 
into three categories based on the position of their cell center relative to the immersed 
boundary.  
 
 
6.2.2 Velocity Reconstruction along the Vessel Walls 
The TCPC vessel walls are treated as rigid, no-slip surfaces. The velocity 
variables at the IB cell centers closest to these wall surfaces are reconstructed via 
quadratic interpolation along the local normal direction to the vessel wall. Using the 
notations defined in Figure 3-5, let G be the IB cell center to be treated, and s the 
triangular element of the immersed-boundary that is the closest to G. Fn
r  is the unit 
normal to element s, and F is the projection of G along Fn
r  onto the surface element s. 
Symmetrically, H represents the projection of G along the wall normal direction Fn
r  onto 
the closest fluid elements (defined by the fluid cell centers h1, h2, h3 and h4). 
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Figure 6-6: Reconstruction of the solution at an IB-cell center (G) by interpolating 
between its projection onto the closest immersed-boundary and fluid elements (points F 
and H, respectively) along the local normal to the immersed-boundary. The light gray 
lines are provided for sole visual display to help localize the centers of the fluid and IB 
cells.  
 
 
In the present study, the walls of the TCPC are considered rigid and the velocity 
at point F, Fv
r , is known and equal to zero at any point in time. The velocity at point H, 
Hv
r ,  is reconstructed from the velocities at the four neighboring fluid cell centers using 
an inverse distance interpolation, as depicted below:  
 
∑
∑
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1
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Hh
Hhh
H
v
v  (6-40) 
 
With Fv
r  and Hv
r  known, the velocity at the IB cell center, Gv
r , can now be 
reconstructed by interpolation. We employ the quadratic interpolation procedure detailed 
by Gilmanov and Sotiropoulos [164], which was found to increase the overall accuracy of 
Triangular surface 
element s  F 
H
h1 
h4 
h3 
h2 
G
nF  
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the flow solver when compared to a linear interpolation procedure. To simplify the 
notation in the subsequent equations, v will describe one of the three cell-centered 
velocity components. The quadratic interpolation assumes that every component of the 
velocity vector varies in a quadratic manner with respect to the normal distance to the 
wall, as depicted by the following equation: 
 ( ) 3221 CdCdCdv ++=  (6-41) 
where C1, C2, and C3 are coefficients to be determined, and d is the normal distance to the 
wall. There is thus a total of four unknowns: the three afore-mentioned coefficients and 
the velocity value at the IB node, Gv . These four unknowns can be fully determined by 
solving the following system of equations: 
( ) FvCv == 30   (6-42) 
( ) GFGFGFG vCdCdCdv =++= 3221   (6-43) 
( ) HFHFHFH vCdCdCdv =++= 3221   (6-44) 
212 CdCd
v
FG
dFG
+=
∂
∂
  (6-45) 
where dFG, dFH and dGH denote the distances between the specified points. To close the 
above system of equations, the derivative of the velocity in G is approximated by first 
computing the velocity derivatives in the middle of the segments FG and GH by central 
differencing, and then reconstructing the derivative in G by linear interpolation. The 
approximation to the velocity derivative in G thus reads as follows: 
 ( )
GH
GH
FG
FG
d d
vv
d
vv
d
v
FG
−
−+
−
=
∂
∂ αα 1  (6-46) 
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where FHGH dd=α . Combining Equations 4-37 through 4-41, we now have a closed 
system of equations, which can be solved to determine Gv . The solution with the above 
notations reads as: 
 
( ) ( ) ( )
( )
FHFG
GH
H
FG
FG
F
FG
FH
FH
G
d
d
d
d
d
d
v
dd
d
v
dd
d
vv
v
ββ
βββ
αα
αα
−−+
−−+++
−
=
11
1
 (6-47) 
where ( )FGGHFGGH ddddd −=β . This quadratic interpolation procedure is applied to all 
three components of the velocity vector. The overall accuracy of the solver with the 
above reconstruction algorithm has been shown to be second-order in space [166].  
 
6.2.3 Other Boundary Conditions 
6.2.3.1 Inflow Boundary Conditions 
The cell centered velocities at IB cells closest to one of the inlets of the immersed 
boundary are imposed so to achieve the desired flow rate and velocity profile. Depending 
on the problem treated, two types of velocity profiles are used in this study, namely flat 
and parabolic velocity profiles. Using the same notation as in Figure 3-5, the prescription 
of a flat velocity profile at an IB cell center, G, simply reads as follows:  
 FG nUv
rr
⋅=  (6-48) 
where Fn
r  is the local normal to the inlet surface, and AQU = is the mean velocity 
across the inlet, Q  defining the desired flow rate and A  the inlet cross-sectional area. For 
a fully developed parabolic profile, Gv
r  would read as: 
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⎛−=
2
12  (6-49) 
where πAR =  is the radius of the inlet cross-section and Gr  is the distance between 
the normal projection of G onto the inlet surface, point F in Figure 3-5, and the center of 
that inlet. 
 
6.2.3.2 Outflow Boundary Conditions 
For the IB cells closest to an outlet surface of the immersed boundary, the 
reconstruction of the cell-centered velocities is performed in two steps. First the 
velocities are reconstructed at all the IB cells pertaining to that outlet by extrapolation. 
Using the same notations as in Figure 3-5, the extrapolation procedure for an outlet IB 
cell, G, reads as follows:  
 HG vv
rr
=  (6-50) 
where H is the projection of G along the normal to the outlet cross-section and onto the 
closest fluid element, and Hv
r is obtained by inverse distance interpolation as in Equation 
5-39. These extrapolated values are then corrected to enforce global mass conservation 
across the fluid domain, as follows: 
 FGG nQvv
rrr
⋅Δ+=  (6-51) 
where QΔ  is the difference between the mass flow rate obtained after the extrapolation 
and the desired mass flow rate, OQ , computed as: 
 ∑
∈
⋅−=Δ
OutletG
FGO nvQQ
rr
 (6-52) 
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6.2.3.3 Pressure Reconstruction along all Boundaries 
Finally, although not required to solve the Navier-Stokes equations, the pressure 
values at the IB cell centers are reconstructed as well, so as to avoid any perception bias 
when visualizing the computed pressure fields. Using the same notations as in Figure 3-5, 
the pressure at an IB cell center G, Gp , is extrapolated from the pressure at point H, Hp , 
by assuming a zero pressure gradient in the direction normal to the boundary, leading to: 
 HG pp =  (6-53) 
where Hp  is reconstructed by inverse distance interpolation as was done for the velocity 
in Equation 5-39: 
 
∑
∑
=
−
=
−
⋅
= 4
1
1
4
1
1
l
l
l
ll
Hh
Hhp
p
h
H  (6-54) 
The same pressure reconstruction procedure is applied to all IB cells irrespective 
of the type of boundary condition. If this approach might be questionable from a physical 
stand point, it should be kept in mind that the reconstructed pressures only serve to 
improve the display, but in no case impact the flow resolution itself. 
 
6.3 The Unstructured Cartesian Grid Paradigm 
The original immersed-boundary method of Sotiropoulos and co-workers [123, 
164] is implemented on a structured Cartesian grid. Regardless of the shape and size of 
the immersed boundary to be handled by the method, the entire background Cartesian 
grid is retained in the data-structure and the external cells, which do not need to be 
included in the computations, are “blanked out” of the calculations. To facilitate our 
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subsequent discussion and the presentation of an alternate formulation, we illustrate the 
structured implementation in the following pseudo-code in terms of the discretization of 
the velocity divergence, as required for the right hand side of the Poisson equation 
(Equations 5-8 and 5-34):  
( ){ }
( ) ( ) ( ){ }
doend
doend
doend
end if           
ifend
x
kjiuhkjiuh
x
kjiuhkjiuh
x
kjiuhkjiuh
kjiD
thenif 
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where mxΔ  with m=1, 2, 3 are the grid increments in three directions, IM, JM, and KM 
are the maximum number of grid nodes along the respective Cartesian coordinate lines, D 
is the discrete divergence operator, and muh  with m=1, 2, 3 is the array storing the three 
surface-centered velocity components. uhm relates to the former notation, um, in the 
following manner: ( ) ( )kjiukjiuh ,,21,, 11 += , ( ) ( )kjiukjiuh ,21,,, 22 +=  and 
( ) ( )21,,,, 33 += kjiukjiuh . We shall refer to this straightforward and quite common 
implementation as the structured Cartesian (SC) grid formulation.  
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For flow problems, such as those considered in [164] and [123], for which the 
volume of the immersed body is typically a small fraction of the background Cartesian 
domain, the standard SC approach is the method of choice. On the other hand, for internal 
flow problems involving even moderately complex, multi-connected conduits the most 
commonly encountered situation is for the external cells to constitute the vast majority of 
the overall grid nodes. For the TCPC shown in Figure 6-7 for example, only 7% of the 
Cartesian grid cells fall within the fluid domain, while the 93% remaining are external 
cells that do not contribute to the numerical solution. For such problems, the 
implementation of a sharp interface Cartesian grid methodology in conjunction with the 
SC approach could be very inefficient and in many cases totally impractical. Indeed, in 
the SC formulation all flow variables are stored in arrays of the size KMJMIM ×× , and 
the large proportion of external cells leads to a large memory overhead allocated to store 
information in cells that are never being used. In addition, even though no computations 
are actually carried at the external cell centers, every do-loop in the code still has to go 
through them and exclude them using an if-statement (see above pseudo-code). This extra 
computational cost, which is hardly detectable when the external cells are few, can grow 
significantly with increasing number of external cells.  
To remedy the aforementioned difficulties of the SC data indexing scheme, we 
have developed an unstructured Cartesian approach. The key idea, illustrated in Figure 
6-8, is to replace the SC grid structure with the grid structure that arises when all grid 
nodes in the exterior of the flow domain are eliminated from the computational domain. 
The resulting grid is an unstructured grid system since the number of grid nodes along a 
certain grid direction is no longer constant and changes arbitrarily from line to line. The  
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Figure 6-7: Example of a TCPC geometry embedded in a Cartesian grid. The multiple, 
interconnected vessels span a large 3D domain but occupy only a small portion of it, 
resulting in only 7% of the Cartesian grid cells falling within the fluid domain.  
 
 
 
 
Figure 6-8: Schematic of a structured and unstructured Cartesian layout 
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simple indexing scheme of the complete Cartesian mesh is thus lost and a critical 
prerequisite for the successful implementation of the UC data structure is the 
development of an efficient indexing scheme for specifying the connectivity of the 
resulting unstructured mesh. We achieve this by taking advantage of the fact that each 
active grid cell (i.e. each cell of the unstructured Cartesian grid) can be referred to using 
two indexing systems: 1) the  structured system ( ) [ ] [ ] [ ]KMJMIMkji ,1,1,1,, ××∈ , and 2) 
the unstructured system, [ ]aN,1∈l , where Na is the total number of active grid cells—  
Na = Nf + NIB, where Nf and NIB denote the number of fluid and IB cells, respectively. We 
define two mapping arrays, SU and US, respectively, which map the two indexing 
systems onto each other as follows: 
 
),,(:
),,(:
kjiUS
kjiSU
→
→
l
l
 6-56  
The SU array maps the structured grid index to its unstructured counterpart 
),,( kjiSU=l  and has dimensions IM×JM×KM. The US array accomplishes the inverse 
mapping and has dimensions 3×Na: 
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l
l
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=
=
=
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In order to optimize programming and memory allocation, the active cells of the 
unstructured Cartesian mesh are numbered serially depending on their type. Accordingly, 
the Nf fluid cells, where the Navier-Stokes equations are discretized and solved, are 
assigned an index fN,1=l , while indices af NN ,1+=l  are assigned to the remaining 
active IB cells where boundary conditions are applied. Using these notations and the two 
mapping arrays, the pseudo-code shown in 5-54 can now be implemented as follows:  
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It should be noted that since the loop is only performed on the fluid cells, i.e. cells 
that fall strictly inside the fluid domain and are neighbored by active cells only, no 
specific condition needs to be added to assess whether the neighboring cells fall within 
the fluid domain.  
The obvious advantage of the UC data structure when compared to its SC 
counterpart arises from the use of one-dimensional arrays of dimension Na which ensures 
that no memory resources are wasted to store the useless external cells. Furthermore, the 
above-explained numbering procedure simplifies programming significantly since all 
computations that should be carried out solely at fluid cells may be performed in a single 
loop running from index 1 through Nf without the need for an “if statement”. Similarly all 
IB cells can be treated by looping through indices af NN ,1+=l . Moreover, this 
sequential indexing ensures that the flow information at grid nodes of similar type are 
allocated a consecutive memory address, which improves the cache hit rate and saves 
time in transferring data between the memory and processor. 
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6.4 Concluding Remarks on the Flow Solver 
An overview of the solver implementation is provided in Appendix C. The 
numerical solver, which comprises a fractional step formulation for the Navier-Stokes 
equations coupled with an unstructured sharp-interface immersed-boundary method, is 
written in Fortran 90, and is thus platform independent and portable. The Poisson solver 
for the pressure correction step is implemented using Petsc libraries [173, 174], a suite of 
data structures and routines for the parallel solution of scientific applications modeled by 
partial differential equations. It includes support for parallel vectors, parallel matrices but 
also Krylov subspace approaches such as the FGMRES method employed in the current 
Poisson solver.  
Furthermore, the present numerical solver has been parallelized using the 
Message Passing Interface (MPI) standard for all communications between processors 
during the computations. A particularity of our system for parallelization stems from the 
unstructured grid layout. Merely dividing the underlying Cartesian grid into even blocks 
will in practice lead to a highly uneven distribution of the active cells between the 
different processors. Accordingly a specific domain-splitting subroutine was 
implemented that divides the Cartesian grid such that the number of active nodes is 
evenly distributed across all processors involved. The subroutine proceeds recursively as 
depicted in the following pseudo-code: 
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where NPm and NPM denote the starting and ending indices of the processors over which 
the grid should be distributed, [ ] [ ] [ ]MmMmMm KKJJII ,,, ××  depict the size of the domain 
covered by these processors and N0 the number of active nodes in that domain. For the 
sake of simplicity, the above pseudo-code only splits the Cartesian grid along the i 
direction. In practice the splitting direction is chosen to be the longest side of the domain 
to be split. If ( ) ( ) ( ) ( )( )1,1,1max1 +−+−+−=+− mMmMmMmM KKJJIIJJ , for example, then 
the Cartesian block under consideration will be split along the j direction. 
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CHAPTER 7 
FLOW SOLVER VALIDATION 
 
In this chapter, we apply the hybrid unstructured Cartesian (UC) immersed-
boundary flow solver developed as part of our first specific aim to simulate various 
internal flow problems of progressively increasing complexity. Our objectives are to 
validate our implementation and demonstrate that, when combined with appropriate data 
storage, immersed-boundary methods can be used to carry out grid refinement studies for 
complex anatomical geometries, which would simply be impractical using the standard 
structured Cartesian (SC) implementation. We first assess the relative performance of the 
SC and UC formulations in terms of storage and computational speed. Next, we report 
simulations and grid refinement studies for the three following test cases: 1) flow through 
a 90 degree curved pipe, 2) flow in an idealized TCPC geometry, 3) highly unsteady flow 
in a patient-specific TCPC geometry. Pulsatile flow simulations in idealized and patient-
specific TCPC geometries are reported in Chapter 8.  
 
7.1 Performance Assessment of the SC and UC approaches 
In this section, we carry out a series of numerical experiments aimed at 
quantifying the computational speed and memory requirements of the UC and SC 
approaches as a function of the ratio active grid nodes to the total number of Cartesian 
grid nodes, defined as: 
 ( )KMJMIMNr a ××=  (7-1) 
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where IBfa NNN +=  is the number of active nodes defined as the sum of the fluid 
nodes, fN , and of the boundary (or IB) nodes, IBN . IM, JM and KM are the number of 
Cartesian grid cells in the three spatial directions. By definition r varies between 0 and 1. 
The SC formulation is expected to be optimal when 1→r , while the UC formulation is 
expected to be the best suited approach when 0→r . 
To design a numerical experiment for which r can be easily varied across a broad 
range of values, we consider a straight circular pipe of radius R and length R, embedded 
in a background Cartesian domain of dimensions RRL 1.21.2 ×× , where L is the 
streamwise extent of the domain (see Figure 7-1). The Cartesian domain is discretized 
with a constant grid spacing h along all three spatial directions. To systematically vary 
the ratio parameter r, we maintain the pipe dimension R and the grid increment h 
constant, but we gradually vary the streamwise grid dimension, L, from 1.1R to 54.1R. As 
shown in Figure 7-1, this procedure results in a pipe of fixed volume (Na remains  
 
  
Figure 7-1: Test case to evaluate the performance of the various approaches as a function 
of the active-to-total grid nodes ratio r. The ratio r is artificially decreased by increasing 
the dimensions of the surrounding Cartesian grid, while keeping the grid spacing and 
hence the number of active nodes, aN , constant. 
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constant) embedded in gradually larger Cartesian domains (IM linearly increases with L), 
allowing us to vary r over nearly two orders of magnitude from 0.7 down to 0.01. 
Calculations are carried out on 11 different grid sizes by initializing all flow 
variables in the interior of the pipe with zero and prescribing the fully-developed 
parabolic velocity solution as boundary condition at the inlet of the pipe. The 
computational time (CT) and memory allocation (MA) are recorded and averaged over 80 
iterations. All simulations are conducted on a single 1.6 GHz 64 bit AMD Opteron 
processor with 2.0 GB RAM. The memory requirement for a given r is assessed based on 
the operating system requirements. Even though this metric does not provide an exact 
measure of the amount of allocated memory, it still provides a measure of the code 
footprint on the overall system. 
The comparative performance of the SC and UC approaches is shown in Figure 
7-2, expressed as the ratio of the SC computational time or memory allocation to that of 
the UC approach. The MASC/MAUC and CTSC/CTUC ratios are greater than one for all 
tested configurations, demonstrating that the UC formulation requires a lower memory 
allocation and allows for faster simulations than the SC method even for r values as high 
as 0.7. More precisely, when r = 0.7, the computational time per iteration and the 
memory allocation are approximately equivalent for the two methods, with a slight 
advantage of the UC approach ( 09.1=UCSC CTCT  and 24.1=UCSC MAMA ). However, 
these ratios increase exponentially with decreasing r. When the number of active nodes 
represent only 5% of the embedding Cartesian grid (i.e. r = 0.05), the performance ratios 
are of 97.5=UCSC CTCT  and 87.9=UCSC MAMA , meaning that the SC approach is 
about 5 times more expensive and requires one order of magnitude more memory than 
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the UC method. The SC implementation is seen to be 10 and 20 times more expensive 
than the UC method for r = 0.025 and 0.012, respectively. 
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Figure 7-2: Comparison of the memory allocation (MA) and computational times (CT) of 
the structured Cartesian (SC) formulation vs. the unstructured formulations UC as a 
function of r. Numbers are expressed as the ratio of the SC quantity (either MA or CT) 
over the corresponding UC quantity. 
 
 
As was discussed in the numerical methods (Chapter 6), the rapidly decreasing 
performance of the SC implementation as r decreases stems from the fact that, in that 
formulation, the external nodes are blanked out of the computation but are retained in the 
data structure. Accordingly, all variables are stored in arrays of dimension IM×JM×KM 
and an “if-statement” is required within each do-loop in order to blank out the external 
nodes from the simulation. 
In the UC approach, on the other hand, memory allocation is optimized in that 
only the active nodes are retained in the data structure and all variables are stored in 
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arrays of dimension Na. The price for this optimal allocation, however, is that the simple 
connectivity of the Cartesian grid is lost and additional data structures and thus additional 
memory space are required to explicitly store the connectivity information. Obviously, if 
all Cartesian grid nodes are active grid nodes (r = 1) the UC method requires more 
storage space than the SC approach. However, as 0→r  the amount of extra memory 
required to store the connectivity information is quickly outweighed by that saved by 
eliminating from the data structure the unused external nodes. Furthermore, serial 
indexing of the fluid nodes, removes the need for an “if statement” in the do-loops. In 
counterpart, the connectivity of the grid is no longer implicit and every differencing 
operation requires looking up a connectivity matrix in order to identify the neighborhing 
nodes. As was seen in Figure 7-2, the cost of looking up the connectivity information 
only at the fluid nodes is outweighed by that of the “if statement” required for all nodes of 
the Cartesian grid, even for r as high as 0.7.  
In summary, the numerical experiments reported in this section clearly show the 
superiority of the UC approaches over the SC implementation especially for small values 
of r. As we will subsequently show, complex cardiovascular anatomies often result in a 
grid structure with r as low as r = 0.05 (see Section 7.4 below). The results reported in 
this section showed that for such low percentage of active grid nodes the standard SC 
implementation of the method of Gilmanov and Sotiropoulos [164] would require 
approximately one order of magnitude more memory for storage and 5 times more 
computational time than the UC formulation. Clearly such excessive computational 
overhead renders the SC approach impractical to use especially when very fine grids are 
required within the flow domain to obtain accurate results.  
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7.2 Steady Flow in a 90o pipe bend  
The geometry and flow conditions for this first case correspond to the 
experimental work of Bovendeerd et al. [175] who carried out experiments for steady 
fully-developed flow in a 90o curved pipe of diameter D and radius of curvature 3×D (see 
Figure 7-3). The inlet and outlet sections are placed 3×D upstream and downstream of 
the bent section, respectively. A fully-developed parabolic velocity profile with a 
Reynolds number of 700 (based on the mean inflow velocity and the pipe diameter) is 
prescribed at the inflow to match experimental conditions. The pipe surface is discretized 
with an unstructured triangular mesh (3,924 nodes) and immersed in rectangular 
Cartesian box of dimensions 6.6D×6.6D×1.1D, which is discretized with a uniform and 
isotropic Cartesian grid. Simulations are carried out for two different mesh resolutions, 
which are summarized in Table 7-1. For both grids the dimensions of the Cartesian box 
remains fixed.  
 
 
Figure 7-3: Dimensions and geometry of the 90o curved pipe. Θ denotes the angle 
between the inlet plane of the bend and a given cross-section in the bend. The zoomed-in 
region shows the layout of the unstructured Cartesian mesh. 
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Table 7-1: Mesh resolutions used for the 90o curved pipe (D is the pipe diameter). 
.  h IM×JM×KM Na r 
 Mesh A1 0.03D 2,032,800 1,648,656 0.174 
 Mesh A2 0.02D 6,860,700 5,427,200 0.181 
 
 
Steady-state streamwise velocity profiles on the symmetry plane of the pipe are 
compared with the laser Doppler velocimetry data from Bovendeerd et al. [175] at seven 
streamwise locations located at angles Θ = 0.0°, 4.6°, 11.7°, 23.4°, 39.8°, 58.5° and 81.9° 
in Figure 7-4 (see Figure 7-3 for definition of the angle Θ). Apart from a slight velocity 
overshoot for the peak velocity at the location Θ = 81.9°, the results obtained with both 
meshes A1 and A2 are in excellent agreement with each other and the experimental data. 
 
 
 
Figure 7-4: Comparison of measured and computed time steady-state velocity profiles at 
seven locations on the symmetry plane of the 90º curved pipe: from (a) Θ = 0, (b) Θ = 
4.6, (c) Θ = 11.7, (d) Θ = 23.4, (e) Θ = 39.8, (f) Θ = 58.5 and (g) Θ = 81.9º, respectively. 
Velocities are normalized by the mean inflow velocity. Distances are normalized by D/2. 
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7.3 Flow in an idealized TCPC geometry  
The second test-case is an idealized representation of a total cavopulmonary 
configuration and corresponds to the experimental study by Ensley et al. [176]. As shown 
in Figure 7-5, the geometry consists of four pipes of equal diameter D=14mm, 
representing the inferior and superior venae cavae (IVC and SVC, respectively) and the 
right and left pulmonary arteries (RPA and LPA). The axes of the IVC and SVC are 
offset by one pipe diameter. Entrance and exit lengths spanned 7.15D between the inlet or 
outlet boundaries and the closest pipe axis. The complete (no symmetry assumption is 
invoked) surface of the pipe junction geometry is discretized with an unstructured 
triangular grid (22,145 nodes) embedded in a rectangular Cartesian box of dimensions 
16.5D×15.5D×1.1D, which is discretized with a uniform and isotropic Cartesian mesh. 
Three different grid sizes are used ranging from 200,000 to 1.3 million active grid nodes, 
(see Table 7-2). All subsequent results are shown at the symmetry plane of the 
connection. 
 
Figure 7-5: Geometry of the pipe junction geometry, which is an idealized representation 
of anatomic TCPC configurations. 
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Table 7-2: Mesh resolutions used for the pipe junction geometry (D is the pipe diameter). 
 h IM×JM×KM Na KMJMIM
Na
××
 
 Mesh B1 0.05D 2,367,643 198,330 0.084 
 Mesh B2 0.03D 7,858,624 651,727 0.084 
  Mesh B3 0.025D 16,195,872 1,353,083 0.084 
 
 
The experiments were conducted at 4 L/min, with 60% of the flow coming 
through the IVC, 40% through the SVC, and a 50/50 RPA/LPA mass flow ratio at the 
outlets. For the computations and in the subsequent results, all quantities are normalized 
by the pipe diameter D and the mean velocity at the IVC inlet. The corresponding 
Reynolds number is Re = 1040. Time-dependent calculations are carried out using a non-
dimensional physical time step Δt = 0.01. Flat flow velocity profiles (plug flow) are 
prescribed at both inlets. Comparisons with the experimental measurements in the IVC 
1.25D upstream of the junction region show that the calculated velocity profiles are in 
good overall agreement with the measurements, which supports the use of a plug velocity 
profile at the inlet sections.  
As indicated in the vorticity snapshots shown in Figure 7-6 and Animation 7-1, 
the flow in the connection region is unsteady as it is characterized by weak, albeit 
persistent and sustainable over the entire simulation interval, unsteady fluctuations of the 
shear layers that emanate from the walls of two inlet pipes and collide in the junction 
region. The flow entering from the IVC is seen to impinge on the upper junction region 
where it extracts wall vorticity of opposite sign and interacts with vorticity from the SVC. 
After impinging on the wall, the IVC shear layer (“red” vorticity in Figure 7-6) bends to 
the left and curves downward to impinge onto the lower wall of the LPA where it 
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interacts with the negative vorticity coming from the wall of the SVC. The interaction of 
the two shear layers results in seemingly aperiodic vortex shedding events when shear 
layer vorticity is injected into the LPA. Since the experimental measurements reported 
only time-averaged results all subsequent presented comparisons between experiments 
and simulations are reported for time-averaged flow quantities.  
As shown in Figure 7-7, the main flow features are captured on all three meshes used in 
the mesh refinement study. These flow features are identified with the letters A through 
D in Figure 7-7 as follows: (A) the flow separation at the junction region of the SVC; (B) 
the saddle of attachment at the upper wall of outlet 2 pipe due to the impingement of the 
IVC flow; (C) the stream from the IVC flow going around the central recirculation region 
and merging with the deflected SVC flow to form a strong shear layer; and (D) the 
recirculating flow region at the center of the junction region. The vorticity plots also 
shown in Figure 7-7 demonstrate that even though most features of the flow are 
adequately resolved even on the coarser mesh, the shear layers emanating from the IVC 
and SVC walls and their merging dynamics in the junction region do become sharper and 
somewhat more intense as the mesh is refined. Overall all three meshes, and especially 
the two finest meshes B2 and B3, yield results that are in good agreement with each other 
and the experimental measurements. 
A characteristic of this test case compared to the 90 degree curved pipe reported 
earlier is that, here, only 8 to 9 percent of the total Cartesian grid nodes are active grid 
nodes. Based on numerical experiments comparing our code performance with the SC 
and UC implementation, conducting the same simulations with the SC formulation would 
have required about 6 to 7 times the allocated memory and 3 times the computational  
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Figure 7-6: Time series on the symmetry plane of the idealized TCPC geometry obtained 
on grid B2. Left: Instantaneous U velocity at point P at the center of the connection. 
Right: Out of plane vorticity field at 6 instants in time.  
 
 
 
 
 
 
 
 
 
 
Animation 7-1: Out-of-plane vorticity field on the symmetry plane of the idealized TCPC 
geometry obtained on grid B2. Note the intermittent vortex shedding at the center of the 
connection. 
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Figure 7-7: Comparison of the measured and computed time-averaged velocity 
(magnitude and streamlines) (Left) and vorticity (Right) fields in the symmetry plane of 
the pipe junction geometry.  
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time required by the UC approach. Furthermore, as was also the case for the curved pipe 
test-case (Sections 7.2), the size of the Cartesian grid required to achieve the active node 
spatial resolution of the two finest meshes, B2 and B3, is excessive especially for the 
finest mesh for which more than 16 million grid nodes are required. 
 
7.4 Non-Pulsatile Flow in a Patient-Specific Intra-Atrial TCPC Anatomy  
The last test-case reported in this section seeks to demonstrate the potential of the 
UC approach as a powerful tool to simulate complex anatomical configurations by 
considering flow through patient specific TCPC anatomies. The anatomy under 
consideration is an intra-atrial connection with a single SVC for which previous 
experimental studies revealed high levels of flow unsteadiness in the central connection 
region. This test-case is included here to demonstrate the complexity of the flow 
structures observed in in vivo anatomies and the level of mesh refinement required for 
obtaining grid insensitive results. The patient-specific geometry shown in Figure 7-8 was 
reconstructed from magnetic resonance images of a 13 year old single-ventricle patient. 
Details on the model generation and experimental study are provided by de Zélicourt et 
al. [177]. Inflow and outflow boundary conditions are prescribed in the calculations to 
match the experimental flow conditions [177] with a constant total volume flow rate of 4 
L/min and mass flow splits of 60/40 between the IVC and SVC inflows and 50/50 
between the LPA and RPA outflows. Plug (flat) flow profiles were prescribed at the IVC 
and SVC inflow planes for all subsequent results unless explicitly indicated otherwise. 
All quantities are normalized based on mean velocity and equivalent hydraulic diameter 
of the IVC. The corresponding Reynolds number is Re=294.  
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Figure 7-8: Patient-specific intra-atrial TCPC anatomy immersed in a Cartesian grid. The 
curvature of the vessels leads to a large number of unused external cells, and only 7% of 
the Cartesian grid cells are active cells and fall within the fluid domain. The arrows 
indicate the main flow directions in the various branches. 
 
The computational domain is illustrated in Figure 7-8. The surface of the TCPC 
anatomy is immersed in a uniform and isotropic Cartesian grid of dimensions 2.5DIVC × 
5.5DIVC ×5.0DIVC, where DIVC is the equivalent hydraulic diameter of the IVC inlet cross-
section. The TCPC surface is discretized with an unstructured triangular mesh with 
15,110 nodes. Three different spatial resolutions are used to discretized the background 
Cartesian domain and carry out a systematic mesh refinement study. The coarsest mesh 
used in these simulations (Mesh C1 in Table 7-3) was set so that its spatial resolution (h = 
0.03DIVC) was equal to the spatial resolution of the experimental particle image 
velocimetry (PIV) data acquired by Zélicourt et al. [177]. Time-dependent calculations 
were carried out using a non-dimensional physical time step of Δt = 0.005. Running-
averages of the velocity components converged after simulating about 200 units of non-
dimensional physical time.  
 
 
- 163  - 
Table 7-3: Mesh resolutions used for the anatomical intra-atrial geometry (DIVC is the 
equivalent hydraulic diameter of the IVC cross-section at the inflow) 
 h IM×JM×KM Na r 
 Mesh C1 0.03DIVC 3,029,400 219,030 0.072 
 Mesh C2 0.02DIVC 10,032,624 740,103 0.074 
  Mesh C3 0.016DIVC 17,116,140 1,260,841 0.074 
 
 
 
In spite of the steady inflow conditions and flow rates well within the laminar 
regime, highly unsteady vortical motion were observed within the connection region. 
This unsteadiness is illustrated in Figure 7-9, which shows the velocity time series at a 
point in the SVC connection. It should be noted that such unsteadiness was observed in 
our simulations throughout the connection. The complex three-dimensional structure of 
the instantaneous flow in this region is further illustrated in Figure 7-10 and Animation 
7-2, which visualizes instantaneous coherent structures using the q-criterion [178]. The 
unsteadiness seems to originate at the unstable saddle point where the IVC and SVC 
streams collide and manifests itself as a seemingly chaotic meandering and flapping of 
the flow. Even though in vitro experiments in the identical TCPC configuration reported 
only time-averaged in-plane velocity measurements, the flow unsteadiness was 
documented using dye flow visualization [177]. These experiments revealed very 
complex and highly unsteady transport of the dye in the connection region characterized 
by intense stretching and folding processes, which are the hallmarks of chaotic transport 
and mixing.  
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Figure 7-9: Calculated time series of the U velocity component at the point of the 
anatomical intra-atrial geometry marked with a dot in the top right inset.  
 
 
 
 
Figure 7-10: Instantaneous coherent structures in the connection region of the anatomical 
intra-atrial geometry visualized with q-criterion for 6 instants in time separated by 1.2 
non-dimensional time units.  
 
- 165  - 
 
 
 
 
 
 
 
 
 
Animation 7-2: Instantaneous coherent structures in the connection region of the 
anatomical intra-atrial geometry visualized with the q-criterion. 
 
 
From a clinical standpoint, the intense flow unsteadiness revealed by both 
simulations and experiments is extremely important as it results in regions of high 
velocity gradients and increased energy dissipation within the TCPC region. This in turn 
increases the workload of the heart and could have serious long term effects on the 
patient’s health and quality of life. As such, surgeons strive to design the TCPC 
connection such that flow unsteadiness and energy dissipation rates are minimized. 
Clearly, being able to systematically refine the mesh for such complex unsteady flow is a 
critical prerequisite for establishing the potential of any CFD algorithm as a reliable 
surgical planning and optimization tool. 
Figure 7-12 to Figure 7-13 show the results of the mesh refinement study. Figure 
7-11 displays the velocity and vorticity fields for a plane taken across the connection 
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perpendicular to the X-axis. As can be observed from Figure 7-11, essentially all the 
dominant flow features (identified with letters A through E) on this plane are captured on 
all three meshes. These include the low velocity region with its small recirculation and 
flow separation patterns at the opening of the SVC (regions A and B) and the double 
vortex structure at the center of the connection (zones D and E), both of which were 
captured on all three meshes. The location of the vortex centers (points D and E) shifts 
between the meshes C1 and C2 but remains exactly the same between the meshes C2 and 
C3. Similarly, the low velocity recirculation points A and B and the shear layer between 
the incoming streams (zone C) are present in Mesh C1 but it is only on meshes C2 and 
C3 that they converge to the same location. The overall features of the vorticity field are 
also captured even on the coarsest mesh C1 but significant quantitative discrepancies 
become evident as the mesh is refined. Changes are mainly dictated by the refinement of 
the wall boundary layers such as in regions F through I in Figure 7-11 or along the LPA 
and RPA vessel walls in Figure 7-12. The structure and intensity of the boundary layers 
do not change significantly on meshes C2 and C3. Even though the vorticity iso-contours 
obtained with those two finer meshes do not exactly coincide, peak and low vorticity 
magnitudes are found in identical regions as shown in Figure 7-11 and Figure 7-12. A 
more quantitative comparison among the solutions on the different meshes is provided in 
Figure 7-13, which shows the profiles of the through-plane velocity magnitude along the 
two sections indicated in the figure. The profiles obtained with meshes C2 and C3 are 
essentially indistinguishable. The results shown in Figure 7-11 to Figure 7-13 collectively 
suggest that, even though the solution on the finest mesh may not be grid independent in 
the strict sense, it is certainly insensitive to further grid refinement insofar as all major 
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Figure 7-11: Comparison of the time-averaged velocity magnitude and in-plane 
streamlines (top row) and out-of-plane vorticity (bottom row) fields obtained with the 
three different mesh refinements used for the anatomical intra-atrial geometry.  
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Figure 7-12: Comparison of the time-averaged out-of-plane vorticity fields obtained with 
the three different mesh refinements in cross-sections of the left (section A, top row) and 
right (section B, bottom row) outflow tracks of the anatomical intra-atrial geometry.  
 
 
Figure 7-13: Comparison of the time-averaged through-plane velocity profiles on the 
three successively finer meshes for the anatomical TCPC geometry on two cross-section 
of the mid-plane. The horizontal axis is the distance along segment AA′ (BB′) measured 
from point A (B).  
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features of the flow are concerned. We believe that reaching strictly grid independent 
solutions for such a complex flow would require increasing the resolution of the 
boundary layers, which could be accomplished by combining the UC method with an 
local mesh refinement strategy. 
Finally, Figure 7-14 compares measured and calculated time-averaged velocity 
magnitude contours and streamlines at the previously defined plane through the TCPC 
region. Though the experimental set-up was designed so as to try and ensure a fully-
developed profile at the inflows, [177], the precise state of the flow at the entrance of the 
IVC and SVC was not documented. To explore the sensitivity of the simulated flow 
patterns to the state of the incoming boundary layers, we carried out three simulations 
using different sets of inflow velocity profiles (see Figure 7-14) including combinations 
of fully developed and plug inflow velocity profiles for the SVC and IVC. Due to the 
smaller dimensions and more tortuous configuration of the SVC when compared to the 
IVC, varying the SVC inflow profile only induced minor variations in the flow fields, 
whereas varying the IVC inflow profile had a drastic effect on the overall flow structures. 
The results obtained using a fully-developed and a plug velocity profiles at the IVC and 
SVC, respectively, are found to be in good overall agreement with the measurements 
especially in light of the fact that the uncertainties regarding the exact state of the inflow 
velocity profiles cannot be conclusively resolved from the available experimental data.  
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Figure 7-14: Comparison of the time-averaged experimental and calculated velocity 
magnitude and in-plane streamlines for the same plane of the anatomical intra-atrial 
geometry as in Figure 13. All numerical results are obtained on Mesh C1 using three 
scenarios for the IVC and SVC inflow boundary conditions (fully developed and plug 
velocity profile combinations).  
 
 
 
7.5 Conclusion 
The results presented in this chapter demonstrate the robustness and accuracy of 
our flow solver implementation, even for cases as complex as the reported in vivo 
anatomy, which featured complex dynamics, including regions of transition to turbulence 
and re-laminarization. In an era when computational simulations for clinical applications 
are becoming widespread, these results underscore the need for careful numerical 
simulations on fine computational meshes in order to properly capture all dynamic 
features of the in vivo flow structures. IB methods are inherently suited to tackle the 
geometrical complexity of in vivo anatomies. However, the fact that often in internal flow 
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applications involving complex, multi-connected geometries only a small fraction of the 
embedding Cartesian grid is located in the interior of the flow domain (typically between 
5 – 10 percent) renders the use of classical structured IB methods impractical for 
cardiovascular applications. Any attempt to carry out grid refinement studies for such 
configurations using standard structured Cartesian approaches would quickly lead to 
excessively high memory and computational time requirements. The proposed 
unstructured immersed-boundary paradigm effectively alleviates this difficulty and 
strikes a balance between computational efficiency and memory requirements.  
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CHAPTER 8 
PULSATILE TCPC SIMULATIONS 
 
In this chapter, we apply the computational fluid dynamics (CFD) solver 
developed and validated in the previous chapters to investigate the impact of pulsatility 
on the hemodynamics and efficiency metrics of the total cavopulmonary connection 
(TCPC). Four cases are considered herein: first, the theoretical scenario of an idealized 
TCPC geometry subjected to sinusoidal inlet flow waveforms; then, the patient-specific 
pulsatile TCPC hemodynamics of three patients having each undergone a different TCPC 
procedure. Each test-case is investigated under both pulsatile conditions and non-pulsatile 
mean flow conditions. Streamtrace and particle tracking animations are provided for each 
one of the four cases to best visualize the pulsatile dynamics and are included as an 
addendum to this thesis. Comparison of the pulsatile and non-pulsatile results for the 
same patient will demonstrate whether pulsatility has strong impact on the clinical end-
points for that patient, whereas the comparison across the three different patients will 
highlight whether some procedures are more sensitive to pulsatility than others. The 
chapter closes with a summary of the main findings. 
 
8.1 Study Objective and Parameters of Interest 
The objective of this study is to gain insights into the pulsatile in vivo TCPC 
hemodynamics, assess whether neglecting pulsatility affects the predicted performance 
ranking of different options, and if so determine whether pulsatility should be accounted 
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for in all options or only under specific conditions. To this end, we first investigate the 
impact of flow pulsatility in a carefully controlled idealized TCPC configuration and in 
three patient-specific scenarios. The patients were selected from the Georgia Tech Fontan 
database of magnetic resonance images (MRI) based on the availability of anatomical 
reconstruction, inflow/outflow flow curves, and 3D in vivo flow reconstruction [80]. 
These three cases were further chosen to constitute a representative sample of the 
geometrical and flow configurations observed across the database. The first two patients 
have a normal vascular configuration, with an inferior vena cava (IVC) and single 
superior vena cava (SVC), and similar pulsatility levels, but feature two different types of 
TCPC configurations, namely an extra-cardiac TCPC for the first patient and an intra-
atrial TCPC for the second. The third patient features a highly abnormal systemic venous 
return with an interrupted IVC and persistent left superior vena cava (LSVC), and is here 
studied as a representative example of the upper range of geometrical complexity and 
flow pulsatility levels that may be expected in the in vivo TCPC configurations.  
For all four case-studies, pulsatile CFD simulations are conducted using the 
experimental or patient-specific geometries and flow curves, with rigid vessel boundaries. 
In addition, in order to quantify the effect of pulsatility on the TCPC efficiency, each 
pulsatile simulation is accompanied by a non-pulsatile counter-part, conducted using the 
same geometry but with the mean vessel flow rate rather than the pulsatile flow curves. 
The relative impact of flow pulsatility is assessed by comparing the flow structures and 
efficiency metrics predicted by the non-pulsatile simulations to those obtained by 
averaging the pulsatile results over multiple cardiac cycles and to the departure of the 
instantaneous pulsatile data points from their time-averaged value.  
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Efficiency metrics of interest are the pressure drops and power losses across the 
connection, the hepatic flow distribution and the particle residence times. Pressure drops 
and power losses constitute surrogate measures for the workload imposed on the single 
ventricle and the pressure build-up in the gastro-intestinal track. Hepatic flow distribution 
to the two lungs is taken as a surrogate measure for the risk of developing pulmonary 
artero-venous malformations (PAVMs), which have been correlated with a low supply in 
humoral hepatic factors[67]. Finally, particle residence time provides a quantitative 
measure for the differences in the pulsatile and non-pulsatile particle pathways, as well as 
an indicator for the risk of thrombus formation. 
Each case study follows the same structure: first, we describe the experimental or 
in vivo geometry and flows and the numerical set-up; next, we compare the pulsatile CFD 
hemodynamics to the experimental or in vivo measurements, as well as to their non-
pulsatile CFD counter-part, followed by a quantitative comparison of the pressure drop 
and power loss levels; finally, we perform a particle tracking analysis to visualize the 
pathways followed by blood borne particles in the pulsatile environment and quantify the 
hepatic flow distribution and particle residence times.  
 
8.2 Idealized TCPC 
The first test-case is an idealized TCPC representation and corresponds to the 
experimental study conducted in our laboratory by Christopher Haggerty and Jessica 
Kanter [179]. This test-case was retained to assess the impact of flow pulsatility in a 
carefully controlled environment and further assess the accuracy of our pulsatile 
simulations in a problem representative of the TCPC flows. 
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8.2.1 Experimental Set-Up 
As shown in Figure 7-5, the geometry consists of four pipes of equal diameter 
D=14mm, representing the inferior and superior venae cavae (IVC and SVC, 
respectively) and the right and left pulmonary arteries (RPA and LPA). The axes of the 
IVC and SVC are offset by 21mm.  
 
 
Figure 8-1: Geometry of the pipe junction geometry, which is an idealized representation 
of anatomic TCPC configurations. 
 
 
 
The experimental pulsatile flow waveforms are shown with full symbols in Figure 
8-2. A steady submersible pump and programmable piston pump were used in 
conjunction to produce a mean flow rate superimposed with sinusoidal oscillations. Flow 
rates were measured in the IVC, SVC and RPA at 500Hz. The period of the oscillations 
was 860 ms, which is equivalent to a heart rate of 70 beats per minute. The IVC flow 
rate, expIVCQ , ranged from 1.88 L/min to 3.38 L/min with a mean of 2.66 L/min. The SVC 
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flow rate, expSVCQ , ranged from 0.93 L/min to 1.76 L/min with a mean of 1.34 L/min. The 
pulsatility index (PI), defined as: 
 
Q
QQ
PI
2
minmax −=  (8-1) 
where maxQ , minQ ,Q  are the maximum, minimum and average vessel flow rate, 
respectively, was 28.3% for the IVC and 31.1% for the SVC. Outflow conditions were set 
using ball valves to impose a constant downstream resistance. 52.5% + 4.4% of the total 
flow rate exited through the RPA and 47.5% + 4.4% through the LPA.  
 
 
Figure 8-2: Experimental (full symbols) and numerical (continuous lines) flow curves. To 
ease the comparison, the experimental flow measurements are down-sampled to a 
frequency of 33.3Hz. 
 
 
8.2.2 Numerical Set-Up 
The characteristic length and velocity scales used to non-dimensionalize the 
problem are the pipe diameter, D, and the time- and space-averaged velocity across the 
IVC inlet cross-section, IVCU . The corresponding mean IVC Reynolds number is Re = 
1155. The Womersley number for the problem is 1.10=α . The flow wave-forms at the 
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IVC and SVC inlets are specified from the Womersley solution of a fully developed 
pulsatile flow within a circular pipe [180]: 
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where J0 denotes the Bessel function of the first kind and order zero, r is the radial 
distance from the center of the pipe, t is the instant in time, 2DR =  is the radius of the 
pipe, ω  represents the angular frequency of the flow oscillation, which is 7.3 rad/s, and 
6105.3 −⋅=ν m2/s is the fluid viscosity. In order to generate the sinusoidal flow waveform 
that varies in accordance with the experiments, the constant K1 and K2 are set to K1=1 and 
K2=0.125 for the IVC, and K1=0.51 and K2=0.073 for the SVC. We use Matlab 7.4 (The 
MathWorks Inc., Natick, MA, USA) to solve Equation 7-2 and the resulting solutions are 
stored and fed into the flow solver to specify the time-varying inlet velocity profile. The 
outflow conditions are prescribed using the time-varying experimental global flow 
distributions to the LPA and RPA (GFDRPA and GFDLPA), defined as: 
 ( ) ( )( ) ( )tQtQ
tQtGFD
SVCIVC
RPA
RPA expexp
exp
+
=  (8-3) 
 ( ) ( )tGFDtGFD RPALPA −= 1  (8-4) 
where expIVCQ , 
exp
SVCQ  and 
exp
RPAQ  are the instantaneous experimental flow rates through the 
IVC, SVC and RPA, respectively. The so-computed inflow and outflow waveforms are 
shown by the continuous lines in Figure 8-2 and are in good overall agreement with the 
experimental flow conditions. 
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The complete (no symmetry assumption is invoked) surface of the pipe junction 
geometry is discretized with an unstructured triangular grid (22,145 nodes) embedded in 
a rectangular Cartesian box of dimensions 16.5D×15.5D×1.1D, which is discretized with 
a uniform and isotropic Cartesian mesh. The Cartesian grid resolution is set to h=0.3D, 
which was shown to appropriately resolve all vortical structures in the mesh sensitivity 
study conducted in Section 6.4. Each pulsatile flow cycle is divided into 2000 time steps, 
corresponding to a non-dimensional time step dT = 0.0089.  
In order to quantitatively assess the impact of pulsatility on the retained efficiency 
metrics, namely power losses and hepatic flow distribution, non-pulsatile flow 
simulations are conducted as a control. These simulations are carried using the same 
spatial and temporal resolution as the pulsatile simulations, h=0.3D and dT = 0.0089, 
respectively. Inflow and outflow conditions are set to match the experimental flow rates 
averaged over the cardiac cycle, with 66.2=IVCQ L/min, 34.1=SVCQ L/min, 
%5.47=RPAGFD  and %5.52=LPAGFD . The mean IVC Reynolds number for the non-
pulsatile problem is the same as in the pulsatile simulations, namely Re=1155. Parabolic 
fully-developed velocity profiles are prescribed at both IVC and SVC inlets, using the 
non-fluctuating part of Equation 7-2 as follows: 
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8.2.3 Pulsatile Flow Fields 
The experimental pulsatile flow fields in the symmetry plane of the idealized 
TCPC were measured by particle image velocimetry (PIV) at 10 evenly spaced time-
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phases across the cardiac cycle, seven of which are shown in Figure 8-3. Instantaneous 
CFD flow fields for the same seven instants in time are shown in Figure 8-4 (and 
animated in Animation 8-1), together with the time-averaged pulsatile flow and the non-
pulsatile results. To better visualize the experimental flow structures, the color-scale used 
to display the in-plane velocity magnitude in Figure 8-3 is optimized for each time-phase, 
while the velocity vectors are shown using the same scaling factors for all time-phases 
thus providing an easy comparison of the relative velocity magnitudes. It may be noted 
that the experimental velocity magnitudes in phases P3 and P5 of Figure 8-3 are 
abnormally lower than in other phases. This is best illustrated by noting that the velocity 
scale used in P5 is about half of that used in P1 despite identical inlet flow rates. The 
discrepancy in the measured magnitudes might be attributed to an inadequate 
optimization of the imaging frequency, but should not alter the captured flow structures, 
which will be the focus of our discussion.  
Similar flow structures are observed in both the PIV and CFD flow fields. In the 
early acceleration phase (P5 and P7), the IVC flow is directed almost exclusively towards 
the RPA. This is due to the fact that in these phases, the RPA flow rate exceeds that of 
the LPA. The LPA and RPA flow curves cross-over at phase P5 and the IVC flow is seen 
to progressively switch to a “vertical” orientation in the late acceleration phase (P8) and 
maintain that orientation throughout the peak and deceleration (phases P9 to P3). In these 
phases, the IVC flow hits the superior aspect of the RPA and a portion of the IVC stream 
splits towards the left, and recirculates around the central connection region into the LPA 
(see CFD results for phases P9 to P3 in Figure 8-4). 
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Figure 8-3: Experimental pulsatile velocity fields as measured by particle image velocimetry (PIV) on the central plane of the 
idealized TCPC connection. The color-contours display the in-plane velocity magnitude, with a color-scale optimized for each of the 
displayed time phases. The velocity vectors (in black) maintain the same scaling factors for all time phases. 
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Figure 8-4: Pulsatile CFD velocity fields on the symmetry plane of the idealized TCPC connection. The color-contours display the in-
plane velocity magnitude, while the flow structures are illustrated by the in plane velocity vectors (in black). See Animation 8-1 for a 
dynamic visualization of the displayed flow structures. 
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Animation 8-1: Pulsatile CFD velocity fields on the symmetry plane of the idealized 
TCPC connection. The color-contours display the in-plane velocity magnitude, while the 
flow structures are illustrated by the in plane velocity vectors (in black). 
 
 
The SVC flow remains exclusively directed to the LPA throughout all time 
phases, turning towards the left branch directly upon entrance in the central connection 
region. The SVC velocity magnitude progressively increases from time-phase P3 to P9, 
in accordance with the measured SVC flow rate. The peak SVC velocities are 
systematically noted just downstream of the connection site, where the SVC flow 
accelerates and turns into the LPA. In phase P5, the SVC stream is confined in the left 
corner of the SVC anastomosis, resulting in a strong transient flow acceleration, which 
disappears in phase P7 as the SVC jet becomes larger with lower velocity values than in 
P5. The SVC velocities then increase again in phases P8 and P9 as the SVC flow rate 
reaches its peak. The SVC flow deceleration gives rise to complex unstable flow 
structures in phase P1, and local flow reversal in phase P3. Flow reversal is apparent 
along the right aspect of the SVC wall in the CFD results and on both the left and right 
side of the SVC in the PIV results. Such flow reversal in the vicinity of the vessel walls is 
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consistent with the flow structures typically observed in a Womersley pipe flows. Flow 
reversal on the right side of the SVC is further enhanced by the competition with the fast 
stream of IVC flow that recirculates around the center of the connection. 
The center of the connection is characterized by low velocities (blue and light 
green) and highly unsteady flow structures. In phases P7 to P9, where the flow 
acceleration leads to two stable SVC and IVC streams oriented towards the closest PA, 
this low flow region is confined to the area lying between the two vessels. During 
deceleration, on the other hand, the low flow region progressively increases, extending 
further below the SVC anastomosis site. It appears to be the largest in phase P3 in the 
experimental PIV measurements and in phase P1 in the CFD flow fields. The complexity 
of the dynamics at the center of the connection is best visualized with the vorticity 
contours shown in Figure 8-5 and Animation 8-2. The portion of the IVC that splits 
towards the LPA leads to the formation of a strong narrow shear layer that interacts with 
the “red” vorticity from the SVC, with an intermittent vortex-shedding into the LPA. The 
center of the connection is characterized by number of small, transient and apparently 
random eddies.  
Overall, the computed pulsatile velocity fields are in good agreement with the 
experimental observations. Differences in the reported magnitudes are mostly believed to 
originate from an erroneous scaling of the measured PIV displacements. Local 
differences in the dynamics of the center of the connection mostly stem from the fact that 
this region is prone to high level of non-periodic unsteadiness. These transient unsteady 
structures are apparent in the instantaneous CFD flow fields but smoothed out in the PIV 
measurements, which represent the time-bin averages over multiple cardiac cycles. 
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Figure 8-5: CFD vorticity fields on the symmetry plane of the idealized TCPC connection 
(see Animation 8-2 for the corresponding dynamic visualization). The instantaneous 
vorticity plots correspond to the same seven instants in time as in Figure 8-4.  
 
 
 
 
 
 
 
 
 
 
 
Animation 8-2: CFD vorticity fields on the symmetry plane of the idealized TCPC 
connection. 
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8.2.4 Comparison of the Time-Averaged Pulsatile and Non-Pulsatile 
Flow Fields 
Figure 8-6 shows the time-averaged pulsatile velocity and vorticity fields, and 
compares them to the results obtained under non-pulsatile conditions using the same 
mean inlet and outlet flow rates. All transient structures are smoothed out in the pulsatile 
time-average resulting in an almost zero vorticity (green) at the center of the connection 
and blunter shear layer boundaries than in the instantaneous vorticity fields. It is 
interesting to note the high degree of similarity between the time-averaged pulsatile and 
non-pulsatile results. The main difference between the two flow fields resides at the 
center of the connection, and is best visualized with the vorticity contours. In the non-
pulsatile results, the IVC consistently splits between the LPA and RPA, leading to a well 
defined shear layer (in red) that extends far into the central connection region. This red 
IVC shear layer gives rise to a small flow separation and slow counter-clockwise 
recirculation in the right corner of the SVC, apparent as a patch of blue, almost stagnant, 
velocities, and a confined patch of blue vorticity.  
In the pulsatile simulations on the other hand, the IVC flow alternates between the 
RPA and a more “vertical” orientation (see Figure 8-4), and the patch of counter-
clockwise blue vorticity in the right corner of the SVC anastomosis shifts from being 
more upstream in phases P3 and P5 of Figure 8-5 to a more downstream position in 
phases P1 and P7. As a result, in the time-averaged pulsatile vorticity field, the red IVC 
shear layer rapidly fades out as it goes around the central connection region, and the 
patch of blue vorticity in the right SVC corner averages to a smaller recirculation region 
than in the non-pulsatile flow field. 
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Figure 8-6: Comparison of the velocity and vorticity fields obtained by averaging the 
pulsatile simulations over 4 cardiac cycles, and in the non-pulsatile simulations 
conducted under the same mean inflow and outflow conditions.  
 
 
8.2.5 Energy Dissipation 
Table 8-1 provides the pulsatile and non-pulsatile power losses averaged over the 
cardiac cycle, as well as the maximum deviations from the mean values recorded in the 
pulsatile simulations. The mean pulsatile pressures fall within a remarkably close range 
of the non-pulsatile values, the maximum difference between the two settings being of 
only 0.03 mmHg in the SVC. The mean pulsatile power losses are 20% higher than their 
non-pulsatile counter-part, which might be attributed to the higher levels of flow 
unsteadiness at the center of the connection.  
The fact that the time-averaged pulsatile pressures and power losses fall within 
the same range as the non pulsatile results is in line with the similarities observed 
between the time-averaged and the non-pulsatile velocity and vorticity fields. However, 
as can be noted from the maximum pressure drops and power loss values reported in 
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Table 8-1, it is apparent that the mean values do not suffice to tell the whole story. The 
pulsatile RPA and LPA pressure drops fall as low as -3.94 mmHg and -4.65 mmHg, 
while power losses reach up to 28.19 mW, i.e. close to four times the mean. The pressure 
fluctuations stem from both the inlet pulsatility and the variations in RPA/LPA flow 
ratios. The maximum power losses are recorded during the flow acceleration phase 
(phases P3 to P9) when the pressure drops are the largest. Symmetrically, the flow 
deceleration hosts the lowest power losses, as the pressure gradient temporarily reverses 
to slow down the flow throughout the connection.  
 
Table 8-1: Pulsatile and non-pulsatile power losses for the idealized TCPC connection 
 Pressure in reference to the IVC (mmHg) Power Loss (mW) IVC SVC LPA RPA 
Pulsatile Average 0 -0.05 -0.57 -0.52 7.90 Max 0 1.56 -4.65 -3.94 28.19 
Non Pulsatile 0 -0.08 -0.59 -0.53 6.58 
 
 
 
8.2.6 Particle Tracking  
In order to assess the impact of pulsatility on the IVC flow distribution (taken as a 
surrogate measure of the hepatic flow distribution) and particle residence times, a 
Lagrangian particle tracking analysis is performed using three sets of data, namely the 
instantaneous pulsatile flow fields, the pulsatile time-average and the non-pulsatile 
results. For each data set, 700 new particles are released in the IVC and SVC every 2.15 
ms for four consecutive cardiac cycles and passively advected by the flow according to 
the method described in Chapter 5 (Section 5.8.3.2).  
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The particle trajectories associated with the instantaneous pulsatile flow fields are 
shown in Figure 8-4 for six evenly spaced time points and animated in Animation 8-3. 
The IVC particles are color-coded based on the time at which they were seeded, while the 
SVC particles are color-coded in black to ease the distinction of the IVC and SVC 
streams. In phases P3, P5 and P7, the flow at the center of the connection is mostly 
dominated by the IVC, which confines the black SVC particles towards the left-side of 
the SVC anastomosis and into the LPA. The constriction of the SVC stream leads to the 
local flow acceleration noted at the SVC connection site for these time-phases (Figure 
8-4). In phase P3, some blue IVC particles are also observed to engulf in the local flow 
reversal on the right side of the SVC anastomosis. Phases P7 and P1 present a larger 
degree of IVC and SVC mixing at the center of the connection than the other phases. In 
phase P1, this may be attributed to the RPA/LPA flow ratio, which is largely in favor of 
the RPA, so that most of the IVC particles flow towards the RPA, opening up the central 
connection region for the SVC flow. In phase P7, the increased mixing stems both from 
the RPA/LPA flow distribution and from the fact that the SVC reaches its peak flow rate 
and thus peak momentum energy.  
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Figure 8-7: Particle positions at six time points separated by 172 ms (corresponding to phases P1, P3, P5, P7 and P9 shown in Figure 
8-4). Phase P1 is shown for both the first and second cardiac cycle to better highlight the dynamics at the center of the connection. The 
IVC particles are color-coded by their release time. Blue particles thus denote particles that were seeded early in the cardiac cycle, 
while orange and red particles denote particles seeded towards the end of the cardiac cycle. The SVC particles are shown in black. 
Animation of the particles is included in Animation 8-3.  
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Animation 8-3: Dynamic particle visualization. The particle color coding is the same as 
in Figure 8-7. 
 
 
8.2.6.1 Particle Residence Time 
Looking at the color-coding of the IVC particles in Figure 8-7, it may be noted 
that only very few blue or light green particles remain at the beginning of the second 
cardiac cycle (P1b). This implies that most IVC particles exit the connection in less than 
a heart beat. The quantitative distribution of the IVC particle residence time is shown in 
Figure 8-8 and compared to the values obtained by applying the same approach to the 
time averaged pulsatile flow field and non-pulsatile results.  
Time-average and non-pulsatile results display very similar distributions, with a 
narrow peak at 344 ms and 360 ms for the time-averaged and non-pulsatile results, 
respectively. As is best seen from the cumulative distribution shown in Figure 8-9, 80% 
of the IVC particles exit the domain in 250 to 560 ms. The increase rate of the cumulative 
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distribution for both time-averaged and non-pulsatile results, slows down beyond 560 ms, 
which corresponds to the relatively uniform distribution of the particle residence times 
between 560 and 970 ms in Figure 8-8. These longer residence times are mostly 
associated with IVC particles evolving at a low velocity in the boundary layers of the 
IVC or PAs.  
In comparison with the time-averaged results, the distribution of the IVC particle 
residence times under pulsatile conditions shows a peak at shorter residence times (272 
ms), but that peak is of smaller amplitude and followed by a slower decay than for the 
time-averaged results. This translates into the fact that the cumulative distribution shown 
in Figure 8-9 rises earlier than the time-averaged one, but increases at a slower rate. It is 
also interesting to note that beyond 560 ms, the residence time distribution in the pulsatile 
simulations keeps decreasing unlike in the time-averaged results where it became more 
uniform. This might be attributed to the flow pulsatility, which increases the flow 
disturbances and, in turn, the chances of the particles in the wall boundary layers to be re-
directed towards the bulk of the flow. 
The cumulative pulsatile and time-averaged curves shown in Figure 8-9 fall back 
on top of each other for residence times of 750 ms or higher. Overall, 94% of the IVC 
particles take less than one cardiac cycle (860 ms) to exit the connection domain in the 
pulsatile simulations, which is in close range to the values of 96% and 95% predicted for 
the time-average and non-pulsatile flow fields. 
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Figure 8-8: Distribution of the IVC particle residence times for the pulsatile, time average 
and non-pulsatile results. 
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Figure 8-9: Cumulative distribution of the IVC particle residence times for the pulsatile, 
time average and non-pulsatile results. 
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8.2.6.2 IVC Flow Distribution 
Throughout all phases shown in Figure 8-7, almost no SVC particles are seen to 
reach the RPA, and it is the IVC particles that divide between the left and right branch to 
match the desired time-varying RPA/LPA flow ratio. The cumulative distribution of IVC 
particles exiting through the RPA or LPA is depicted in Figure 8-10 as function of the 
time elapsed since the first particle release. The results obtained by applying the same 
approach to the pulsatile time-average and non-pulsatile flow fields are shown as well for 
comparison.  
The flow distributions to the RPA or LPA start to rise at approximately 430 ms, 
which corresponds to the time needed by the first particles to flow across the domain. The 
pulsatile distribution follows the same trendline as the time-averaged or non-pulsatile 
results. The pulsatile IVC distribution to the LPA falls below the mean at the beginning 
of each cardiac cycle, which also corresponds to the phases were the global flow 
distribution to the LPA is the lowest. As flow to the LPA increases in the later part of the 
cardiac cycle, the pulsatile IVC flow distribution reaches the same values as the time-
averaged or non-pulsatile results. The impact of the instantaneous fluctuations attenuates 
as more cardiac cycles are taken into account. Results stabilize after four cardiac cycles. 
At the end of the fifth cardiac cycle, the distribution of the IVC particles is computed to 
be 75.7/24.3 RPA/LPA for the pulsatile simulations vs. 74.3/25.3 and 74.9/25.1 when 
using the pulsatile time-average and the non-pulsatile results, respectively. 
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Figure 8-10: Comparison of the IVC flow distribution associated with the pulsatile flow 
fields, the pulsatile time-average and the non-pulsatile simulations. The number of 
cardiac cycles is indicated in blue below the x-axis for an easier reading. 
 
 
 
8.2.7 Summary 
Overall, the time-averaged pulsatile and the non-pulsatile results for the idealized 
TCPC geometry were in very close match. Slight differences were observed in the 
velocity and vorticity fields at the center of the connection, where the impact of the 
pulsatile flow instabilities is the highest. However, these small discrepancies did not 
translate into significant variations in the reported pressure drops, IVC flow distributions 
or particle residence times. On the other hand, the pulsatile fluctuations lead to 1) 
increased flow disturbances at the center of the connection with a number of small local 
eddies, which were unseen in the non-pulsatile results, 2) large variations in the LPA and 
RPA pressure drops, whose maximum values deviate by as much as 4 mmHg from the 
mean, to accommodate for the repeated flow accelerations and decelerations, 3) large 
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variations in power losses, the maximum value being close to four times the mean. The 
cumulated effect of the flow instabilities and pressure translated into a 20% increase in 
power losses for the pulsatile results compared to the non-pulsatile ones.  
 
 
8.3 Patient 1 (CHOP 095): Extra-Cardiac TCPC 
The first in vivo anatomy retained for this study is an extra-cardiac TCPC with a 
single SVC and normal systemic venous return. The patient-specific anatomy, shown in 
Figure 8-11, was reconstructed from anatomical MR images of an 8 year-old female 
Fontan patient. In vivo flow rates were assessed by phase-contrast MRI (PC MRI) 
acquired through each one of the vessel cross-sections at 23 evenly spaced time-points 
across the cardiac cycle. The 3D in vivo flow structures were reconstructed from a stack 
of coronal PC MRI acquired at the same frequency. Details on the model generation, flow 
condition extraction and 3D velocity field reconstruction are provided in Chapter 5.  
8.3.1 In Vivo Flows Conditions and Numerical Set-Up 
The in vivo inlet and outlet flow conditions as measured by PC MRI are illustrated 
by the square symbols in Figure 8-12, in terms of the time-dependent cardiac output 
(computed as the sum of the instantaneous IVC and SVC flow rates) and time dependent 
inlet and outlet flow distributions. The patient’s heart rate was 91 beats per minute, 
corresponding to a cardiac cycle duration of 659 ms. The mean cardiac output over the 
cardiac cycle was 2.7L/min, with an average mass flow splits of 62/38 between the IVC 
and SVC and 43/57 between the RPA and LPA. The geometric and flow characteristics 
of the problem are summarized in Table 8-2. 
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Cardiac Output (CO): 2.7 L/min  
Figure 8-11: Patient-specific anatomy of the extra-cardiac test-case. The arrows indicate 
the main inflow/outflow directions. The mean in vivo flow rates, averaged over the PC 
MRI phases are reported next to each one of the vessels expressed as a percentage of the 
mean cardiac output. 
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Figure 8-12: Inlet and outlet flow rates as obtained from the in vivo PC MRI 
measurements (symbols) and as prescribed for the CFD simulations (continuous lines). 
The CFD flow conditions are imposed using the in vivo flow ratios (Left) at the outlets 
and in vivo flow rates (Right) at the inlets. The vertical black lines depict the five time-
phases for which the PC MRI and CFD flow fields will be discussed in details. 
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Table 8-2: Geometric and CFD flow characteristics at the two inlets (IVC and SVC) and 
outlets (RPA and LPA) of the extra-cardiac TCPC. 
Vessel IVC SVC LPA RPA 
Area (cm2) 2.91 1.91 0.57 0.64 
Fl
ow
 R
at
e 
(L
/m
in
) Mean 1.79 0.92 1.54 1.17 
Max 2.51 1.26 2.25 1.63 
Min 0.78 0.37 0.25 0.61 
Pulsatility index 48.5% 48.5% 64.6% 43.3% 
 
 As discussed in Chapter 5, the in vivo flow rate measurements could not be used 
directly for the CFD simulations because the sum of the in vivo inflows (IVC and SVC) 
did not match the sum of the in vivo outflows (LPA and RPA). Accordingly, the CFD 
inlet boundary conditions are prescribed to match the in vivo flow rates, while the outlet 
boundary conditions are computed based on the time-varying in vivo mass flow ratios. 
The inlet and outlet flow distributions and flow curves used in the CFD simulations are 
shown by the continuous lines in Figure 8-12. The IVC and SVC flow curves are almost 
exactly in phase, reaching their minimum flow rate at t = 500 ms and t = 476 ms, 
respectively. A slightly larger phase shift is observed between the RPA and LPA flow 
curves, which reach their minimum at t = 455 ms and t = 505 ms, respectively. 
In the simulations, all quantities are normalized based on mean velocity and 
equivalent hydraulic diameter of the IVC, DIVC, yielding a characteristic Reynolds 
number Re=565, a Womersley number α=15.9 and a non-dimensional cardiac cycle 
duration T=3.52. The pulsatility indices associated with the CFD inflow and outflow 
curves are 48.5% for both IVC and SVC, 43.3% for the RPA and 64.6% for the LPA. 
Plug (flat) flow profiles are prescribed at the IVC and SVC inflow planes and scaled to 
match the instantaneous flow rate. 
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The TCPC surface is discretized with an unstructured triangular mesh with 11,498 
triangular elements. The background Cartesian domain is discretized with a resolution h 
= 0.02DIVC. Pulsatile calculations are carried out using a non-dimensional physical time 
step of Δt = 0.001, corresponding 3520 time steps per cardiac cycle, and iterated over 10 
cardiac cycles. Finally, the non-pulsatile time-dependent simulations are carried using the 
time-averaged inflow and outflow conditions and the same temporal and spatial accuracy 
as in the pulsatile simulations. 
 
8.3.2 3D Flow Structures 
The 3D in vivo flow structures reconstructed from the coronal PC MR images are 
shown in the top panels of Figure 8-13 and Figure 8-14 for five selected time phases out 
of the 23 that were acquired. The lower panels of these two figures display the pulsatile 
CFD results obtained for the same five instants in time, as well as the non-pulsatile flow 
fields obtained under the mean inflow and outflow conditions. Both figures display the 
instantaneous flow structures using 3D ribbons seeded in the IVC and SVC. In Figure 
8-13, these 3D ribbons are color-coded by their vessel of origination (in orange for IVC 
streamtraces and green for SVC streamtraces) to best illustrate the interaction between 
the two incoming caval flows. In Figure 8-14, the ribbons are color-coded by velocity 
magnitude and the anterior half of the TCPC is blanked out of the image to gain better 
insights into the flow structures at the center of the connection. The dynamic 
visualization of these streamtraces across the cardiac cycle is provided in Animation 8-4 
and Animation 8-5 for the in vivo PC MRI and pulsatile CFD results,  respectively. 
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Figure 8-13: Global flow structures as reconstructed from the coronal PC MRI images (Top) and as computed by CFD (Bottom) for 
five time phases across the cardiac cycle. The non-pulsatile CFD flow structures are provided as well for comparison. The IVC and 
SVC interactions are illustrated by 3D streamtraces color-coded by their vessel of origin (IVC: orange; SVC: green). Animation of the 
PC MRI and CFD streamtraces are included in Animation 8-4 and Animation 8-5, respectively. 
- 200 - 
Velocity Magnitude 
(cm/s) 0               20              40
P
C
 M
R
I
C
FD
P2                      P8                     P14              P17                  P20
Pulsatile Phases
Non-pulsatile
SVC
RPA
IVC
LPA
A
 
Figure 8-14: Global flow structures as reconstructed from the coronal PC MRI images (Top) and as computed by CFD (Bottom) for 
five time phases across the cardiac cycle. The non-pulsatile CFD flow structures are provided as well for comparison. The 3D 
streamtraces are color-coded by velocity magnitude and the anterior half of the domain is blanked out for a better visualization of the 
inner flow structures.  
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Animation 8-4: Dynamic visualization of the in vivo flow structures as reconstructed 
from the coronal PC MRI images. The 3D streamtraces color-coded by their vessel of 
origin (IVC: orange; SVC: green). 
 
 
 
 
 
 
 
 
 
 
Animation 8-5: Dynamic visualization of the pulsatile CFD flow structures. The 3D 
streamtraces color-coded by their vessel of origin (IVC: orange; SVC: green). 
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8.3.2.1 General Considerations 
Looking at the velocity magnitudes reported in Figure 8-14, it is noteworthy that 
the PC MRI and CFD values fall within the same range at the center of the connection 
but drastically differ in the pulmonary outflow tracks. As was mentioned above, the sum 
of the PC MRI outflow rates is systematically lower than the sum of the inflows, leading 
to inconsistent in vivo measurements. This discrepancy, which is consistently observed 
across our patient database, has been attributed to larger measurement errors in the PAs 
than in the VCs due to the smaller dimensions of the former vessels [181]. It should also 
be pointed out that the in vivo velocities measured in the IVC are less uniform than in the 
CFD results, although falling within the same range. This is most likely due to the flat 
inlet velocity profiles used in this study, and results could be further improved by 
smoothing and interpolating the in vivo velocity profiles onto the CFD inlet cross-
sections.  
Despite this assumption at the inlets, the agreement between the measured and 
computed flow structures is quite remarkable. As is best visualized from Figure 8-13, the 
IVC streamtraces occupy most of the central connection area in both the PC MRI and 
CFD flow fields, constraining the SVC streamtraces towards the left side of the SVC 
anastomosis site. This behavior is similar to what was observed in the idealized TCPC 
case, and results in an almost exclusive distribution of the SVC flow to the LPA 
throughout the cardiac cycle. The flow pulsatility mostly impacts the flow structures in 
the IVC and at the center of the connection, which will be the focus of the subsequent 
section. 
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8.3.2.2 Phase-by-Phase Analysis 
The temporal location of the five selected time phases is illustrated by the thick 
black lines in the right panel of Figure 8-12. Phase P2 corresponds to the late 
acceleration, P8 lies in the plateau of the cardiac output curve, P14 is located mid-way 
through the deceleration, P17 corresponds to the lowest cardiac output and P20 to the 
early acceleration.  
In the late acceleration and peak flow phases (P2 and P8), the IVC features stable 
flow structures, its streamtraces being nicely aligned with the vessel axis. A small flow 
separation can be noted on the left side of the IVC anastomosis due to the curvature of 
the IVC baffle (red arrows in Figure 8-14). The collision of the IVC and SVC 
streamtraces leads to the formation of a flow stagnation point in the IVC (black in Figure 
8-14), around which the IVC streamtraces divide into those going towards the RPA and 
those going towards the LPA. The CFD and PC MRI flow structures for those two time 
phases are in remarkable agreement. A slight difference can be noted in phase P8 of 
Figure 8-13 where some of the SVC streamtraces are seen to travel close to the anterior 
wall of the connection and follow a helical flow pattern into the PAs in the CFD results 
but not in the PC MRI flow fields. This difference can for the most part be attributed to 
the low resolution and poor signal-to-noise ratio of the PC MRI measurements in the 
vicinity of the vessel walls. 
The flow separation region noted in phases P2 and P8 is present throughout the 
cardiac cycle and can also be clearly identified in the non-pulsatile flow fields. It is least 
pronounced in the late acceleration phase (P2) and most pronounced in phase P14 during 
the flow deceleration. As the flow decelerates towards the minimum cardiac output 
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(phases P14 and P17), flow instabilities develop half-way through the baffle, resulting in 
tortuous 3D streamlines in the upper half of the IVC baffle (red arrow in Figure 8-13). At 
the connection site, the decreasing kinetic energy of the SVC, allows the IVC to penetrate 
further into the central connection region along the right side of the SVC anastomosis 
location (black arrows in Figure 8-13  and Figure 8-14). Penetration of the IVC into the 
SVC pathway is more pronounced in the PC MRI measurements than in the CFD results, 
especially in phase P14. This might here again be due to the choice of flat inlet velocity 
profiles. The use of Womersley velocity profiles in the idealized TCPC led to the 
development of a local flow reversal at the SVC anastomosis site, which allowed for a 
deeper penetration of the IVC stream. A similar phenomenon might be at stake here. As 
the analytical Womersley solution only applies for circular pipes, a possible alternative 
would be to interpolate the in vivo inflow conditions, or further extend the entrance 
length to allow a wall boundary layer to develop. Finally, as the flow starts accelerating 
again in phase P17, the flow structures re-stabilize and strongly resemble those reported 
for P2.  
Results obtained under the non-pulsatile mean flow conditions demonstrate flow 
structures that closely resemble those of phases P2 and P8, where the IVC flow was most 
stable. Similarities include presence of the flow separation at the IVC anastomosis, 
stagnation point at the center of the connection and a highly preferential distribution of 
the SVC flow to the LPA. In absence of any destabilizing pulsatile effects, the flow 
recirculation (red arrows) is better defined in the non-pulsatile flow field than in any of 
the pulsatile time phases. In addition, slightly more SVC streamtraces succeed to reach 
the RPA by flowing along the anterior wall of the connection, than in the pulsatile flow 
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fields. However, these differences are minor overall and the non-pulsatile flow fields are 
in good agreement with the global pulsatile flow structures. 
 
 
8.3.3 Power Losses 
The average pulsatile pressure and power losses over the cardiac cycle and the 
maximum deviations from these mean values are given in Table 8-3, together with the 
corresponding values obtained in the non-pulsatile simulations. The mean pulsatile 
pressures and power loss values fall remarkably close to the non-pulsatile values. The 
largest difference in terms of pressures is seen in the LPA, where the pulsatile pressure 
drop is 0.15 mmHg or 7% larger than in the non-pulsatile simulations. The mean pulsatile 
power losses are 2 mW larger than their non-pulsatile counterpart, which represents less 
than a 5% increase. Under both flow conditions, the maximum pressure drops are 
recorded in the LPA, which may be attributed to the fact that the LPA featured both a 
smaller diameter and a larger flow rate than the RPA (see Table 8-2).  
 
Table 8-3: Pulsatile and non-pulsatile power losses for the extra-cardiac TCPC 
 Pressure in reference to the IVC (mmHg) Power Loss (mW) IVC SVC LPA RPA 
Pulsatile Average 0 -0.01 -2.08 -1.28 48.51 Max 0 0.21 -3.24 -2.03 70.65 
Non Pulsatile 0 -0.01 -1.95 -1.26 46.50 
 
 
The largest PA pressure drops recorded in the pulsatile simulations are -3.24 
mmHg for the LPA and -2.03 mmHg in the RPA, which represents a maximum deviation 
of 56% and 59% from the corresponding time-averaged values. The highest pulsatile 
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power losses are recorded during the first 350 ms of the cardiac cycle, corresponding to 
the plateau observed in the cardiac output waveform. The maximum pulsatile power loss 
is 70.65 mW representing a 46% increase compared to the time-averaged value. Overall, 
the fluctuations of the instantaneous pressure and power loss values are less marked in 
this anatomical case than in the idealized setting. This may be attributed to the lower flow 
rates measured in this patient, compared to the idealized test-case, and to the smaller PA 
dimensions, which reinforce the stabilizing viscous effects. 
 
 
8.3.4 Particle Tracking 
For the assessment of the Lagrangian particle pathways and efficiency metrics, 
1800 new particles were released at the IVC inlet cross-section every 33 ms for ten 
consecutive cardiac cycles. The computed IVC and SVC particle trajectories are 
illustrated in Animation 8-6. Figure 8-15 shows the IVC particle trajectories only, for the 
two last cardiac cycles (cycles 9 and 10). The IVC particles are color-coded based on the 
cardiac cycle during which they were seeded. Particles seeded during cardiac cycle 9 
appear in dark orange, while other colors (light orange, yellow or green) denote particles 
that were seeded in earlier cardiac cycles. To better visualize the progression of the IVC 
particles as they exit the TCPC domain, particles seeded in the last cardiac cycle (cycle 
10) are not displayed. Few of the dark orange particles reach the PAs by the end of the 
cardiac cycle in which they were seeded (namely cycle 9), and quite a large proportion of 
them remain within the IVC and the center of the connection even after the following 
cardiac cycle. It may also be noted that in phase P2 of the cardiac cycle 9, some green 
particles (which were seeded three cardiac cycles prior to the one visualized) are still  
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Figure 8-15: Progression of the particles seeded at the IVC inlet of the extra-cardiac 
anatomy for two consecutive cardiac cycles. The IVC particles are color-coded by their 
seeding time. Particles seeded in cardiac cycle 9 appear in dark orange, while the lighter 
orange, yellow or green particles were seeded in earlier cardiac cycles.  
 
 
 
 
 
 
 
 
 
Animation 8-6: IVC and SVC particle pathways. The particles are color-coded by their 
vessel of origin (IVC: orange; SVC: green) 
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present in the flow separation region on the left side of the IVC anastomosis. These green 
particles are washed out in the later part of cardiac cycle 9, and are replaced by yellow 
particles (seeded in cycle 7) in phase P2 of cardiac cycle 10. These results demonstrate 
that particles that get entrapped in the IVC flow separation region remain within the 
TCPC domain for about 3 cardiac cycles. 
8.3.4.1 Particle Residence Time 
The quantitative distribution of the IVC particle residence time is shown in Figure 
8-16 and compared to the values obtained by applying the same approach to the time 
averaged pulsatile flow field and non-pulsatile results. The associated cumulative 
distributions are shown in Figure 8-17.  The distribution of the particle residence times 
under pulsatile conditions displays a main peak at 497 ms followed by a second peak of 
lower amplitude at 759 ms. As can be seen from Figure 8-15, particles seeded at the 
beginning of a cardiac cycle, while the IVC flow rate is high, reach the connection site by 
P14 (which corresponds to t = 400 ms) and flow into the RPA. Most of these particles 
thus correspond to the first peak in Figure 8-16. Particles seeded later in the cardiac cycle 
take a little longer to flow across the TCPC domain, due to the IVC flow deceleration 
between phases P14 and P19, spreading the first peak towards higher particle residence 
times. The secondary peak corresponds to the particles that re-circulate around the 
connection region prior to reaching either one of the PAs. As is best illustrated in the 
cumulative distribution shown in Figure 8-17, no IVC particle exits the TCPC in less than 
367 ms, and only 46% of them exit the domain in one cardiac cycle or less. The 95% 
probability of an IVC particle reaching either one of the PAs corresponds to t = 1377 ms, 
which is to say a little over two cardiac cycles.  
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Figure 8-16: Distribution of the IVC particle residence times for the pulsatile, time 
average and non-pulsatile results in the extra-cardiac anatomy. The number of cardiac 
cycles is indicated in blue below the x-axis for an easier reading. 
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Figure 8-17: Cumulative distribution of the IVC particle residence times for the pulsatile, 
time average and non-pulsatile results in the extra-cardiac anatomy. The number of 
cardiac cycles is indicated in blue below the x-axis for an easier reading. 
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The distribution of the particle residence times computed using the non-pulsatile 
flow fields closely match the pulsatile time-average, and follow the same overall trends 
as the pulsatile results. A first narrow peak is observed at 459 ms that reaches up to 10%, 
followed by a secondary peak of lower amplitude around 700 ms. Both these peaks are 
higher and narrower than their pulsatile counterpart. This stems from the fact that the 
time-average or non-pulsatile results correspond to a single flow configuration leading to 
a lower spread in the possible residence times. However, these differences remain small 
and have little impact on the cumulative distributions reported in Figure 8-17, where the 
pulsatile, time-average and non-pulsatile curves fall within 5% of each other.  
 
8.3.4.2 IVC Flow Distribution 
The distribution of the IVC particles between the left and right lung is illustrated 
in Figure 8-18. The distribution of IVC particles to the RPA rises to 100% at t = 367 ms 
and remains at 100% until t = 621 ms. All particles exiting the TCPC domain between 
367 and 621 ms are thus directed towards the RPA, which is in line with the longer 
residence times reported earlier for particles that had to flow across the central 
connection region prior to reaching the LPA. Time-averaged and non-pulsatile data 
points are almost indistinguishable from one another, and converge towards a 70/30 
RPA/LPA distribution of the IVC flow. This IVC flow distribution may be contrasted to 
the 43/57 RPA/LPA global flow distribution, reflecting a highly preferential distribution 
of the IVC to the RPA. 
The pulsatile measurements closely follow the non-pulsatile trend. It may be 
noted that the pulsatile distribution to the RPA consistently falls above the non-pulsatile 
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measurements at the beginning of a new cardiac cycle. This overshoot corresponds to the 
high flow phase (P2 and P8). As was observed from the 3D streamtraces shown in Figure 
8-13, the SVC flow occupies most of the central connection region during these first time 
phases, leading to the formation of a flow stagnation point in the IVC. As a result, the 
IVC particles shown in Figure 8-15 do not penetrate into the central connection region 
and flow almost exclusively to the RPA in phases P2 and P8. As the flow decelerates in 
later part of the cardiac cycle, the mixing between the IVC and SVC increases, and the 
IVC distribution re-equilibrates to the same values as for the non-pulsatile simulations. 
The pulsatile IVC flow distribution converges to 69/31 RPA/LPA after 5 cardiac cycles. 
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Figure 8-18: Comparison of the IVC flow distribution associated with the pulsatile flow 
fields, the pulsatile time-average and the non-pulsatile simulations in the extra-cardiac 
anatomy. The number of cardiac cycles (0T, 1T, etc) is indicated in blue below the x-axis 
for an easier reading. 
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8.3.5 Summary 
In summary, in this subsection we studied a patient-specific extra-cardiac 
configuration designed with almost no-offset between the IVC and SVC anastomosis 
sites. The caval inflow curves were almost exactly in phase and had a pulsatility index of 
48.5%. The computed pulsatile flow dynamics were in very good agreement with the in 
vivo flow fields reconstructed from PC MRI. The SVC flow was almost exclusively 
directed to the LPA throughout all cardiac phases. Pulsatility mostly affected the fluid 
dynamics in the IVC baffle and at the center of the connection, transiently opening and 
shutting off the access of the IVC particles to the LPA. Overall, the non-pulsatile flow 
simulations provided an excellent representation of the mean pulsatile efficiency metrics, 
especially in terms of particle residence times and IVC flow distribution. The largest 
differences between the two were observed in the pressure and power loss measurements. 
The unsteady flow features in the IVC and central connection region lead to slightly 
higher power losses under pulsatile conditions (48.51 mW) compared to those obtained 
under the non-pulsatile conditions (46.50 mW). However, this difference was less than 
5% of the non-pulsatile losses, which might be deemed reasonable. Furthermore, the 
maximum recorded pressure drops and power losses across the cardiac cycle remained 
within 50% of the time-averaged values, and were associated with the early phases of the 
cardiac cycle when both pressure drops and inflow rates were the highest. 
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8.4 Patient 2 (CHOP 068): Intra-Atrial TCPC 
The second Fontan patient retained for this study was a 6 year old female with a 
normal systemic venous return and pulsatility levels of the same order of magnitude as 
Patient 1. This patient test-case was retained to assess the impact of flow pulsatility in a 
typical intra-atrial configuration, which typically results in more irregular TCPC 
geometries and more flow mixing at the connection site than extra-cardiac TCPCs.  
 
8.4.1 In Vivo Data 
Patient 2 had undergone a hemi-Fontan connection in stage 2 followed by an 
intra-atrial completion of the TCPC in stage 3. The in vivo TCPC anatomy as 
reconstructed from the anatomical MRI data is shown in Figure 8-19. The patient’s heart 
rate was 68 beats per minute corresponding to a cardiac cycle duration of 883 ms. The in 
vivo inlet/outlet flow rates and the 3D in vivo velocity field reconstructions were obtained 
from PC MRI measurements acquired at 25 time points in the cardiac cycle. The time-
dependent in vivo flow measurements are illustrated by the full symbols in Figure 8-20, 
where they are expressed in terms of the time-dependent cardiac output (computed as the 
sum of the instantaneous IVC and SVC flow rates) and flow distributions. The mean 
cardiac output was 1.08L/min, with an average mass flow split of 68/32 IVC/SVC and 
58/42 RPA/LPA. All geometric and flow characteristics are summarized in Table 8-4. 
 
- 214 -  
IVC
68% CO
RPA
58% CO
LPA
42% CO
SVC
32% CO
Cardiac Output (CO): 1.08 L/min  
Figure 8-19: Intra-atrial TCPC geometry of the second patient test-case retained for the 
pulsatile investigation.  
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Figure 8-20: Inlet and outlet flow conditions for the patient-specific extra-cardiac 
anatomy. The full symbols denote the in vivo PC MRI measurements, while the 
continuous lines denote the boundary conditions imposed on the CFD simulations. The 
dotted vertical lines indicate the time-points retained in the subsequent figures. 
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Table 8-4: Geometric and CFD flow characteristics at the two inlets (IVC and SVC) and 
outlets (RPA and LPA) of the patient-specific intra-atrial TCPC. 
Vessel IVC SVC LPA RPA 
Area (cm2) 3.37 1.61 0.75 0.77 
Fl
ow
 R
at
e 
(L
/m
in
) Mean 0.74 0.34 0.46 0.62 
Max 1.28 0.62 0.27 0.38 
Min 0.37 0.22 0.67 0.83 
Pulsatility index 61.0% 58.3% 43.5% 36.0% 
 
 
8.4.2 Numerical Set-Up 
Following the same procedure as for Patient 1, the CFD inlet boundary conditions 
are prescribed to match the in vivo IVC and SVC flow rate measurements, while the 
outlet boundary conditions are computed based on the in vivo RPA/LPA mass flow ratios. 
The inlet and outlet flow distributions and flow curves used in the CFD simulations are 
shown by the continuous lines in Figure 8-20. It may be noted that the amplitude of the 
flow rate variations are about twice larger in the IVC than in the SVC or any of the PAs. 
However, since the IVC is also the vessel that has the largest mean flow rate, the IVC 
pulsatility index (61.0%) is of the same order as that of the SVC (58.3%). The IVC flow 
rate reaches its peak at t = 497 ms, which also corresponds to the minimum SVC flow 
rate. The peak SVC flow rate occurs towards the end of the cardiac cycle at t = 795 ms. 
The flow distribution to the LPA and RPA is almost uniform through the cardiac cycle, 
varying between 40-45% for the LPA and 55-60% for the RPA. As a result, the two 
outlet flow curves closely follow the trend of the cardiac output flow curve. 
In the simulations, all quantities are normalized based on mean velocity and 
equivalent hydraulic diameter of the IVC, DIVC, yielding a characteristic Reynolds 
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number Re=217, a Womersley number α=14.8 and a non-dimensional cardiac cycle 
duration T=1.56. The TCPC surface is discretized with 12,666 triangular surface 
elements, and the background Cartesian mesh with a resolution h = 0.02DIVC. 
Calculations are conducted using a non-dimensional time step Δt = 0.000782, which 
corresponds to 2,000 time steps per cardiac cycle. Non-pulsatile simulations are 
conducted as well, using the time-averaged cardiac output and flow distributions, and the 
same spatial and temporal resolution as above.  
As will be discussed below, the inlet velocity profiles in the in vivo 3D PC MRI 
measurements were not aligned with the vessel axis but rather significantly skewed 
towards the RPA at the SVC inlet and towards the left at the IVC inlet. In order to 
improve the correspondence between the CFD and in vivo measurements, the mean in 
vivo flow direction was computed by averaging the PC MRI measurements over a slice at 
the IVC and SVC inlets and over the cardiac cycle, and used as the main flow direction 
for the CFD inlet boundary conditions.  
 
8.4.3 3D Flow Structures 
The in vivo flow structures as reconstructed from the coronal PC MR images are 
shown in the top row of Figure 8-21, using 3D streamtraces color-coded by their vessel of 
origin. These flow structures are shown for five time-phases, corresponding to the time-
points indicated in Figure 8-20. Phase P7 corresponds to the first local minimum in the 
IVC flow curve, phase P15 to the peak IVC flow rate, phase P19 to the second local 
minimum in the IVC flow curve and phase P23 to the peak SVC flow rate.  
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The in vivo flow structures (top row in Figure 8-21) are characterized by: a large 
vortex along the right aspect of the connection site (region A), a large flow separation 
region in the intra-atrial baffle with hardly any IVC streamtraces (region B), and finally a 
preferential distribution of the green SVC streamtraces to the RPA, while the orange IVC 
streamtraces split between the LPA and RPA in region C. The flow separation region in 
the intra-atrial baffle finds its roots in both the local expansion of the intra-atrial conduit, 
which bulges out at that location, and the skewed IVC profile at the entrance of the 
connection, which is preferentially oriented towards the left. The SVC flow, on the other 
hand, enters the TCPC with a preferential orientation towards the right. As a result, even 
though the intra-atrial baffle appears not to have any significant offset, the two IVC and 
SVC flows do not enter the connection region along the same axis for a head-on collision, 
but rather on two parallel axes, the IVC flow more to the left and the SVC more to the 
right, resulting in the formation of the large counter-clockwise vortex in region A. The 
size of this vortex varies across the cardiac cycle, depending on the relative velocities of 
the IVC and SVC streams. It expands from phases P1 to P15, going through the local 
minimum of the IVC flow curve and the peak IVC flow rate. It seems to almost disappear 
during the strongest flow deceleration phase (P19) and re-appears towards the end of the 
cardiac cycle (P23) as the IVC flow rate starts to increase again.  
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Figure 8-21: Global flow structures as reconstructed from the coronal PC MRI images (Top) and as computed by CFD (Bottom) for 
five time phases across the cardiac cycle. The 3D streamtraces color-coded by their vessel of origin (IVC: orange; SVC: green). 
Letters A, B and C point to the flow structures discussed in the text. The dynamic PC MRI and CFD flow structures may also be 
visualized in Animation 8-7 and Animation 8-8, respectively.  
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Animation 8-7: Dynamic visualization of the global in vivo flow structures as 
reconstructed from the coronal PC MRI images. The 3D streamtraces color-coded by 
their vessel of origin (IVC: orange; SVC: green). 
 
 
 
 
 
 
 
 
 
 
 
Animation 8-8: Dynamic visualization of the pulsatile CFD flow structures. The 3D 
streamtraces color-coded by their vessel of origin (IVC: orange; SVC: green). 
 
- 220 -  
The 3D flow structures obtained from the pulsatile CFD simulations for the same 
five instants in time are illustrated in the bottom row of Figure 8-21 (animation included). 
For each time phase, an insert shows the SVC streamtraces alone to better visualize the 
dynamics at the center of the connection. The dominant CFD flow patterns are in good 
agreement with the PC MRI measurements, including: 1) a region of flow recirculation at 
the center of the connection (region A’), where the SVC streamtraces recirculate prior to 
exiting towards the RPA (see inserts for phases P1, P7, P19 and P23); 2) a flow 
separation region on the right side of the IVC baffle, in which IVC streamtraces get 
entrapped and recirculate (region B’); and 3) a flow stagnation point on the posterior wall 
of the LPA, from which the IVC streamtraces split between the right and left pulmonary 
branches  (region C’).   
On the other hand, the maximum expansion of the central recirculation is 
significantly smaller in the CFD simulations (A’) than in the PC MRI flow fields (A). In 
addition, in the CFD simulations, this vortical region is the largest in phase P7 when the 
IVC flow rate is the lowest, and tends to disappear as the IVC flow increases towards its 
peak (P15), whereas the opposite trend is observed in the PC MRI measurements. The 
extent of this central recirculation region is dictated by the competition between the IVC 
and SVC streams, which is turn dictated by the main IVC and SVC flow direction and 
velocity profiles. The choice of inlet velocity profiles is a key determinant for the 
computed velocity fields, especially for the SVC whose inlet fell close to the domain of 
interest. Efforts were made in the present simulations to match the global orientation of 
the flow at the IVC and SVC inlets. However, the inlet velocity profile in the PC MRI 
data was highly non-uniform, showing two local peaks, which most likely correspond to 
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the independent contribution of the right SVC and innominate veins to the global superior 
venous return. The contribution of each one of these two vessels varies across the cardiac 
cycle, impacting the global flow direction and its spatial distribution. Further refinement 
of the CFD simulations could thus entail extending the computational domain so as to 
include the main vascular branches upstream of the region of interest, or interpolating the 
PC MRI velocity profiles. 
Figure 8-22 compares the time-averaged pulsatile flow structures to the results 
obtained in the non-pulsatile simulations, conducted under the mean inflow and outflow 
conditions. The time-averaged pulsatile results display all the major features identified in 
the instantaneous pulsatile flow fields, namely a flow separation on the right side of the 
IVC baffle, a preferential orientation of the IVC flow towards the LPA and a preferential 
orientation of the SVC flow towards the LPA. The non-pulsatile results very closely 
reproduce the time-averaged flow fields, hinting towards a small impact of the flow 
pulsatility on the global hemodynamic performance of the connection. 
 
Pulsatile Average Non Pulsatile
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Figure 8-22: Comparison of the time-averaged pulsatile flow structures to the results 
obtained in the non-pulsatile simulations conducted under the mean flow conditions. 
Streamtraces are color-coded by their vessel of origin (orange: IVC; green: SVC). 
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8.4.4 Power Losses 
Table 8-5 summarizes the pressure measurements at the inlets and outlets of the 
intra-atrial geometry and the associated power losses, for both the pulsatile and non-
pulsatile flow fields. The non-pulsatile values are in remarkable agreement with the mean 
pulsatile measurements. This observation is in line with the similarities observed in the 
previous section between the time-averaged pulsatile flow structures and their non-
pulsatile counter part. The maximum pulsatile pressure drops in the LPA and RPA are of 
less than 0.4 mmHg, which is well within the clinically accepted range for a successful 
Fontan. The maximum power loss is 7.893 mW and is associated with the peak flow rate. 
 
 
Table 8-5: Pulsatile and non-pulsatile power losses for the intra-atrial TCPC 
 Pressure in reference to the IVC (mmHg) Power Loss (mW) IVC SVC LPA RPA 
Pulsatile Average 0 0.004 -0.100 -0.125 1.291 Max 0 0.173 -0.354 -0.310 7.893 
Non Pulsatile 0 0.003 -0.097 -0.121 1.292 
 
 
8.4.5 Particle Tracking 
In order to better visualize the flow pathways followed by blood-borne elements 
and quantify the IVC flow distribution and particle residence time, particles were 
released at the IVC and SVC inlet cross-sections every 55 ms for ten consecutive cardiac 
cycles. The number of particles released was 1,900 in the IVC and 800 in the SVC. In 
order to assess the impact of flow pulsatility on the metrics of interest, this particle 
tracking approach was applied to the instantaneous pulsatile flow fields as well as to the 
pulsatile time-average and to the non-pulsatile results. 
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The particle pathways under pulsatile conditions are shown in Figure 8-23 and 
Animation 8-9. Their non-pulsatile counterpart is shown in Figure 8-24. In both figures, 
the SVC particles are color-coded in black, while the IVC particles are color-coded by 
their seeding-time. To ease the comparison, the same color-scale is used in the two 
figures, where particles seeded before t = 883 ms (which corresponds to the first cardiac 
cycle for the pulsatile simulations) appear in dark blue, and particles seeded around 1,700 
to 1,766 ms (which corresponds to the end of the second cardiac cycle in the pulsatile 
simulations) appear in red. A large number of similarities can be observed between the 
pulsatile and non-pulsatile results. Particles released in the IVC first flow along the left 
aspect of the IVC baffle until they reach the LPA anastomosis location, where a portion 
of them goes into the LPA (light blue particles in P25) while the others turn towards the 
RPA. This corresponds to the splitting point observed with the instantaneous streamtraces 
(region C’ in Figure 8-21). However, it is interesting to note, that the portion of IVC 
particles that turn towards the right do not flow directly into the RPA as was predicted by 
the instantaneous streamtraces but rather get entrapped in the recirculation region located 
below the SVC anastomosis site. IVC particles that get entrapped in that recirculation 
tend to stay within the TCPC fluid domain for a longer period of time than others, as is 
best illustrated by the large number of dark blue particles that remain in that region even 
towards the end of the second cardiac cycle in P25. In both pulsatile and non-pulsatile 
results, the light blue particles that were seeded at the beginning of the second cardiac 
cycle are only seen to exit the fluid domain in P25, which suggests that most particles 
remain within the fluid domain for at least one cardiac cycle. 
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Figure 8-23: Pulsatile particle trajectories in the second cardiac cycle (t = 883 ms to 1766 
ms). The SVC particles are color-coded in black, while the IVC particles are color-coded 
based on their seeding time. Dark blue particles thus denote particles seeded in the first 
cardiac cycle that are still in the fluid domain during the cardiac cycle shown here. In 
order to better visualize the dynamics at the center of the connection, the anterior half of 
the domain is blanked out of the image. An animation of the pulsatile particle pathways is 
included in Animation 8-9. 
 
 
 
 
 
 
 
 
 
 
Animation 8-9: Dynamic visualization of the pulsatile particle trajectories using the same 
color-coding as in Figure 8-23.  
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Figure 8-24: Particle trajectories through the non-pulsatile velocity fields. The SVC 
particles are color-coded in black, while the IVC particles are color-coded based on their 
seeding time. Dark blue particles thus denote particles seeded before 883 ms that are still 
in the fluid domain at the instants shown in this figure. P15 and P25 indicate the 
correspondence for the pulsatile results. In order to better visualize the dynamics at the 
center of the connection, the anterior half of the domain is blanked out of the image. 
 
 
 
The main difference between the pulsatile and non-pulsatile results resides in the 
right side of the IVC baffle. The color-contours formed by particles released at the same 
time are more irregular in the pulsatile results than in the non-pulsatile ones. This reflects 
the fact that pulsatile flow variations do not uniformly affect the flow through a given 
cross-section. In addition, in the non-pulsatile simulations, the absence of pulsatile flow 
disturbances allows a larger portion of the light blue and green particles, seeded early in 
the cycle, to exit the fluid domain within the same cardiac cycle than was the case under 
pulsatile conditions. 
8.4.5.1 Particle Residence Time 
The quantitative distribution of the IVC particle residence time under pulsatile 
conditions is shown in Figure 8-25 and compared to the results obtained using the time-
averaged pulsatile flow field and non-pulsatile results. The associated cumulative 
distributions are shown in Figure 8-26. As can be seen from Figure 8-25, the distribution  
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Figure 8-25: Distribution of the IVC particle residence times for the pulsatile, time 
average and non-pulsatile results in the intra-atrial anatomy. The number of cardiac 
cycles is indicated in blue below the x-axis for an easier reading. 
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Figure 8-26: Cumulative distribution of the IVC particle residence times for the pulsatile, 
time average and non-pulsatile results in the intra-atrial anatomy. The number of cardiac 
cycles is indicated in blue below the x-axis for an easier reading. 
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of the particle residence times under pulsatile conditions is very similar to that obtained 
using the pulsatile time-average or the non-pulsatile flow fields. A main peak is observed 
around one cardiac cycle followed by a progressive decay until 6 cardiac cycles. The 
main peak corresponds to the particles flowing along the left-most aspect of the IVC 
baffle that enter directly into the LPA, without mixing in the center of the connection. In 
the pulsatile results, this peak occurs for residence times of 836 ms, with a probability of 
4.6%. The non-pulsatile results predict a higher occurrence of 5.5% at slightly short 
residence time (788 ms). However, as can be noted from Figure 8-26, these differences 
are small and only have a minor impact on the cumulative distribution. The 95% 
probability of an IVC particle reaching either one of the PAs corresponds to t = 3,932 ms 
or about 4.5 cardiac cycles. Such extended residence time is worthwhile noting, 
especially since the particles that remain the longest in the fluid domain are the ones that 
get entrapped in slow recirculating fluid regions. Assuming that such particle pathway 
could be representative of the trajectories followed by blood cells, such extended 
residence time could in practice translate into higher risks of thrombus formation, 
allowing activated platelets to come in contact and aggregate. 
 
8.4.5.2 IVC Flow Distribution 
The distribution of the IVC particles between the LPA and RPA is illustrated in 
Figure 8-27 for the pulsatile, pulsatile time-average and the non-pulsatile particle tracking 
analyses. The LPA and RPA distributions start to rise towards the end of the first cardiac 
cycle, in accordance with the shortest particle residence times reported above. For all 
cases, the IVC flow is predominantly directed to the LPA as could be anticipated from 
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the flow structures and particle pathways. The non-pulsatile results over-estimate the IVC 
distribution to the LPA with an LPA/RPA ratio of 65/35 vs. 58/42 under pulsatile 
conditions. This difference stems from the differences in IVC and SVC mixing between 
the two flow settings. The bulgy aspect of the intra-atrial geometry favors the appearance 
of flow disturbances or recirculation at the center of the connection, which are further 
enhanced under pulsatile conditions as was noted in the particle tracking visualization 
(Figure 8-24). The increased mixing under pulsatile conditions allows for an IVC flow 
distribution that is in closer match with the global flow distribution of 42/58 LPA/RPA. 
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Figure 8-27: Comparison of the IVC flow distribution associated with the pulsatile flow 
fields, the pulsatile time-average and the non-pulsatile simulations for Patient 2. The 
number of cardiac cycles is indicated in blue below the x-axis for an easier reading. 
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8.4.6 Summary 
In summary, the non-pulsatile flow fields in Patient 2 captured most of the 
dominant pulsatile flow structures, including the region of flow separation in the IVC 
conduit, the almost exclusive distribution of the SVC flow towards the RPA and the 
preferential orientation of the IVC flow towards the LPA. The non-pulsatile pressure 
drops and power losses for Patient 2 were also in excellent agreement with the mean 
pulsatile values. While it is evident that the non-pulsatile losses cannot provide a 
representation of the dynamic range covered by the pulsatile power losses over the 
cardiac cycle, matching the mean pulsatile power losses provides a good representation 
of the power requirements imposed by the TCPC on the single ventricle.  
On the other hand, the use of non-pulsatile boundary conditions under-estimated 
the amount of flow mixing at the center of the connection, resulting in a more biased IVC 
flow distribution than was the case under pulsatile conditions. Such difference in IVC 
flow distribution was not observed in the extra-cardiac TCPC of Patient 1, which featured 
comparable pulsatility levels but only a very limited amount of IVC-SVC flow 
interactions under both non-pulsatile and pulsatile conditions. Beyond the pulsatility 
index, a parameter of importance for the estimation of the impact of pulsatility upon the 
Lagrangian metrics (namely the hepatic flow distribution) might thus be the amount of 
IVC-SVC flow interactions, which are naturally favored in intra-atrial connection, due to 
the large and bulgy baffle. 
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8.5 Patient 3 (CHOP M8): Abnormal Systemic venous Return and High 
Hepatic Flow Pulsatility 
The last patient-specific case retained for our pulsatile investigation was a 6 year 
old male, with an interrupted IVC with azygous (AZ) continuation, a persistent LSVC, 
and significant flow reversal in the hepatic veins. This patient test-case was retained as a 
representative example of the highest levels of geometrical complexity and flow 
pulsatility that may be expected in an in vivo Fontan configuration.  
8.5.1 In Vivo Data  
Patient 3’s TCPC anatomy is shown in Figure 8-28 together with the mean inlet 
and outlet flow distributions obtained from the in vivo PC MRI measurements. The time-
dependent in vivo flow measurements are displayed by the full symbols in Figure 8-29. 
All flow and geometric characteristics are summarized in Table 8-6.  
 
LSVC
41% CO
HepV
6% CO
RPA
41% CO
LPA
59% CO
AZ
21% CO
SVC
32% CO
Cardiac Output (CO): 2.8 L/min  
Figure 8-28: In vivo anatomy and mean flow distribution for Patient 3 
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Figure 8-29: Inflow and outflow waveforms as measured by PC MRI (full symbols) and 
as prescribed for the CFD simulations (continuous lines). 
 
 
 
 
Table 8-6: Geometric and CFD flow characteristics at the four inlets (HepV, SVC, AZ 
and SVC) and two outlets (RPA and LPA) of Patient 3’s TCPC anatomy. 
Vessel HepV SVC AZ LSVC LPA RPA 
Area (cm2) 1.40 0.46 1.22 0.70 0.94 0.81 
Fl
ow
 R
at
e 
(L
/m
in
) Mean 0.16 0.91 0.59 1.16 1.66 1.16 
Max 0.77 1.01 0.79 1.29 2.05 1.44 
Min -0.39 0.75 0.43 0.95 1.27 0.74 
Pulsatility 
index 361% 15% 31% 15% 24% 30% 
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The patient’s heart rate was 101 heart beats per minute, corresponding to a cardiac 
cycle duration T = 593 ms. The mean systemic venous return (i.e. the sum of the hepatic, 
azygous, SVC and LSVC flow rates) was 2.82 L/min distributed as follows: 6% coming 
through the extra-cardiac baffle, 32% through the SVC, 21% through the azygous, and 
41% through the LSVC. A distinctive feature of a patient with an interrupted IVC is that 
the TCPC baffle only carries the hepatic venous return, while the rest of the inferior 
venous return is carried by the azygous vein into one of the SVCs. As a result the mean 
flow rate carried by the TCPC baffle is typically low (here only 6% on average), and flow 
fluctuations can easily translate into high pulsatility indices. For the patient case 
considered here, the hepatic flow rate varied by as much as 0.6 L/min around its mean 
value leading to a pulsatility index of 361% and hepatic flow reversal (negative flow rates 
in the left panel of Figure 8-29) for 232 ms out of the 593 ms of the cardiac cycle 
duration. 
It is also interesting to note that the two lower systemic venous returns (namely 
the HepV and AZ) decreased concurrently, while the superior venous returns (the SVC 
and LSVC) followed the exact opposite pattern, increasing when the AZ and LSVC 
decreased. Finally, the mid-PA segment was severely stenosed with an average cross-
sectional area of only 0.16 cm2 (compared to 0.46 cm2 for the SVC, which was the next 
smallest vessel), and only little flow was measured by PC MRI through that section. 
Looking at the flow distributions on the left side of the connection it may be noticed that 
the LSVC and AZ combined represent 62% of the cardiac output, which almost exactly 
matches the 59% exiting through the LPA. It might thus be inferred that, on average, only 
3% of the cardiac output travels through the mid-PA. 
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8.5.2 Numerical Set-Up 
For the CFD simulations, all distances are normalized by the equivalent hydraulic 
diameter of the HepV inlet cross-scetion, DHepV. The surface of the TCPC is discretized 
with 69,918 triangular surface elements progressively refining the mesh towards the 
narrow mid-PA section. The background Cartesian grid is discretized with a resolution of 
0.015DHepV, yielding a computational mesh size of 2.8 million grid cells and ensuring a 
minimum of 22 grid cells across the mid-PA diameter.  
The characteristic velocity for the pulsatile simulations is set to be the mean 
HepV velocity at its peak flow rate, yielding a characteristic Reynolds number Re=344.6 
and a non-dimensional cardiac cycle duration T=4.01. The Womersley number based on 
the hepatic baffle diameter is α=11.6. Pulsatile simulations are conducted using a non-
dimensional time-step Δt = 0.002, which corresponds to 2,005 time steps per cardiac 
cycle. For the non-pulsatile simulations, the characteristic velocity is set to be the mean 
IVC velocity over the cardiac cycle, resulting in a characteristic Reynolds number 
Re=73.3. The non-pulsatile simulations are conducted using a non-dimensional time-step 
Δt = 0.005. For both sets of simulations, plug (flat) velocity profiles are prescribed at the 
four inflow planes and scaled to match the desired instantaneous or mean flow rates. 
The inlet and outlet flow waveforms prescribed in the pulsatile simulations are 
shown by the continuous lines in Figure 8-29. The PC MRI measurements obtained in the 
LPA featured high levels of data loss, which is typically the hallmark of important flow 
disturbances. The measurements at that outlet were thus substituted with the LPA flow 
waveform was computed as: 
 ( ) ( ) ( )tQtQtQ RPA
iI
ILPA −= ∑
∈ nflow
 (8-6) 
- 234 -  
where ( )tQLPA , ( )tQRPA  and ( )tQI  describe the flow rates through the LPA, RPA and the 
inflows (namely the HepV , SVC, AZ and LSVC) at any given instant t. The global flow 
distribution favored the LPA with a 41/59 RPA/LPA flow split. Flow pulsatility in the 
pulmonary arteries was of the similar levels as in the AZ, LSVC and SVC with 30% 
pulsatility in the RPA and 24% in the LPA.  
 
8.5.3 3D Flow Structures 
The instantaneous pulsatile flow structures as obtained from the PC MRI 
measurements and CFD simulations are shown in Figure 8-30 for five time-points across 
the cardiac cycle. The flow structures are illustrated using 3D streamtraces color-coded 
by their vessel of origin (animation included). 
As can readily be seen from Figure 8-30, PC MRI measurements in Patient 3 were 
discontinuous and characterized by large areas of missing data. Such PC MRI data loss is 
typically associated with regions of turbulent flows or important mixing, where the 
random directions and interactions of the moving protons results in dephasing and loss of 
signal coherence. Nonetheless, it is interesting to note that the regions of PC MRI data 
loss are in remarkable agreement with the regions of flow disturbances observed in the 
pulsatile CFD results. The first such region is the center of the Kawashima connection on 
the left, where the AZ and LSVC flow structures are illustrated by short discontinuous 
streamtraces in the PC MRI flow fields. In the pulsatile CFD results, this region is 
associated with a complex mixing of the LSVC and AZ flows, as is illustrated by the 
intertwined red and green streamtraces at the left connection site in phase P3, P6 and P21. 
In phases P12 and P18, where the AZ flow rate reaches its minimum and the LSVC its  
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Figure 8-30: Instantaneous 3D streamtraces in the 3D PC MRI reconstruction and 
pulsatile CFD simulations for five time points across the cardiac cycle. 3D streamtraces 
in the non-pulsatile simulations are provided as a ground of comparison. For all results, 
the 3D streamtraces are color coded by their vessel of origin. Dynamic visualizations of 
the PC MRI and CFD flow structures are provided in Animation 8-10 and Animation 
8-11, respectively.  
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Animation 8-10: Dynamic visualization of the in vivo 3D flow structures as reconstructed 
from PC MRI.  
 
 
 
 
 
 
 
 
 
 
 
Animation 8-11: Dynamic visualization of the pulsatile CFD flow structures. 
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 maximum, the red azygous streamtraces have little interaction with the LSVC 
streamtraces and flow directly into the LPA. The LSVC flow is still observed to follow a 
complex recirculation pattern at the center of the Kwashima connection.  
The second region of major PC MRI data loss is the hepatic baffle at time phases 
P12 and P15, during the hepatic flow reversal, but less so in phases P3, P6 or P21. In 
phase P3, when the hepatic flow rate is the highest, the PC MRI hepatic streamtraces are 
well defined and smoothly follow the vessel axis, turning towards the RPA at the 
connection site. The CFD hepatic streamtraces at the same instant in time follow a very 
similar flow pattern with little flow disturbances at the SVC and HepV collision site. 
Similar quality in the PC MRI signal is observed in the early hepatic flow deceleration 
phase (P6), although the CFD results reveal the onset of flow instabilities halfway 
through the hepatic baffle. As the hepatic flow reverses in phases P12 and P15, the upper 
half of the hepatic baffle is the host of important flow disturbances as is illustrated by the 
disappearance of any coherent streamtrace in the PC MRI data, and the intertwined blue 
and orange streamtraces in the CFD results. These flow disturbances are due to both the 
destabilizing effects of flow deceleration and the deep penetration of the SVC flow (blue 
streamtraces) almost halfway into the hepatic baffle. It should be pointed out here, that 
the orange streamtraces represent the instantaneous forward and backward pathway 
followed by streamtraces seeded at the hepatic inlet, which should not be mistaken for the 
pathway followed by the hepatic nutrients. As the hepatic flow accelerates and the SVC 
flow decelerates (phase P21), the PC MRI hepatic streamtraces extend further into the 
baffle than in previous phases, flowing along the right side of the baffle towards the RPA. 
In the corresponding CFD results, the hepatic streamtraces recover an overall coherence, 
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and follow a smooth path until slightly downstream of the connection site. The SVC 
streamtraces still penetrate into the hepatic baffle but to a lower extent than in the 
previous phases. Throughout all time-phases, only little LSVC flow travels through the 
mid-PA segment towards the RPA, which is coherent with the global mass flow 
distribution between the LPA and RPA. 
The non-pulsatile CFD flow structures are shown in the bottom left panel of 
Figure 8-30 for comparison with the instantaneous pulsatile CFD flow fields. The non-
pulsatile flow fields show some of the characteristics of the pulsatile results under the low 
hepatic flow rates. The common features include an intense flow recirculation in the left 
connection site, penetration of the blue SVC streamtraces into the hepatic baffle, and 
flow instabilities in the extra-cardiac conduit. The recirculation in the left connection site 
is uniquely composed of green LSVC streamtraces, the azygous streamtraces flowing 
directly into the LPA with minimal interaction with the LSVC flow. The penetration of 
the SVC into the hepatic baffle is due to the low mean hepatic flow rate, and resultant 
low hepatic kinetic energy, which does not allow for the hepatic flow to compete against 
the SVC flow. While these flow structures do share some common traits with the 
pulsatile ones, they oversee the richness of the pulsatile dynamics, notably the intense 
flow instabilities that develop in the hepatic baffle during the reversed flow phase. 
 
8.5.4 Power Losses 
The mean pulsatile pressures and power losses over the cardiac cycle and the 
maximum deviations from these mean values are given in Table 8-7, together with the 
corresponding values obtained in the non-pulsatile simulations. In both sets of results the 
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left-sided pressures, namely the AZ, LSVC and LPA pressures, are more than 1 mmHg 
higher than the right-sided pressures in the HepV, SVC and RPA. This phenomenon is 
illustrated in Figure 8-31 for the non-pulsatile flow fields, where the left side of the 
connection is color-coded in orange and red, denoting high pressure values, while the 
right side of the connection is color-coded in shades of blue denoting low pressure 
values. The elevated left-to-right pressure gradient results from the high hydrodynamic 
resistance imposed by the stenosed mid-PA segment, which requires a large pressure 
head to ensure the desired left-to-right flow rate.  
The most distinctive characteristic of this patient-case compared to the other three 
configurations studied in this chapter is that the non-pulsatile power losses fail to capture 
the mean pulsatile energy dissipation levels. Due to the highly unstable pulsatile 
dynamics, the mean pulsatile power loss is 18.33 mW, which is 10 mW higher than the 
non-pulsatile value. Maximum power losses fall significantly above that range with a 
peak at 45.57 mW, which coincides with the peak reversed flow in the hepatics. The 
pulsatile pressures significantly deviate from their mean values across the cardiac cycle, 
as well, with a maximum pressure difference of over 2 mmHg in the azygous. The non-
pulsatile results for Patient 3 thus appear as an inadequate representation of the pulsatile 
dynamics. 
 
Table 8-7: Pulsatile and non-pulsatile power losses for the TCPC with an interrupted IVC 
 Pressure in reference to the IVC (mmHg) 
Power 
Loss 
(mW) 
HepV SVC AZ LSVC RPA LPA  
Pulsatile Average 0 0.60 1.15 1.75 -1.08 0.54 18.33 Max 0 1.80 3.17 2.90 -2.06 -0.39 45.57 
Non Pulsatile 0 0.39 2.42 3.00 -0.91 1.81 8.54 
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Figure 8-31: Pressure levels in the non-pulsatile flow field. Contrary to all other figures 
shown in this chapter, the anatomy is shown from the posterior side so as to best visualize 
the pressure contours in the two PAs. 
 
 
 
8.5.5 Particle Tracking 
Given the high level of flow pulsatility in the hepatic baffle, the instantaneous 
streamtraces visualized above only provide limited insights into the pathways followed 
by blood borne elements. Particle tracking was thus performed by seeding particles not 
only in the hepatic baffle, but also in the SVC, AZ and LSVC to better visualize the 
dynamic interactions and mixing between the different inflows. For the pulsatile 
simulations, 2535, 2015, 118 and 832 new particles were released every 15 ms for ten 
consecutive cardiac cycles in the HepV, AZ, LSVC and SVC cross-sections, respectively. 
HepV particle tracking was also performed in the non-pulsatile simulations to provide a 
ground of comparison for the hepatic flow distribution and particle residence times.  
- 241 -  
8.5.5.1 Dynamic Pulsatile Particle Pathways 
The dynamic particle pathways as computed in the pulsatile flow fields are 
illustrated in Figure 8-32 and Figure 8-33 (and Animation 8-12). Figure 8-32 displays the 
pathways followed by particles seeded at all four inlets, with the particles color-coded by 
their vessel of origin, while Figure 8-33 displays the hepatic particles only, color-coded 
by their seeding time.  
Looking at the dynamics in the left side of the connection (Figure 8-32), the 
mixing of the azygous and LSVC flow is illustrated by patches of red particles among the 
green ones in phases P12 to P21 of the second cardiac cycle. Some blue SVC particles 
penetrate halfway into the mid-PA segment in phases P3 to P9 (cycle 1), but do not reach 
the left connection site before the flow direction inverses and green LSVC particles start 
flowing into the mid-PA. In the second cardiac cycle, once the particle distributions start 
stabilizing, the particles in the mid-PA segment mostly appear in green (LSVC), which is 
consistent with the mean left-to-right flow direction in that section.  
On the right side of the connection, the dark-blue SVC particles are seen to 
penetrate deep down into the hepatic baffle during the reversed flow period (P9 to P18). 
During the hepatic flow acceleration (from phase P21 in the first cardiac cycle to phase 
P6 in the second cardiac cycle), the SVC particles are expelled from the baffle but a 
significant proportion of them remains present in the hepatic baffle throughout the 
cardiac cycle. Looking at the hepatic particles (in orange), it may be noted that none of 
the particles seeded in the first cardiac cycle succeed in reaching beyond the first half of 
the hepatic conduit. The reversed flow phase results in a highly skewed particle profile 
(which can be taken as representative of the local velocity profile) in phases P15 and P18,  
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Figure 8-32: Particle positions at seven time points separated by 77 ms. The corresponding phases in the PC MRI acquisition (P3 to 
P21) are provided to better locate the displayed particle fields on the inflow and outflow curves. The particles are color coded by their 
vessel of origin to better elucidate the inflow interactions.  
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Figure 8-33: Hepatic particle positions at seven time points separated by 77 ms. The corresponding phases in the PC MRI acquisition 
(P3 to P21) are provided to better locate the displayed particle fields on the inflow and outflow curves. The hepatic particles are color 
coded by their seeding time to visualize their residence time and evolution across the cardiac cycle. An animation of the particle 
pathways is provided in Animation 8-12.  
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Animation 8-12: Dynamic visualization of the hepatic particle pathways. The particles 
are color coded by their seeding time using the same color scheme as in Figure 8-33. 
 
 
with a slower particle progression rate along the inner side of the baffle curvature. In the 
second cardiac cycle, the first seeded particles flow up to the two third of the hepatic 
baffle before the hepatic flow starts reversing in P9. The hepatic particles that are the 
furthest up into the baffle get caught into the SVC recirculation region and are 
continuously ejected towards the RPA even during the reversed flow phase.  
The temporal evolution of the HepV particle location is best visualized in Figure 
8-33, where they are color-coded based on their seeding time. The dark blue hepatic 
particles seeded at the beginning of the first cardiac cycle only reach the RPA towards the 
middle of cycle 2, pointing to a particle residence time of 1.5 cardiac cycle or more. 
During the reversed flow phase, the particles closest to the inlet of the extra-cardiac 
conduit backflow into the hepatic veins (P12 to P18 of cycle 1). Further along the extra-
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cardiac conduit, the reversed flow gives rise to high levels of instabilities and mixing 
which is best visualized in phases P12 to P18 of cycle 2, where the dark blue hepatic 
particles spread in all directions and occupy the entire upper half of the extra-cardiac 
baffle. Due to the low mean hepatic flow rate and alternate forward and backward flow 
motion, some particles remain within the extra-cardiac baffle for over two cardiac cycles, 
and a significant proportion of HepV particles seeded in cycle 1 can still be observed up 
until phase P9 in cycle 3. 
 
8.5.5.2 Hepatic Particle Residence Time 
The distribution of the hepatic particle residence times is quantified in Figure 8-34 
for both pulsatile and non-pulsatile flow conditions. The pulsatile distribution (left panel 
in Figure 8-34) peaks around t = 1204 ms, meaning that most hepatic particles remain 
within the fluid domain for a little over two cardiac cycles. The residence times under 
steady conditions show a peak distribution for slightly longer times, around t = 1476 ms. 
More importantly the non-pulsatile distribution decay at a slower rate after the first peak 
than their pulsatile counterpart. The important mixing occurring under pulsatile 
conditions randomizes the pathways followed by particles seeded at different locations, 
yielding more uniform residence times across the particles. 
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Figure 8-34: Distribution of the hepatic particle residence times for Patient 3, under 
pulsatile and non-pulsatile flow conditions. The number of cardiac cycles is indicated in 
blue below the x-axis for an easier reading. 
 
 
8.5.5.3 Hepatic Flow Distribution 
As could be anticipated from the fact that only very little flow was observed to 
travel through the high resistance mid-PA segment, the hepatic flow distribution for 
Patient 3 was of a 100% to the RPA under both pulsatile and non-pulsatile conditions. 
The perfect agreement between the pulsatile and non-pulsatile results stems from the 
absence of any flow going from the right to the left side of the connection, but does not 
imply that the non-pulsatile results provide an adequate description of the pulsatile 
hepatic flow distribution under pulsatility levels as high ass 631%. Indeed, as was 
observed in the particle tracking visualizations (Figure 8-32 and Figure 8-33), the high 
pulsatility of the hepatic flow leads to a thorough mixing of the hepatic and SVC streams, 
so that the distribution of the hepatic nutrients will follow the distribution of the 
combined HepV and SVC flows. This mixing is underestimated under non-pulsatile 
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conditions, and it might be anticipated that, in a geometry with a more balanced right and 
left resistance, hepatic pulsatility levels as high as the ones reported here (PI=361%) 
would lead to a more balanced hepatic distribution than predicted under steady 
conditions.  
 
8.5.6 Summary 
In summary, Patient 3 represented the most complex in vivo scenario considered 
in this study both in terms of its geometrical complexity and hemodynamics, with high 
levels of unsteadiness and mixing. A specificity of this patient compared to Patients 1 and 
2 was that the hepatic flow was reversed for almost half of the cardiac cycle, resulting in 
an especially low mean flow rate through the baffle, which accounted for only 6% of the 
cardiac output. Hepatic flow reversal led to a deep penetration of the SVC flow down into 
the hepatic baffle, highly unstable dynamics, and intense mixing between the hepatic and 
SVC flows, all of which were significantly underestimated under non-pulsatile 
conditions. Although pulsatile and non-pulsatile results both predicted a peak in the 
hepatic particle residence time around two cardiac cycles, the thorough mixing of the 
hepatic and SVC flows under pulsatile conditions limited the occurrence of even longer 
residence times (5 or 6 cardiac cycles) that were otherwise seen in the non-pulsatile 
results. Furthermore, the mean pulsatile power losses were about twice those obtained 
under non-pulsatile conditions, unlike all three previous cases where the non-pulsatile 
losses appeared as a good representation of the mean pulsatile ones. Based on all of these 
observations, the non-pulsatile assumption does not appear acceptable when pulsatility 
indices reach levels as high as 361%, as was the case for Patient 3. Finally, since almost 
no-flow was seen to travel through the stenosed mid-PA segment, both pulsatile and non-
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pulsatile results predicted that the entirety of the hepatic nutrients would flow to the RPA 
and into the right lung. From a clinical standpoint, such unilateral hepatic distribution sets 
Patient 3 at high risk for the development of pulmonary arteriovenous malformations in 
the contra-lateral lung (i.e. in the left lung). 
 
8.6 Conclusion 
This chapter presented a detailed comparison of the pulsatile and non-pulsatile 
TCPC hemodynamics and their impact on the surrogate markers for TCPC efficiency, 
namely power losses, hepatic (or IVC) flow distribution and particle residence time. The 
first test-case presented was an idealized representation of the TCPC, followed by three 
patient-specific studies. Although this patient pool is far too small to draw any clear-cut 
conclusion, non-pulsatile simulations appear to provide an adequate representation of the 
mean pulsatile power losses and pressure drops for moderate pulsatility indices as in the 
idealized geometry, Patient 1 and Patient 2. The impact of the pulsatile forcing on HFD 
not only depended upon the pulsatility index but also on the amount of IVC-SVC 
interaction. The error in the non-pulsatile HFD predictions was thus higher in the intra-
atrial anatomy, which naturally favored flow unsteadiness and IVC-SVC mixing due to 
its irregular geometry, than in the idealized or extra-cardiac geometries for which the 
IVC-SVC interactions were very limited. Finally, when flow pulsatility reaches levels as 
high as 361% (as was the case for Patient 3), the non-pulsatile assumption clearly fails to 
represent the pulsatile dynamics, significantly underestimating the amount of flow 
mixing, unsteadiness and energy dissipation. A detailed discussion of the impact of 
pulsatility on the TCPC efficiency metrics is provided in Section 10.2. 
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CHAPTER 9 
PATIENT-SPECIFIC SURGICAL PLANNING 
  
In this chapter, we present a novel surgical planning approach based on 
hemodynamic performance and underscore the potential benefits of such an approach to 
treat patients with complex single-ventricle heart defects (SVHD). We focus our attention 
on SHVD patients with an interrupted inferior vena cava (IVC). The chapter is divided 
into three main sections. The first section presents the clinical problem and the patient 
groups retained for the study. The two subsequent sections present the surgical planning 
results for our two groups of patients, namely patients with a single SVC and patients 
with persistent LSVC. The chapter closes with a summary of the main findings. 
 
9.1 Patient Selection 
9.1.1 Clinical Problem 
SVHD patients featuring an interrupted inferior vena cava (IVC) with azygous 
vein (AZ) continuation are one of the most challenging subgroups of SVHD patients 
from a clinical and surgical perspective. These patients feature a highly abnormal 
systemic venous return where all systemic blood flow from the lower limbs is directed to 
the AZ instead of the IVC. Furthermore, an interrupted IVC is often associated with 
complex heterotaxy syndromes where the vascular structures and bowels do not follow 
their normal orientation. These patients thus combine complex intra-cardiac SVHDs with 
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a large number of anatomical and flow abnormalities, making it even more difficult for 
surgeons to identify the best-suited surgical approach. 
This patient subgroup has been reported with an especially high incidence of 
pulmonary arterio-venous malformations (PAVMs) after completion of the total 
cavopulmonary connection (TCPC) [182]. PAVMs are intrapulmonary arterial to venous 
shunts, which bypass the pulmonary gas exchange units, resulting in a net decrease in 
oxygen saturation. PAVMs also lead to a drop in pulmonary vascular resistance, which 
tends to direct more flow to the diseased lung, creating a positive feedback loop of 
increasing hypoxemia. 
Although the underlying mechanism leading to PAVMs is unknown, studies have 
shown PAVMs to be correlated with an insufficient supply in liver derived factors 
present in the hepatic venous blood [14, 67, 69, 70]. Appearance of PAVMs after TCPC 
completion is thus attributed to an unbalanced hepatic flow distribution (HFD) to the left 
and right lungs due to an inadequate design of the hepatic baffle. Once the extent of 
PAVMs is such that oxygen saturation is critically low, the only palliative option is to re-
operate and re-orient the hepatic baffle to achieve a better HFD [67]. Although several 
approaches for this palliative surgery have been proposed and discussed in the literature, 
there is still no consensus as to the best surgical approach to adopt for a specific patient. 
The small patient population and the large number of anatomical and functional 
variations pose a severe obstacle to the establishment of surgical guidelines from clinical 
studies alone. This is the exact setting where hemodynamics, via the HFD to the left and 
right lung, could make or break the surgery, and where virtual surgical-planning could 
make a significant clinical impact.  
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9.1.2 Patient Groups 
Six single-ventricle patients with interrupted IVC and severe PAVMs were 
enrolled in the study. All six patients were recommended for surgical planning in order to 
identify the TCPC option that would best distribute the hepatic flow to the two lungs and 
lead to the disappearance of the existing PAVMs. The TCPC geometries at the time of 
PAVM diagnosis are shown in Figure 9-1. For clarity, each TCPC geometry is identified 
by three key parameters: the location of the PAVMs as per clinical diagnosis, the patient 
code name in the Georgia Tech Fontan patient database (CHOP M1 for instance), and the 
imaging modality used to capture the anatomy (magnetic resonance imaging, MRI, or X-
ray computed tomography, CT). 
The TCPC anatomy comprises the left and right pulmonary arteries (LPA and 
RPA, respectively) and the systemic veins, namely the hepatic veins (HepV), the azygous 
vein (AZ), the superior vena cava (SVC) and the innominate vein (IV). In a normal 
systemic venous configuration, the venous return from the lower limbs is carried by the 
IVC and the AZ only drains the deoxygenated blood from the posterior walls of the 
abdomen and the thorax into the SVC. The AZ is thus normally of small dimensions, and 
minimally contributes to the total systemic venous return. In patients with an interrupted 
IVC, on the other hand, the AZ is the carrier of all lower systemic venous return. As can 
be observed in Figure 9-1, the dimension of the AZ in these patients is comparable to that 
of the other systemic veins. For SVHD patients with an interrupted IVC, the staged  
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Figure 9-1: Patient TCPC anatomies. The geometries are identified with the location of 
the PAVMs as per clinical diagnosis, the patient code name in the Georgia Tech Fontan 
patient database, and the imaging modality used to capture the anatomy. The right most-
column shows the heart anatomy in red. 
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TCPC procedure entails first the connection of the all superior venous returns (including 
the IV, SVC and AZ) to the PAs, and then the connection of the HepV. The superior 
cavopulmonary connection in presence of a large AZ is typically called the Kawashima 
connection. 
The six enrolled patients are separated into two groups. Group A, or single SVC 
group, includes the three patients for whom the SVC, AZ and IV merge together before 
connecting to the PAs. Group B includes the three patients who feature an additional 
systemic venous abnormality in the form of a persistent left superior vena cava (LSVC). 
The corresponding anatomies (B1 through B3 in Figure 9-1) are characterized by the fact 
that, first, the IV is absent and then, the left superior venous return drains into the LSVC, 
which is connected to the PAs at a different location than the SVC. 
 
9.1.3 Patient Data 
The clinical and anatomical characteristics of the six patients enrolled in the study 
are summarized in Table 9-1. Patients A1, A2, B1 and B2 had a completed TCPC and 
were diagnosed with severe unilateral PAVMs. Patient A3 was still at the Kawashima 
stage. Patient B3 had previously undergone a TCPC that had been taken down due to a 
clot in the hepatic baffle. Accordingly, the anatomical reconstructions shown in Figure 
9-1 for Patients B3 and A3 do not feature a hepatic baffle. Both A3 and B3 were 
diagnosed with bilateral PAVMs.  
Table 9-2 summarizes the in vivo velocity information available for each patient. 
For patients A1, A3, B2 and B3 flow information was available from MRI for all TCPC 
vessels. Patients A2 and B1 had coils or pacer wires and could not be exposed to  
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Table 9-1: Summary of the clinical and geometrical characteristics of the six patients 
enrolled in the study. EC TCPC: completed TCPC with an extra-cardiac baffle. IA 
TCPC: completed TCPC with an intra-atrial baffle. 
 Group A: Single SVC Group B: Persistent LSVC 
 A1 A2 A3 B1 B2 B3 
GT codename CHOP M1 CHOA M1 CHOP M4 CHOP M3 CHOP M7 CHOP M2 
Sexe Female Male Female Female Male Female 
Age 4 6 3 12 11 4 
Anatomy Heterotaxy, Dextrocardia Heterotaxy 
Heterotaxy, 
Levocardia Heterotaxy 
Heterotacy, 
Dextrocardia Heterotaxy 
TCPC Stage EC TCPC IA TCPC Kawashima EC TCPC EC TCPC 
Kawashima 
(TCPC taken 
down) 
PAVM Left Right Bilateral Left Right Bilateral 
BSA 0.61 m2 0.75 m2 0.635 m2 0.73 m2 1.22 m2 0.64 m2 
Ve
ss
el
 D
im
en
si
on
s 
(c
m
2 ) 
HepV 1.96 2.46 1.91 3.67 2.76 4.62 
IV (or 
LSVC) 1.09 1.83 n/a 1.94 0.57 1.01 
AZ 1.03 1.31 0.58 1.01 1.81 0.86 
SVC 1.13 1.26 1.34 1.46 1.16 1.29 
LPA 1.56 0.81 0.76 2.68 1.78 1.21 
RPA 1.06 2.41 1.28 3.55 0.98 0.84 
 
 
Table 9-2: Flow boundary conditions. Patient specific data are denoted in black, while the 
gray figures denote missing flow information that was taken to be identical to patient A1.  
 
 Group A: Single SVC Group B: Persistent LSVC 
 A1 A2 A3 B1 B2 B3 
QS 3.43 L/min 3.43 L/min 3.86 L/min 3.25 L/min 3.95 L/min 2.93 L/min 
Fl
ow
 d
is
tr
ib
ut
io
n 
HepV 21% 21% 32% 21% 10% 21% 
IV (or 
LSVC) 22% 22% n/a 22% 19% 26% 
AZ 24% 24% 17% 24% 31% 15% 
SVC 33% 33% 51% 33% 40% 38% 
LPA 70% n/a 49% 72% 65% 39% 
RPA 30% n/a 51% 28% 35% 61% 
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the magnetic field. The anatomy was acquired using CT but the flow information was 
missing. For patient B1, cardiac catheterization measurements of the LPA flow rate and 
cardiac output in the ascending aorta (which was assumed to be equal to QS, the sum of 
all systemic venous return) partly compensated for the lack of MRI flow data. No such 
catheterization information was available for Patient A2. The missing flow data, namely 
the inlet flow distribution for Patient B1, and both the inlet flow distribution and QS for 
Patient A2, were defined based on other patient data that were available when Patients 
A2 and B1 were enrolled, which, at the time, were mostly limited to the flow 
measurements obtained for Patient A1. In Table 9-1, these extrapolated values are 
distinguished from the patient-specific measurements using a gray-colored font. 
 
9.1.4 Performance Assessment and Optimization Metrics 
A critical step for surgical planning is to define the clinically relevant 
optimization metrics, and their relative importance to ultimately determine the optimal 
surgical option on a patient-by-patient basis. For the patients considered in this study, the 
primary objective of the surgery was to revert the existing PAVMs and enable proper 
lung development, via a balanced hepatic flow distribution (HFD) and lung perfusion. 
The goal is to achieve an HFD close to 50/50 RPA/LPA when the GFD is close to 50/50 
RPA/LPA as well. The hepatic flow distributions to the right and left lung (HFDRPA and 
HFDLPA, respectively) are defined as: 
 
LPAHepRPAHep
RPAHep
RPA QQ
Q
HFD
→→
→
+
=  (9-1) 
 
LPAHepRPAHep
LPAHep
LPA QQ
Q
HFD
→→
→
+
=  (9-2) 
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where RPAHepQ →  and LPAHepQ →  represent the amount of hepatic flow going to the RPA and 
LPA, respectively, which are quantified by uniformly seeding weightless point particles 
across an HepV cross-section and passively advecting them across the computed flow 
fields (see Section 4.8.3.1 for more details). 
However, as discussed in the clinical background (Section 1.5), a balanced HFD 
distribution is not the only parameter of importance. The ideal TCPC should also 1) 
minimize pressure drops to minimize the increase in central pulmonary resistance, 2) 
minimize power losses, to minimize the workload imposed on the heart, 3) feature no 
regions of elevated shear stresses nor flow recirculation to minimize the thromboembolic 
potential of the connection, and, and above all 4) be surgically feasible. 
The power losses, LossE& , are computed for each corrective anatomy envisioned 
using an integrated control volume energy balance:  
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where 1060=ρ kg/m3 is the density of blood, and Pi, Qi and Ai represent the pressure, 
flow rate and cross-sectional area of the inlet or outlet i. Qi is positive if i corresponds to 
an inlet and negative for an outlet. By taking into account the pressure differences 
between the inlets and outlets, power losses constitute a surrogate measure for the global 
pressure drop and hemodynamic resistance associated with each surgical option. They 
may also be interpreted as a measure of the energy lost by viscous dissipation in shear 
layers along the vessel walls or at the center of the connection, or in turbulent flow 
structures. Finally, surgical feasibility is accounted for at the design stage by including 
the surrounding organs within the virtual-surgery interface, so that the surgeons or user 
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can ensure that the options considered fall within the constraints imposed by the 
surrounding structures and do not impinge on the pulmonary veins, for example.  
The surgical options designed for each patient are closely reviewed with all of the 
above parameters in mind. However, it is very likely that no option will fulfill all 
optimization conditions at the same time. For the purpose of this study, priority will thus 
be set on surgical feasibility and HFD. Power losses and flow structures will be used as 
secondary measures to discriminate between equal performing options. 
 
 
9.2 Surgical Planning Results for Patients with a Single SVC (Group A) 
The results of the surgical planning campaign conducted for patients with a single 
SVC are here described. For each patient, we first present the clinical case report, 
followed by a detailed analysis of the pre-operative hemodynamics. We then describe the 
envisioned surgical options, and discuss their hemodynamic performance in terms of 
hepatic flow distribution and power losses.  
The hepatic flow distribution is expressed in terms of HFDRPA, which represents 
the HFD to the RPA. Similarly, the lung perfusion is expressed in terms of GFDRPA, 
which represents the global flow distribution (GFD) to the RPA. The objective of the 
surgical planning campaign is thus to identify the option that yields 1) a balanced HFD 
and lung perfusion to enable proper pulmonary development, i.e. achieve HFDRPA=50% 
when GFDRPA is close to 50% as well, and 2) low vascular resistance (i.e. low power 
losses or pressure drops) to minimize the workload imposed on the heart.  
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9.2.1 Patient A1 (CHOP M1) 
9.2.1.1 Pre-operative Clinical diagnosis 
Patient A1 was a 4 year-old Fontan patient, female, who presented to the 
Children’s Hospital of Philadelphia (CHOP) with an oxygen saturation of 72% in the 
ascending aorta. The patient had complex heterotaxy syndrome, single-ventricle, 
dextrocardia, total anomalous pulmonary venous connection to the right atrium, and an 
interrupted IVC with AZ continuation. Dye injection X-ray angiography revealed the 
formation of severe left lung PAVMs, responsible for the observed hypoxemia.  
The patient anatomy at the time of diagnosis is shown in Figure 9-2 from three 
view angles. The geometric and flow characteristics at each one of the inflows and 
outflows are summarized in Table 9-3. Patient A1 had undergone a Kawashima 
procedure followed by an extra-cardiac connection of the HepV to the PAs. The extra-
cardiac conduit was a 16 mm graft (cross-sectional area of 1.96cm2) curved towards the 
LPA. The AZ adjoined the Kawashima connection on the right hand side, just above the 
RPA. The LPA exhibited a severe stenosis, possibly due to a compression by the over-
riding aorta. The LPA cross-sectional-area at the point of highest constriction was 0.37 
cm2 vs. 1.56 cm2 for the outlet cross-section. As will be discussed in subsequent 
paragraphs, this stenosis and the large vessel curvature of the two pulmonary arteries 
introduced large disturbances in the flow giving rise to a very complex unsteady flow.  
For that reason, the PAs in the numerical model were extended by 5 vessel diameters to 
ensure that outflow boundary conditions were applied sufficiently far downstream to 
avoid spurious wave reflections that could lead to numerical instability.  
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Figure 9-2: Patient A1’s pre-operative TCPC geometry. The black arrows depict the 
global flow direction for each inlet and outlet. The inlet/outlet cross-sectional areas as 
well as the smallest LPA cross-sectional area are indicated in blue.  
 
 
 
Table 9-3: Geometric and flow characteristics of Patient A1 at the time of PAVM 
diagnosis, and flow boundary conditions used for the CFD simulations. QS: sum of the 
systemic inflows. QP: sum of the pulmonary outflows. 
 
 
Cross-
sectional 
Area (cm2) 
MRI Flow 
measurements CFD Flow Conditions 
Q (L/min) Q (%) Q (L/min) Q (%) Characteristic Velocity (cm/s) 
Systemic Venous Return 
HepV 1.96 0.72 21% 0.72 21% 6.15 
LSVC 1.09 0.75 22% 0.75 22% 11.49 
AZ 1.03 0.82 24% 0.82 24% 13.31 
SVC 1.13 1.13 33% 1.13 33% 16.67 
QS  3.43   3.43     
Pulmonary Flows  
LPA 1.56 2.52 70% 2.39 70% 25.57 
RPA 1.06 1.09 30% 1.04 30% 16.24 
QP   3.61   3.43     
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9.2.1.2 Pre-Operative Hemodynamics 
Dominant flow structures: Figure 9-3 illustrates the dominant flow structures and 
pressure variations observed within the pre-operative anatomy. The pressures reported in 
the right panel are expressed with respect to the mean pressure at the HepV inlet. The 
pressure at any given point in the geometry thus corresponds to the pressure differential 
between that point and the HepV. The left panel demonstrates the main flow structures 
using 3D streamtraces color-coded by velocity magnitude. As can be observed from 
Figure 9-3, velocities within the connection remain low, on the order of 10 to 20 cm/s. A 
sudden flow acceleration is noted as flow enters into the LPA. This is in part due to the 
fact that the LPA is the vessel that conveys the largest share of the flow (QLPA=70%QS), 
and is worsened by the LPA stenosis just downstream of the connection. At the center of 
the LPA stenosis, the average velocity magnitude is of 160 cm/s, and is accompanied by 
a mean pressure drop of 6.2 mmHg. A slight pressure recovery can be noted downstream 
of the stenosis, as the LPA expands and the flow slows down. 
To better understand the interaction between the four inflows, Figure 9-4 shows 
the same 3D streamtraces as in Figure 9-3, but color-coded by their point of origination 
rather than by velocity magnitude. Streamtraces from all inlets mix in the center of the 
connection where they are tangled together. A portion of the SVC flow goes along the 
anterior wall of the connection down into the hepatic baffle, resulting in an intense 
recirculation at the opening of the baffle (structure A in Figure 9-3). The flow structures 
in the LPA are dominated by a large-scale helical structure, which is consistent with what 
is typically observed in pulmonary arteries downstream of the TCPC [84, 85, 183]. A 
similar helical flow, though of lower intensity, is observed in the RPA.  
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Figure 9-3: Global flow structures and pressure fields in the pre-operative anatomy of 
Patient A1. Left: Time-averaged 3D streamtraces color-coded by velocity magnitude 
(Vmag). The color-scale is optimized to show velocity variations in the body of the 
connection. Right: Corresponding pressure field expressed with reference to the mean 
pressure at the HepV inlet. A non-linear color-scale is used to show the small pressure 
variations within the connection as well as the pressure drop across the stenosis.  
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Figure 9-4: Time-averaged flow structures within the pre-operative anatomy for patient 
A1. Streamtraces are color-coded based on their vessel of origination.  
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It is noteworthy that, despite the noted mixing at the center of the connection, 
streamtraces in the LPA mostly originate from the AZ, SVC and IV (in red and orange in 
Figure 9-4) , while almost all HepV streamtraces (in blue in Figure 9-4) exit through the 
RPA outlet. The AZ, which is oriented towards the LPA, constrains the IV and SVC 
streams towards that vessel. The HepV is also oriented towards the LPA but cannot 
sustain the flow competition at the center of the connection and is forced into the RPA. 
The flow recirculation within the baffle (region A in Figure 9-4) further constrains the 
HepV towards the RPA. A detailed HFD quantification reveals that 91% of the hepatic 
flow goes to the RPA while only 9% goes to the LPA. Such preferential HFD to the RPA 
is consistent with the presence of PAVMs in the left lung.  
 
Impact of the instantaneous flow instabilities: All of the above analysis was conducted 
using the converged running average of the CFD simulations. However, given the level 
of mixing observed within the baffle, the question may arise as to whether the time-
averaged results smooth out some of the instantaneous characteristics. To investigate this 
point, Figure 9-5 and Figure 9-6 compare the coherent flow structures in the time-
averaged flow fields to the instantaneous ones. The coherent flow structures are captured 
using the Q-criterion, which isolates regions where the vorticity dominates the shear. The 
iso-surfaces displayed thus correspond to independent vortex cores.  
The collision of the HepV inflow with the combined azygous, SVC and IV 
inflows leads to the formation of a stable elongated vortex core (structure H) that spans 
the entire connection region and penetrates into both PAs. Nearly perpendicular to 
structure H is another stable and elongated structure (structure V) that emanates from the  
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Figure 9-5: Coherent structures visualized with Q-criterion. (left) Time-averaged velocity 
structures. (right) instantaneous structures at 4 consecutives instants in time  (Right). The 
stable elongated vortex core (structure H) results from the collision of the HepV flow 
with the AZ, SVC and IV flows. Structure V emanates from the shear layer between the 
AZ and SVC flows and then dives into the hepatic baffle (region A). An animation of 
these flow structures is provided in Animation 9-1. 
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Figure 9-6: Instantaneous coherent structures in the LPA visualized with Q-criterion for 
the same 4 instants in time as in Figure 9-5. The flow is characterized by chaotic flow 
structures just after the stenosis and relaminarization towards the vessel outlet.  
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Animation 9-1: Dynamic visualization of the coherent structures visualized with Q-
criterion. Note that the structures within the center of the connection remain fairly stable 
in time, while the flow downstream of the stenosis is characterized by chaotic flow 
structures followed by a progressive relaminarization towards the vessel outlet. 
 
 
shear layer between the AZ and SVC inflows and then dives into the hepatic baffle 
(region A). The vortices created in region A are ejected towards the RPA anastomosis 
where they interact with the structure H again. This second interaction results in 
seemingly aperiodic vortex shedding events causing smaller vortical cores to be ejected 
further down the RPA. These instantaneous structures (in particular structure H and those 
at the opening of the hepatic baffle) are also present in the time-averaged flow field, 
which demonstrates their quasi-steady character. Despite the intense mixing noted within 
the baffle, the flow structures in the connection and in the RPA thus demonstrate low 
levels of unsteadiness.  
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The enormous complexity of the flow in the LPA region is best visualized in Figure 
9-6, which shows the instantaneous coherent structures in the LPA extended vessel for the 
same time instants as those shown in Figure 9-5. The flow is characterized by chaotic flow 
structures and the emergence of intense velocity fluctuations. The instabilities observed in 
the LPA outflow track stem from the presence of a severe LPA stenosis just downstream of 
the connection. As highlighted above, the flow entering the LPA is already unsteady and 
three-dimensional due to the complex vortical structures created in the connection center. 
As the flow accelerates in the constriction these large-scale vortical structures stretch and 
intensify. The sudden increase in the diameter of the LPA downstream of the stenosis 
imposes an adverse streamwise pressure gradient (Figure 9-3), which destabilizes the flow 
and causes the rapid breakdown of the LPA jet into a seemingly chaotic, turbulent-like 
state. Downstream of the stenosis, the small-scale vortical structures start to decay and 
larger vortices begin to emerge, which suggests that the flow begins to re-laminarize again 
due to the stabilizing effect of viscosity. 
 
Pre-Operative Summary: The main clinical symptom of this patient is severe hypoxemia 
due to the presence of left-sided PAVMs. Analysis of the pre-operative hemodynamics 
reveals that 91% of the hepatic blood flows through the RPA towards the right lung, while 
only 9% reach the left lung. This highly preferential HFD to RPA stems from the fact that 
1) the orientation of the AZ at its connection site directs the AZ blood towards the LPA, 
which entrains the two other superior inflows in its wake towards the left, 2) the HepV 
stream is of low velocity and low energy and cannot sustain flow competition with the 
superior inflows. The preferential distribution of the superior inflows to the LPA presents a 
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hemodynamic barrier to the HFD to LPA, constraining the hepatic flow to the RPA. This is 
re-inforced by the curvature of the HepV baffle. Moreover, it is apparent that the severe 
LPA stenosis just downstream of the vessel anastomosis results in number of detrimental 
hemodynamic features, including elevated pressure drops, a drastic increase in velocity as 
the flow goes through the stenosis, and a transition in flow regimes immediately 
downstream of the stenosis. The rise of small turbulent vortex cores downstream of the 
stenosis increases the shear forces that will be imposed on traveling platelets and red blood 
cells. 
Accordingly, surgical recommendations include 1) dilating the LPA stenosis to 
decrease the power loss and stresses on the blood elements, and 2) redesigning the hepatic 
baffle to improve HFD. Dilation of the LPA stenosis may be performed by the trans-
catheter insertion of a balloon-dilated stent. It is expected that such dilation will primarily 
result in lower pressure drops and power losses but will not significantly affect HFD. 
Accordingly, since the primary symptom of Patient B1 is hypoxemia, we will focus our 
attention on modifying the baffle design to improved HFD. The strategies designed should 
seek to either minimize the head-on collision between the HepV and the other inflows, or 
increase the energy of the stream coming through the baffle for it to better resist flow 
competition at the center of the connection.  
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9.2.1.3 Surgical Planning Options 
Based on the analysis of the pre-operative hemodynamics conducted above, four 
re-operative strategies are investigated herein. These four options were designed using 
the virtual surgery framework described in Chapter 5, and the resulting geometries are 
displayed in Figure 9-7 together with the pre-operative anatomy. Option 1 makes use of 
an extra-cardiac baffle similar to the pre-operative one, but shifted further towards the 
left. Option 2 consists of using a ‘Y’ shaped graft similar to the Optiflo proposed by 
Soerensen et al. [98]. The right and left branches are connected on either side of the 
Kawashima connection (i.e. on either side of the point of convergence of all the superior 
inflows) to prevent any head-on collision with the superior inflows and avoid mixing at 
the center of the connection. The right branch is set to a smaller diameter than the left to 
increase the resistance of the HepV-to-RPA pathway, and hopefully decrease the HFD to 
RPA. Option 3 seeks to increase the energy of the flow coming through the extra-cardiac 
conduit by connecting the azygous vein to the hepatic veins, and merging the AZ and 
HepV flows within the extra-cardiac conduit. Finally, Option 4 seeks to both increase the 
energy of the HepV pathway and avoid head-on flow collisions by merging the AZ and 
HepV flows together in the azygous vein. The hepatic flow is routed through a HepV-to-
AZ shunt into the azygous vein and the extra-cardiac conduit is taken down.  
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Figure 9-7: The four surgical planning options investigated for patient A1 viewed from 
the posterior side. The pre-operative anatomy is provided for comparison. The surgical 
procedure associated with each one of these options is briefly described by the red 
annotations. 
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CFD simulations are conducted for each of the surgical options to compare their 
hemodynamic performance. Emphasis is set on achieving a balanced HFD to the two 
lungs. Because the post-operative outflow conditions are likely to differ from the pre-
operative conditions, two outflow distributions are investigated:  
- the pre-operative GFD of 30/70 RPA/LPA to represent the acute post-operative 
state, before any PAVM resorbtion and changes in pulmonary vascular resistance 
- and a GFD of 50/50 RPA/LPA to model the global flow distribution that would be 
achieved in long-term if the left-sided PAVMs resorbed and the pulmonary vascular 
resistances rebalanced. 
The results for each of these flow conditions are provided hereafter. The CFD results are 
displayed in the anatomy without the numerical vessel extensions. To better visualize the 
flow dynamics at the center of the connection, all displayed flow fields are viewed from the 
posterior side. In the figures shown for Patient A1, the LPA is thus on the left and the RPA 
on the right. 
 
9.2.1.4 Hemodynamic Performance at a GFD of 30/70 RPA/LPA 
As previously mentioned, the parameters of interest to select the optimal surgical 
option are the HFD and hemodynamic resistance. Figure 9-8 compares the hemodynamic 
performance of all four surgical options in the acute post-operative stage, in terms of 
HFD and static pressure drops. HFD is reported in terms of HFDRPA and HFDLPA, which 
represent the percentage of the hepatic flow going to RPA and LPA, respectively. The 
global flow structures are illustrated as well to better understand the reported HFD 
values.  
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Figure 9-8:  Comparison of the hemodynamic performance of the four surgical planning options at GFDRPA=30%. The objective is to 
reduce HFDRPA down to a level that is in closer match to GFDRPA, and to minimize the pressure drops across the connection. The 
pressure scale is optimized to show differences in the body of the connection and not for the pressure drops across the LPA stenosis. 
The pre-operative hemodynamics are provided for reference.  
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Option 1: The extra-cardiac baffle in Option 1 is shifted to the left, avoiding a direct 
head-on collision between the HepV flow and the superior inflows. Looking at the top 
row of Figure 9-8, it can be observed that, thanks to the offset, none of the superior 
inferior inflows penetrate into the baffle. The HepV streamtraces (in dark blue in Figure 
9-8) are free to occupy the entire baffle and not constrained towards the right side as was 
the case in the pre-operative anatomy. However, as the HepV streamtraces exit the baffle, 
they are caught by the superior inflows that seek to reach the left lung and forced into the 
LPA. As a result, Option 1 leads to a complete inversion of the HFD compared to the pre-
operative flow distribution. HFD goes from 91/9 RPA/LPA in the pre-operative anatomy 
to 1/99 in Option 1. Such an increase in HFDLPA will definitely lead to the disappearance 
of the left-sided PAVMs, but carries the risk to yield right-sided PAVMs if the HFD does 
not rapidly reach a more balanced 50/50 distribution as the lungs remodel. The pressure 
field of Option 1 is similar to that of the pre-operative anatomy, indicating comparable 
energy losses.  
Option 2: The flow structures observed in Option 2 show number of similarities with the 
pre-operative ones. The AZ flow forces the IV and SVC flows towards the LPA, and part 
of the SVC flow penetrates into the left branch of the Y-graft constraining the HepV flow 
towards the right branch. As a result, this option fails to improve the hepatic flow 
distribution, with only 6% of the HepV flow reaching the LPA.  
Option 3: In Option 3, the AZ flow is directed to the HepV baffle. The SVC and IV 
streamtraces (in orange in Figure 9-8) come straight down into the connection site, rather 
than being forced towards the LPA by the azygous flow, as was the case in the pre-
operative anatomy. This results into a head-on collision between the IV+SVC streams 
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and the combined AZ and HepV streams, but is not accompanied by the superior IV and 
SVC inflows penetrating into the baffle. Combining the AZ and HepV flows increases 
the velocity and kinetic energy in the extra-cardiac baffle, allowing those two combined 
flows to sustain the competition with the IV and SVC. As a result, HFD to the left lung 
increases from 9% in the pre-operative anatomy up to 37% in Option 3. A potential 
drawback of combining the AZ and HepV flows is increasing the overall resistance of the 
TCPC. However, the pressure drops associated with this option are of the same order as 
those of the original anatomy.  
Option 4: Finally, in Option 4, the HepV and AZ flow merge together into the azygous 
vein. All the superior venous returns thus enter the connection from its superior aspect, 
which avoids the competitive head-on collision observed in the pre-operative anatomy. 
An intense mixing can be observed at the center of the connection, with streamtraces of 
all colors entangled together (Figure 9-8). Thanks to this intense mixing Option 4 is the 
option that has the best performance from an HFD distribution stand-point, achieving a 
32/68 RPA/LPA ratio, which is in close match with the global cardiac output distribution 
of 30/70 RPA/LPA to the lungs. On the other hand, Option 4 features the highest pressure 
drops of all tested options. The pressure difference between the HepV and the center of 
the connection is of about 0.50 mmHg compared to less than 0.20 mmHg for the pre-
operative anatomy and Options 1 to 3. Combining the hepatic and azygous streams into 
the azygous vein increases the viscous friction along the AZ vessel walls, which in turn 
increases the hemodynamic resistance and pressure drop required to drive the HepV and 
AZ flows up towards the connection site.  
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9.2.1.5 Hemodynamic Performance at a GFD of 50/50 RPA/LPA 
Results under the pre-operative flow conditions demonstrated that Option 2 would 
result in an HFD similar, if not worse, to that of the pre-operative anatomy. This option is 
thus not expected to improve patient outcome, and is therefore not retained as a potential 
candidate for the surgery nor is it retained for subsequent investigation. Options 1, 3 and 
4, on the other hand, represent potential candidates, as they were seen to increase HFDLPA 
under the pre-operative flow conditions. Nonetheless, the pre-operative GFD can at best 
represent the acute post-operative stage, and the question arises as to how these options 
would perform in the long-term. In order to discriminate between Options 1, 3 and 4, we 
thus compare their hemodynamic performance at a GFD of 50/50 RPA/LPA, to emulate 
the flow conditions after the left PAVM have resorbed and the left pulmonary resistance 
has increased. The corresponding flow structures, HFD and pressure fields are displayed 
in Figure 9-9 using the same conventions as in Figure 9-8.  
Option 1: Overall, the flow structures and relative HFD performance of Options 
1, 3 and 4 are similar to what was noted under the pre-operative flow conditions. Option 
1 still yields a highly biased HFD to the LPA, which only decreases to 96% from the 99% 
measured with the pre-operative flow splits. The left-sided HepV offset favors HFD to 
the LPA. In addition, the IV and SVC flows (orange streamtraces in the top row of Figure 
9-8) constitute a barrier that prevents the HepV from reaching the RPA. Based on the 
flow behaviors observed at GFDRPA=30% and 50%, it might be expected that Option 1 
will provide only little hepatic flow to the right lung unless all of the AZ, IV and SVC 
flows are directed to the RPA. Accordingly, Option 1 will most likely lead to right-sided 
PAVMs and does not appear as a suitable candidate for the surgery. 
- 274 -  
  Option 1 Option3 Option 4 
G
lo
ba
l F
lo
w
 
St
ru
ct
ur
es
 
Streams 
from
HepV
AZ
SVC 
or IV
 
LPA RPA
HepV AZ
IV
SVC
(A)
 
H
ep
at
ic
 F
lo
w
 
D
is
tri
bu
tio
n  HFD to
RPA
LPA  
96% 4%
21%
79%
 
43% 57%
Pr
es
su
re
 F
ie
ld
  Pressure 
(mmHg)
0.0
-0.5
-1.0  
 
Figure 9-9:  Comparison of global performance measures at a GFD of 50/50 RPA/LPA. 
Only the three options that yielded a higher HFDLPA than the pre-operative anatomy 
when the GFD was of 30/70 RPA/LPA are considered here.  
 
 
Option 3: Option 3 (second column in Figure 9-9) allows for some mixing 
between the superior and inferior inflows. This is manifested by the intertwined red, blue 
and orange streamtraces at the center of the connection. However, due to the curvature of 
the extra-cardiac baffle, the AZ and HepV streamtraces (in blue and red in the top row of 
Figure 9-9) detach from the left side of the baffle (region A). The IV flow further 
constrains the AZ and HepV flows towards the right and into the RPA. As a result, 
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despite some mixing at the center of the connection, this option only provides 21% of the 
hepatic flow to the left lung when GFDRPA=50%.  
Option 4: Finally, Option 4 (last column in Figure 9-9) is here again the host of 
an intense mixing at the center of the connection. HFDLPA goes from 68% to 43% when 
GFDLPA decreases from 70% to 50%. The intense mixing of all inflows at the center of 
the connection ensures that the HFD closely follows the GFD. It may thus be assumed 
that Option 4 would lead to the disappearance of the left-sided PAVMs in the acute stage, 
and still maintain a normal left and right lung function as the GFD rebalances from 30/70 
to 50/50 RPA/LPA in the long term. This option is hindered by higher pressure drops 
than the others even at GFDRPA=50%, but this is deemed acceptable in view of the 
improvements in HFD. 
 
9.2.1.6 Surgical Planning Summary 
Four surgical planning options were created based on the pre-operative 
hemodynamics assessment of Patient A1. Each of these options was investigated under 
the acute post-operative conditions (simulated using the pre-operative CFD of 30/70 
RPA/LPA) and after a possible disappearance of the left-sided PAVMs (simulated using 
a GFD of 50/50 RPA/LPA). The HFD for Patient A1 was shown to be highly dependent 
upon the interaction between the superior and hepatic inflows. Options 1 and 2, which 
maintained the four inflows separated, did not show major improvement in the 
distribution of the hepatic flow. Varying the HepV offset towards the LPA, as 
demonstrated with Option 1, led to a complete switch of the HFD from 91% HFD to the 
RPA in the pre-operative anatomy to 4%. This points to a very high sensitivity of the 
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HFD to the HepV offset due to a limited mixing between the low energy HepV flow and 
the combined superior inflows. Similarly, splitting the HepV baffle as in Option 2 failed 
to improve HFD to the left lung.  
Merging the AZ and HepV was observed to be the best strategy for Patient A1. 
Combining the two flows into the baffle, as in Option 3, increased the energy of the 
inferior venous return and in turn the mixing of the inferior (AZ and HepV) and superior  
(IV and SVC) inflows. Although Option 3 did improve HFD, this improvement was not 
deemed sufficient to completely heal the PAVMs. Optimal results from an HFD 
standpoint were obtained by redirecting the HepV flow into the AZ (Option 4). Though 
coming at a slightly higher cost in terms of pressure drops, this option led to a complete 
mixing of all venous inflows (namely the AZ, IV, SVC and HepV flows) and an apparent 
linear relationship between the global and hepatic flow distributions. This suggests that 
Option 4 would lead to the disappearance of the left-sided PAVMs in the acute stage, and 
still maintain a normal left and right pulmonary function as the GFD rebalances from 
30/70 to 50/50 RPA/LPA.  
The corrective surgery was eventually performed with Option 4. Five month 
follow-up data support this choice with a clear improvement in the overall clinical 
condition and an increase of oxygen saturation levels 72 to 94%, implying regression of 
the PAVMs.  
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9.2.2 Patient A2 (CHOA M1) 
9.2.2.1 Pre-Operative Anatomy and Clinical Diagnosis 
Patient A2 was a 6-year old male referred by the Children Hospital of Atlanta 
(CHOA). This patient had a heterotaxy syndrome, SVHD, and an interrupted IVC. He 
had undergone a Kawashima procedure followed by an intra-atrial procedure to complete 
the HepV-to-PA conduit. The patient showed signs of increasing hypoxemia, with an 
arterial oxygen saturation below 83% at the time of examination. He was diagnosed with 
severe right lung PAVMs. Angiogram examination revealed that most of the dye injected 
into the hepatic veins flowed into the left lung, re-instating the correlation between the 
presence of PAVMs and a poor supply in hepatic blood. 
Patient A2 featured number of coils, which prevented regular MRI acquisition, so 
that CT images had to be used to reconstruct the in vivo TCPC geometry. The coils still 
induced imaging artifacts in the images of the intra-atrial baffle, whose geometry had to 
be reconstituted using the virtual surgery environment. Three landmarks were used to 
guide the virtual design and ensure that the re-created HepV baffle accurately represented 
the in vivo pre-operative anatomy. These were: 1) the location of the HepV stump, which 
could be identified in the CT images, 2) the location of a stump on the PAs, which was 
taken to be the location of the HepV to PA anastomosis, and 3) the angiogram images 
used for PAVM diagnosis, where the dye clearly illustrated the hepatic blood flow 
pathway. The resulting anatomy is shown in Figure 9-10. The cross-sectional areas of 
each of the inlet and outlet vessels are listed in Table 9-4. The LPA, with a cross-
sectional area of only 0.81 cm2, was significantly smaller than the RPA (2.41cm2).   
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Figure 9-10: Patient A2’s pre-operative TCPC anatomy. The geometry was reconstructed 
from CT and the hepatic baffle added using the virtual surgery interface. The black 
arrows depict the global flow direction for each inlet and outlet. 
 
 
Table 9-4: Geometric characteristics of Patient A2 at the time of PAVM diagnosis, and 
flow boundary conditions used for the CFD simulations. In vivo flow measurements were 
unavailable since the patient was imaged by CT. Inflow conditions for the CFD 
simulations were taken to be the same as for Patient A1. Outflow conditions were varied, 
but the flow rates and characteristic velocities at a 50/50 RPA/LPA flow split are 
provided as an example. QS: sum of the systemic inflows. QP: sum of the pulmonary 
outflows. 
 
 Cross-sectional Area (cm2) 
In Vivo Flow 
measurements CFD Flow Conditions 
Q (L/min) Q (%) Q (L/min) Q (%) 
Characteristic 
Velocity (cm/s) 
Systemic Venous Return 
HepV 2.46 n/a n/a 0.72 21% 4.89 
IV 1.83 n/a n/a 0.75 22% 6.84 
AZ 1.31 n/a n/a 0.82 24% 10.49 
SVC 1.26 n/a n/a 1.13 33% 14.92 
QS  n/a  3.43   
Pulmonary Flows  
LPA 0.81 n/a n/a 1.71 50% 35.22 
RPA 2.41 n/a n/a 1.71 50% 11.86 
QP  n/a  3.43   
- 279 -  
Table 9-4 also provides the flow conditions used for the CFD simulations. No pre-
operative flow measurements were available as he had only undergone a CT evaluation. 
The CFD inflow conditions were thus taken to be the same as for Patient A1 and the 
global flow distribution at the outlet was varied over a wide range of RPA/LPA mass 
flow ratios for both the pre-operative anatomy and the surgical planning options. From 
the characteristic velocities listed in Table 9-4, it is noteworthy that that the mean 
velocity across the HepV baffle was two to three times lower than that across the AZ and 
SVC. The HepV stream for Patient A2 will thus show a low kinetic energy compared to 
the other two inlets. Based on the experience gained from Patient A1, the HFD can thus 
be expected to be very sensitive to the flow competition between the HepV stream and 
the other three inflows. 
 
9.2.2.2 Pre-operative Hemodynamics 
Based on the observation that both the right-sided PAVMs and the larger RPA 
diameter will tend to decrease the resistance of the pathway to the right lung compared to 
the left lung, the pre-operative hemodynamics were assessed for GFDs that favored flow 
to the RPA, ranging from 50/50 RPA/LPA up to 80/20 RPA/LPA.  
Flow structures and pressures: The results obtained at the two extremities of the tested 
range, namely 50/50 and 80/20 RPA/LPA, are displayed in Figure 9-11, in terms of 
pressure, velocity and flow structures. All pressures are expressed in reference to the 
mean pressure at the HepV inlet. For both reported flow conditions, the IV and HepV 
flows were associated with low velocities (on the order of 5 to 7 cm/s) and low pressure 
drops. Velocities in the azygous vein were slightly higher (on the order of 10 cm/s) due to 
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the smaller diameter of that vessel compared to the IV and HepV. The pressures in that 
vessel are also slightly higher than in the other two, because a higher pressure head is 
required to drive the azygous flow to the center of the connection. The SVC was the 
fastest of all inflows, due to the fact that it carried one third of the systemic return and 
featured the smallest of the inflow cross-sections. At GFDRPA=50% (top row in Figure 
9-11), the velocities in the RPA fall within the same range as in the SVC. The mean RPA 
velocity is of 11.8 cm/s, with a peak around 18 cm/s. The associated pressure drop from 
the HepV is of only 0.15 mmHg. In contrast, the mean velocity at the LPA outlet is of 35 
cm/s, accompanied by a mean pressure drop of 0.88 mmHg. These higher values 
compared to the RPA find their origin in the smaller dimension of the LPA, whose outlet 
cross-section is about three times smaller than the RPA, thus opposing a higher resistance 
to the flow. Figure 9-12 displays the pressures recorded through the connection in 
relation to the control volume power losses. It may be noticed that the high pressure 
drops in the LPA correspond to elevated power losses. The mean LPA pressure shows a 
strong dependency on the global flow distribution, dropping rapidly when the LPA flow 
rate increases (decreasing GFDRPA). The fast decrease in LPA pressures translates into a 
fast decrease in the control volume power losses. The power loss curve reaches its 
minimum around GFDRPA=75%, which is in close match to the point where the LPA and 
RPA pressure curves intersect. When GFDRPA is lower than 75%, the increase in power 
losses is thus imparted by the LPA. Symmetrically, when GFDRPA is larger than 75%, the 
power losses are dominated by the energy dissipation rate in the RPA. At GFDRPA=80%, 
the mean RPA velocity and pressure drop are of 19 cm/s and 0.31 mmHg, respectively, 
compared to 14 cm/s and 0.20 mmHg in the LPA (Figure 9-11).  
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Figure 9-11: Hemodynamics of the Patient A2’s pre-operative anatomy at a GFD of 50/50 RPA/LPA and 80/20 RPA/LPA. The 
velocities and pressure fields are shown from the posterior view to better visualize the changes in the PAs. The flow structures are 
shown from both the posterior and anterior views. 
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Figure 9-12: Dependence of the pressure (left) and power loss (right) to the flow 
distribution for the pre-operative anatomy of patient A2. The pressure corresponds to the 
average pressure values computed across each inlet/outlet. Note that the pressure in the 
HepV was taken as the pressure of reference and thus has a zero pressure value for all 
flow conditions.  
 
 
Hepatic flow distribution: Figure 9-13 depicts the computed hepatic flow distribution to 
the right lung (HFDRPA) as a function of the global flow distribution to that lung 
(GFDRPA). The HFDRPA=GFDRPA line represents the ideal scenario where the lungs 
receive hepatic nutrients in proportion with the amount of blood flow. In a normal 
physiology, this is ensured by a complete mixing of all systemic venous returns in the 
right atrium and ventricle prior to their redistribution to the pulmonary arteries. For 
Fontan patients, the HFD will solely depend on the design of the TCPC and resultant 
interaction of the inflows at the center of the connection. For Patient A2, all HFDRPA 
measurements fall far below the HFDRPA=GFDRPA line, testifying for a highly 
preferential HFD to the left lung.  
The mechanism behind this preferential HFD to LPA can be better understood by 
going back to the flow structures shown in Figure 9-11. For all tested flow conditions, the 
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AZ streamtraces (in red), which enter the connection the farthest to the right, flow into 
the RPA. The SVC (in blue) and IV (in green) inflows split sequentially to adjust for the 
desired GFD. At GFDRPA=50%, only the SVC splits between the RPA and LPA, while 
the IV streamtraces are exclusively directed to the LPA. When GFDRPA increases to 80%, 
the SVC streamtraces switch completely towards the RPA, and it is the IV streamtraces 
that split between the LPA and RPA. The HepV (in orange) remains almost exclusively 
directed to the LPA for all tested flow conditions. From the point of view of the hepatic 
flow distribution, the pre-operative anatomy thus behaves the same way as a connection 
with a large offset towards the LPA, even though the offset was only of small magnitude 
in the pre-operative anatomy. Such sensitivity to even a small left-sided offset might be 
attributed to the low velocities and resultant low kinetic energy of the HepV flow, which 
prevents it from mixing with the other inflows. 
 
 
 
Figure 9-13: Hepatic flow distribution obtained by CFD in the pre-operative anatomy. 
The plot is split in four quadrants to help the visual interpretation.   
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9.2.2.3 Surgical Planning Options  
Eight options are considered for the surgical planning campaign conducted for 
Patient A2. The corresponding anatomies are shown in Figure 9-14. The investigated 
parameters include 1) the HepV offset, progressively shifting the HepV from the right to 
the left of the connection, 2) the surgical procedure used, namely comparing intra-atrial 
and extra-cardiac approaches, 3) splitting the HepV in two branches using a Y-shaped 
Optiflo graft, and 4) merging the AZ and HepV streams together, either in the hepatic 
baffle or in the azygous vein. 
Options 1 through 3 use an intra-atrial baffle of similar dimension as the pre-
operative anatomy, but vary the position of the HepV anastomosis site to identify the 
HepV offset that would best split the hepatic flow between the two lungs. Option 1 
connects the HepV the furthest towards the RPA. In Option 2, the HepV faces the AZ 
vein, while, in Option 3, it faces the SVC. To investigate if the procedure used made a 
significant impact on the associated HFD, Option 4 connects with an offset similar to 
Option 2, but using an extra-cardiac baffle.  
In Options 5 and 6, the HepV is split in two branches following the Optiflo 
concept proposed by Soerensen et al. [98]. The objective of such a design is to split the 
hepatic flow to the left and right lung while avoiding head on flow collision of the HepV 
flow with the superior inflows. Both options make use of the existing intra-atrial graft 
thereby limiting the surgical procedure to the addition of a HepV-to-RPA branch, which 
is brought further to the RPA in Option 5 than in Option 6. 
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Figure 9-14: Geometry of the eight surgical planning options designed for Patient A2. The first four options vary the location of the 
HepV anastomosis site with respect to the superior inflows (HepV offset). Options 5 and 6 investigate the benefits of a Y-shaped 
Optiflo graft to avoid head-on collision. Options 7 and 8 seek to improve mixing by the redirecting either the AZ blood into the HepV 
baffle (Option 7) or the hepatic blood into the AZ vein (Option 8). 
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Finally, Options 7 and 8 aim at improving the hepatic flow distribution by 
including either an AZ-to-HepV (Option 7) or a HepV-to-AZ (Option 8) connection. In 
Option 7, the objective is to increase the momentum of the flow coming through the 
intra-atrial baffle, and thereby allow the HepV flow (in combination with the AZ flow) to 
compete with the superior inflows at the center of the connection. In Option 8, the intra-
atrial baffle is taken down and the HepV flow is routed through a HepV-to-A shunt into 
the azygous vein. All venous returns enter the connection from the superior aspect of the 
PAs. The objective is to suppress all head-on collision and force flow mixing at the center 
of the connection. Options 7 and 8 are similar to Options 3 and 4 proposed for patient A1. 
 
9.2.2.4 HFD Performance  
The performance of the eight surgical planning options is assessed through series 
of numerical simulations using the same inflow conditions as for the pre-operative 
hemodynamics. The outflow conditions are adjusted so as to best predict the point at 
which an equal HFD to both lungs would be achieved. The performance at equal lung 
perfusion, i.e. when the global flow distribution is 50/50 RPA/LPA, is assessed for all 
options. Figure 9-15 shows the hepatic flow performance the surgical planning options 
over all tested flow conditions. The results are split into two graphs for clarity. The left 
panel shows the HFDRPA achieved by Options 1 to 4, while the right panel shows the 
performance of Option 5 to 8. The pre-operative performance is provided as well in order 
to visualize the improvement brought in by the different options. As a reminder, the 
HFDRPA=GFDRPA curve (black dashed line) represents the best scenario where the 
hepatic flow distribution directly aligns itself to the global flow distribution.  
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Figure 9-15: Comparison of the hepatic flow distribution achieved by the eight surgical planning options over the whole range of 
tested flow conditions. The results are separated in two graphs for clarity. The pre-operative anatomy is provided in the left panel to 
visualize the improvement brought in by the different options.  
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Options 1 to 4: The left panel of Figure 9-15 compares the HFD performance of the pre-
operative anatomy and Options 1 through 4. The curves can be distinguished between 
those that fall above the HFDRPA = GFDRPA line, which is indicative of a favorable HFD 
to the RPA, and those that fall below, indicating a favorable HFD to the LPA. The former 
category includes Options 1, 2 and 4, for which the HepV connects opposite to the 
aygous vein or further to the RPA. Symmetrically, Option 3 and the pre-operative 
anatomy, where the HepV connects opposite to the SVC or further to the LPA, favor 
HFD to the LPA. The worst performers are the pre-operative anatomy and Option 1, 
which fall the farthest away from the central line. Option 1, which has the largest offset 
towards the RPA, demonstrates an almost exclusive distribution of the hepatic flow to the 
RPA. This behavior is symmetric to what was observed for the pre-operative anatomy, 
indicating a very limited level of mixing between the hepatic blood and the other inflows. 
Options 2, 3, and 4, which were connected to the center of the connection more closely 
followed the central HFDRPA = GFDRPA curve. However, it is striking to note that even a 
slight variation in the HepV anastomosis site leads to large changes in the measured HFD 
at all tested conditions. 
To better understand the mechanism behind the observed HFD, Figure 9-14 
compares the path followed by the hepatic flow in the eight surgical planning options at 
50/50 RPA/LPA since this flow condition was tested for all geometries. The hepatic 
streamtraces going to the RPA and LPA are color-coded in blue and red, respectively. 
HFDRPA and HFDLPA are reported next to each option using the same color-coding. The 
dashed axis superimposed on Option 2 indicates the HepV stagnation point, which 
corresponds to the point where the superior inflows (IV, SVC and AZ combined) collide  
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Figure 9-16: Hepatic flow splits in the pre-operative anatomy and the eight surgical planning options at a global flow distribution of 
50/50 RPA/LPA. The location of the HepV stagnation point in Option 2 is reported on the other configurations that made use of an 
intra-atrial baffle to compare their locations. 
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into the HepV stream dividing it between the LPA and RPA. This axis is reported in the 
other intra-atrial geometries to compare the position of their flow stagnation point to that 
of Option 2. It is striking to note that the dashed axis points almost exactly to the flow 
stagnation point of Options 3, 5 and 6, demonstrating that the HepV flow splits in the 
same location in these three options as in Option 2. The fact that the location of the 
stagnation point is insensitive to the HepV offset demonstrates that, in these options, the 
HepV has little to no impact on the superior inflows. Rather, it is the superior inflows that 
dictate its distribution. Options 1 connects far to the right of the stagnation point and 
leads an exclusive HFD to RPA. Option 2 is slightly offset to the right of the stagnation 
and directs 87% of its flow to the RPA. Symmetrically, Option 3, which includes a slight 
offset to the left of the stagnation point, directs 64% of its flow to the LPA, while the pre-
operative anatomy which lies almost entirely to the left of that point leads to an exclusive 
HFD-to-LPA. The hepatic flow distribution in the intra-atrial options appears to be 
related to the area of the baffle that lies to the left and right of the stagnation point.  
The dynamics of Option 4, which uses an extra-cardiac approach, are slightly 
different. The baffle does not connect on the inferior aspect of the PAs but rather on its 
anterior side. This approach slightly improves mixing within the connection, resulting in 
HFDRPA measurements (light green symbols in Figure 9-15) that are close to the center 
line at GFDRPA = 30%. When GFDRPA increases, the HFD measurements for Option 4 
tend towards the ones obtained for Option 2, which has a similar HepV offset but uses an 
intra-atrial approach. This points to the HepV offset as being the main determinant for the 
hepatic flow distribution in Patient A2, while the type of procedure used (i.e. extra-
cardiac vs. intra-atrial) only is a second order factor. The optimal HepV anastomosis site 
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appears to be related to the stagnation point of the superior inflows. The fact that such 
location does not depend only on geometric considerations, but also on the flow rates 
going through the different vessels, makes it difficult to identify and even more to 
generalize. Furthermore, the very high sensitivity of the HFD to the exact HepV location 
makes the classic intra-atrial and extra-cardiac options dangerous to implement in vivo 
for this patient. 
Options 5 and 6: The Optiflo approaches (Option 5 and 6) provide an attractive 
alternative to this difficulty. As can be seen from the right panel of Figure 9-15, both of 
these options yield a close to 50/50 HFD, when the global flow distribution is of 50/50 
RPA/LPA. This represents an ideal situation where the two lungs can be both properly 
perfused and receive a sufficient amount of hepatic nutrients. It is interesting to note that 
in Figure 9-16 the stagnation point for those two options falls at the exact same location 
as in Option 2. The Optiflo options are thus subjected to the same constraint as the classic 
intra-atrial approaches, but the advantage is that they circumvent the difficulty of 
identifying the best suited connection location. The only thing to ensure is that the two 
branches reach far enough into the PAs to seat on either side of the inflow splitting point.  
Option 7: The HFD measurements for Option 7 in Figure 9-15 are notably closer to the 
centerline than those of the pre-operative anatomy, reflecting an improvement in HFD 
despite the fact that Option 7 used the same intra-atrial design as the pre-operative 
anatomy. Looking at Figure 9-16, it can be noticed that, the HepV streamtraces are not 
flattened by the superior inflows at the exit of the HepV baffle. On the opposite, they 
cross the entire diameter of the LPA, impinge on the superior wall, and then split between 
the left and right. Combining the AZ and HepV flows without changing the baffle 
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diameter increases the velocity and kinetic energy of the flow coming through the intra-
atrial conduit, thus allowing it to resist the superior inflows. Despite the noted 
improvement, the HFDRPA curve for Option 7 still falls far below the HFDRPA=GFDRPA 
line in Figure 9-15, which indicates a preferential HFD to the LPA. As such this option 
does not seem indicated for Patient A2. Using a more centered baffle design would most 
likely improve the performance of this option, but was not attempted for Patient A2. 
Option 8: Results for Option 8 closely follow the central line in Figure 9-15. The 
streamtraces in Figure 9-16 span the entire connection area, reflecting an increased 
mixing between the different inflows. As was observed for Patient A1, this mixing leads 
to an almost perfectly balanced HFD at GFDRPA=50%. For lower GFDRPA values, results 
slightly depart from the central curve in favor of left lung, but remain within reasonable 
bounds with an HFDRPA of 40.8% at GFDRPA=30%. 
 
9.2.2.5 Power Loss Performance  
Considering the power loss behavior over a wide range of operating conditions is 
also an important factor in the clinical decision process. For a given set of flow 
conditions, higher power losses reflect a higher TCPC resistance, leading to increased 
central venous pressures and workload imposed on the heart. The power losses computed 
for the pre-operative anatomy and the surgical planning options are provided in Figure 
9-17.  
Options 1 to 4: The power losses associated with the “offset variation” options (Options 
1 through 4) and the pre-operative anatomy collapse onto a single curve, indicating that 
the LPA-RPA offset only has little impact on power losses. The absence of difference 
between the extra-cardiac approach (Option 4) and the intra-atrial options (Options 1 to  
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Figure 9-17: Power losses for all options tested for patient A2. 
 
 
 
3), also suggests that HepV curvature is only a small contributor to the overall energy 
dissipation rate. Accordingly, power losses are not a strong discriminator between 
Options 1 and 4.  
Options 5 and 6: From a power loss point of view, the best performance is achieved with 
the two Optiflo options (Options 5 and 6), which yield the lowest power losses of all 
tested options at GFDRPA=50%. The adjunction of the HepV-to-RPA branch to the 
existing intra-atrial baffle increases the total cross-section area offered to the hepatic flow 
compared to the pre-operative anatomy or to Options 1 through 4. This increase in area 
leads to a reduction in the mean hepatic velocity, which in turn decreases the friction 
losses in the hepatic baffle. In addition, splitting the hepatic flow between the LPA and 
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RPA avoids flow mixing at the center of the connection, further reducing the amount of 
energy dissipation within these two options. 
Options 7 and 8: Option 7 (orange triangles in Figure 9-17) is another attractive option 
from a power loss point of view, leading to a decrease in power losses compared to the 
pre-operative anatomy. This stems from the fact that the AZ is the smallest of the four 
inflows and, in the pre-operative anatomy, was associated with higher pressure drops than 
the HepV. By diverting the azygous flow away from this narrow vessel and into the 
hepatic baffle, Option 7 brings down the net energy balance, though not as low as 
Options 5 and 6. Option 8 (light green diamonds in Figure 9-17), on the contrary, features 
the highest power losses of all tested options, with values that are consistently 1.4mW to 
1.5mW higher than those measured in the pre-operative anatomy or in Options 1 through 
4. This increase may be attributed to the fact that, in this option, both the HepV and AZ 
flows go up the narrow azygous vein, resulting in an increased viscous dissipation along 
the azygous vessel walls. Finally, it is interesting to note that the power losses in Options 
7 and 8 follow a trend similar to that of the pre-operative anatomy and Options 1 through 
4, quickly increasing when GFDRPA decreases below 70%. As was established during the 
pre-operative hemodynamic analysis, this trend finds its origin in the small dimension of 
the LPA, which makes it more expensive to drive flow through the LPA than through the 
RPA. 
 
9.2.2.6 Surgical Planning Summary 
In summary, eight re-operative options were examined for Patient A2, which 
mayy be grouped into three broad categories: the HepV offset variations using either 
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intra-atrial or extra-cardiac grafts (Options 1 through 4), the Optiflo options (Options 5 
and 6) and the options combining HepV and AZ flows (Options 7 and 8). HFD appeared 
to be highly sensitive to the offset between the HepV anastomosis site and the center of 
the Kawashima connection. Such a high sensitivity makes the traditional intra-atrial and 
extra-cardiac options dangerous to implement in vivo, leaving very little error margin 
during their actual surgical implementation. An AZ-to-HepV shunt, as in Option 7, 
slightly reduced the sensitivity to the offset. However, Option 7 made use of the pre-
operative intra-atrial baffle and thus still resulted in a preferential HFD to the LPA. It 
might be inferred that and AZ-to-HepV shunt combined with a more centrally connected 
baffle would yield better performance but this would require two procedures (designing 
an AZ-to-HepV shunt and shifting the intra-atrial baffle) which would prolong the time 
spent during the surgery. The two Optiflo options (Options 5 and 6) and the HepV-to-AZ 
shunt (Option 8) yielded very satisfactory results in terms of HFD. However, due to the 
small dimension of the Patient A2’s azygous vein, Option 8 came at an elevated energy 
cost. As a result, an Optiflo approach appeared better suited for Patient A2 and was the 
option recommended for surgery.   
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9.2.3 Patient A3 (CHOP M4) 
9.2.3.1 Pre-Operative Anatomy and Clinical Diagnosis 
The third patient of the single SVC group, Patient A3, was a 3 year old female 
patient born with a heterotaxy syndrome, SVHD, interrupted IVC, and a malaligned 
atrioventricular canal to the right ventricle. This patient had previously undergone a 
Kawashima procedure and was awaiting TCPC completion. She was diagnosed with 
bilateral PAVMs, which were attributed to the absence of any hepatic flow to the lungs 
due to the incomplete TCPC. The patient was referred for an MRI examination to enable 
a surgical planning investigation and identify the best TCPC completion procedure. 
Patient A3’s pre-operative anatomy at the time of diagnosis is shown in the left 
panel of Figure 9-18. The right panel also displays the heart and great vessels to better 
represent the spatial constraints faced by the surgeon. The inlet and outlet cross-sections 
are listed in Table 9-6, together with the available in vivo MRI flow measurements and 
CFD flow conditions. It should be pointed out that the MRI flow measurements for the 
superior inflows were acquired downstream of the IV and SVC confluence. Accordingly, 
only the common SVC trunk was considered in the CFD simulations and not the 
individual IV and SVC branches. The SVC was oriented almost perpendicularly to the 
pulmonary arteries with no visible preferential direction, while the AZ vein came in at an 
angle, its axis oriented towards the LPA. Due the young age of Patient A3 compared to 
Patient A2 (3 vs. 6 years of age), the vessel cross-sectional areas reported here are 
significantly smaller than in the last case. As an example, the cross-sectional area offered 
to the superior venous returns in Patient A3 was limited to the SVC cross-sectional, i.e. to 
1.34 cm2, whereas for Patient A2 the cross-sectional area offered to the superior venous  
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Figure 9-18: On the left, Patient A3’s pre-operative TCPC anatomy is shown as a stand 
alone structure. The dotted red liens show the point where the vessels were cut for the 
CFD simulations. On the right, the TCPC (in gray) is shown with the heart (in red) to 
better represent the spatial constraints faced by the surgeons. 
 
 
Table 9-5: Geometric and flow characteristics of Patient A3 at the time of PAVM 
diagnosis, and flow boundary conditions used for the CFD simulations. QS: sum of the 
systemic inflows. QP: sum of the pulmonary outflows. 
 
 
Cross-
sectional 
Area (cm2) 
In Vivo Flow 
measurements CFD Flow Conditions 
Q 
(L/min) Q (%) Q (L/min) 
Q 
(%) 
Characteristic 
Velocity (cm/s) 
Systemic Venous Return 
HepV 1.91 1.23 32% 1.23 32% 10.75 
AZ 0.58 0.64 17% 0.64 17% 18.44 
SVC 1.34 1.98 51% 1.98 51% 24.65 
QS  3.85   3.85     
Pulmonary Flows  
LPA 0.76 1.22 49% 1.89 49% 41.38 
RPA 1.28 1.26 51% 1.96 51% 25.46 
QP   2.48   3.85     
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returns by the SVC and IV combined amounted to of 2.27 cm2. In addition, the AZ was 
compressed in the anterior-posterior direction, resulting in a cross-sectional area of only 
0.58 cm2 compared to more than 1 cm2 in the earlier patient cases. The LPA cross-
sectional area was only about half that of the RPA. Based on the experience gained with 
Patient A2, it might thus be expected that the power losses will show a strong 
dependency on the LPA flow rate. 
Finally, a few points a worth noting regarding the pre-operative in vivo flow 
distributions. First, the SVC carried a significantly higher share of the flow (51% QS) 
than previous patients, while the AZ carried a significantly lower share of the flow (17% 
QS). This is consistent with Patient A3’s younger age, since the systemic venous return 
has been shown to progressively switch from the upper to the lower limbs as children 
grow [76]. The hepatic veins carried a non-negligible share of the venous return with 
32% QS. Finally, unlike Patients A1 and A2, Patient A3 featured an almost balanced 
global flow distribution, with 51% and 49% Qp going to the RPA and LPA, respectively. 
This stemmed from the fact that both lungs had PAVMs, so that there was no major 
imbalance in the right and left pulmonary vascular resistances. 
 
9.2.3.2 Surgical Planning Options 
Figure 9-19 shows the eight surgical options that were designed for Patient A3. 
Options 1 through 6 vary the anastomosis location of the HepV baffle, progressively 
shifting the HepV offset from the right to the left of the Kawashima connection. Option 1 
is an extra-cardiac baffle that is connected onto the anterior aspect of the SVC 
anastomosis, to the right of the AZ vein. Option 2 and 3 connect with a similar offset, but  
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Figure 9-19: Surgical planning options implemented for Patient A3. All geometries are viewed from the anterior side.  
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onto the inferior aspect of the SVC anastomosis site using an intra-atrial approach. 
Option 3 also includes a slight flaring towards the LPA, so as to open up the connection 
on its left side, and promote hepatic flow distribution to the LPA. Option 4 uses an extra-
cardiac graft to reach the PAs slightly on the left of the SVC, opposite to the AZ 
connection site. Finally, Options 5 and 6 reach to the left of the AZ vein, using an extra-
cardiac graft in Option 5 and an intra-atrial graft in Option 6. 
Based on the positive results obtained for Patients A1 and A2, Options 7 and 8 
seek to promote mixing between the superior and inferior inflows by combining the 
HepV and AZ flows. In Option 7 the azygous flow is routed towards the hepatic baffle 
through an AZ-to-HepV shunt. This option then makes use of the same flared intra-atrial 
baffle design as in Option 3. Option 8 performs the opposite combination, routing the 
hepatic flow through a HepV-to-AZ shunt into the AZ vein. 
9.2.3.3 HFD Performance 
The performances of the eight surgical planning options are assessed through 
series of numerical simulations using the pre-operative in vivo flow rates at the inflows. 
The performance under the pre-operative outflow boundary conditions, i.e. when the 
global flow distribution is 51/49 RPA/LPA, is assessed for all options to predict the 
behavior in the acute post-operative stage. The outflow conditions are then varied so as to 
best predict the point at which an equal HFD to both lungs would be achieved. The 
hepatic flow distributions associated with the eight surgical planning options are 
displayed in Figure 9-20 for all tested flow conditions. For better readability, the results 
are split in two graphs. The left panel shows the results obtained for Options 1 through 6, 
while the right panel displays the results obtained for Options 7 and 8.  
- 301 -  
 
Figure 9-20: Hepatic flow distribution in the eight surgical planning options tested for Patient A3.  
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Options 1 to 6, offset variations: Focusing on the right panel of Figure 9-20, it may be 
noticed that the HFDRPA measurements for Option 1 (blue symbols) fall far above the 
HFDRPA=GFDRPA line, testifying for a preferential HFD to the RPA. HFDRPA 
measurements for the intra-atrial options 2 and 3, and the extra-cardiac option 4 fall 
within close range of the HFDRPA=GFDRPA line, testifying for an HFD that closely 
follows the global flow distribution to the right and left lung. Finally, the two options 
connected to the left of the Kawashima (i.e. Options 5 and 6) show a highly preferential 
HFD to the LPA, with HFDRPA measurements that fall far below the HFDRPA=GFDRPA 
line. From these results it is apparent that the HepV offset is a key determinant for the 
hepatic flow distribution. In addition, the HFDRPA measurements of Options 2, 3 and 4 
follow a trend almost parallel to the HFDRPA=GFDRPA line, showing a lower dependency 
of HFDRPA on the global flow distribution than what was observed for Patient A2. This 
stems from the fact that Patient A3 had a higher proportion of the systemic venous return 
coming through the hepatic veins than Patient A2, so that the HepV flow could more 
readily oppose the superior venous returns.  
It is also interesting to note that the intra-atrial option 2 had a significantly better 
HFD performance than the extra-cardiac option 1, even though both connected with a 
similar HepV offset. To elucidate the dynamics leading to these HFD, Figure 9-21 and 
Figure 9-22 compare the flow structures associated with the three extra-cardiac and three 
intra-atrial options under the pre-operative GFD of 51/49 RPA/LPA. The flow structures 
are displayed as 3D streamtraces color-coded by their vessel of origination. From Figure 
9-21, it can be observed that, in Option 1, the hepatic streamtraces (orange) come in with 
a preferential orientation towards the LPA due to the  
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Figure 9-21: Flow structures and HFD associated with the three extra-cardiac options 
(Options 1, 4 and 5) at the in vivo GFD of 51/49 RPA/LPA.  
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Figure 9-22: Flow structures and HFD associated with the three intra-atrial options 
(Options 2, 3 and 6) at the in vivo GFD of 51/49 RPA/LPA. All options are viewed from 
the anterior side. 
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curvature of the extra-cardiac baffle. These streamtraces then collide with the SVC flow 
(in blue), which prevents their entry into the LPA. As a result, despite the curvature of the 
extra-cardiac graft, most hepatic flow turns towards the RPA, leading to the high HFDRPA 
values reported in Figure 9-20.  
The dynamics of the intra-atrial options (illustrated in Figure 9-22) are drastically 
different. In Option 2, the hepatic flow also collides with the SVC flow, but in a head-on 
manner, where both SVC and HepV streams come in opposite directions. This leads to 
the formation of a stagnation point at the center of the connection, from which both SVC 
and HepV streams split towards the LPA and RPA. As a result, even though Option 2 has 
an offset similar to the extra-cardiac Option 1, significantly more hepatic flow goes to the 
LPA than in the extra-cardiac implementation. Flaring the HepV baffle towards the left 
allows a better splitting of the HepV stream and further improves hepatic flow 
distribution. Options 5 and 6 both reach too far to the left, so that the HepV streamtraces 
flow directly into the LPA without interacting with the SVC and AZ streams, leading to 
the small HFDRPA values reported in Figure 9-20. 
Options 7 and 8: The HFD performance of the two options combining AZ and HepV 
flows (Options 7 and 8) are shown in the right panel of Figure 9-20, while the associated 
flow structures are illustrated in Figure 9-23 under the pre-operative GFD of 51/49 
RPA/LPA. Option 7 seeks to reduce the sensitivity to the HepV offset by combining the 
AZ and HepV streams into the same intra-atrial baffle as in Option 3. However, for this 
patient, the AZ stream (red streamtraces in Figure 9-23) flows along the left side of the 
baffle, thus forcing more of the hepatic flow into the RPA than was the case in Option 3. 
As a result, the HFDRPA measurements for Option 7 (blue triangles in  
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Figure 9-23: Flow structures and HFD associated with the two options combining AZ and 
HepV flows (Options 7 and 8) at the in vivo GFD of 51/49 RPA/LPA. Both anterior and 
posterior views are provided for a better understanding of the AZ and HepV interactions. 
 
 
 
Figure 9-20) fall above the HFDRPA=GFDRPA line, demonstrating a preferential HFD to 
the RPA at all tested flow conditions. Due to the smaller dimensions and less regular 
shape of the AZ, routing the HepV to the AZ (Option 8) forces the AZ and HepV streams 
to mix thoroughly as is testified by the entangled red and orange streamtraces in Figure 
9-23. The mixed streams then collide with the SVC and split between the two lungs. As a 
result, HFDRPA measurements for Option 8 fall within close range to the 
HFDRPA=GFDRPA line, testifying for a proper hepatic flow distribution. Option 8 thus led 
an HFD performance comparable to that of Options 2, 3 and 4 but with drastically 
different hemodynamics. 
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9.2.3.4 Power Loss Performance 
Beyond HFD another parameter of interest is the amount of energy dissipated 
through the connection. The power losses associated with the eight surgical planning 
options are displayed in Figure 9-24. For clarity, the results are separated into two graphs, 
the left panel focusing on the offset variation options (Options 1 through 6) and  the right 
panel showing the results for the two options combining AZ and HepV flows (Options 7 
and 8). Both graphs use the same scale for ease of comparison. 
Options 1 to 6: In the right panel of Figure 9-24, the power losses measured for the first 
six options almost overlap, demonstrating that for intra-atrial or extra-cardiac baffles of 
the same diameter, the baffle design and HepV offset have only little impact on the 
amount of energy dissipation. All six options follow a trend of decreasing power losses as 
GFDRPA increases from 20% to 70%. Measurements for Option 6 then reveal a steep 
increase in power losses as GFDRPA increases to 80% and 90%. The mechanism for 
decreasing and subsequently increasing power losses is best illustrated by looking at the 
measured pressure drops, as illustrated in Figure 9-25 for Option 6. Due to the smaller 
LPA cross-sectional area (0.76 cm2) compared to the RPA (1.28 cm2), the former vessel 
is the highest source of resistance to the blood flow. As a result, the highest pressure 
drops are recorded in the LPA until the flow to that vessel drops below 40% of the 
cardiac output (i.e. until GFDRPA exceeds 60%). While part of the potential energy is 
transformed into kinematic energy to accelerate the flow through the LPA, part of it is 
also dissipated in friction along the vessel walls. At GFDRPA=60-70%, the LPA and RPA 
pressures are almost equal, which corresponds to the minimum observed in the power  
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Figure 9-24: Power Loss measured across the eight surgical planning options attempted for Patient A3 for all tested GFD conditions.  
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Figure 9-25: Pressure fields associated with Option 6 for a GFD varying between 40/60 
and 90/10 RPA/LPA. All pressures are expressed taking the mean pressure across the 
HepV inlet as a reference. 
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loss curves. As GFDRPA increases beyond 70%, it may be noticed that it is the RPA that 
features the highest pressure drops, reflecting both a stronger flow acceleration and 
higher energy dissipation.  
Options 7 and 8: The left panel of Figure 9-24 displays the power losses associated with 
the two options that combine HepV and AZ flows. Option 7, where the combined flows 
are directed to an intra-atrial baffle, leads to energy dissipation levels comparable to those 
of Options 1 to 6. Adding the AZ flow to the HepV flow increases the energy dissipation 
through the baffle, but this increase is compensated by the absence of energy dissipation 
through the AZ vein. Option 8, on the other hand, is associated with significantly higher 
power losses than Options 1 through 7. From the velocity and pressure fields displayed in 
Figure 9-26, a sudden flow acceleration can be noted in the azygous vein after the AZ 
and HepV flow have merged together. This flow acceleration is here again associated 
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with a sudden pressure drop and increased energy dissipation by wall friction, leading to 
a higher baseline energy dissipation than in the seven former options. The dependency on 
the global flow distribution is then similar to that of Option 1 through 7, reaching a 
minimum between GFDRPA=60% and 70%. Apart from this latter option, which yielded 
significantly higher energy dissipation than Options 1 through 7, power losses did not 
significantly discriminate between the different surgical options. 
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Figure 9-26: Velocity and pressure fields associated with Option 8 at the pre-operative 
GFD of 51/49 RPA/LPA. The anatomy is viewed from the posterior side to better 
visualize the flow acceleration and pressure drops in the AZ vein. 
 
 
9.2.3.5 Surgical Planning Summary 
A total of eight options were investigated for Patient A3, looking into the impact 
of the HepV offset (Options 1 through 6), the choice of baffle design (intra-atrial options 
2, 3 and 6 vs. extra-cardiac options 1, 4 and 5), and different combination of HepV and 
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AZ flows (Options 7 and 8). A particularity of Patient A3 stemmed from a higher hepatic 
flow rate compared to A1 and A2. As a result, HFD showed a lower sensitivity to HepV 
offset, especially when using an intra-atrial design. The intra-atrial baffles that connected 
directly opposite to the SVC and AZ anastomosis site (Options 2 and 3) lead to a close to 
ideal HFD. The extra-cardiac options, on the other hand, were more sensitive to HepV 
offset, as the interaction between the HepV and SVC flows resulted from a combination 
between the angle of incidence (governed by the extra-cardiac baffle curvature) and the 
connection site (governed by the HepV offset). Such sensitivity leaves little margin for 
error and as such extra-cardiac options were not recommended for Patient A3. Merging 
the AZ flow into the hepatic baffle (Option 7) did not appear as a satisfactory option 
either, as the azygous flow constrained the hepatic flow towards the right side of the 
baffle and into the RPA. The opposite approach, merging the HepV flow into the AZ 
(Option 8), lead to an increased mixing of the venous returns and achieved satisfactory 
HFD to both lungs. From an HFD stand-point both the intra-atrial options 2 and 3 and the 
HepV-to-AZ option 8 appeared as suitable candidates. However, while power losses did 
not discriminate between the first seven options, they were significantly higher in Option 
8 than in Options 2 and 3. Based on the above observations, the recommendation for 
Patient A3 was thus to perform an intra-atrial connection with no or minimal HepV offset 
as in Options 2 and 3. 
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9.2.4 Summary of the Single SVC Cases 
A few conclusions and trends can be derived from the three patient cases studied 
in this section. All three patients demonstrated a high sensitivity of the HFD to the offset 
between the HepV connection site and the Kawashima connection. For the two first 
patients, the sensitivity to HepV offset was such that the traditional intra-atrial or extra-
cardiac procedures did not appear as suitable surgical options. Due to the fact that the 
intra-atrial or extra-cardiac baffles only carried the hepatic blood flow (instead of the 
combined hepatic and lower limb venous returns in patients without an interrupted IVC), 
the velocities in the baffle were typically lower than in all the other inflows, resulting in a 
lower kinetic energy and an incapacity of the HepV flow to sustain the competition with 
the superior inflows. The optimal offset thus appeared to be governed by the superior 
inflows, their relative contributions to the total systemic venous return and their main 
flow directions. All of these considerations make it difficult to identify the best baffle 
design and anastomosis site, pointing to traditional extra-cardiac or intra-atrial 
connections as suboptimal approaches for patients with an interrupted IVC and a single 
SVC. Patient A3 presented a notable exception as the recommended option was to 
perform an intra-atrial connection. However, it should be pointed out that this patient 
featured a higher HepV flow rate than the other two, which allowed the HepV flow to 
better resist the superior inflows and reduced the sensitivity to offset. In such cases, the 
optimal solution was to minimize the HepV offset, so as to maximize the interaction and 
mixing between the different inflows. 
Optiflo options, which divide the hepatic flow into a left and right branch and 
seek to avoid the direct collision and competition with the superior inflows, could appear 
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as an attractive alternative. The key design parameter appeared to be design the graft such 
that the point where it would split into two branches would be aligned with the flow axis, 
effectively dividing the HepV flow into a left and right stream. This was difficult to 
ensure with an extra-cardiac graft (as for Patient A1) due to the baffle curvature which 
tended to favor hepatic flow to one branch over the other. An intra-atrial implementation 
as was suggested for Patient A2 appeared as more efficient, even though it may be more 
challenging to perform surgically. An added weakness of the Optiflo options is that they 
do not solve the problem of the low HepV energy, such that the HepV flow is still 
subjected to the influence of the superior inflows. In cases such as Patient A1, where the 
superior inflows have a strong preferential orientation to one lung (the left lung for 
Patient A1), the HepV flow might still be forced towards the contra-lateral branch of the 
graft (the right branch for Patient A1). As a result, even though using an Optiflo appeared 
as the optimal solution for Patient A2, these results may not be generalized to all patients.  
Increasing the energy of the blood flowing through the baffle (would it be an 
extra-cardiac, intra-atrial or Optiflo) by merging the AZ and HepV flows into the baffle 
was attempted for all patients. For Patients A1 and A2, such approach lead to significant 
improvements in HFD, but the HFD was still highly dependent on the HepV offset. In 
addition in some cases, such as Patient A3, the AZ flow effectively constrained the HepV 
to one side of the baffle, leading to suboptimal HFD performance. As such, merging the 
AZ flow into the HepV baffle does not appear as a general approach. Furthermore, for all 
three patients considered in this section, this option never stood out as the best approach. 
Re-routing the HepV flow into the azygous vein appeared as a well performing 
option from an HFD stand point for all three patients. This approach maximized the 
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mixing between all systemic venous returns, thus ensuring that the HFD closely followed 
the global flow distribution. However, this option was plagued by higher energy losses 
than all other alternatives. Accordingly, while merging the HepV flow into the AZ vein 
might be the best option by default, individualized surgical planning studies might help 
identify better performing alternatives. 
Finally, it is worth pinpointing that within each patient case, there was no notable 
difference in pressure drops and power losses among the surgical options, apart for the 
HepV-to-AZ option which systematically increased the pressure drops and energy 
dissipation rate across the AZ vein. The largest pressure drops were observed in the PAs 
and the power loss dependence upon GFD was governed by the relative RPA and LPA 
cross-sectional areas. Comparing across different patients, it might be noticed that the 
power losses for Patient A3 spanned a significantly higher range (between 5 and 40 mW) 
than for Patient A2 (between 1 and 6 mW). This stemmed from Patient A3’s smaller 
vessel dimensions but similar cardiac output, which translated into higher velocities and 
higher energy dissipation rate across all vessels. All of these results point to the vessel 
cross-sectional areas and the mass flow rates through each vessel as being the main 
predictors for energy dissipation, while other parameters such as the HepV offset or type 
of baffle used (intra-atrial vs. extra-cardiac) play a secondary role. The primary 
mechanism for energy dissipation in the TCPC is thus the viscous friction along the 
vessel walls, while the disturbances at the center of the connection (which will be 
impacted by the baffle design and offset) are only second order parameters. Accordingly, 
apart for the HepV-to-AZ options, power losses did not significantly discriminate 
between the different surgical options and HFD was the main optimization parameter. 
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9.3 Group B: Patients with a Persistent LSVC 
This section covers the surgical planning investigations that were carried for the 
three patients with a persistent LSVC. These patients differ from the former patient group 
in that the left and right superior venous returns reach the PAs in two different locations, 
leading to drastically different interactions between the different inflows. Results are 
organized in a similar fashion as for Group A. The clinical diagnosis and pre-operative 
anatomy are provided first, followed by a review of the associated flow structures. We 
then present the different surgical planning options and compare their relative 
performance in terms of hepatic flow distribution (expressed as HFDRPA) and energy 
efficiency (expressed as power losses). 
 
9.3.1 Patient B1 (CHOP M3) 
9.3.1.1 Pre-Operative Clinical Diagnosis and Data 
The first patient of the persistent LSVC group, Patient B1, was a female patient 
born with a heterotaxy syndrome, SVHD, coarctation of the aorta, persistent LSVC, and 
an interrupted IVC. She had undergone a staged TCPC procedure, but presented to the 
Children’s Hospital of Philadelphia (CHOP) at the age of 12 years with symptoms of 
increasing hypoxemia. Dye injection X-ray angiography revealed the formation of severe 
left lung PAVMs, responsible for the observed hypoxemia.  
Patient B1 featured number of pacer wires, which prevented regular MRI 
acquisition, so that CT images had to be used to reconstruct the in vivo TCPC geometry. 
The anatomical data was supplemented by cardiac catherization flow measurements in 
the aorta and LPA, which were used as a basis for the CFD boundary conditions. The pre-  
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Figure 9-27: On the left, Patient B1’s pre-operative TCPC anatomy is shown as a stand 
alone structure. On the right, the TCPC (in gray) is shown with the heart (in red) to better 
represent the spatial constraints faced by the surgeons. 
 
 
Table 9-6: Geometric and flow characteristics of Patient B1 at the time of PAVM 
diagnosis, and flow boundary conditions used for the CFD simulations. In vivo flow 
measurements were limited to the aortic cardiac output and LPA flow rate obtained from 
catheterization. QS and QP were taken to be equal to the measured cardiac output, while 
the inflow distributions (in %) were defined based on other patient data available at the 
time of the study, which were mostly limited to Patient A1. These extrapolated values are 
denoted in purple. QS: sum of the systemic inflows. QP: sum of the pulmonary outflows. 
 
 Cross-sectional Area (cm2) 
In Vivo Flow 
measurements CFD Flow Conditions 
Q 
(L/min) Q (%) Q (L/min) Q (%) 
Characteristic 
Velocity (cm/s) 
Systemic Venous Return 
HepV 3.67 n/a n/a 0.68 21% 3.10 
LSVC 1.94 n/a n/a 0.78 22% 6.70 
AZ 1.01 n/a n/a 0.71 24% 11.79 
SVC 1.46 n/a n/a 1.07 33% 12.24 
QS  3.25   3.25     
Pulmonary Flows  
LPA 2.68 2.34 n/a 2.34 72% 14.55 
RPA 3.55 n/a n/a 0.91 28% 4.28 
QP   n/a   3.25     
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operative anatomy at the time of diagnosis is shown in Figure 9-27. The right panel also 
displays the heart and great vessels to better represent the spatial constraints faced by the 
surgeon. The inlet and outlet cross-sections are listed in Table 9-6, together with the 
available in vivo flow measurements and the flow conditions used in the CFD 
simulations. 
The SVC and LSVC were connected to the PAs with a bidirectional Glenn in 
stage 2, followed by an extra-cardiac connection in stage 3 to route the hepatic flow to 
the pulmonary arteries. The extra-cardiac conduit was wrapped around the anterior side 
of the heart, reaching the PAs just opposite the SVC. The LSVC connected to the PAs on 
the left of the aortic arch. The segment of the pulmonary arteries that lies between the 
SVC and LSVC is referred to as the “mid-PA” in the remainder of this section. The over-
riding aortic arch was of especially large dimensions, limiting the access to the mid-PA 
segment and thus imposing a severe constraint for the surgical planning options to be 
designed. 
As mentioned above, in vivo flow measurements were for the most part 
unavailable for Patient B1, due to coils that prevented MRI flow acquisition. The pre-
operative flow conditions listed in Table 9-6 were derived from the available 
catheterization flow measurements and from the flow distributions observed in other 
patients. The pre-operative in vivo flow measurements included a cardiac output of 3.25 
L/min and an LPA flow rate of 2.34 L/min. The inflow boundary conditions for the CFD 
simulations were obtained by distributing the cardiac output to each one of the TCPC 
inlets according to the flow distribution measured for Patient A1. The RPA flow rate was 
obtained by subtracting QLPA to the cardiac output. The resultant flow distribution at the 
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outlet was of 28/72 RPA/LPA. Such unbalanced flow distribution is in accordance with 
the diagnosed left PAVMs, which reduce left lung resistance and thereby increase the 
total amount of flow going through the LPA. It is important to recall here that a large 
global flow distribution (GFD) to the LPA does not necessarily imply that a large portion 
of the hepatic flow goes to the LPA. On the opposite, the presence of left-sided PAVMs 
indicates that, in the pre-operative anatomy, the hepatic flow distribution (HFD) was 
most likely biased towards the RPA. 
9.3.1.2 Pre-operative Hemodynamics 
Prior to designing surgical planning options for Patient B1, it is important to 
understand the mechanisms that lead to the formation of left-sided PAVMs in the pre-
operative anatomy. The flow simulations were conducted using the flow conditions 
derived from the catheterization measurements. The corresponding flow structures, 
velocity and pressure fields are illustrated in Figure 9-28. The results are shown from the 
posterior view to better visualize the interaction between the SVC and HepV on the right 
side of the connection. The distribution of the different venous returns is best visualized 
from the left panel of Figure 9-28, where the 3D streamtraces are color-coded by their 
vessel of origination. Both LSVC and AZ streams (green and red streamtraces) are 
directed exclusively towards the LPA. It is important to note that those two streams 
combined already contribute 46% QS to the LPA. The SVC and HepV flows combined 
can thus only reach the LPA if that vessel receives more than 46% of the cardiac output. 
However, it might be noted that despite the fact 72% of the cardiac output goes to the 
LPA, almost none of the HepV streamtraces (orange) flow towards that vessel. This 
stems from the competition between the SVC and HepV flows on the right side of the  
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Figure 9-28: Hemodynamics in the Patient B1’s pre-operative anatomy. From left to 
right: Global flow structures shown using 3D streamtraces color-coded by their vessel of 
origin; the same 3D streamtraces color-coded by velocity magnitude; pressure field. The 
pressures are expressed relative to the mean pressure at the HepV inlet. Region A: the 
HepV flow detaches from the left side of the baffle. Region B: high pressures at the point 
where the SVC flow impinges on the vessel wall. 
 
 
connection. The SVC is connected with a slight angle towards the mid-PA, which favors 
SVC flow distribution to the LPA. In counterpart, velocities in the HepV are three to for 
times smaller than those in the SVC, leading to a lower kinetic energy, which poses a 
barrier to a proper mixing between the two streams and forces the HepV stream away 
from the SVC into the RPA. In addition, due to the curvature of the extra-cardiac graft, 
the HepV flow detaches halfway through the baffle (region A in Figure 9-28) and 
concentrates on the right side of the baffle. This flow detachment combined with the 
preferential distribution of the SVC towards the LPA yields most of the HepV to go 
towards the RPA. As a result, the pre-operative HFDRPA was computed to be of 85.3 % 
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vs. only 14.7% for HFDLPA. Such uni-lateral hepatic flow distribution towards the right 
PA is in good agreement with the diagnosed left-sided PAVMs and the decreasing 
oxygen saturation levels. 
The right panel of Figure 9-28 shows the pressure distribution in the pre-operative 
anatomy. A local pressure rise can be observed on the right side of the connection, 
directly opposite the SVC anastomosis, at the point where the SVC flow impinges on the 
pulmonary vessel wall (region B in Figure 9-28). The mean pressure difference between 
the HepV inlet and the RPA cross-section is -0.05 mmHg. However, this difference is 
negligible in front of the pressure drop recorded across the mid-PA segment. Due to its 
small dimensions, the mid-PA segment leads to a sudden flow acceleration, with 
velocities two to three times higher than in the rest of the connection (central panel). This 
sudden acceleration yields a sudden pressure drop, with the pressure field suddenly 
changing from red to blue. The mean pressure differential between the HepV and LPA 
cross-section is -0.39 mmHg, i.e. about eight times that between the HepV and RPA. The 
mid-PA segment thus represents the highest source of energy dissipation in the pre-
operative anatomy.  
In summary, the analysis of the pre-operative hemodynamics points to the 
curvature of the hepatic baffle, its position relative to the SVC as the two most 
detrimental features from an HFD point of view. Additional detrimental factors include 
the low HepV velocities and the fact that the AZ and LSVC combined already account 
for 46% QS. Finally, the narrow mid-PA segment stands as the major source of energy 
dissipation.  
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9.3.1.3 Surgical Planning Options 
Based on the knowledge gained from the pre-operative analysis, nine surgical 
planning options were designed (Figure 9-29) that seek to re-equilibrate HFD to the left 
and right lungs, and if possible to reduce the dissipation through the mid-PA segment. 
The approaches retained include 1) shifting the HepV connection site away from the 
SVC, 2) using surgical approaches other then a posterior extra-cardiac to reduce the 
baffle curvature, 3) combining the AZ and HepV flows, and 4) splitting the HepV 
between the LPA and RPA.  
Options 1 through 5 vary the surgical procedure used (intra-atrial vs. extra-
cardiac) and the HepV anastomosis site, shifting it away from the SVC. Options 1 and 2 
reach the mid-PA segment using an extra-cardiac baffle routed along the anterior side of 
the heart as in the pre-operative anatomy. Option 1 connects to the mid-PA slightly closer 
to the SVC anastomosis than Option 2. Due to the presence of the atrium and pulmonary 
veins, reaching the mid-PA segment with either of these two options requires a high 
degree of curvature, as is best evidence from the top view of these two options. Option 3 
connects approximately at the same location as Option 2 but using an extra-cardiac 
conduit routed along the posterior side of the heart. The posterior design might pose some 
difficulties for its surgical implementation, but is still investigated as it circumvents the 
difficulties posed by the aortic arch and avoids having a large curvature in the baffle just 
before the anastomosis. Along the same lines, Options 4 and 5 make use of an intra-atrial 
approach, which allows for a direct access to the mid-PA with minimum vessel curvature. 
Option 4 connects the HepV to the center of the mid-PA, while Option 5 connects 
slightly further toward the LSVC. 
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Figure 9-29: Surgical planning options implemented for Patient B1. The pre-operative anatomy is provided as a reference. All 
geometries are view from the anterior side. A top view is provided for Options 1 through 4 to highlight the differences in the curvature 
and angle of incidence of the different hepatic baffles. 
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Options 6 through 8 seek to address the difficulties posed by the low velocities in 
the hepatic baffle by merging the azygous and hepatic flows. In Option 6, it is the hepatic 
flow that is directed towards the azygous vein. This is achieved by adding a shunt 
between the hepatic and azygous veins and ligating the HepV baffle. Attention was paid 
to avoid the descending aorta during design of the HepV-to-AZ shunt. Options 7 and 8 
use a similar shunt, but the objective in these options is to direct the azygous flow into the 
hepatic baffle. The hepatic baffle is thus left open and the azygous vein is ligated just 
downstream of the shunt. The two options differ in the graft used to route the combined 
AZ and HepV flows to the pulmonary arteries. Option 7 makes use of the existing extra-
cardiac baffle whereas Option 8 uses a more central extra-cardiac baffle (identical to the 
one used for Option 1). Finally, Option 9 splits the hepatic flow between the pre-
operative extra-cardiac baffle and the azygous vein. This option makes use of the same 
shunt as the Options 6 through 8, but neither the HepV nor the azygous vein are ligated, 
allowing the hepatic and azygous blood to freely take one path or the other. 
 
9.3.1.4 HFD Performance  
The performance of the nine surgical planning options is assessed through series 
of numerical simulations using the same inflow conditions as for the pre-operative 
hemodynamics. In order to predict the behavior in the acute post-operative stage, all 
options are first tested under the pre-operative outflow conditions, i.e. when the global 
flow distribution is 28/72 RPA/LPA. The outflow conditions are then varied so as to best 
predict the point at which an equal HFD to both lungs would be achieved. The hepatic 
flow distributions associated with the nine surgical planning options are displayed in 
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Figure 9-30 for all tested conditions. For better readability, the results are split in two 
graphs. The left panel shows the results obtained for Options 1 through 5, while the right 
panel displays the results obtained for Options 6 through 9. The pre-operative operating 
point (dark blue symbol in the upper left quadrant of the graphs) is showed in both graphs 
as a reference.  
Options 1 to 4: Focusing on the left panel, it can be noticed that Options 1 through 4 
show very similar trends, following a close to linear behavior between the point where 
HFDRPA rises from 0% and the point where it reaches 100%. Upon investigation of the 
associated flow structures, all four options demonstrated similar dynamics and inflow 
interactions. Figure 9-31 shows the evolution of the global flow structures associated 
with Option 4 as a typical example of what was observed. In that option, the AZ and 
LSVC streams (in red and green, respectively) go almost exclusively to the LPA, while 
the SVC (in blue) goes the RPA. The hepatic blood distribution is seen to closely depend 
on the flow split, adjusting its contribution to the left and right lung to match the global 
flow distribution. At a GFD of 28/72 RPA/LPA, the HepV streamtraces (orange) are 
solely directed to the LPA. They progressively switch towards the RPA as the amount of 
flow going to that vessel increases, and exclusively directed to the RPA when GFDRPA 
reaches 50%. Looking more precisely at the HFDRPA values shown in Figure 9-30 for 
Option 4 (yellow circles), it may be noticed that the HFDRPA measurements start rising at 
a GFDRPA close to 30%. This value is in close match to the SVC flow rate of 33% QS. 
This means that Option 4 only demonstrates a minimal amount of mixing between the 
SVC and hepatic flow, and that the hepatic flow only goes towards the RPA when the 
SVC does not suffice to match the desired RPA flow rate. On the other side of the 
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Figure 9-30: Hepatic flow distribution in the nine surgical planning options tested for Patient B1. The pre-operative HFD is provided 
as a reference.  
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Figure 9-31: Global flow structures observed in Option 4 for a global flow distribution 
varying between the pre-operative flow split of 28/72 RPA/LPA and 50/50 RPA/LPA. 
This option is shown as a representative example of what was observed in Options 1 
through 4. 
 
 
spectrum, HFDRPA for Option 4 reaches 100% at GFDRPA=50%. This point is in close 
match to the sum of the SVC and HepV flows, which is 54% QS, meaning that the AZ 
and LSVC streams only start to contribute to the RPA flow once the SVC and HepV 
alone do not suffice to match that demand. This in turn reflects the absence of mixing 
between the hepatic flow and the left venous returns (AZ and LSVC). Based on a linear 
regression, Option 4 is expected to distribute hepatic flow equally to both lungs for 
GFDRPA = 42%. This is a drastic improvement compared to the performance of the pre-
operative anatomy. The only concern could be that the RPA/LPA flow distributions 
where both lungs receive at least some amount of hepatic flow is limited to a narrow 
range between GFDRPA=30% and 50%.  
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Option 5: The HFDRPA measurements for Option 5 (orange circles in Figure 9-30) 
drastically deviate from those of Option 1 through 4, falling below the HFDRPA=50% line 
for all tested conditions. This demonstrates a preferential HFD to the right lung. The HFD 
curve for that option appears to rise at a GFDRPA=29% as was the case for Options 1 
through 4, but to grow at a slower rate. Looking at the evolution of the global flow 
structures (Figure 9-32) provides a better understanding of the slower growth rate. The 
AZ, LSVC and HepV flows mix thoroughly prior to dividing between the LPA and RPA. 
For every percent increase in its flow rate, the RPA flow rate receives a combined 
contribution from the AZ, LSVC and HepV. This explains the slower growth rate, which 
could be advantageous as it will spread the range of flow conditions over which this 
option will provide hepatic flow to both lungs. On the other hand, this results in an HFD 
that is highly biased towards the right lung. By extrapolating the measurement curve, 
Option 5 is expected to yield an even hepatic flow distribution around GFDRPA=66%, 
which appears too far from the ideal 50% value. 
To summarize the knowledge gained on the “offset variations”, all options 
connected to the mid-PA (Option 1 through 4) resulted in very similar HFD.  Reaching 
too far to the left as in Option 5 favored HFD to the LPA. These results combined 
demonstrate that the exact position of the anastomosis site on the mid-PA or the degree of 
curvature has only little impact on HFD. The only parameter of importance is to ensure 
that the HepV anstomosis is offset away from both the SVC and the LSVC. In addition, 
HFDRPA for the first five options followed a linear behavior which appeared to be 
dictated by simple mass balance considerations. 
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Figure 9-32: Global flow structures observed in Option 5 for a global flow distribution 
varying between the pre-operative flow split of 28/72 RPA/LPA and 60/40 RPA/LPA. 
 
 
The HFD results for the second set of options, combining AZ and HepV flows 
(Options 6 through 9), are shown in the right panel of Figure 9-30.  
Option 6: The HFDRPA results for Option 6 (red diamonds in Figure 9-30) fall below 
those reported for Option 5, indicating a higher bias of the HFD towards the LPA than in 
the former option. The mechanism behind this biased flow distribution is best understood 
by looking at the flow structures shown in Figure 9-33 for GFDRPA =50%. Merging of the 
HepV to the AZ veins results in a helical pattern in the AZ, with red and orange 
streamtraces intertwined. When both flows reach the left connection site, the orange 
HepV streamtraces are clustered along the left aspect of the AZ vein, while the red AZ 
streamtraces flow along the right side of the vessel. Both AZ and HepV streams split 
between the LPA and RPA to adjust for the desired GFD, but due to their spatial 
repartition within the vessel, it is mostly the red AZ streamtraces that are directed to the 
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RPA, while the HepV flow goes to the LPA. Option 6 thus appears to be equivalent, from 
an HFD standpoint, to placing the HepV between the AZ and LSVC, the LSVC being on 
its right and the AZ on its left. It can thus be expected that as long as the sum of the SVC 
and LSVC flows suffices to match QRPA, all of the HepV flow will go to the LPA, and 
that the hepatic flow will only split towards the RPA when QRPA > QSVC+QLSVC, which is 
57% QS. This observation is in accordance with the trend followed by the HFDRPA 
measurements for Option 6, which only start to rise when more than 50% of the flow 
goes to the RPA. Extrapolating the existing points, it might be predicted that Option 6 
would require a global flow distribution of 67/33 RPA/LPA to achieve an HFDRPA=50%. 
If Option 6 performs better than the pre-operative anatomy, it still has too large of a bias 
in HFD to be recommended for surgery. 
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Figure 9-33: Flow structures and HFD for the four the four options combining azygous 
and hepatic flows (Options 6 through 9) at a GFDRPA of 50%. This flow condition was 
chosen as representative of the relative performance of Options 6 through 9. 
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Option 7: Option 7 uses the same baffle design as the pre-operative anatomy, but has the 
combined AZ and HepV blood flowing through it. As can be observed from Figure 9-33, 
this leads to an intense mixing between the SVC, AZ and HepV streamtraces in the right 
connection site. Due to the mixing observed within the right connection, each percent 
increase in RPA flow is provided by the AZ, HepV and SVC flows in combination, 
reducing the relative contribution of the HepV. As a result, the HFDRPA measurements for 
Option 7 rise at a lower rate than what was observed in Options 1 through 4 or in Option 
6. Merging the AZ flow into the pre-operative baffle thus had the two following 
advantages: 1) by increasing the momentum of the flow through the extra-cardiac baffle, 
it increases mixing at the center of the connection, and 2) by leading to a complete 
mixing of the AZ, HepV and SVC inflows, it reduces the sensitivity of the HFD to the 
global flow distribution. However, due to the right-sided position of the pre-operative 
extra-cardiac baffle, Option 7 favors HFD to the RPA, with its measurement points 
falling above the ideal HFDRPA=GFDRPA line. 
Option 8: Option 8 uses a similar approach but directs the combined AZ and HepV flows 
towards the mid-PA segment via the same extra-cardiac baffle as in Option 1. The 
corresponding flow structures are displayed in Figure 9-33. The SVC and LSVC flows 
are exclusively distributed to the closest PA, while the AZ and HepV flows split between 
the LPA and RPA to match the desired GFD. Accordingly, the HFDRPA measurements for 
Option 8 (orange triangle in Figure 9-30) remain at 0% until GFDRPA exceeds 30%, 
which corresponds to the contribution of the SVC. HFDRPA then increases with GFDRPA, 
as the amount of flow to the RPA exceeds what can be provided by the SVC alone. This 
behavior is similar to what was observed in Options 1 through 4. However, the HFDRPA 
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growth rate is slower for Option 8 than in the four former options, since both AZ and 
HepV flows contribute equally to increase the RPA flow. Extrapolating the 
measurements, Option 8 might be predicted to yield an HFDRPA of 50% at a GFD of 
56/44 RPA/LPA. To provide a ground of comparison, the extra-cardiac Option 4 yielded 
an HFDRPA of 50% at a GFD of 42/58 RPA/LPA. Both types of options thus appear to 
yield similar performance. However, the lower growth rate of Option 8 compared to 
Option 4, for which HepV and AZ were not combined, should ensure a liberty from 
PAVMs over a broader range of GFDRPA. As an example, Option 8 ensures that both 
lungs receive a minimum of 40% of the hepatic nutrients ( [ ]%60%,40∈RPAHFD ) for a 
GFDRPA varying between 51.0% and 60.0%, while this range is reduced to 
[ ]%6.45%,3.41∈RPAGFD  for Options 1 through 4. 
Option 9: Option 9 is the last option that was investigated for Patient B1. It combines the 
pre-operative extra-cardiac graft, which was shown to favor HFD to the RPA, and the 
HepV-to-AZ shunt of Option 6, which was shown to favor HFD to the LPA. The 
resulting HFDRPA are shown by the light blue H symbols in Figure 9-30. HFDRPA was of 
58.7% under the pre-operative flow conditions (GFDRPA=28%), which was a drastic 
improvement compared to HFDRPA=85.3% measured in the pre-operative anatomy. 
However, these values rapidly increased and, despite an improvement compared to the 
pre-operative anatomy, Option 9 was still seen to highly favor HFD to the RPA (with 
measurement points far above the centerline). The reason for the inefficient splitting of 
the hepatic flow between the shunt on the left and the extra-cardiac baffle on the right is 
best visualized in Figure 9-33. The HepV-to-AZ shunt departs from the HepV axis with a 
close to 90 degree angle. As a result, a large flow separation region forms at the entrance 
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of the shunt. Only a small portion of the flow impinges on the shunt wall and diverts 
away from the extra-cardiac baffle towards the HepV-to-AZ. The decrease in RPA 
pressure when GFDRPA increases further only worsens the phenomenon, making the 
HepV path through the extra-cardiac baffle more favorable, and shifting all hepatic blood 
away from the shunt. When GFDRPA reaches 60%, all of the hepatic flow goes through 
the extra-cardiac baffle, and the shunt actually carries a small portion of the AZ flow 
towards the RPA.  
9.3.1.5 Energetic Performance and Power Loss Measurements 
Beyond HFD another parameter of interest is the amount of energy dissipated 
through the connection. The power losses associated with the nine surgical planning 
options is shown in Figure 9-34. For clarity, the results are separated into three different 
graphs grouping the options based on their HFD behavior: (i) the options that were 
connected to the mid-PA segment and left the azygous flow track untouched (Option 1 
through 4); (ii) the options that favored HFD to LPA (Options 5 and 6); and finally (iii) 
all remaining options (Options 7, 8, and 9).  All graphs also display the pre-operative 
performance as a reference, and use the same scale for ease of comparison.  
Option 1 to 4: In Figure 9-34(a) the power losses measured for the first four options 
almost overlap and only cover a narrow range, going from 0.76mW to 1.16mW. These 
options appear to reach a minimum power loss around 40-45% GFDRPA, which 
corresponds to the point where the hepatic flow is equally distributed to the LPA and 
RPA.  
Option 5: Figure 9-34(b) shows that, at GFDRPA=30% and 50%, the power losses 
measured for Option 5 fall within 6% of those measured for Option 4, demonstrating that  
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Figure 9-34: Power Loss measured across the pre-operative anatomy and surgical 
planning options for all tested GFD conditions. The surgical planning options are 
separated in three groups based on the trends observed in the power losses. The pre-
operative power loss is provided in all graphs as a reference point.  
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the HepV offset only had little impact on the energy dissipation in the 30% to 50% range. 
However, as GFDRPA increases to 60%, the power losses for Option 5 suddenly increase 
to 1.7mW. This change in power loss behavior in Option 5 is due to the left-sided offset 
of the HepV. As was pointed out during the pre-operative hemodynamic analysis, the 
mid-PA is a major source of energy dissipation. Due to the left-sided offset of Option 5 
(and Option 6), more flow has to travel through the mid-PA segment at a given GFDRPA 
than in Options 1 through 4, and this flow has to travel through the entire segment vs. 
only half of it in Options 1 through 4. Both of these mechanisms lead to a sudden rise in 
power losses as GFDRPA increases beyond 50%.  
Option 6: The power losses computed for Option 6 show a dependency on GFDRPA 
similar to Option 5, increasing quickly as GFDRPA increases beyond 50%. This behavior 
is consistent with the fact that both surgical options result in a similar distribution of the 
inflows, with the LSVC, AZ and HepV flows merging on the left side and only the SVC 
on the right side (see streamtraces shown in Figure 9-33). It is also noteworthy that the 
power losses in Option 6 fall consistently 1 to 1.5mW above those of Option 5. 
Combining the azygous and hepatic streams into the azygous vein leads to elevated 
friction losses against the AZ vessel walls, increasing the overall level of energy 
dissipation in the connection. 
Option 7: The power losses for Option 7 (Figure 9-34(c)) follow a trend opposite to that  
observed for Options 5 and 6, drastically decreasing as GFDRPA increases. This inversion 
in power loss trends stems form the fact that Option 7 results in a distribution of the 
inflows that is opposite to that of Options 5 and 6, with a vast majority of the blood flow 
(SVC, AZ and HepV) entering through the right side of the connection, and only the 
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LSVC flow entering through the left. Accordingly, in Option 7, power losses are 
minimum when a majority of the flow exits through the RPA, minimizing the flow rate 
through the mid-PA segment. They increase quickly as GFDRPA decreases and flow 
through the mid-PA segment increases.  
Option 8: Option 8, shown in Figure 9-34(c), follows a flatter profile than Options 5,6 
and 7, indicating a lower dependency of the power losses upon GFDRPA. This might be 
attributed to the fact that, similarly to Options 1-4, the baffle is connected to the mid-PA 
segment. However, since Option 8 routes both AZ and HepV streams through the baffle, 
the energy dissipated by friction in the baffle is higher than in Options 1-4, and 
consequently, the power loss levels are also higher than in Options 1-4. Power losses for 
Option 8 appear to tend towards a minimum around GFDRPA=50%, which corresponds 
the point where the combined AZ and HepV flows are almost equally distributed to the 
LPA and RPA. 
Option 9: Finally Option 9 is the option that leads to the lowest power losses overall. 
Losses under the pre-operative flow conditions (GFDRPA=28%) are of the same order as 
in the pre-operative anatomy and Options 1-5, but they keep decreasing beyond 
GFDRPA=50%. This might be attributed to the fact that, when flow to the RPA increases 
beyond the contribution of the SVC and HepV flows combined, part of the azygous flow 
reaches the RPA through the Hep-to-AZ shunt and extra-cardiac baffle rather than by 
flowing across the mid-PA section. This bypass reduces the flow rate through the narrow 
mid-PA section, and thereby the amount of energy dissipated by friction in that section. 
As GFDRPA increases power losses for Option 9 tend towards the same value as Option 7, 
for which all of the azygous flow is forced through the extra-cardiac baffle.  
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9.3.1.6 Summary 
A total of nine options were investigated for Patient B1, looking into the impact 
of the HepV offset (Options 1 through 5), the baffle curvature (Options 1 through 4), and 
different combination of HepV and AZ flows (Options 6 through 9). Among the options 
that left the AZ unaltered (Options 1 through 5), HepV offset was observed to be the 
strongest determinant for HFD. The best performance was obtained when connecting the 
hepatic baffle to the mid-PA segment (Option 1-4). When the hepatic baffle was 
connected to the mid-PA, the HFD was more or less insensitive to the baffle curvature as 
well as to the exact HepV connection point along the mid-PA section.  
Merging AZ and HepV flows into the azygous vein (Option 6) was equivalent to a 
left-sided offset, and thus not recommended from an HFD point of view since it resulted 
in the HepV flow totally bypassing the RPA, and only going to the LPA. Such option is 
thus expected to heal the left-sided PAVMs, but yield right-sided PAVMs in the long 
term. Option 9, which sought to split the hepatic flow between the pre-operative baffle 
and the azygous vein, was not recommended either as it effectively resulted in a biased 
HFD to RPA distribution. Using the same shunt but ligating the azygous vein to merge 
the AZ and HepV flows into the hepatic baffle (Options 7 and 8) provided promising 
results. Combining the AZ and HepV flows reduced the sensitivity of the HFD to the 
baffle offset and widened the range of LPA/RPA flow splits that could be achieved while 
still maintaining a proper supply in hepatic nutrients to both lungs. The optimal HFD 
results were obtained with Option 8 where the combined AZ and HepV flows were 
directed to the mid-PA segment. 
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The power losses were observed to be relatively insensitive to the design of the 
hepatic baffle, and mostly dictated by the laminar friction along the different vessels. Due 
to the small dimensions of the mid-PA segment, power losses in Options 5, 6 and 7 
showed a very strong dependency on the global flow distribution. Connecting the baffle 
to the mid-PA segment appeared to be an efficient strategy to reduce power loss levels. 
An alternate solution might be to dilate the mid-PA segment using a stent, thus reducing 
the friction losses in that region. Finally, Options 6 through 8 came at a slightly higher 
energy cost than Options 1-4 due to the HepV and AZ flow combination into a single 
vessel, but these power loss values remained low so that this added cost in Option 8 was 
discarded in view of the better HFD performance. 
Based on the above observations, it was recommended to either modify the extra-
cardiac connection to reach the mid-PA segment or to shunt the azygous flow towards the 
hepatic baffle, or if time allowed to perform both of the above. 
 
- 337 -  
9.3.2 Patient B2 (CHOP M7) 
9.3.2.1 Pre-Operative Clinical Data and Diagnosis 
Patient B2 was an 11 year-old male born with a single ventricle, a heterotaxy 
syndrome with dextrocardia, an interrupted IVC and a persistent LSVC. This patient had 
undergone a Kawashima operation followed by an extra-cardiac connection of the hepatic 
veins to the pulmonary arteries. The patient reportedly had right PAVMs. 
The patient anatomy at the time of diagnosis is shown in Figure 9-35, with and 
without the surrounding cardiovascular structures. Since the patient had dextrocardia the 
apex of the heart is pointed towards the right. The Kawashima connection was performed 
on the right hand side, merging AZ and SVC flows. The extra-cardiac baffle was 
wrapped around the left side of the heart and connected opposite to the LSVC. Both the 
SVC and LSVC were angled towards the mid-PA segment.  
Table 9-7 summarizes the characteristic dimensions and flow rates of each one of 
the inflows and outflows. The LSVC was notably smaller than the other vessels with a 
cross-sectional area of only 0.57 cm2, compared to 2.75 cm2 for the hepatic baffle. The 
LPA was the smaller of the two PAs with a cross-sectional area of 0.98 cm2 vs. 1.78 cm2 
for the RPA. The clinical report also mentions the presence of a kink or narrowing further 
downstream in the RPA.  
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Figure 9-35: Pre-operative anatomy for Patient B2. Left: TCPC geometry, with arrows 
indicating the main flow direction at each inflow and outflow. Right: TCPC geometry (in 
blue) and surrounding cardiovascular structures (in red).  
 
 
Table 9-7: Geometric and flow characteristics of Patient B2 at the time of PAVM 
diagnosis, and flow boundary conditions used for the CFD simulations. QS: sum of the 
systemic inflows. QP: sum of the pulmonary outflows. 
 
 
Cross-
sectional 
Area (cm2) 
MRI Flow 
measurements CFD Flow Conditions 
Q (L/min) Q (%) Q (L/min) Q (%) Characteristic Velocity (cm/s) 
Systemic Venous Return 
HepV 2.76 0.41 10% 0.41 10% 2.49 
LSVC 0.57 0.77 19% 0.77 19% 22.47 
AZ 1.81 1.20 31% 1.20 31% 11.05 
SVC 1.16 1.57 41% 1.57 40% 22.53 
QS  3.95   3.95     
Pulmonary Flows  
LPA 1.78 2.30 65% 2.57 65% 24.08 
RPA 0.98 1.23 35% 1.38 35% 23.35 
QP   3.54   3.95     
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9.3.2.2 Pre-Operative Hemodynamics 
MRI assessment of the pre-operative flow rates revealed two notable features: 
first, the HepV only accounted for 10% of the systemic venous return, which is about half 
of what was noted in the other patients; then, the pre-operative GFDRPA was of only 35% 
despite the presence of right PAVMs. This low flow distribution to the RPA might be 
attributed to the kink noted downstream, which increases the resistance of the right 
pulmonary pathway. The first question that arises is whether dilating the distal RPA 
stenosis, and thereby increasing GFDRPA, would suffice to increase HFDRPA to normal 
levels. The hemodynamics of the pre-operative anatomy where thus assessed for global 
flow distributions varying from 40/60 RPA/LPA up to 60/40 RPA/LPA. 
Figure 9-36 displays the global flow structures and HFD observed in the pre-
operative anatomy for GFDRPA=40% to 60%. The flow structures are displayed as 3D 
streamtraces color-coded by their vessel of origination. For all tested conditions, HepV 
(orange) and LSVC (green) flows are directed to the LPA, maintaining HFDRPA at 0%. 
This uni-sided distribution of the HepV and LSVC flows even at GFDRPA=60% stems 
from the fact that the AZ and SVC flows combined account for 70% QS. Thus, unless 
GFDRPA exceeds 70%, the AZ and SVC suffice to provide all the blood needed in the 
RPA. The AZ flow, which enters the connection the furthest to the right, is almost 
exclusively directed to the RPA. For the tested range of GFDRPA, it is the SVC that splits 
between the LPA and RPA to match the desired GFD.  
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Figure 9-36: Flow structures and HFD in the pre-operative anatomy of Patient B2, for 
GFDRPA ranging from 40% to 60%.  
 
 
9.3.2.3 Surgical Planning Option 
Seven surgical planning options were envisioned and tested for Patient B2. The 
corresponding geometries are displayed in Figure 9-37. Based on the knowledge gained 
from Patient B1, it can be predicted that an equal distribution of the hepatic flow to the 
left and right lung (HFDRPA=50%) would correspond to a GFDRPA of 5% if the HepV was 
connected to the right of the AZ, 75% if it was connected between the SVC and LSVC, 
and 95% if it was connected to the left of the LSVC. None of these conditions appear as 
being acceptable. On the other hand, complete mixing of the SVC and HepV inflows 
could yield to an HFDRPA of 50% at GFDRPA=55.5%, which would be an ideal 
configuration. Accordingly, Option 1 is the only option that varies the HepV offset,  
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Figure 9-37: Geometries of the seven surgical planning options attempted for Patient B2. 
The pre-operative anatomy is shown as well for comparison. 
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setting the baffle right opposite the SVC in an effort to increase mixing. The pre-
operative extra-cardiac baffle is taken down and replaced by an intra-atrial approach to 
reach far enough towards the SVC. 
Options 2 and 3 try to prevent all competitive mixing between the HepV and the 
superior inflows using Y-shaped Optiflo baffles. In order for the right branch of the Y to 
reach far enough towards the SVC, both options require an intra-atrial approach. Option 2 
makes use of the same intra-atrial baffle as Option 1, with the addition of an HepV-to-
LPA branch. Option 3 reaches further towards the RPA and LPA. 
Since the HepV flow only accounts for 10.4%QS it can be anticipated that even if 
one of the above options succeeds to achieve a balanced HFD for a GFDRPA close to 
50%, the operative range for that option will remain very narrow. Options 4 through 7 
thus combine the AZ and HepV flows in an effort to both improve mixing and widen the 
operative range. In Option 4, the hepatic flow is routed to the azygous vein using a 
HepV-to-AZ shunt. The hepatic baffle is ligated and removed from the computational 
domain. Option 5 makes use of the same HepV-to-AZ shunt, but the HepV baffle is left 
open, allowing the HepV flow to split between the extra-cardiac graft and the azygous 
vein. Finally, in Options 6 and 7, it is the AZ flow that is routed to the hepatic baffle via 
an AZ-to-HepV shunt. The azygous vein is ligated and removed from the computational 
domain. In Option 6 the combined AZ and HepV flows are routed through the pre-
operative extra-cardiac baffle, while Option 7 makes use of the Optiflo baffle designed 
for Option 3. 
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9.3.2.4 HFD Performance 
Figure 9-38 displays the HFDRPA associated with the seven surgical planning 
options envisioned for Patient B2. The HFDRPA performance of the pre-operative 
anatomy is shown as well as a reference. For ease of understanding, the results are spread 
over two graphs. The left panel displays the HFDRPA measurements obtained for Options 
1 through 3, while the right panel shows the results associated with Options 4 through 7. 
Global considerations for Options 1 through 3: As can be seen from the left panel of 
Figure 9-38, Option 1, where the HepV was shifted towards the center of the connection, 
and Option 2, where the HepV was split using an Optiflo graft, do not yield any 
significant improvement compared to the pre-operative anatomy. Even when 70% of the 
systemic venous return is directed to the RPA (GFDRPA = 70%), HFDRPA remains close to 
0% in Option 1 and 13% in Option 2. Option 3, which uses an Optiflo as in Option 2 but 
reaching further to the RPA and LPA, yields a better performance. At GFDRPA=50%, the 
hepatic flow distribution is close to ideal with an HFDRPA of 45.7%. However, this only 
corresponds to a local maximum and HFDRPA for Option 3 falls back to 22.7% at 
GFDRPA=70%. The presence of local maxima in the HFDRPA measurements of Options 1 
and 3 is one of the most notable features of the results obtained for Patient B2. To better 
elucidate the reason for this non-monotonous behavior, Figure 9-39 displays the flow 
structures associated with these three first options across all tested flow conditions.  
Option 1: Focusing on Option 1 (top row in Figure 9-39), it can be noticed that the flow 
patterns of AZ (in red) and LSVC (in green) streams do not evolve significantly between 
GFDRPA=40% and 60%. Both streams are exclusively distributed to the closest 
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Figure 9-38: Hepatic flow distribution measured in the seven surgical planning options implemented for Patient B2. The dotted central 
diagonal serves as a reference, indicating the ideal scenario where HFDRPA = GFDRPA.  
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Figure 9-39: Flow structures observed in Options 1, 2 and 3 for Patient B2. The 
associated HFDRPA are provided below each flow field in green. 
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pulmonary artery, the LSVC flowing to the LPA and the AZ to the RSVC. On the other 
hand, significant changes can be noticed in the interaction between the SVC and HepV 
flows. At GFDRPA=40%, a large proportion of the SVC flow is directed towards the LPA 
to match the desired GFD. The SVC and HepV streams thus directly face one another. 
This feature was intended and meant to increase the mixing between the two streams. 
However, the low HepV flow rate and large HepV diameter result in a low kinetic energy 
for that inflow. The HepV is unable to sustain the momentum of the SVC, resulting in a 
high penetration of the SVC into the hepatic baffle. Most of the SVC flow entering the 
hepatic baffle exits towards the LPA, forcing a larger proportion of the HepV towards the 
RPA. This corresponds to the local maximum of 10.3% observed in the HFDRPA curve of 
Option 1 for GFDRPA=40%. As GFDRPA increases to 50%, part of the SVC flow turns 
towards the RPA within the connection itself. This results in a lower penetration of the 
SVC into the HepV baffle, but also creates a large recirculation region within the 
connection that prevents the HepV from reaching the RPA. This blockage results in an 
exclusive distribution of the hepatic flow to the LPA, and thus to an HFDRPA of 0%. It is 
interesting to note that at GFDRPA=70%, part of the LSVC stream actually flows in a 
direction opposite to that of the HepV, crossing the mid-PA segment towards the RPA. 
This is due to the angulated orientation of the LSVC towards the mid-PA. 
Option 2: The interaction between the four different inflows in Option 2 (middle row in 
Figure 9-39) follows a similar dynamics as in Option 1. The HepV distribution is strongly 
dominated by the SVC flow. A major difference compared to Option 1 is the presence of 
the left branch of the Optiflo, which allows the HepV flow to reach to the LPA. As a 
result, when GFDRPA is below or equal to 50% and the SVC penetrates into the HepV 
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baffle, most of the HepV flow exits via the left branch rather than mixing with the SVC. 
This explains why, despite the fact that Options 1 and 2 featured the same intra-atrial 
baffle, no local maximum was observed at GFDRPA=40% in Option 2. Another distinctive 
feature of Option 2 compared to Option 1, is that at GFDRPA values of 60% or more, the 
LSVC flow gets entrapped into the left branch of the Optiflo. This prevents the LSVC 
from competing with the HepV to go towards the RPA. As a result, HFDRPA continuously 
increases with increasing GFDRPA. 
Option 3: Option 3 (bottom row in Figure 9-39) differs from Option 2 in that the two 
branches of the Optiflo reach further towards the RPA and LPA. The right branch is not 
exactly aligned with the SVC axis, but rather slightly shifted to the right. As a result at 
the lower GFDRPA values, the SVC flow does not penetrate into the baffle, allowing the 
HepV flow to reach for the RPA when GFDRPA=40% and 50%. However, when GFDRPA 
increases beyond 50%, the large portion of the SVC flow that turns towards the RPA 
opposes a high resistance to the HepV flow and restricts its access to the RPA. Further-
more, as the left branch lies further to the left than in Option 2, the LSVC flow does not 
get entrapped at GFDRPA=60 and 70%. Accordingly when GFDRPA increases beyond 
50%, the competition between the SVC, LSVC and HepV flows pushes the lowest energy 
stream, i.e. the HepV, towards the LPA, leading to a temporary decrease in HFDRPA. 
Based on the above observations, it is apparent that the low HepV flow rate in 
Patient B2 represents an obstacle to a proper hepatic flow distribution to the left and right 
lung. Combining the HepV and AZ flows to try and improve the momentum of the 
combined stream and thereby improve mixing might provide a solution to that problem. 
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The right panel of Figure 9-38 displays the HFDRPA curves obtained for the four different 
combinations of the HepV and AZ streams tested in Options 4 through 7.  
Option 4: In Option 4, where the HepV is directed to the AZ vein, HFDRPA (blue 
diamonds in Figure 9-38) is of 100% even at GFDRPA=40%, demonstrating a highly 
preferential HFD to RPA. The mechanism behind such uni-sided flow distribution can be 
better visualized from Figure 9-40, which displays the 3D flow structures associated with 
Option 4 through 7 at a GFDRPA=50%. In Option 4, the combined AZ and HepV streams 
(in red and orange, respectively) enter the connection on the far right and flow 
exclusively to the RPA. Since, the AZ is the vessel that lies the furthest to the right, 
merging the HepV stream into the AZ vein is the equivalent of a right-sided HepV offset.  
Option 5: In Option 5, where the AZ flow is merged into the pre-operative extra-cardiac 
graft, the HFDRPA measurements (light red triangles in Figure 9-38) demonstrate a clear 
improvement compared to the pre-operative anatomy. As can be observed from Figure 
9-40, combining the HepV and AZ streams allows the flow coming through the extra-
cardiac baffle to compete with the LSVC, resulting in a better distribution of the 
combined HepV and AZ streams to the two lungs. However, this option still results in a 
highly preferential HFD to the LPA due the left-sided offset of the pre-operative extra-
cardiac graft. In addition, the AZ stream constrains the HepV towards the left side of the 
baffle further shifting the HFD towards the LPA. 
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Figure 9-40: Flow structures in Options 4 through 7 at GFDRPA=50%. The associated 
HFDRPA are provided below each flow field in green. 
 
 
Options 6 and 7: Both Options 6 and 7 (H and Y symbols in Figure 9-38) succeed in 
achieving a balanced HFD at a close to balanced GFD. Option 6 uses a HepV-to-AZ 
shunt similar to Options 4 and 5 but both the AZ vein and the pre-operative extra-cardiac 
graft are kept opened. This design allows the HepV flow to reach the LPA through the 
extra-cardiac baffle at low GFDRPA, and reach the RPA through the AZ vein at high 
GFDRPA. The success of Option 7, which combines the AZ and HepV streams into the 
Optiflo graft designed for Option 3, resides in an intense mixing of the lower and superior 
inflows within the connection area (Figure 9-40). Such mixing was impossible in the pre-
operative anatomy and in Options 1-3 due to the low momentum of the HepV, and only 
limited in Option 5 due to the left-sided offset of the extra-cardiac graft. Merging the AZ 
flow to the HepV and using a Y-shaped Optiflo graft to distribute the combined flows to 
the two sides of the connection addresses both of these issues. 
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9.3.2.5 Power Loss Performance 
The power losses associated with the seven investigated options are displayed in 
Figure 9-41. Power losses in the pre-operative anatomy are included as well for 
comparison. Results for Options 1-3 and Options 4-7 are displayed in two separate graphs 
for clarity, but both graphs are displayed using the same scale to ease the comparison 
between the different options. No notable difference in energetic performance may be 
noted across the different options. This is due to the fact that the flow dynamics in these 
options mostly differ in the path followed by the HepV flow, which is only a small 
contributor to the overall energy dissipation.  
Options 1 to 3: Power losses in Option 1, where the HepV baffle connects towards the 
center, are slightly higher at lower GFDRPA than those measured in the pre-operative 
anatomy. For these low GFDRPA values, more flow has to travel through the mid-PA 
segment to reach the LPA than in the pre-operative anatomy due to the fact that HepV is 
connected further to the right in Option 1 than in the pre-operative anatomy. This 
increased flow through the mid-PA in turn increases the energy dissipation in that 
segment, yielding the observed increase in power losses. The Optiflo options (Options 2 
and 3) slightly deviate from Option 1 at lower GFDRPA values. The HepV-to-LPA branch 
increases the effective cross-sectional area available to reach the LPA, which in turn 
translates in a measurable decrease in power losses when GFDRPA is lower than 50%. 
Options 4 and 6: Options 4 and 6 featured the highest power losses of all investigated 
options, due to the presence of the HepV-to-AZ shunt that directs at least part of the 
HepV flow to the azygous vein. The noted increased in energy dissipation through the 
azygous vein in both of these options is consistent with what was observed for other 
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Figure 9-41: Power losses measured across the pre-operative anatomy and the first four surgical planning options (Left), and across 
the options that combined azygous and hepatic flows (Right).  
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patients, even though the magnitude of the increase is smaller than for other patients due 
to the small HepV rate.  
Options 5 and 7: The power losses obtained for Options 5 and 7, which merge the AZ 
flow into the HepV baffle, are almost overlaid onto one another, restating the fact that 
vessel diameters and flow rates are the two predominant factors for energy dissipation, 
while the exact baffle geometry is only a second order parameter. At GFDRPA=40%, 
Options 5 and 7, respectively, lead to a 5.7% and 8.9% decrease in energy dissipation 
compared to the pre-operative anatomy. Redirecting the AZ flow towards the HepV 
baffle, which has a larger diameter than the azygous vein, reduces the amount of energy 
lost in wall friction by the AZ flow prior to entering the connection. This translates into a 
net energy gain at low GFDRPA. However, at GFDRPA=60%, those two options are 
observed to yield a 5 to 9% increase in energy dissipation. The right-sided position of the 
azygous vein in the pre-operative anatomy provides an advantage at higher GFDRPA, 
reducing the distance traveled by the AZ flow as well as the mixing in the connection. 
Both of these features are lost when connecting the AZ to the HepV as in Options 5 and 
7. As a result, the power losses in these two options rise faster when GFDRPA exceeds 
50% than they did in the pre-operative anatomy.  
Finally, it should be noted that, apart for Options 4 and 5, the reported increase or 
decrease in power losses do not exceed 0.5mW. As such power losses do not appear as a 
stringent optimization constraint for Patient B2. 
9.3.2.6 Summary 
A total of seven options were investigated for Patient B2. The first three options 
sought to optimize the shape and connection location of the HepV baffle without 
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modifying the course of the other inflows. However, these three first options failed to 
increase HFDRPA and were thus not recommended for surgery. The failure of Options 1 
through 3 finds its roots in the especially low HepV flow rate recorded in Patient B2, 
which only accounts for 10% of the systemic return, resulting in a very low kinetic 
energy compared to the other inflows. As a consequence, the HepV flow could not 
sustain any competition with the superior inflows, and its distribution in Options 1-3 was 
mostly imposed by the SVC and LSVC. This resulted in an irregular behavior of the 
HFDRPA, with local maxima followed by steep decreases.  
Combining the AZ and HepV streams as in Options 4 through 7 was an efficient 
measure to restore a monotonous HFDRPA behavior and increase HFDRPA. Combining 
HepV and AZ flows into the azygous vein as in Option 4 led to too drastic of an increase, 
resulting in an exclusive HFD to RPA, and thus did not constitute a recommendable 
surgical option. The best results were obtained when using either Option 5 or Option 7. 
Option 5 divided the HepV stream between the azygous vein and the pre-operative extra-
cardiac baffle, which were connected to the right and left of the connection, respectively. 
This allowed the hepatic flow to linearly switch extra-cardiac conduit to the azygous, i.e. 
from the LPA to the RPA, as GFDRPA increased from 40% to 60%. Option 7 merged the 
AZ and HepV flows into a Y-shaped Optiflo connection. The two branches of the Y were 
designed so as to reach to beyond the LSVC on the left side, and beyond the SVC on the 
right. The HFD for that option more gradually switched from the left to the right, 
spreading the range over which both lungs receive some amount of hepatic flow.  
Based on these observations, Option 7 was selected as the best possible option for 
Patient B2. This option might, however, pose some difficulties during the surgical 
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performance as it would entail converting the pre-operative extra-cardiac baffle into an 
intra-atrial Optiflo. An alternate option could be to keep an extra-cardiac approach but 
displace the baffle towards the mid-PA segment thus achieving the same levels of mixing 
as in Option 7. Finally, all of the above options seek to achieve a balanced HFD when 
flow to the lungs is balanced as well (GFDRPA=50%). However, it should be restated that 
in the pre-operative anatomy a GFDRPA=50% could not be achieved due to a stenosis in 
the RPA downstream of the segment considered in the surgical planning study. For 
optimal HFD to the two lungs, it might thus be critical to also alleviate the RPA stenosis, 
either during the surgery or by deploying a stent via catheter.  
 
 
9.3.3 Patient B3 (CHOP M2) 
9.3.3.1 Pre-Operative Clinical Diagnosis 
The last patient, Patient B3, was a 4 year-old female Fontan patient who was born 
with a single ventricle, an interrupted IVC and a persistent LSVC. This patient had 
undergone a Kawashima operation followed by an extra-cardiac connection of the hepatic 
veins to the pulmonary arteries. The extra-cardiac connection was later taken down due to 
a clot in the hepatic baffle. After removal of the extra-cardiac connection, Patient B3 was 
diagnosed with severe bilateral PAVMs. She was recommended for a second TCPC to 
restore hepatic flow to the pulmonary arteries. 
The patient anatomy at the time of diagnosis is shown in Figure 9-42, and its 
characteristic dimensions are summarized in Table 9-7. Since the former extra-cardiac 
connection had been taken down, the hepatic veins are routed to the right atrium. All 
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hepatic veins merge together just upstream of the atrium, resulting in a large total cross- 
sectional area of 4.62 cm2. The azygous vein ascends along the left side of the aorta and 
connects to the LSVC. The aorta is thus located between the azygous and hepatic veins, 
which is a constraint to keep in mind for the design of HepV-to-AZ or AZ-to-HepV 
shunts. The mid-PA segment is narrow, with a cross-sectional area of only 0.24 cm2 
compared to 1.21 cm2 for the LPA and 0.84 cm2 for the RPA. Only little flow was noted 
through that segment during the MRI examination. 
 
No pre-operative hemodynamics evaluation was conducted for Patient B3, since 
this patient did not feature a completed TCPC at the time of diagnosis. However, a few 
points are worthwhile noting from the pre-operative in vivo flow rates listed in Table 9-7. 
First, since the hepatic veins are not connected to the PAs, the sum of the in vivo LPA 
and RPA flow rates do not add up to QS but rather to the sum of the AZ, LSVC and SVC 
flow rates. The situation will be different in the surgical planning simulations where the 
HepV flow will be adjoined to the other systemic venous returns and distributed to the 
two lungs as well. To emulate the acute post-operative stage, it will be assumed that QS 
will be distributed in the same proportions as the pre-operative QP. All surgical planning 
options will thus be investigated at a 61/39 RPA/LPA flow ratio. The outflow conditions 
will then be varied to best predict the point at which each option will yield a balanced 
HFD. The next point of interest is that the AZ and LSVC flows combined  
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Figure 9-42: Pre-operative anatomy of Patient B3 with and without the surrounding 
cardiovascular structures. The superior cavopulmonary connection and hepatic veins are 
shown in grey, while the surrounding structures are shown in red. The black arrows 
indicate the main flow direction at each one of the inflows and outflows. 
 
 
 
 
Table 9-8: Geometric and flow characteristics of Patient B3 at the time of PAVM 
diagnosis. QS: sum of the systemic inflows. QP: sum of the pulmonary outflows. 
 
Cross-
sectional 
Area (cm2) 
MRI Flow 
measurements CFD Flow Conditions 
Q (L/min) Q (%) Q (L/min) Q (%) Characteristic Velocity (cm/s) 
Systemic Venous Return 
HepV 4.62 0.63 21% 0.63 21% 2.26 
LSVC 1.01 0.77 26% 0.77 26% 12.73 
AZ 0.86 0.43 15% 0.43 15% 8.39 
SVC 1.29 1.10 38% 1.10 38% 14.28 
QS  2.93  2.93   
Pulmonary Flows  
LPA 1.21 0.90 39% 1.15 39% 15.84 
RPA 0.84 1.40 61% 1.78 61% 35.33 
QP  2.30  2.93   
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balanced HFD. The next point of interest is that the AZ and LSVC flows combined 
account for 41% QS, while the SVC flow accounts for 37.6% QS. The left (i.e. the LSVC 
and AZ) and right (i.e. the SVC) superior inflows are thus almost perfectly balanced. 
Setting the HepV between the left and right superior inflows might thus constitute an 
efficient surgical planning option.  
9.3.3.2 Surgical Planning Options 
An exhaustive parametric investigation was conducted for Patient B3 during the 
surgical planning phase. Fourteen virtual surgeries were generated. The corresponding 
anatomies are shown in Figure 9-43 viewed from the anterior side. A top view is also 
provided for the anterior extra-cardiac options to better visualize changes in the curvature 
of the hepatic baffle. The investigated parameters include 1) offset of the HepV 
anastomosis site, 2) curvature of the HepV baffle, 3) combinations of the hepatic and 
azygous flows, and 4) splitting of the hepatic flow in two branches. 
In Options 1 through 9, the HepV anastomosis site is progressively shifted from 
the RPA to the LSVC. Options 1 to 3 are considered to have a right-sided offset. Option 1 
is connected approximately one diameter to the right of the SVC, Option 2 half a 
diameter to the right of the SVC and Option 3 is connected onto the SVC with a slight 
offset to the left compared to the SVC axis. Options 4 to 8 are considered to be centered. 
These options are connected to the mid-PA segment, their anastomosis location 
progressively shifting from right to left. Option 4 is connected one diameter away from 
the SVC. Options 5, 6 and 7 attach to the center of the mid-PA segment, and Option 8 
reaches the mid-PA only one diameter away from the LSVC. Finally, Option 9 connects 
opposite to the LSVC anastomosis, and is considered to have a left-sided offset. 
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Figure 9-43: Virtual surgical planning options tested for Patient B3. All anatomies are viewed from the anterior side. A top view is 
also provided for the extra-cardiac options 1 to 5 to better visualize changes in the curvature of the HepV baffle. The nomenclature of 
the different vessels and the main flow directions are shown on Option 10. 
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In addition to the offset variation, Options 1 to 9 also differ in the type of surgical 
procedure used. Options 1 to 5 use an extra-cardiac graft wrapped along the anterior side 
of the heart. These options result in a highly curved hepatic baffle. The curvature is best 
visualized in the top views provided in Figure 9-43. To reach the mid-PA with a lower 
curvature in the vicinity of the anastomosis, Option 6 uses an extra-cardiac graft wrapped 
along the posterior side of the heart. The aortic arch and descending aorta impose a limit 
to the offset that may be reached with extra-cardiac grafts. Options 7 to 9 thus use an 
intra-atrial approach to reach further towards the LSVC. 
Options 10 to 12 merge the hepatic and azygous flows into a common vessel. In 
Option 10, the hepatic flow is routed to the azygous vein via a HepV-to-AZ shunt. In 
Options 11 and 12, it is the azygous flow that is routed through an AZ-to-HepV shunt 
towards the hepatic baffle. Option 11 uses the same anterior extra-cardiac graft as in 
Option 5, while Option 12 uses the same posterior extra-cardiac graft as in Option 6.  
Finally, in Options 13 and 14, the HepV baffle is split into two branches directed 
towards the LPA and RPA, respectively. In Option 13, this is achieved using the anterior 
extra-cardiac graft of Option 2 for the right branch, and a HepV-to-AZ shunt for the left 
branch. Option 14 makes use of a Y-shaped extra-cardiac graft, wrapped around the 
anterior side of the heart. The right branch of the graft is connected to the SVC, while the 
left branch reaches under the aortic arch towards the LSVC. 
9.3.3.3 HFD Performance 
Figure 9-44 displays the hepatic flow distribution, HFDRPA, as a function of the 
global flow distribution, GFDRPA, for all fourteen options. For clarity, the results are 
distributed over four different graphs based on the option types. 
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Figure 9-44: HFD performance across for the fourteen surgical options designed for 
Patient B3. Top Left: Results for the Options 1-3 with a right-sided offset. Top Right: 
Results for Options 4-8 connected to the mid-PA segment. Bottom Left: Results for 
Options 9 and 10 with a left-sided offset or equivalent. Bottom Right: Results for Options 
11-14, which either merge the AZ into the HepV (Options 11 and 12) or split the HepV in 
two branches (Options 13 and 14). 
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Options 1 to 3: The top left panel of Figure 9-44 shows the performance of the three 
right-sided options, Options 1 to 3. Options 1 and 2, which were connected to the right of 
the SVC, result in a highly preferential HFD to the RPA, with all measurement points 
falling close to HFDRPA=100% even when GFDRPA is as low as 30%. In contrast, HFDRPA 
measurements for Option 3 only reach 100% at GFDRPA=60% and fall almost on top of 
the HFDRPA=GFDRPA line between GFDRPA=30% and 40%. To better understand the 
underlying hemodynamic mechanisms and inflow interactions, Figure 9-45 displays the 
3D streamtraces associated with Options 2 and 3 at GFDRPA = 50% and 61%. In Option 
2, the HepV streamtraces (in orange) are exclusively directed to RPA for all tested flow 
conditions. Due to the lower velocities and kinetic energy of the HepV stream compared 
to the SVC flow, the HepV cannot sustain the competition against the SVC and the right- 
sided offset, even though small, leads to a complete switch of the HepV streamtraces  
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Figure 9-45: Comparison of the flow structures and HFD associated with the right-sided 
options 2 and 3 under the pre-operative outflow conditions (GFDRPA=61%) and an equal 
blood flow distribution to the two lungs (GFDRPA=50%). The streamtraces are color-
coded by their vessel of origin. 
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towards the RPA. This opens up a flow separation on the left-side of the HepV 
anastomosis, into which the SVC streamtraces (in blue) engulf further constraining the 
hepatic flow towards the right. For lower GFDRPA values, the SVC streamtraces (in blue) 
split between the RPA and LPA to match the global flow distribution, while at higher 
GFDRPA values it is the LSVC streamtraces (in green) that split between the two 
outflows. It might be thus expected that, when the HepV baffle is connected to the right 
of the SVC axis as in Options 1 and 2, the hepatic flow only splits between the left and 
right lung when the flow to the LPA increases beyond the contribution of the SVC, AZ 
and LSVC flows combined, which is to say when flow to the LPA exceeds 79% QS and 
GFDRPA falls below 21%. 
In Option 3, the HepV flow axis falls slightly to the left of the SVC axis. As a 
result, when GFDRPA=50%, it is the orange HepV streamtraces that split to adjust for the 
global flow distribution, while all of the SVC flow goes to the RPA. When 
GFDRPA=60%, the RPA flow exceeds what can be provided by the SVC and HepV alone 
(QHepV+QSVC=59%QS) and it is the LSVC that splits between the RPA and LPA as was 
the case in Option 2. It might also be noted that, in Figure 9-44, the HFDRPA for Option 3 
increased at a slower rate for GFDRPA values below 50%. This reflects the fact that at 
small GFDRPA values the SVC does not uniquely flow to the RPA, but that both SVC and 
HepV streams split between the left and right lung. Based on a linear regression it might 
be predicted that Option 3 would yield a balanced hepatic flow distribution (HFDRPA = 
50%) for GFDRPA = 42%. 
Options 4 to 8: The top right panel of Figure 9-44 shows the HFD performances of the 
five centered options (Options 4 to 8). It is striking to note that, irrespective of the baffle 
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design and exact anastomosis location, the HFDRPA curves described by these five 
options are almost overlaid onto one another. It may be noted that all of these 
measurements start to rise above the HFDRPA=0% line around GFDRPA=35%, which 
corresponds almost exactly to the contribution of the SVC of 38% QS. Unlike Option 3, 
the SVC flow in these options is thus exclusively directed to the RPA for all tested flow 
conditions. As long as the SVC flow suffices to match the desired RPA flow rate (i.e. as 
long as GFDRPA < 30%), all of the HepV flow is thus directed to the LPA. As GFDRPA 
increases beyond 35%, HFDRPA measurements for Options 4 to 8 increase almost linearly 
and reach HFDRPA=100% for a global flow distribution of about 60/40 RPA/LPA. The 
HepV thus splits between the RPA and LPA until the RPA flow rate exceeds the sum of 
the HepV and SVC flows, which account for 59% QS combined. Option 8, which is only 
one diameter away from the LSVC, slightly deviates from Options 4 to 7 at 
GFDRPA=60%, reflecting some mixing between the HepV and LSVC. Finally, the point at 
which Options 4 to 8 cross the HFDRPA=50% line varies between GFDRPA=46% and 
GFDRPA=48%. All five options thus achieve a balanced HFD for a close to balanced 
GFD. Furthermore, the very low sensitivity of the HFD performance to the exact baffle 
geometry and implementation location makes them attractive for the surgery, allowing 
for some degree of freedom to adjust to unforeseen constraints in vivo. 
Options 9 and 10: The HFD performance for left-sided options (Options 9 and 10) is 
shown in the bottom left panel of Figure 9-44. Option 9 connects opposite to the LSVC, 
using an intra-atrial baffle. Until GFDRPA=50%, the HFDRPA measurements for that 
option follow a pattern similar to what was observed in Options 4 to 8. HFDRPA starts 
increasing around GFDRPA=37% and reaches 50% at GFDRPA=50%. This implies that, 
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similarly to Options 1 through 4, the SVC is exclusively directed towards the RPA and 
that, between GFDRPA=37% and 50%, the HepV is the only inflow to be split between the 
RPA and LPA to adjust for the desired flow split. Beyond GFDRPA=50%, the HFDRPA 
measurements for Option 9 increase at a slower rate than what was observed for Options 
4 through 8. Looking at the flow structures shown in Figure 9-46, it might be observed 
that at GFDRPA=61%, the flow through the mid-PA segment of Option 9 is composed of a 
mixture of green and orange streamtraces, originating from the LSVC and HepV, 
respectively. The LSVC thus starts to contribute to the RPA flow rate earlier in Option 9, 
than in Options 4 to 8, explaining the slower increase rate of the HFDRPA measurements 
beyond GFDRPA=50%.  
In Option 10, the HepV flow reaches the pulmonary arteries via the azygous vein 
and through the left Kawashima connection. This option results in a strong bias of the 
HFD towards the LPA, with all HFDRPA measurements falling far below the 
HFDRPA=GFDRPA line. HFDRPA starts rising around GFDRPA=40% to 45% at a much 
slower rate than the previous options. As can be observed from Figure 9-46, at 
GFDRPA=61% all SVC (blue) and LSVC (green) streamtraces are directed to the RPA, 
while only a small portion of the mixed AZ and HepV streamtraces (in red and orange) 
flow across the mid-PA segment towards the RPA. This biased distribution stems from 
the fact that the azygous vein is the left-most vessel in the connection, so that the 
combined AZ and HepV flows are the last ones to switch from the LPA to the RPA. 
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Figure 9-46: Comparison of the flow structures and HFD associated with the two left-
sided options (Options 9 and 10) under the pre-operative outflow conditions 
(GFDRPA=61%). The streamtraces are color-coded by their vessel of origin. 
 
 
Options 11 and 12: Options 11 and 12 re-route the AZ flow through an AZ-to-HepV 
shunt and into one of the centrally connected extra-cardiac baffles (baffles from Options 
5 and 6). Similarly to Options 5 and 6, the HFDRPA measurements for Options 11 and 12 
(bottom left panel of Figure 9-44) rise above the HFDRPA=0% line for a global flow 
distribution of about 35/65 RPA/LPA. This indicates that similarly to the former options, 
the hepatic flow is exclusively directed to the LPA until the RPA flow exceeds what can 
be provided by the SVC alone. The difference between the two classes of options resides 
in the range of GFDRPA values over which the hepatic flow switches from being 
exclusively directed to the LPA (HFDRPA = 0%) to going exclusively to the RPA 
(HFDRPA = 100%). For Options 5 and 6, this range is confined to GFDRPA values between 
35% and 60%, while in Options 11 and 12 it extends to 70% or beyond. This larger 
transition range stems from the addition of the AZ flow to the HepV baffle, which allows 
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both streams to concurrently split between the left and right lung. Based on a linear 
interpolation, Options 11 and 12 are expected to achieve a balanced HFD (HFDRPA=50%) 
for a close to balanced GFD, between GFDRPA = 54% and 57%. The wider transition 
range might provide an additional advantage, allowing both lungs to receive hepatic 
nutrients even if the global flow distribution deviates from a 50/50 flow split. 
Options 13 and 14: The two last options (Options 13 and 14) divide the HepV flow into 
two branches, directed to the LPA and RPA, respectively. Both options result in an even 
distribution of the hepatic flow, with HFDRPA measurements that closely follows the 
trend previously observed in Options 4 through 8 (Figure 9-44). However, as can be 
visualized from Figure 9-47, the underlying hemodynamics drastically differ from those 
observed in the former options. In Option 13, the HepV flow progressively switches from 
the HepV-to-AZ shunt to the extra-cardiac conduit. At low GFDRPA values, only little 
HepV flow goes through the extra-cardiac baffle, and the SVC streamtraces (blue) are 
seen to penetrate deep down into the baffle. On the other end of the spectrum, when 
GFDRPA = 61%, a portion of the AZ flow is diverted through the HepV-to-AZ shunt 
towards the RPA, thus bypassing the mid-PA segment. Similarly, in Option 14, the HepV 
flow progressively switches from the left to the right branch of the Y-shaped graft. At 
GFDRPA = 30%, a few SVC streamtraces penetrate deep down into the right branch of the 
graft and flow back up the left branch, thus bypassing the mid-PA segment. A symmetric 
behavior is observed with the LSVC streamtraces at high GFDRPA values. These two 
options achieve a balanced HFD for a close to balanced GFD of 47/53 RPA/LPA. 
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Figure 9-47: Comparison of the flow structures and HFD associated with Options 13 and 
14 across all tested flow conditions. The streamtraces are color-coded by their vessel of 
origin. 
 
 
9.3.3.4 Power Loss Performance 
Figure 9-48 shows the power loss measurements obtained across all fourteen 
surgical planning options. For clarity, the results are separated into three graphs, based on 
the trends followed by the power losses. All options apart from the HepV-to-AZ 
connection (Option 10) yield power losses of the same order of magnitude, ranging 
between 2.6mW and 6.4mW. The trends mostly differ in the location of their minimum, 
and in their dependence on GFDRPA.  
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Figure 9-48: Power losses measured across all surgical planning options for Patient B3. 
For clarity, the results are separated based on the trends followed by the power loss 
curves. Top Left: baffles connected within one diameter of the SVC (Options 1 to 4). Top 
Right: baffles connected more than one diameter away from the SVC (Options 5 to 9 and 
12). Bottom: the HepV-to-AZ (Option 10) and the two Y-grafts (Options 13 and 14). 
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Options 1 to 4: The top left panel of Figure 9-48 displays the results that show a stronger 
dependence to low GFDRPA values. This includes the four first extra-cardiac options, 
which are all connected within one diameter of the SVC. In these options, 59% of the 
systemic venous return (i.e. QHepV + QSVC) comes in through the right side of the 
connection. When GFDRPA is lower than 59%, some of the SVC or HepV flow has to 
travel across the narrow mid-PA segment towards the LPA. Power losses reach their 
minimum at GFDRPA=50% when only 9% QS travels across the mid-PA.  
Options 4-9 and 11-12: The top right panel of Figure 9-48 displays the results that show 
a stronger dependence to high GFDRPA values and reach their minimum at GFDRPA=40%. 
This includes Options 5 to 9, all of which use a baffle connected more than one diameter 
away from the SVC. The AZ-to-HepV options (Options 11 and 12) also fall in this 
category, as they make use of the same baffles as Option 5 and 6, respectively. Power 
losses in these six options are here again dominated by the dissipation occurring in the 
mid-PA segment. The minimum observed at GFDRPA=40% corresponds to the point 
where less than 10% of the left-sided inflows (HepV, AZ and LSVC combined) travels 
across the mid-PA segment, towards the RPA. The power loss curves slightly deviate 
from one another at higher GFDRPA values. Power losses in the left-sided Option 9 show 
a higher dependency on GFDRPA than in the centrally located options. The left-sided 
offset increases the distance that the left inflows have to traveled through the mid-PA. 
This in turn increases the amount of dissipation in the mid-PA, resulting in a higher 
sensitivity to GFDRPA. Options 11 and 12, on the other hand, display a slightly lower 
dependency on GFDRPA, with power losses that are lower than those measured in the 
other options. Here again the difference in power losses finds its origin in the amount of 
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energy dissipation occurring in the mid-PA segment. Connecting the AZ flow in the 
center of the mid-PA segment reduces the distance that the AZ flow has to travel through 
that narrow section and thus the energy dissipation. 
Options 10, 13 and 14: The bottom panel of Figure 9-48 displays the power loss results 
for the three remaining options, namely the HepV-to-AZ connection (Option 10) and the 
two options that divided the HepV into two branches (Options 13 and 14). Power losses 
in Option 10 are higher than in any other option for all tested conditions. This results 
from the increased blood flow through the azygous vein, which increases the dissipation 
along the azygous vessel walls. These power losses reach there minimum for GFDRPA 
below 40% and rapidly increase as GFDRPA increases beyond 40%. As was the case in 
the left-sided Option 9, this rapid power loss increase is due to an increasing dissipation 
in the mid-PA segment when the flow to the RPA increases. Options 13 and 14, where 
the HepV flow is distributed to the LPA or RPA through two different branches, yield the 
lowest power losses of all tested options. The left and right branches allow the HepV 
flow to reach the LPA or RPA without going through the mid-PA segment, reducing the 
flow rate and dissipation in the mid-PA segment. However, the performance gain does 
not exceed 0.3mW, and thus does not constitute a decisive parameter per se.  
 
9.3.3.5 Summary 
A total of fourteen surgical planning options were investigated for Patient B3. The 
first nine options investigated the impact of the HepV offset, and the curvature of the 
HepV baffle. Options 10 through 12 explored different combinations of the AZ and 
HepV flows, and the two last options looked into the potential benefit of splitting the 
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hepatic pathway into two branches. The parametric variations of the HepV offset 
revealed that, when the HepV was connected beyond the SVC (as in Options 1 and 2) or 
beyond the LSVC (as in Option 10), the resultant HFD was highly biased to the closest 
lung. On the other hand, all options where the HepV connected to the mid-PA segment 
(Options 3 to 9) yielded similar HFD performance, irrespective of the exact HepV 
anastomosis location, or the procedure used to perform the surgery. HFDRPA typically 
increased from 0% to 100% between GFDRPA=35% and 60%, achieving an HFDRPA of 
50% for an almost balanced global flow distribution. Option 3, where the HepV was 
connected to the SVC anastomosis site, slightly favored HFD to the RPA compared to 
Option 4 through 9. Symmetrically, Option 9, where the HepV faced the LSVC 
anastomosis site, slightly favored HFD to the LPA. However, both of these differences 
were of small magnitude compared to the variations observed when the HepV was 
connected beyond the SVC or LSVC. This in practice implies that even a slight offset 
towards the mid-PA suffices to equilibrate the HFD to the left and right lung. This 
finding is of critical importance since it is often difficult in these patients to reach the 
center of the mid-PA segment due to the presence of the overriding aorta. It should be 
emphasized that the success of Option 3 to 9 relied on the fact that the QSVC was almost 
equal to QLSVC+QAZ allowing for the hepatic flow to transition from the LPA to the RPA 
over a range of GFDRPA values centered around 50%.  
Merging the AZ and HepV flows into one of the centrally connected baffles (as in 
Options 11 and 12) widened the range of GFD conditions for which both lungs received 
some hepatic nutrients. This presents the advantage of allowing for a greater tolerance to 
the global flow distribution. However, such approach would require two consecutive 
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procedures, creating an extra-cardiac baffle connection on the one hand and an A-to-
HepV shunt on the other, which may not be necessary in view of the good performance 
of the centrally connected baffles alone. Finally, Options 13 and 14, where the HepV was 
split into an RPA and an LPA branch, resulted in the same HFD trends as the centrally 
connected baffles (Options 4 to 8). As these two options bypassed the mid-PA segment, 
they also resulted in slightly lower power losses than the other options. However, the 
energy gain recorded in Options 13 and 14 was only of small amplitude and did not 
appear as a major decision criterion. 
Based on these observations, the surgical planning recommendation was to either 
connect the HepV baffle between the SVC and LSVC (as in Options 3 through 9), or to 
split the HepV into a right and a left branch (as in Options 11 and 12). The surgical 
procedure was performed using an anterior extra-cardiac graft connected to the SVC 
anastomosis site as in Option 3.  
 
9.3.4 Summary of the Persistent LSVC Case Studies 
Reviewing the three case studies conducted in this section, a few trends and 
guidelines might be drawn. Similarly to the single SVC group, HFD was predominantly 
dictated by the location of the HepV anastomosis site relative to the superior inflows. 
Connecting the HepV to the right or to the left of all other systemic venous returns 
(namely the SVC, AZ and LSVC) led to a highly preferential HFD to the closest lung. 
However, while trying to avoid any right or left-sided offset presented a major challenge 
in patients with a single SVC, the presence of a persistent LSVC drastically simplified 
the problem. Provided that the right and left superior venous returns were almost equal, 
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the equivalent of a no-offset design was to connect the hepatic baffle between the SVC 
and LSVC. The resultant HFD was then more or less insensitive to the exact anastomosis 
location along the mid-PA segment and to the type of connection used (intra-atrial vs. 
extra-cardiac, anterior vs. posterior grafts). From a surgical standpoint, this finding is of 
importance as it provides surgeons with some degree of freedom regarding the exact 
implementation, and allows them to adapt the procedure to unforeseen difficulties.  
Dividing the hepatic baffle into two branches (using either a Y-shaped Optiflo 
graft, or the azygous and a regular extra-cardiac graft) lead to more mitigated results. In 
Patient A1 for example, splitting the hepatic flow between the azygous vein and a right-
sided extra-cardiac baffle yielded unsatisfactory HFD performance, whereas the same 
option performed well in Patients A2 and A3. The success of these options is thus less 
general than the centrally-connected baffles and highly depends on the design of the left 
and right branch.  
In all three patients, routing the HepV flow into the azygous, which was one of 
the best performing options for the single SVC group, resulted in poor HFD performance 
with a unilateral hepatic flow distribution to the lung closest to the AZ. Due to the 
dissociation of the left and right systemic venous returns, HepV-to-AZ connections in 
patient with a persistent LSVC were equivalent to a left or right-sided HepV offset. This 
highlights the need to break down SVHD patients into smaller subgroups, as the best 
performing procedures for one subgroup may be sub-optimal for others. 
As pointed out above, a key factor for the centrally connected options to 
concurrently achieve a balanced HFD and GFD, is for the sum of the left and sum of the 
right superior inflows to contribute almost equally to the systemic venous return. When 
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this was the case, as in Patients A1 and A3, a centrally connected baffle performed 
ideally without any further addition. However, in cases such as Patient A2 where the sum 
of the LSVC and AZ flow rates represented over 70% QS while the SVC accounted for 
only 20% QS, a centrally connected baffle alone failed to improve HFD. This patient 
presented the added particularity of having a very low hepatic flow (only 10% QS), which 
resulted in a total incapacity for the HepV flow to compete against the other systemic 
venous returns. For that particular case, combining the AZ and HepV streams into the 
baffle appeared as a critical step towards the re-establishment of a balanced HFD, by both 
reducing the difference between the left and right superior venous returns, and increasing 
the energy of the flow coming through the baffle.  
Finally, similarly to what was observed in the single SVC group, power losses 
mostly depended upon the vessel cross-sectional areas and flow rates, whereas the exact 
geometry of the hepatic baffle only appeared a second order parameter. As such they 
were not a strong decision factor for the TCPC optimization. A specificity of the 
persistent LSVC group was that the mid-PA segment was often undersized, leading to 
increased energy dissipation in that section. In the surgical planning campaign this was 
addressed by connecting the HepV to the mid-PA and flaring the anastomosis to dilate 
the stenosed segment. Alternatively, narrow mid-PA segments could be dilated by 
balloon angioplasty.  
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9.4 Conclusion 
This chapter reviewed the experience gained over six patient-specific surgical 
planning studies. For each patient, the investigated options included 1) variations in the 
HepV offset, 2) variations in the surgical technique (intra-atrial vs. extra-cardia), 3) 
splitting the HepV conduit into two branches, and 4) combining the HepV and AZ flows. 
The optimization objectives were to both ensure a proper lung development via a 
balanced HFD and GFD, and minimize the workload imposed on the heart by minimizing 
the TCPC pressure drops and power losses.  
This study first points to the need to break down SVHD patients into targeted 
subgroups as recommendations for patients with a single SVC, for example, were not 
applicable to patients with a persistent LSVC. In addition to anatomical considerations, 
the flow rates across each one of the systemic vessels (namely, the HepV, SVC, AZ and 
IV or LSVC) were a key determinant of the optimal option retained. Patients should thus 
not only be classified based on their vascular configuration but also, based on the relative 
contribution of the each individual vessel to the total systemic venous return. Evaluation 
of the pre-operative flow rates (via PC MRI or catheterization) and careful examination 
of the relative orientation of the systemic vessels are thus two major steps towards 
identifying the best procedure to follow. 
It should be pointed out that the results shown herein represent over 200 
individual CFD simulations. This may pose a limit to the application of such patient-
specific optimization to the general population. However, by reviewing these patient-
specific studies and appropriately categorizing them, a few clear cut observations were 
drawn which may provide guidelines towards improving the TCPC design for patients 
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with an interrupted IVC. Prior to any application, these guidelines would need to be 
verified on a larger patient pool, with clinical follow-up data to assess their validity. 
Cases with a large number of malformations, such as Patient B2, would still be best 
addressed with an individualized surgical planning investigation. 
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CHAPTER 10 
DISCUSSION 
 
10.1 Unstructured Cartesian Immersed-Boundary Paradigm 
In this study, we developed an unstructured immersed-boundary (IB) paradigm to 
simulate the three-dimensional, time accurate blood flow dynamics through anatomically 
realistic total cavopulmonary connections (TCPC). The motivation behind this work was 
to develop a powerful and reliable numerical methodology that could be integrated with 
in vivo imaging (such as MRI) for a fast assessment of the in vivo flow fields, as well as 
with advanced virtual-surgery environments for the pre-operative optimization and 
planning of the TCPC surgery, on a patient-specific basis.  
IB methods are inherently suited to tackle the geometrical complexity of in vivo 
anatomies. However, with exception the pioneering work by Peskin and McQueen [134, 
139] and the more recent work of Yokoi et al. [140], the use of immersed boundary 
methods in simulating complex anatomical blood flows is not as wide-spread as one 
would anticipate given the ease with which such methods can handle arbitrarily complex 
geometries. One possible explanation for the scarcity of applications of IB methods to 
anatomical flows lies in the manner in which such methods handle the Cartesian grid 
nodes that are not part of the flow domain (i.e. the nodes that reside outside of the fluid in 
the solid side of a fluid/solid interface). The common practice is to retain such non-fluid 
grid nodes in the grid structure but blank them out of the computation. Such structured IB 
formulation performs well for external flow problems around bodies whose size is a 
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small fraction of the background Cartesian grid. However, a drastically different situation 
can be encountered when IB methods are applied to internal flow problems even when 
the geometry to be simulated is a fairly simple one. This situation is only exacerbated 
when attempting to model in vivo cardiovascular flows which typically involve tortuous, 
multi-connected vessels where only a small fraction of the embedding Cartesian grid is 
located in the interior of the flow domain (typically between 5 – 10 percent). Any attempt 
to carry out grid refinement studies for such configurations using standard IB approaches 
would quickly lead to excessively high memory and computational time requirements.  
A clear example of this shortcoming can be found in the recent work of Yokoi et 
al. [140] who employed an IB approach to simulate blood flow in a complex cerebral 
aneurism anatomy (see Figure 10-1) immersed in a Cartesian grid with 160×50×75 
nodes. Yokoi et al. did not provide any information about the number of nodes lying in 
the interior of the aneurysm model but given the complexity of their geometry it is 
apparent that the vast majority of the Cartesian nodes resided in the exterior of the flow 
domain and thus unnecessarily burdened the computation. Furthermore, Yokoi et al 
reported results for only one mesh, and the feasibility of carrying out grid convergence 
studies for complex anatomical geometries using IB methods remained to be 
demonstrated. 
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Figure 10-1: Shape model made by silicon (Image courtesy: [140]) 
The proposed unstructured immersed-boundary paradigm effectively alleviates 
the difficulties faced by structured IB methods for internal flow applications. All 
Cartesian grid nodes that do not belong to the fluid domain are eliminated from the data 
structure rather than just being blanked out of the computations, resulting in an 
unstructured albeit Cartesian computational mesh. The connectivity information is 
provided by introducing two arrays mapping the structured and unstructured Cartesian 
indexing systems onto one another. Such unstructured Cartesian paradigms are gaining in 
popularity, and have already been applied in level-set approaches to track intricate 
dynamic surfaces with high spatial resolution [148]. The proposed unstructured Cartesian 
implementation strikes a balance between computational efficiency and memory 
requirements and leads to a readable and easy to maintain code implementation while 
drastically reducing storage requirements and computational costs. 
The accuracy of our flow solver is demonstrated in Chapter 7 with an in depth 
validation against controlled in vitro experiments in test-cases ranging in complexity 
from a 90 degree curved pipe to a patient-specific intra-atrial anatomy with high levels of 
flow instabilities, regions of transition to turbulence and re-laminarization. The potential 
of the unstructured Caretsian approach is further demonstrated in that chapter by carrying 
out for the first time a comprehensive grid sensitivity study for internal flow 
configurations as complex as that in a real-life TCPC anatomy.  
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Blood flows through the venae cavae and center of the TCPC connection are 
characterized by relatively low Reynolds numbers. The characteristic IVC Reynolds 
number for the cases presented in this thesis ranged from around 1000 in the two 
idealized TCPCs presented in Chapter 7 and Chapter 8, and between 100 and 600 for the 
patient-specific TCPC anatomies. The characteristic IVC Reynolds number for the intra-
atrial validation test-case presented in Chapter 7 in particular is only Re  = 294. As a 
result, the entrance flows into the TCPC are mostly dominated by the boundary layers 
forming along the vessel walls and their dynamic interaction at the center of the 
connection. The mesh refinement studies conducted in Chapter 7 demonstrated that these 
boundary layers and associated dominant flow structures were properly captured with a 
spatial discretization of h=0.03DIVC in the case of the idealized TCPC and h=0.02DIVC in 
the case of the anatomical intra-atrial TCPC. Achieving such spatial resolution with a 
structured Cartesian approach would have already required 8 and 10 million Cartesian 
grid cells, respectively, while only 650 and 740 thousand unstructured Cartesian grid 
elements were required here to achieve the same results. The results presented in this 
work thus demonstrate the potential of the unstructured Cartesian paradigm as a tool for 
carrying out fine mesh simulations of complex anatomical flows. It is important to point 
out that for all reported test-cases, even the simplest ones, the fluid cells only represented 
6 – 18 percent of the total Cartesian grid cells and that this ratio could drop even further 
in highly tortuous geometries such as the aneurysm studied by Yokoi et al. [140]. 
The results presented throughout this thesis also underscore that despite relatively 
low Reynolds numbers, the interaction of the caval flows can lead to highly unstable 
chaotic mixing at the center of the connection, as may be visualized in the instantaneous 
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time-series shown for the intra-atrial validation test-case in Chapter 7. Flow in the 
pulmonary arteries can also host very complex dynamics including regions of transition 
to turbulence and re-laminarization, such as what was seen for Patient A1 in Chapter 9. 
These complex flow phenomena are induced by the complexity of the anatomical 
geometries, including regions of strong curvature and rapid changes in cross-sectional 
areas, and by the increased levels of 3D unsteady perturbations such geometrical features 
impart on the flow. These observations further reinforce the need for fine temporal and 
spatial discretization in order to properly characterize the in vivo TCPC flow structures.  
Finally, beyond the validation of the numerical scheme, which was clearly 
demonstrated in Chapter 7, reproducing the in vivo TCPC flows requires matching the in 
vivo boundary conditions, including the wall motion and inlet/outlet flow conditions. 
While the TCPC wall motion was negelected in this thesis, efforts were made to match 
the in vivo flow conditions. Inlet/outlet flow rates were prescribed based on the in vivo 
PC MRI flow measurements. In the pulsatile investigation, the inlet velocity profiles were 
prescribed to best match the global in vivo flow directions at the inlets. As demonstrated 
for the intra-atrial anatomy in Chapter 7, where we compared the flow structures obtained 
using three different types of inflow conditions, the choice of inlet velocity profiles can 
have a significant impact upon the flow structures at the center of the TCPC connection. 
Future work may thus seek to further refine the in vivo modeling approach, by either 
interpolating the in vivo PC MRI measurements onto the inlets of the computational 
domain, or extending the domain further upstream to reduce the impact of the inlet 
boundary conditions on the flow structures at the center of the TCPC.  
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In summary, the results presented in Chapter 7 underscore the need for careful 
numerical validation and simulations on fine computational meshes in order to properly 
capture all dynamic features of the in vivo flow structures. This is of critical importance 
and should be re-emphasized as we enter an era when computational simulations for 
clinical applications are becoming increasingly widespread. 
10.2 Investigation of the Pulsatile TCPC Hemodynamics 
The first aspect of our study investigates the impact of pulsatility on the 
hemodynamics of different TCPC connection types. The objective of this study is two-
folds: first, assess the impact of flow pulsatility on chosen clinical end-points and 
determine whether some procedures are more sensitive to pulsatility than others; and then 
assess the range of validity of our simulations by comparing the pulsatile CFD flow fields 
to the in vivo flow structures measured by PC MRI. To this end, in Chapter 8, we 
compare the hemodynamics and efficiency metrics obtained using the pulsatile in vivo 
flow curves to the ones obtained using the mean in vivo flow rates in three patients 
having each undergone a different TCPC procedure, as well as in an idealized 
representation of the TCPC. To ease our subsequent discussion, the main observations 
and results of Chapter 8  are summarized in Table 10-1 for each one of the four test-
cases. The clinical endpoints retained are (i) the TCPC power losses taken as a surrogate 
metrics for the workload imposed on the single ventricle; (ii) the hepatic or IVC flow 
distribution taken as a surrogate measure for the risk of pulmonary artero-venous 
malformations; and (iii) the hepatic or IVC particle residence times taken as a measure of 
the differences in particle pathways and an indicator for the risk of thrombus formation in 
the TCPC baffle. 
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 Table 10-1: Summary of the pulsatile investigations and of the comparison of the 
performance metrics under pulsatile and non-pulsatile (NP) conditions 
 
 Idealized TCPC Patient 1 Patient 2 Patient 3 
Geometry 
Connection 
type 
4 straight pipes 
of equal 
diameter 
Extra-cardiac 
Normal systemic 
venous return 
Intra-atrial 
Normal systemic 
venous return 
Extra-cardiac 
Interrupted IVC 
Persistent LSVC 
offset 1.5D towards the RPA 
0.5D or less 
towards the RPA 
0.5D or less 
towards the LPA 
0D offset with 
SVC 
AIVC (cm2) 1.96 2.91 3.37 1.40 
min of ALPA, 
ARPA (cm2) 
1.96 0.57 (LPA) 0.75 (LPA) 0.81 (RPA) 
Cardiac output (L/min) 4 2.7 1.08 2.82 
QIVC (L/min) 2.66 1.79 0.74 0.16 
VIVC (cm/s) 22.6 10.3 3.7 1.9 
GFDIVC (%)     mean 67 62 68 6 
                    [min;max] [64;70] [60;73] [51;84] [-14;23] 
GFDRPA (%)     mean 53 43 58 41.1 
                    [min; max] [43; 61] [37;50] [56;60] [29;45] 
PI (%) 
IVC 28.3 48.5 61 361 
Max (other 
than IVC) 76.3 (LPA) 64.6 (LPA) 58.3 (SVC) 31 (AZ) 
Cardiac 
cycle 
beats/min 70 91 68 101 
ms 860 659 883 593 
Comparison between 
pulsatile and NP Flow 
Fields 
NP slightly 
underestimates 
the instabilities 
at the center of 
the TCPC 
Very similar 
NP 
underestimates  
instabilities and 
mixing at the 
center of the 
TCPC 
NP does not 
capture the 
instabilities and 
mixing of the 
HepV baffle 
Resi-
dence 
times 
(ms) 
 comparable Almost identical Almost identical Different  
Puls    Mode 272 497 836 1204 
     [Min; Max] [218; 913] [433; 1376] [750; 3958] [881; 3107] 
NP      Mode 360 459 788 1476 
     [Min; Max] [290; 841] [437; 1360] [741; 3906] [1384; 4850] 
PL 
(mW) 
Puls Mean 7.90 48.51 1.29 18.33 
        Max 28.19 70.65 7.89 45.57 
NP 6.58 46.50 1.29 8.54 
HFDRPA 
(%) 
Puls Mean 75.7 69 42 100 
NP 74.9 70 35 100 
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Imposing pulsatile flow boundary conditions will obviously lead to different 
instantaneous velocity and pressure fields, and in turn different instantaneous power 
losses and flow distributions, than non-pulsatile mean flow conditions. The first question 
that arises is thus to determine whether the body is most sensitive to the transient 
fluctuations in power losses or flow distributions, or whether it is the long-term time-
averaged effect that has the largest impact. Power losses are taken as a surrogate measure 
of the workload imposed on the single ventricle, which is separated from the TCPC by a 
network of arteries, veins and capillaries. It might thus be inferred that the transient 
power loss fluctuations will be damped out, and that the time-averaged power loss value 
offers a good representation of the ventricular power requirements. Similarly, the mean 
HFD appears as a good representation of the overall hepatic delivery to the two lungs. 
Accordingly, the focus of our discussion will be on the comparison of the non-pulsatile 
efficiency metrics against the mean pulsatile values, averaged over the cardiac cycle. 
 
10.2.1 Power Loss Comparisons 
10.2.1.1 Power Loss Normalization  
The non-pulsatile and mean pulsatile power losses reported in Table 10-1 span a 
wide range of values, going from losses as low as 1.29 mW in Patient 2 to losses as high 
as 46.50 mW in Patient 1. Such a large span is not surprising and falls well with the range 
of power losses reported in previous experimental and computational investigations. de 
Zélicourt et al. [95] reported losses between 1 and 50 mW in idealized TCPCs of varying 
vessel dimensions, while Whitehead et al. [92] reported losses up to 2,000 mW in patient-
specific anatomies under elevated cardiac outputs (CO), simulating exercise conditions. 
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While increased power losses due to geometrical constraints reflect a detrimental impact 
of the TCPC design on the cardiovascular resistance, high power losses due to a high 
cardiac output reflect a good overall ventricular performance and as such should not be 
mistaken for a faulty TCPC design. A critical step towards understanding the contribution 
of different geometric factors to the overall TCPC power losses is thus to first devise a 
proper normalization framework. Dasi et al. [97] suggested using 23 BSACOρ , where ρ 
is the density of blood ( 31060 −⋅= mkgρ ) and BSA is the body surface area, as a 
normalization factor for all power-derived clinical metrics. Since our focus is on the 
TCPC itself, we modify the above expression to represent the total power entering the 
TCPC as:  
 230 INACOρε =  (10-1) 
where AIN is the sum of the inlet cross-sections. For normal subjects, the vessel cross-
sectional areas should scale with the BSA and both metrics should be equivalent, but this 
might not be the case in Fontan patients who accumulate a large number of 
cardiovascular malformations. 
 
10.2.1.2 Power Losses Comparison across Templates 
For a fairer comparison of the power losses across templates, Table 10-2 provides 
the mean pulsatile power losses and their non-pulsatile counterpart normalized by the 
dynamic power scale of each model, 230 INACOρε = . After normalization, Patient 2’s 
no longer is the best performer, but rather figures among the two least efficient 
connections together with Patient 1. Plotting these normalized power losses against the 
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minimum PA cross-sectional area (see Figure 10-2), it is apparent the normalized 
minimum vessel dimension is a dominant factor in the TCPC dissipation rate, while the 
type of connection does not appear to play a significant role.  
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Figure 10-2: Normalized pulsatile and non-pulsatile power losses as a function of the 
minimum PA cross-sectional area indexed by AIN.  
 
 
Table 10-2: Pulsatile and non-pulsatile power losses normalized by their dynamic power 
scale, 0εPL . 
 Idealized Patient 1 Patient 2 Patient 3 
Pulsatile 3.9 116.7 51.8 23.8 
Non-Pulsatile  3.2 111.8 51.8 11.1 
 
 
10.2.1.3 Non-Pulsatile Power Loss Analysis 
Going back to the experimental study of de Zélicourt et al. [95], the authors 
demonstrated that, all flow splits and geometrical factors held constant, the power losses 
(PL) measured under non-pulsatile conditions followed a power law dependence on the 
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cardiac output, as βαCOPL = . Depending on the model under consideration, β ranged 
between 2.5 to 2.8 and α between 0.17 and 3.8. The authors pointed to the vessel 
dimensions as the major determinant for the scaling factor α.  
Dasi et al. [97] conducted a similar regression analysis using non-pulsatile 
experimental power loss measurements obtained in six patient-specific anatomies, and 
suggested the following expression for the TCPC power losses: 
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where ALPA and ARPA are the LPA and RPA cross-sectional areas, QLPA and QRPA are the 
LPA and RPA flow rates, and CLPA and CRPA are two resistance coefficients, which were 
determined by fitting the theoretical power loss curve to the experimental measurements.  
Both of the above studies established a net dependence of the non-pulsatile power losses 
on the flow rate to the power 2.75. The dependence on Re-0.25, which was empirically 
determined by Dasi et al. [97], compares well with the behavior of internal friction factor 
(Blasius, 1911), which is known to reduce with increasing Reynolds number as Re-0.25, 
for moderate Reynolds numbers but not fully developed turbulent conditions. This 
behavior also corroborates well with the decreasing non-dimensional energy dissipation 
observed by Whitehead et al. [92] in their comparison of extra-cardiacs and intra-atrial 
TCPCs. 
A potential limitation of Equation 9-2 is that it does not isolate the contribution of 
the viscous dissipation occurring in each one of TCPC vessel to the overall dissipation. 
These terms are included in the CLPA and CRPA coefficients, thus requiring experimental 
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or CFD measurements across a range of different flow splits to be able to bets fit them. 
We thus formulate the viscous dissipation along the walls of each vessels, Vε , as  
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where the subscript i spans each one of the inlet and outlet vessels; Ai, and Li are the 
cross-sectional area and length of vessel I; Qi, is the mean flow rate going through vessel 
i; and Rei is the mean Reynolds number of vessel i based on Qi and Ai.  
Following the same procedure as Dasi et al. [97], we normalize the non-pulsatile 
power losses computed for each model by Vεε ⋅0 , and plot them against the minimum 
PA diameter normalized by AIN, to check for any additional dependence on the vessel 
diameters. The results are displayed in Figure 10-3. Similarly, to what was observed in 
[97], the normalized power losses show a strong dependence on the normalized minimum 
PA area, closely following a power law (R2=0.98) with an exponent of -1.25. 
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Figure 10-3: Normalized power losses plotted as a function of the normalized minimum 
PA area. Note the power law dependence. 
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The normalized PA area represents a measure of the sudden vessel constriction 
encountered by flow as it goes from the combined inlet vessels into the smaller 
pulmonary arteries. 
Performing a bilinear fitting of the computed power losses to ( ) 25.1−INLPA AA  and 
( ) 25.1−INRPA AA , we find an analytical power loss expression of the form: 
 
⎥
⎥
⎦
⎤
⎢
⎢
⎣
⎡
+⎟⎟
⎠
⎞
⎜⎜
⎝
⎛
+⎟⎟
⎠
⎞
⎜⎜
⎝
⎛
⋅=
−−
γααεεε
25.125.1
0
IN
RPA
RPA
IN
LPA
LPAV A
A
A
A
 (10-4) 
where the empirical values for the coefficients LPAα , RPAα  and γ  are 0.51, 0.62 and 1.3, 
respectively. γ  may be seen as the contribution of the viscous energy dissipation rate 
along the TCPC vessel walls, assuming undisturbed vessel flows. LPAα and RPAα  account 
for the deviations from this ideal behavior due to 1) the sudden constrictions and 
expansions encountered when going from the inlets into the LPA and RPA, and 2) to the 
helical flow patterns observed in the PAs, which inherently increase the amount of energy 
dissipated by wall friction in these vessels.  
Figure 10-4 shows the comparison between the analytical power losses,ε , 
computed according to Equation 9-4 and the actual values obtained from the non-
pulsatile CFD results. As may be noted in the figure, the CFD power losses for Patient 3 
are slightly higher than the analytical prediction, while they are slightly lower than the 
analytical value for the idealized TCPC. These deviations find their root in the fact that 
LPAα , RPAα  and γ   should not be held constant across models, but rather should depend 
on local geometric characteristics of the connection, such as the curvature and orientation 
of the different vessels, as well as on the LPA/RPA flow ratio. However, the small 
sample size used herein did not allow for the detection of such fine dependences. 
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Figure 10-4: Comparison of the non-pulsatile CFD power losses and the values obtained 
with the analytical expression given in Equation 9-3. 
 
Provided with a larger sample size, each one of the terms in Equation 9-3 could 
also be further refined to capture the impact of the local vessel characteristics. For 
example, in Equation 9-4, INLPA AA  and INRPA AA  were considered to be a good 
representation of the energy expense of forcing the combined inflows into the LPA and 
RPA. In practice, this term could be broken down into the contribution of the dimensional 
mismatch between the inlet vessels and the central connection area, and between the 
central connection area and the outlet vessels. Furthermore, using the vessel cross-
sectional areas measured at the inlets and outlets of the TCPC domain might not to be the 
best representation of the sudden expansions or constrictions experienced by the flow. 
Possible alternatives include using the vessel cross-sectional areas at the anastomosis site, 
or the smallest cross-sectional areas measured within a certain distance of the 
anastomosis site, which might better capture the effect of a PA stenosis. 
Finally, given the differences observed between the non-pulsatile and pulsatile 
losses, especially for Patient 3, it is obvious that the generalization of such an approach to 
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a pulsatile framework will have to account for the measured levels of pulsatility, and the 
associated increase in energy dissipation. 
 
10.2.2 Hepatic Flow Distribution 
For all cases, the distribution of the hepatic (or IVC) particles is preferentially 
oriented towards the closest pulmonary artery, namely the RPA for the idealized TCPC, 
Patient 1 and Patient 2, and the LPA for Patient 3. In the idealized TCPC and Patient 1, 
the measured HFDRPA closely follows QRPA/QIVC implying that almost all of the RPA 
flow comes from the IVC, and that only the exceeding IVC flow is directed to the LPA. 
The hepatic flow distribution for Patient 2 slightly departs from that behavior, reflecting a 
higher IVC-SVC mixing at the center of the intra-atrial connection. For Patient 3, the 
connection almost behaved as two independent left- and right-sided connections, with the 
SVC and hepatic flows being exclusively directed to the RPA and the azygous and LSVC 
flows going only to the LPA. Such behavior might be attributed first to the abnormal 
configuration of the venous returns; then to the surgical construct, which sets the SVC 
and HepV far apart from the left superior venous returns; and finally to the presence of a 
severe mid-PA stenosis, which further limits the communication between the left and 
right sides of the connection.  
No significant difference is seen between the pulsatile and non-pulsatile HFD 
predictions for the idealized TCPC, Patient 1 and Patient 3. A larger deviation is seen in 
the intra-atrial anatomy (Patient 2), where the addition of pulsatility increased the level of 
IVC-SVC mixing already noted under non-pulsatile conditions. An even more drastic 
increase in HepV-SVC mixing was noted for Patient 3, due to the extremely high levels 
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of HepV pulsatility, which could be expected to lead to large differences between the 
pulsatile and non-pulsatile HFD predictions had the combined HepV and SVC not all 
been distributed to the same lung. 
 
10.2.3 Particle Residence Times 
10.2.3.1 Residence Time Normalization 
Similarly to the power losses, the particle residence will depend on the vessel 
flow rates, at the risk of masking differences across TCPC designs. Prior to any 
comparisons, the first step is thus, here again, to devise an adequate normalization factor. 
The time needed by an IVC or HepV particle to travel across the TCPC will depend on 
the characteristic velocities through the baffle and PAs, and on the vessel lengths. Since it 
is difficult to appropriately model the slowest velocities through the different vessels, we 
focus our attention on the particles flowing through the center of the vessels. Assuming 
that the vessel velocities adopt a fully developed parabolic profile, the characteristic 
velocity, *iV , at the center of a vessel i is given by:  
 
i
i
i A
Q
V ⋅= 2*  (10-5) 
where Qi is the mean vessel flow rate and Ai is the vessel cross-sectional area measured at 
the inlet or outlet of the TCPC domain. Using the characteristic vessel velocities given by 
Equation 9-5, we define the characteristic particle residence time, T*, as: 
 **
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where XPA designates the PA receiving the highest portion of the hepatic flow (i.e. the 
RPA for the idealized TCPC, Patient 1 and Patient 3, and the LPA for Patient 2), and LIVC 
and LXPA are the lengths of the IVC (or HepV) baffle and of the chosen PA. 
T* represents the shortest residence time expected for a given set of vessel lengths 
and flow rates. The remaining variables include local geometric factors (such as the 
presence of vessel extensions or constrictions, curvature or connection angle) and local 
flow characteristics (such as the presence of flow recirculation or detachment regions, or 
mixing between different inflows), which are both tightly inter-related. 
10.2.3.2 Comparison of the Characteristic and Minimum Non-Pulsatile Residence 
Times 
Using the characteristic residence times, T*, computed using Equation 9-6, we 
first compare the normalized minimum residence times across cases and under pulsatile 
and non-pulsatile conditions. These shortest residence times are taken to be the 5% bound 
of the cumulative probability functions, accounting for the 5% fastest particles in the 
domain. The computed T*and normalized shortest residence times are provided in Table 
10-3 for the four models studied.  
 
 
Table 10-3: Particle residence times corresponding normalized by the characteristic 
particle residence time, T*.  
  Idealized TCPC Patient 1 Patient 2 Patient 3 
T* (ms) 279 434 703 1337 
Resd. Time 
Pulsatile 
Mode 0.98 1.15 1.19 0.90 
[Min-Max] [0.78; 3.28] [1.00; 3.17] [1.07; 5.63] [0.66; 2.32] 
Resd. Time 
Non-Pulsatile 
Mode 1.29 1.06 1.12 1.10 
[Min-Max] [1.04; 3.02] [1.01; 3.14] [1.05; 5.56] [1.04; 3.63] 
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The normalized shortest residence times under non-pulsatile conditions are close 
to 1 for all considered cases, demonstrating that TCPC design did not significantly impact 
the propagation of the fastest particles, most likely flowing along the vessel centerlines 
away from any irregularities in the vessel walls.  
10.2.3.3 Comparison of the Pulsatile and Non-Pulsatile Residence Times 
Table 10-3 details the ranges in normalized particle residence times observed 
across the four test-cases, under both pulsatile and non-pulsatile conditions. No 
significant difference is observed between the normalized pulsatile and non-pulsatile 
residence times for Patients 1 and 2, while quite a large variation is observed for the 
idealized TCPC and Patient 3. As will be detailed in the subsequent paragraphs, these 
difference stem from two very difference mechanisms: in the idealized TCPC, the wider 
range in particle residence times stems from the short characteristic propagation time, T*, 
compared to the heart cycle duration, while for Patient 3 the shorter pulsatile residence 
times result from the high levels of SVC-HepV mixing. 
To better illustrate the role played by the relative duration of the characteristic 
propagation time, T*, Figure 10-5 graphically compares T* to the cardiac cycle duration 
for the idealized TCPC and the two patients with a normal systemic venous return, 
Patients 1 and 2. For the two patient-specific cases, T* is more than half of the cardiac 
cycle and significantly longer than either the forward or backward flow phases (defined 
as the times during which the instantaneous flow rate is higher or lower than the mean, 
respectively). As a result, all IVC particles are exposed to both forward and backward 
flow rates, irrespective of the time when they enter the TCPC. In the idealized TCPC on 
the other hand, the characteristic propagation time, T*, is about one fourth of the cardiac 
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cycle duration and one half of either forward or backward flow phases. Accordingly, 
particles entering the TCPC at the beginning of the forward flow phase benefit from flow 
rates higher than the mean flow for their entire traverse of the TCPC, leading to shorter 
minimum residence times than under the mean non-pulsatile conditions. Symmetrically, 
particles seeded at the beginning of the backward phase are carried by flow rates lower 
than the mean flow, leading to longer maximum residence times than under the mean 
non-pulsatile conditions.  
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Figure 10-5: Graphical representation of the characteristic propagation time, T*, relative 
to the cardiac cycle and forward flow phase duration in the idealized TCPC and the two 
patients with a normal systemic venous return, Patients 1 and 2. 
 
 
- 396 -  
For Patient 3, the shorter pulsatile residence times do not find their roots in the 
faster forward flows, since even the fastest particles take close to 1.5 cardiac cycles to 
cross the TCPC domain, but rather in the drastic increase in mixing between the HepV 
and SVC streams under pulsatile conditions compared to the non-pulsatile predictions. As 
was pointed out in Chapter 8 (Section 8.5), due to the very high pulsatility levels 
recorded in Patient 3 (PIHepV = 361%), the non-pulsatile flow conditions fail to represent 
the richness of the pulsatile dynamics, and in particular the levels of instabilities and 
HepV-SVC mixing observed throughout the hepatic baffle. As a result a portion of the 
hepatic particles is carried by the faster SVC flow, translating in a 36% decrease in the 
shortest and longest residence times. The peak pulsatile residence time is only 18% lower 
than the non-pulsatile one, reflecting the adverse effect of the backward flow phase, 
which, for Patient 3, actually translates into hepatic flow reversal.  
In terms of the characteristic non-dimensional numbers of the problem, these 
observations imply that whether or not the non-pulsatile residence times adequately 
describe the pulsatile values depends on 1) the pulsatility index, high pulsatility indices 
implying increased mixing, which will change the residence times, and 2) the ratio of T* 
to the cardiac cycle duration, T*/T, a high ratio indicating a long relative propagation 
time, which will average out the pulsatile effects, while a smaller ratio would yield a 
larger impact of the forward and backward flow phases, leading to a lager spread between 
the minimum and maximum pulsatile residence times. It might also be worthwhile noting 
that T*/T scales as α2/Re allowing for a fast assessment of the relative duration of the 
characteristic residence time. 
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10.2.3.4 Residence-Times Comparison across Templates 
Finally, comparing the residence time ranges across the different cases, no 
significant difference is observed in terms of the minimum residence times (5%) or the 
mode (residence time associated with the highest probability) across the four different 
geometries, nor is there any significant difference in maximum residence times 
(corresponding to the 95% cumulative probability) across the three extra-cardiac TCPCs 
(idealized TCPC, Patient 1 and Patient 3). On the other hand, there is a notable increase 
in the maximum normalized residence time when going from the extra-cardiac 
geometries, for which it is typically on the order of 3, to the intra-atrial anatomy of 
Patient, for which it reaches up to 5.63 under pulsatile conditions. These extended 
residence times are associated with particles that get entrapped in small flow separation 
and recirculation regions, due to irregularities in the intra-atrial IVC baffle. Such flow 
features and extended residence times could be very detrimental in terms of thrombo-
embolic risks, favoring platelet aggregation and thrombus formation. 
 
10.2.4 Summary of the Pulsatile Investigation 
10.2.4.1 Relevance of the Current Findings to the Broader Patient Population  
In an effort to generalize our observations to a larger patient pool, Figure 10-6 and 
Figure 10-7 show the in vivo flow structures associated with three intra-atrial and three 
extra-cardiac anatomies as reported by Sundareswaran et al. [80]. Similarly to the intra-
atrial anatomy examined in this thesis, the three intra-atrial anatomies are characterized 
by irregular baffle geometries, important flow recirculation at the center of the 
connection, and small recirculation regions localized along the irregularities in the intra-
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atrial wall geometry. The extra-cardiac options, on the other hand, are associated with 
cylindrical geometries, and undisturbed IVC flow structures aligned with the vessel axis. 
The flow structures at the center of the extra-cardiac connections do not feature the large 
flow recirculation region seen in the intra-atrial TCPCs. The IVC and SVC streamtraces 
collide head-on, forming a stagnation point at the center of the connection around which 
they divide between the LPA and RPA.  
These in vivo flow structures are in good qualitative agreement with the ones that 
were observed during our pulsatile investigation in the intra-atrial and extra-cardiac 
anatomies. This resemblance supports the fact that although based on a very small sample 
size, our findings are representative of the differences between intra-atrial and extra-
cardiac TCPCs.  
 
 
 
CHOP 073 CHOP 078 CHB 4
 
Figure 10-6: Intra-atrial flow structures as reconstructed from 3D PC MRI for three 
patients in the Georgia Tech Fontan database. (Image courtesy [80]) 
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CHOP 091 CHOP 089 CHOP 090
 
Figure 10-7: Extra-cardiac flow structures reconstructed from 3D PC MRI for three 
patients in the Georgia Tech Fontan database. (Image courtesy [80]) 
 
  
10.2.4.2 Lessons Learnt from the Intra-Atrial vs. Extra-Cardiac Comparison  
Comparing the results across patients, the connection type had little impact on the 
reported power losses, which mostly depended upon the vessel cross-sectional areas, the 
strongest determinant being the minimum PA cross-sectional areas. For the Langangian 
metrics, on the other hand, the intra-atrial anatomy was found to favor both 1) IVC-SVC 
mixing at the center of the connection, due to the bulgier shape of the intra-atrial baffle 
compared to extra-cardiac grafts, and 2) long particle residence times, due to local 
irregularities in the baffle geometry. While the former point might be desirable as a mean 
to ensure a more balanced HFD, the latter might on the opposite be detrimental as longer 
particle residence times will in turn favor cell-to-cell contacts, which might yield higher 
thromboembolic risks.  
Comparing the results across patients, the reported power losses mostly depended 
upon the vessel cross-sectional areas, the strongest determinant being the minimum PA 
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cross-sectional areas. In comparison, other geometrical parameters (intra-atrial vs. extra-
cardiac, caval offset, vessel flaring or vessel curvature) only had a second order effect on 
the reported power loses, but had a stronger impact on the hepatic flow distribution. The 
primary course of action to minimize the workload imposed on the single ventricle is thus 
to prevent any local vessel constriction and dilate any existing pulmonary stenosis, while 
the other geometrical parameters might be better optimized with respect to hepatic flow 
distribution. 
In Figure 10-7, CHOP 090 favors the IVC flow distribution to the RPA due to a 
right-sided caval offset, while in absence of caval offset CHOP 091 favors the IVC flow 
distribution towards the LPA due to the baffle curvature. Similarly, in the idealized and in 
vivo extra-cardiac connection, the IVC flow went in priority to the closest PA and only 
the remaining flow went to the contra-lateral lung. While this situation might be 
acceptable when the IVC accounts for the majority of the systemic venous return, it will 
become problematic if the IVC or hepatic flow rate is significantly lower than that of the 
SVC, such as in patients with an interrupted IVC, for example.  
The intra-atrial anatomy was found to provide an advantage in that regard, as the 
bulgy intra-atrial baffle favored IVC-SVC mixing at the center of the connection, 
providing a mean to more evenly distribute hepatic flow to the two lungs. In counterpart 
the local irregularities and sudden changes in the baffle cross-sectional area yielded small 
recirculation regions where particles got entrapped, resulting in extended particle 
residence times in the intra-atrial anatomy compared to the extra-cardiac ones. 
Accordingly, while a bulgy connection area might be desirable as a mean to ensure a 
more balanced hepatic flow distribution, sudden geometrical changes might on the 
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opposite be detrimental as longer particle residence times will in turn favor cell-to-cell 
contacts, which might yield higher thromboembolic risks.  
An interesting direction to explore might thus be to try and optimize the shape of 
the central connection area, in such a way that the IVC and SVC flows would thoroughly 
mix at the center of the connection, but that all regions of the connection would be 
properly washed out. Intra-atrial TCPCs building upon a hemi-Fontan procedure in the 
second stage, as in all the intra-atrial geometries shown in Chapter 7 and in Figure 10-6, 
could achieve that purpose provided intra-atrial tunnels offered sufficient control over the 
wall geometry to avoid local irregularities. The solution could thus potentially reside in 
designing an artificial graft that would reproduce the features of these hemi-Fontan plus 
intra-atrial connections, including the bulgy connection area, little to no IVC curvature 
nor left-right caval offset, and the anterior posterior offset between the vanae cavae and 
pulmonary arteries. 
 
10.2.4.3 Impact of Flow Pulsatility 
Across the different cases considered, flow pulsatility was found to enhance the 
levels of flow unsteadiness observed under non-pulsatile conditions; yield higher mean 
power losses than the predicted non-pulsatile value; and, in cases where IVC-SVC 
mixing was already observed under non-pulsatile conditions, improve the hepatic flow 
distribution by further enhancing the natural flow unsteadiness and mixing. The impact of 
pulsatility on the particle residence times mostly depended 1) the level of pulsatility, 
reflected by the pulsatility index, and 2) on the characteristic propagation time, T*, 
relative to the cardiac cycle duration, T, which might be expressed as a function of α2/Re. 
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T*/T ratios below ½, as in the idealized TCPC, led to a larger spread in the recorded 
residence times, with faster particle propagations during the forward flow phase and 
longer ones during the backward flow phase.  
This being said, the differences between the non-pulsatile performances and the 
mean pulsatile values remained very slight for the idealized TCPC, Patient 1 and Patient 
2, all of which had a maximum pulsatility index lower than 80%. A drastically different 
situation was encountered for Patient 3, who featured a hepatic pulsatility index of 361%, 
and hepatic flow reversal for about half of the cardiac cycle. Pulsatile losses for that 
patient were more than twice the predicted non-pulsatile value; the amount of flow 
unsteadiness and mixing in the hepatic baffle under pulsatile conditions had no common 
measure with their non pulsatile counterpart; and, due to the increased HepV-SVC 
mixing, the pulsatile residence times were significantly shorter than under non-pulsatile 
conditions. 
 
Implications for Patient-Specific Modeling: Based on the data presented in this thesis, 
the non-pulsatile assumption appears to predict the actual pulsatile efficiency metrics 
with a reasonable accuracy for lower pulsatility levels (below 80%), but there clearly is a 
threshold above which the non-pulsatile predictions no longer correlate to the actual in 
vivo measures. The definition of the exact threshold above which the non-pulsatile 
assumption fails would require a larger number of cases, progressively varying 1) the 
pulsatility index in each one of the vessels, 2) the phase shift between the superior and 
inferior waveforms, and 3) the TCPC geometry (mostly the IVC and SVC offsets, and the 
connection type) to assess the impact of flow pulsatility for varying degrees of IVC-SVC 
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interactions. Of particular interest might be the quantification of the impact of pulsatility 
indices around 100%, threshold over which the flow is reversed for part of the cardiac 
cycle, and which might thus be expected to yield significant differences. 
It should also be noted that the high pulsatility levels in the hepatic baffle for 
Patient 3 might be a consequence of the adverse pressures and kinetic energy of the SVC 
flow. In such case, it might interesting to couple the CFD results with a lumped 
parameter model, to try and determine the configuration that would minimize the SVC 
and HepV interactions and potentially avoid hepatic flow reversal. 
Finally, it should be re-emphasized that the efficiency metrics considered herein 
focused on time-averaged quantities, which are, by definition, more easily captured under 
mean non-pulsatile conditions than the dynamic ranges that pulsatile pressures, shear 
stresses or power losses may cover over a cardiac cycle. If capturing the maximum 
pulsatile power losses, for example, was of primary interest, this would obviously 
drastically lower the range of pulsatility indices for which the non-pulsatile assumption 
appears acceptable.  
 
Clinical Implications: One argument that has been put forth in the long-standing debate 
over intra-atrial and extra-cardiac connections, is that intra-atrial TCPCs might yield 
higher pulsatility levels due to the contraction of the atrial wall. However, one question 
that arises from the results presented above is “Should pulsatility be favored, or is it 
actually detrimental to the TCPC efficiency?” This question is multi-faceted. On the one 
hand, pulsatility was observed to generally increase the mean power losses. Furthermore, 
pulsatile levels over 100% imply flow reversal in one of the vessels, and thus an 
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inefficient systemic venous return. On the other hand, pulsatility was also shown to 
increase mixing, especially in intra-atrial anatomies, which might help better distribute 
the hepatic flow to the two lungs; and the pulsatile energy bill was shown to be small 
compared to the baseline energy dissipation rate when the maximum pulsatility index was 
below 70-80%. In addition, some studies have suspected flow pulsatility in the PAs as a 
positive factor for PA development [184]. Accordingly, ensuring a certain level of 
pulsatility might indeed be beneficial, as long as it remains within reasonable bounds.  
 
10.3  Patient Specific Surgical Planning 
In the second arm of our study, we combined the accurate and versatile CFD 
solver developed as part of our first specific aim with the virtual-surgery interface 
developed by Rossignac et al. [101], thereby allowing surgeons to first interactively 
visualize the patient’s anatomy prior the surgery, virtually perform multiple different 
surgical options within the virtual-surgery environment, and finally compare their 
hemodynamic efficiency so as to identify the best suited surgical approach on a patients-
specific basis. Application and benefits of such an integrated surgical planning are 
demonstrated in Chapter 9, focusing on single-ventricle patients featuring an interrupted 
IVC with azygous continuation, who represent a particularly challenging clinical 
scenario. The two main optimization metrics were to minimize power losses, and evenly 
distribute blood flow and hepatic nutrients to the left and right lung. As this subgroup of 
patients is especially prone to PAVMs, emphasis was set on identifying the surgical 
option that best distributed the cardiac output and the hepatic nutrients.  
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Over the course over this study, six patients were referred for the prospective 
surgical planning of a completion or redo of the final stage of the TCPC, i.e. to connect 
the hepatic veins to the pulmonary arteries. While such individualized investigation 
provides a direct benefit to the patient under consideration, its impact for the global 
patient community is more limited, as most clinical centers to date do not have access to 
patient-specific surgical planning interfaces. Accordingly in this discussion section, we 
concentrate our attention on reviewing the results obtained across all six patients, to draw 
general guidelines and identify cases for which individualized surgical planning remains 
the only recommendable approach. 
As will be discussed in the subsequent paragraphs, the hepatic flow distribution 
(HFD) in patients with an interrupted IVC is highly sensitive to the configuration of the 
superior venous returns. Accordingly, the six patients enrolled in this study were 
separated into two groups: (i) single SVC patients who had a normal systemic venous 
return, and for whom SVC, inominate and azygous flows merged together in the 
Kawashima connection; and (ii) patients with a persistent left superior vena cava 
(LSVC), which resulted in two separated superior connections, one on the right with the 
SVC and one on the left with the LSVC, the azygous vein connecting to either one of the 
SVC or LSVC. 
 
10.3.1 Optimizing Flow Distribution and HFD for Patients with a Single 
SVC 
Comparing the options recommended for each one of the three single SVC 
patients leads to controversial conclusions. Using a Y-shaped Optiflo graft, for example, 
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was the best performing option for patient A2 both in terms of hepatic flow distribution 
and energy dissipation, but was also the worst performer for Patient A1, and could not 
even be attempted in Patient A3 due to spatial constraints imposed by the surrounding 
organs. Similarly, the best option for Patient A3, namely an intra-atrial connection with 
no-offset compared to the SVC axis, was actually not recommended for the other two 
patients because the HFD in Patients A1 and A2 showed too sensitive to even slight 
variations in connection angle and offset. 
10.3.1.1 Idealized Analysis 
The common denominator behind all of these observations is the fact that due to 
the low hepatic flow rate compared to the sum of the superior venous returns, the optimal 
solution for a given patient is in large part dictated by the orientation and flow rates of the 
combined SVC, IV and AZ vessels. This can be better understood by looking at Figure 
10-8, where we compare, in highly idealized TCPCs, the impact of a large right-sided 
offset on the IVC of a patient with a normal systemic venous return and the hepatic 
distribution of a patient with an interrupted IVC. For both cases, the cardiac output (CO) 
is assumed to be 4 L/min with a 50/50 RPA/LPA global flow distribution. The IVC flow 
rate is set to 60% CO, which is representative of the in vivo caval flow distributions for 
patients older than 6 or 7 years of age, and the HepV flow rate to 20% CO as a 
representative example of what was observed in our surgical planning studies.  
Even with an offset such that the IVC and SVC do not have any direct interaction, 
the IVC flow would still split between the LPA and RPA would it only be to ensure 
global mass conservation. Under the conditions described, the IVC is expected to 
contribute 0.4 L/min to the RPA flow rate, leading to an HFD of 17%, which would 
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increase linearly with any increase in RPA mass flow split. In the interrupted IVC case, 
on the other hand, the HepV only contributes 0.8 L/min, such that all hepatic flow will go 
to the RPA unless the RPA flow rate falls below 0.8 L/min. A balanced 50/50 HFD 
would correspond to the scenario where the RPA flow rate is only 0.4 L/min, which 
would be an unacceptably unbalanced global flow distribution and would most likely be 
associated with severe left-sided PAVMs. This analysis explains the failure of all options 
with even a slight offset towards the RPA or LPA. 
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Figure 10-8: Idealized representation of the impact of a right-sided offset on the IVC flow 
distribution of a patient with a normal venous return and the hepatic flow distribution of a 
patient with an interrupted IVC. In both cases, the cardiac output is assumed to be 4 
L/min with a 50/50 RPA/LPA global flow distribution. The IVC and hepatic flow rates 
were set at 60% CO and 20% CO, respectively, as representative examples of what is 
seen in vivo. 
 
 
A potential alternative could be to avoid any caval offset. As illustrated in Figure 
10-9 with similar idealized representations as in Figure 10-8, such approach might work 
for normal systemic venous returns leading to a head on collision between the IVC and 
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SVC flows and forcing both inflows to split towards the LPA and RPA. However, as was 
highlighted in the pulsatile investigation, a small deviation from the zero-offset 
configuration may lead to a preferential IVC distribution to one of the lungs, even with a 
normal venous return. This sensitivity is amplified in patients with an interrupted IVC 
due to the low HepV flow rate, which leads to a low kinetic energy and effectively 
prevents the HepV to compete with the superior inflows. As a result, if the superior 
inflows have a preferential direction towards one lung, then the path of least resistance 
for the HepV flow will be to flow to the other lung. Furthermore, any flaring or 
enlargement of the hepatic baffle towards the connection site will allow the high energy 
superior inflows to engulf into the hepatic baffle, further constraining the hepatic flow 
towards one side. 
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Figure 10-9: Idealized representation of the absence of any caval offset on the IVC or 
hepatic flow distribution for a patient with a normal venous return and a patient with an 
interrupted IVC. In both cases, the cardiac output is assumed to be 4 L/min with a 50/50 
RPA/LPA global flow distribution. The IVC and hepatic flow rates were set to 60% CO 
and 20% CO, respectively, as representative examples of what is seen in vivo. 
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10.3.1.2 Application to the Understanding of HFD Behavior In Vivo 
The simplified analysis conducted above sheds light onto the different 
performances observed for the same option in different patients. To better illustrate our 
point, Figure 10-10 and Figure 10-11 review the hepatic flow distribution in view of the 
superior inflow directions and resultant splitting point across selected options for Patients 
A1 and A2. As can be observed by comparing the pre-operative anatomy to Option 1 for 
Patient A1 (Figure 10-10) or the pre-operative anatomy and Options 1 through3 for 
Patient A2 (Figure 10-11), it is not so much the location of the hepatic baffle with respect 
to the geometrical center of the Kawashima connection that matters, than its position with 
respect to the splitting point imposed by the superior inflow directions.  
This observation did not only apply to the classic intra-atrial or extra-cardiac 
approaches, but also to the Y-shaped Optiflo grafts. Failure of the Optiflo option (option 
2) for Patient A1 stemmed from the fact that the left branch did not reach far enough to 
the LPA and offered a large opening area to the SVC. As a result, similarly to what was 
seen in the pre-operative anatomy, the SVC penetrated into the left hepatic branch 
constraining the flow to the RPA. For Patient A2 on the other hand the left and right 
branch of the Y-graft fell on either side of the splitting point, allowing the hepatic flow to 
flow freely through either one of the branches. The success of the intra-atrial option with 
no caval offset for Patient A3 stemmed from the fact that the hepatic flow accounted for 
30% CO, which was significantly larger than in Patients A1 and A2, and allowed the 
HepV flow to sustain the collision with the superior inflows. In addition, the superior 
inflows entered the connection with no strong preferential direction, thus allowing the 
combined superior and hepatic flows to split in equal amounts towards the two lungs.  
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Figure 10-10: Comparison of the hepatic flow distribution to the flow splitting point 
imposed by the superior inflows for Patient A1 under the pre-operative flow conditions. 
The superior inflow directions are schematized based on the global flow structures 
displayed in the left panel for the pre-operative anatomy and reported onto the options 
shown in the right panel. 
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Figure 10-11: Comparison of the hepatic flow distribution to the flow splitting point 
imposed by the superior inflows for Patient A2 under a 50/50 RPA/LPA global flow 
distribution. The dotted line represents the location of the flow splitting point in Option 2, 
which is reported in the other options for comparison. 
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Finally, for all three patients, re-routing the hepatic flow into the azygous vein 
resulted in hepatic flow distribution that closely followed the global flow distribution due 
to a thorough mixing of all inflows at the center of Kawashima connection (Figure 
10-12). On the other hand, this option was also consistently associated with the highest 
power losses of all tested options, approximately doubling the TCPC energy expenditure 
for the three patients considered. 
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Figure 10-12: HepV-to-AZ connection for the three single SVC patients and the 
associated global and hepatic flow distributions to the RPA (GFDRPA and HFDRPA, 
respectively) 
 
 
10.3.1.3 Summary 
In summary, for patients with an interrupted IVC and a single SVC, the optimal 
TCPC configuration not only depends on the geometrical considerations (such as offset, 
flaring or curvature), but also on the superior/inferior flow ratios and flow directions, 
making it especially challenging for surgeons to identify the best suited approach based 
on anatomical considerations alone. This is a typical scenario where virtual surgical 
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planning may help, allowing for the optimal TCPC to be designed on a patient-by-patient 
basis. In lieu of a better option or individualized surgical planning, re-routing the hepatic 
flow into the azygous vein may be the recommended approach, as it ensures proper 
hepatic flow distribution for all three patient considered via a thorough blood mixing. 
However, this option also comes at high energy expenses, such that more efficient 
alternatives should be pursued whenever possible. 
 
10.3.2 HFD Optimization for Patients with a Persistent LSVC 
Similarly, to what was seen with single SVC patients, patients with a persistent 
LSVC demonstrated a high sensitivity to the caval offset, due to the inability of the low 
energy hepatic flow rate to compete against the superior venous return. However, thanks 
to the separation of the left and right superior inflows, this second group of patients 
presented a somewhat simpler scenario to handle than single SVC patients, and more 
systematic guidelines can be extracted from the results displayed.  
10.3.2.1 Idealized Analysis 
To better understand the HFD behaviors observed across our patient pool, let us 
first frame an idealized scenario, based upon the geometrical configuration depicted in 
Figure 10-13. In absence of flow collision and mixing, the venous returns will tend flow 
towards the path of least resistance, which can be accounted for by modeling the 
hydrodynamic resistance of each vascular segment, but can also be well understood based 
on global flow conservation considerations. 
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 Connection to the RPA Connection to the mid-PA Connection to the LPA 
LSVC
+ AZSVC
RPA LPA
HepV  
Figure 10-13: Idealized representation of the impact of various HepV offset locations on 
HFD distribution for a patient with an interrupted IVC and persistent LSVC.  
 
 
In the case of a hepatic baffle connected to the RPA for example (left panel in 
Figure 10-13), all hepatic blood flow will be directed to the RPA unless the RPA flow 
rate drops below the hepatic one. In the later scenario, the hepatic flow would split 
between the right and left branches, supplying all blood flow to the RPA while the rest 
would flow to the LPA. HFDRPA for such an option would thus be governed by the 
following equation: 
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where QHepV and QRPA, are the hepatic and RPA flow rates, respectively. Symmetrically, 
in the case of a left-sided offset, HFDRPA would be governed by: 
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While in patients with a single SVC, the determination of the zero-offset position 
revealed very challenging, the separation of the left and right systemic venous returns 
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offers a potential solution allowing the hepatic baffle to be placed on the mid-PA, in 
between the SVC and LSVC. For the idealized configuration depicted in Figure 10-13 
(b), we may assume that, as long as the SVC suffices to provide the desired RPA flow 
rate (i.e. QRPA < QSVC), all hepatic flow goes to the LPA. If the RPA demand exceeds 
what can be provided by the SVC alone, the hepatic flow splits between the right and left 
branch, until the point where QRPA exceeds the contribution of the hepatic and SVC flows 
combined and all hepatic flow goes to the RPA. The idealized HFDRPA for a connection 
to the mid-PA reads as: 
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 (10-9) 
 
Although based on very simple mass conservation principles, the idealized 
framework derived above provides an excellent description of what was seen for the 
patients enrolled in our surgical planning study. This is illustrated in Figure 10-14 where 
we compare the HFDRPA patterns predicted using Equations 9-7 to 9-9 to the ones 
obtained from the CFD simulations for Patient B3, observing a remarkable agreement 
between the two approaches for the ½ diameter offset to the RPA case and the central 
connection to the mid-PA.  
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Figure 10-14: Comparison of the hepatic flow distributions predicted from the idealized 
Equations 9-7 to 9-9 to the values computed from CFD a right-sided and mid-PA options 
for Patient B3 (Options 2 and 7 in Chapter 9, Section 9.3.3) 
 
 
10.3.2.2 Extraction of the General HFD Behaviors in Patients with Persistent LSVC 
The strengths of our idealized framework are that it very well captures the general 
trends observed across our patient cohort, without the underlying patient-to-patient 
variations, thereby allowing for a fast understanding of the driving mechanisms behind 
the hepatic flow distribution in patients with a persistent LSVC.  
 
RPA/LPA Offset and HepV-to-AZ shunts: From the Equations 9-7 and 9-8, it may be 
seen that offsetting the hepatic baffle towards the RPA will yield a balanced 
HFDRPA=50% when QRPA = 0.5QHepV, and symmetrically that an offset towards the LPA 
would yield a balanced HFD for QLPA = 0.5QHepV. Given the fact that, in patients with an 
interrupted IVC, only 20% CO enters the connection through the hepatic baffle, these 
equations imply that an offset towards either one of the PAs will result in PAVMs in the 
contra-lateral lung. While apparently trivial, this result is of importance since extra-
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cardiac hepatic conduits typically reach the SVC with a slight offset towards the RPA, 
which results in a complete unilateral distribution of the hepatic flow to the RPA, as 
shown in Figure 10-14. HepV-to-AZ connections are also highly not recommended for 
patients with a persistent LSVC, as they result in a unilateral HFD to the PA closest to the 
azygous vein connection very much similar in their effect to an LPA or RPA offset (see 
Figure 10-15). 
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Figure 10-15: HFD performance of an HepV-to-AZ connection for Patient B1 (symbols), 
compared to the effect of a left sided offset as predicted by Equation 9-8. 
 
 
Mid-PA Connections: The best options for Patients B1 and B3 were to connect the 
hepatic baffle to the mid-PA segment. The associated HFD behavior is displayed in the 
right panel of Figure 10-14 for Patient B3. As described for the idealized mid-PA 
connection, this configuration resulted in the all of the hepatic flow going to the RPA, if 
the LSVC+AZ flows sufficed to meet the demand of the LPA, and all to the LPA if the 
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RPA flow rate was below that of the SVC. For RPA/LPA flow splits falling in between 
those two extremes, it was the hepatic flow that adjusted its distribution to meet the LPA 
and RPA demands. However, this approach failed to provide satisfactory results for 
Patient B2. This can readily be understood by looking at the distribution of the superior 
venous returns for Patients B1 and B3 and contrasting them to the ones observed in 
Patient B2.  
For Patient B1, the SVC contributed 33% CO while the LSVC and AZ flows 
combined accounted for 43%. As a result, the mid-PA options reached a balanced HFD 
of 50/50 for a global flow distribution of 45/55 RPA/LPA, which was an almost ideal 
configuration. Results were even better for Patient B3 (Figure 10-14), for whom the SVC 
and LSVC+AZ flows contributed almost equally to the systemic venous return 
(accounting for 38% and 41% CO, respectively), which yielded a balanced HFD for a 
close to perfectly balanced global flow distribution of 48.5/51.5 RPA/LPA. For patient 
B2 on the other hand, the LSVC flow only accounted for 19% CO while the right-sided 
superior venous returns (here the AZ and SVC) carried 71% of the total venous return. 
The resultant 50/50 HFD as predicted by Equation 9-9 would be associated with a global 
flow distribution of 76/24 RPA/LPA. In effect, all attempts to concurrently balance HFD 
and global flow distribution with a centrally connected baffle failed for that patient. 
Accordingly, while mid-PA connections appear as a simple and efficient approach 
for patients with persistent LSVC, the in vivo flow rates should be taken into 
considerations prior to any implementation. In cases with highly unbalanced left and right 
superior venous returns, such as Patient B2, the mid-PA options should be avoided and 
other options should be pursued. 
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Sensitivity of the mid-PA connections to the hepatic baffle design and exact 
anastomosis location: Similarly to what was seen for single SVC patients, even a small 
offset variation in the surroundings of the SVC lead to a drastic shift in the HFD behavior 
due to the low momentum of the hepatic flow, leading from a highly preferential flow 
distribution to the RPA when the hepatic baffle was even slightly offset towards the right 
(Figure 10-14_left), to a centered HFDRPA when the baffle was connected with a slight 
offset to the mid-PA (Figure 10-16_top left). On the other hand, provided that the hepatic 
baffle was placed between the SVC and LSVC (Figure 10-16), its exact position along 
the mid-PA segment has little impact on the overall HFD performance. Nor do the type of 
baffle used, angle at the connection site, vessel flaring or baffle curvature. When the 
hepatic baffle is connected less than ½ diameter away from the SVC (top left panel in 
Figure 10-16), the computed HFDRPA slightly departs from the theoretical line for lower 
GFDRPA values, reflecting some amount of mixing and interaction between the hepatic 
and SVC flows. Symmetrically, when the baffle is connected less than ½ diameter away 
from the LSVC (top right panel in Figure 10-16), the computed HFDRPA values depart 
from the theoretical line for higher GFDRPA values, due to HepV-LSVC flow interactions. 
However, these variations remain small overall, and all mid-PA options could be used to 
the same effect.  
This observation is invaluable from a surgical standpoint as it implies that even 
small offsets may suffice to achieve the desired performance, thus rendering these 
options feasible even in patients where the overriding aorta significantly restricts the 
access to the mid-PA segment. 
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Figure 10-16: Sensitivity of the mid-PA connections to the hepatic baffle design and 
exact anastomosis location along the mid-PA segment (illustrated with for Patient B3) 
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Sensitivity of the mid-PA connections to the LPA/RPA flow distribution: The range 
of RPA/LPA flow ratios over which both lungs receive at least part of the hepatic flow 
(i.e. 0%<HFDRPA<100%) is directly related to the contribution of the hepatic flow rate to 
the systemic venous return. For Patient B3 (Figure 10-16), for example, this transition 
range spanned from GFDRPA = 33% to GFDRPA = 57%, and ensured that both lungs 
received at least 20% of the hepatic flow rate for global flow distributions ranging 
between 38/62 and 52/48 RPA/LPA. This transition range will be drastically reduced for 
patients with a low hepatic flow rate, such as Patient B3 for whom QHepV only accounted 
for 10% CO. Such low relative hepatic flow rate will result in the hepatic flow 
transitioning from the LPA to the RPA over a very narrow range of RPA/LPA flow 
ratios, providing a very low tolerance to transient or permanent changes in pulmonary 
vascular resistances.  
 
Decreasing the sensitivity to the RPA/LPA ratio, AZ-to-HepV shunts: While a low 
hepatic flow rate cannot be increased, combining the azygous and hepatic flows, for 
example, could achieve the same purpose. Assuming complete mixing of the AZ and 
HepV streams and a mid-PA connection, the corresponding idealized HFD distribution 
would read as:  
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Equation 9-10 is equivalent of Equation 9-9, with the only difference that the hepatic 
flow distribution is proportional to the distribution of the combined AZHepV QQ +  instead 
of HepVQ  alone.  
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The impact of redirecting the azygous flow into a centrally connected hepatic 
baffle is illustrated in Figure 10-17 for Patient B1. First, it might be noted that the 
theoretical HFDRPA behavior given by Equation 9-10 falls in close agreement with the 
actual CFD measurement for that option. Similarly to the earlier mid-PA cases, this 
agreement is due to the low level of interaction between the different inflows, which to a 
scenario very similar to the idealized framework. The impact of combining azygous and 
hepatic flows can be visualized by comparing the orange and green lines in the figure. As 
the SVC is left untouched, both curves start to rise above 0% for the same GFDRPA value 
of 33%. However, the addition of the azygous blood flow reduces rate of increase, since 
for every increase in RPA blood flow, both AZ and HepV flows adjust their distribution 
in favor of the RPA. As a result the range of GFDRPA values over which the hepatic 
flow switches from the left to the right increases from 33-54% with the hepatic flow 
alone to 33-78% with the combined azygous and hepatic flows.  
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Figure 10-17: Impact of combining azygous and hepatic flows into a centrally connected 
baffle for Patient B1. The orange line depicts the HFDRPA behavior prediceted under 
idealized conditions (Equation 9-10), while the green line shows the prediction for the 
same hepatic baffle design but without the addition of the azygous flow (Equation 9-9). 
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While the addition of an AZ-to-HepV shunt may not be necessary for patients 
such as Patients B1 or B3 for whom the hepatic blood flow contributed more than 20% to 
the systemic venous return, it may be a well suited or even necessary approach for 
patients with low hepatic flow rates. Indeed, a significant problem for Patient B2 
stemmed from the fact that the hepatic flow rate was so low that the superior venous 
returns engulfed deep down into the baffle, creating large regions of flow disturbances 
and blocking the hepatic flow path. The addition of the azygous flow resolved that part of 
the problem, providing sufficient kinetic energy to the combined azygous and hepatic 
streams to avoid penetration of the SVC or LSVC into the baffle. Furthermore in cases 
such as patient B2, where the SVC+AZ flows accounted for a significantly larger amount 
of the systemic venous return compared to the lone LSVC, redirecting the azygous flow 
to the hepatic baffle might also be a way to re-establish a better balance between the left 
and right superior venous returns. 
 
Alternate Options, Splitting the hepatic conduit in two branches: The last set of 
options that was attempted was to split the hepatic flow into a right and left branch using 
either a Y-shaped graft or an H-connection, with an HepV-to-AZ shunt on one side and a 
hepatic baffle on the other, which was designed with a voluntary offset away towards the 
closest PA. For Patients B1 and B3, these options were very similar in their HFD 
behavior to a centrally connected hepatic baffle, without marked advantage over the 
former options. The scenarios were these options might be the best suited is when the 
SVC and LSVC fall too close to one another for a mid-PA segment to clearly defined. In 
those cases, a Y-shaped graft or H-connection circumvents the problem of identifying 
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where the LSVC anastomosis ends and where SVC begins. Patient B2 was a good 
example of such situation and the best suited option for that patient was to either use an 
H-connection or an AZ-to-HepV shunt merging into a Y-shaped hepatic graft. 
 
10.3.2.3 Summary 
In summary, for patients with almost equal right and left superior venous returns, 
and a well defined mid-PA segment, the simplest and most efficient approach was to 
connect the hepatic baffle to the mid-PA segment. This option provides the added 
advantages of a low sensitivity as to the exact surgical implementation, allowing room for 
error and adaptation to unexpected constraints. For patients, with an identifiable mid-PA 
but either low hepatic flow rate or highly unbalanced right and left superior venous 
returns, combination of the hepatic and azygous flows might be an adequate solution. The 
simple set of equations presented herein provides a rough, yet efficient mean to assess 
whether a mid-PA connection would perform well or if the addition of an AZ-toHepV 
shunt might be beneficial. Finally, for patients such patient B2, with an undefined mid-
PA, unbalanced right and left superior inflows and low hepatic flow rate, individualized 
surgical planning remains the most recommendable approach. 
 
 
10.3.3 Minimizing Power Losses 
Across all six patients, power losses showed little dependency on parameters such 
as curvature, offset or the angle of connection. The strongest power loss determinants 
were the vessel dimensions and vessel flow rates. This is consistent with the observations 
of the pulsatile study, where the baseline TCPC power losses were found to scale as: 
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The clinical implication of this observation is that, first, power losses are a low 
discriminator in between different surgical options. With the exception of HepV-to-AZ 
shunts, emphasis may be thus set on hepatic flow distribution without having to 
compromise the energy efficiency. Next, forcing the hepatic flow into the azygous vein 
was associated with high power losses across all patients. This stems from the fact that 
the azygous is typically one of the smaller vessels, although carrying an important portion 
of the inferior venous return. Further increasing the flow rate through that vessel will 
increase the associated losses as follows: 
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Even if we assumed the azygous vein to have the same cross-sectional area as the hepatic 
baffle, the increase in power losses, ΔPL, would scale as: 
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and an even larger increase might be expected for cases where the azygous vein is 
smaller than the hepatic baffle. Accordingly, this option should be avoided when other 
alternatives are feasible. Finally, local vessel constrictions or stenoses were a major factor 
for high power losses and pressure drops. A typical example of high pressure drops due 
to an LPA stenosis is provided by Patient A1, while Patient B3 provides a typical 
example of a narrow mid-PA segment. These local stenoses should be dilated at the time 
of surgery, allowing blood to flow freely to the two lungs. For the bilateral SVC patients, 
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mid-PA connections might offer the advantage of combining the TCPC completion and 
mid-PA stenosis dilation into one single intervention.  
 
10.3.4 Conclusion of the Surgical Planning Investigation 
In this section we presented the feasibility and potential benefits of an integrated 
surgical planning framework for the optimization of the TCPC design for patients with an 
interrupted IVC. These patients are especially at need for such virtual surgery 
environments as they present a large number of anatomical and venous return 
abnormalities that make the identification of the best-suited approach based on 
anatomical considerations alone difficult if not impossible. As a result, patients with 
interrupted IVC present an especially high incidence of PAVMs due to an inadequate 
design of the hepatic baffle. Our patient-specific investigations provided the operating 
surgeon with additional information as to what may be the better suited option. Taking 
this framework to the next stage would now require the acquisition of patient follow-up 
data to asses the accuracy of our post-operative projections/predictions, as well as to gain 
further insights into the relative importance of different optimization metrics. For single 
SVC patients in particular, HepV-to-AZ shunts were systematically among the best 
performers in terms of HFD but the worst in terms of energy efficiency. Weighing the 
importance of one parameter against the other would require long-term follow-up on a 
large patient pool to compare the parallel evolution of pulmonary and ventricular 
function, and the HFD and power loss metrics.  
Finally, by reviewing the experience gained over the six patients enrolled in this 
study, some general recommendations may be extracted for patients with bilateral SVCs. 
- 426 -  
However, these recommendations are first based on a very small patient pool, and then 
only apply to a subset of patients, who feature a well defined mid-PA and relatively 
balanced left and right superior venous returns. For patients falling outside of this 
template, and for all single SVC patients, individualized surgical planning remains the 
best suited strategy. 
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CHAPTER 11 
CONCLUSIONS 
 
At the beginning of this research endeavor, it was hypothesized that a robust and 
thoroughly validated image-based numerical modeling framework would constitute a 
critical asset for the surgical treatment of patients with complex single-ventricle heart 
defects (SVHD), and in particular for the optimization of the total cavopulmonary 
connection (TCPC) procedure for the most complex and rare forms of SVHDs. Towards 
this end, the primary contributions of this thesis are three fold: a) the development of a 
novel unstructured immersed boundary approach for accurate and efficient numerical 
simulations in arbitrarily complex in vivo anatomies; b) the application of this numerical 
framework to probe the pulsatile in vivo TCPC hemodynamics and understand the impact 
of pulsatility on the predicted efficiency metrics; and c) the establishment of a novel 
surgical planning approach based on hemodynamic performance and the demonstration 
of its potential benefits to treat patients with complex SVHDs. 
 
11.1 Numerical Approach 
The current study presents a computational fluid dynamic (CFD) solver tailored to 
capture the geometric intricacies of in vivo cardiovascular structures and the inherent 
instabilities of the TCPC flows. The formulation retained uses a sharp interface immersed 
boundary approach [123, 164], which is recast into an unstructured Cartesian grid layout. 
This simple, yet powerful, approach combines the following advantages: 1) an easy 
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handling of arbitrarily complex in vivo anatomies; 2) the accuracy of Cartesian methods; 
and 3) a significant increase in computational efficiency and reduction in memory 
footprint, compared to classic structured Cartesian grid solvers for internal flow 
applications. The efficacy and accuracy of our method is demonstrated by applying it to 
conduct systematic mesh refinement studies for internal flow problems ranging in 
complexity from steady flow in a 90 degree curved pipe to highly unsteady flows in an 
actual, patient-specific anatomy reconstructed from magnetic resonance images (MRI), 
and comparing our results against experimental measurements obtained in a controlled in 
vitro environment.  
Results from these validation simulations demonstrate the robustness and 
accuracy of our flow solver implementation, even for cases as complex as the reported in 
vivo intra-atrial anatomy, which featured complex dynamics and chaotic mixing. The 
complexity of the flow dynamics observed in the in vivo TCPC anatomies would it be in 
the validation section or later during the pulsatile or patient-specific surgical planning 
investigations re-emphasizes the need for high resolution simulations prior to drawing 
any clinical recommendations. This is of prime importance, especially in an era when 
image-guided computational modeling is attracting increasing attention as a tool for 
refining in vivo flow measurements or predicting the outcome of different surgical 
scenarios. 
 
11.2 Investigation of the Pulsatile TCPC Hemodynamics 
After validation, the unstructured immersed-boundary CFD solver was applied to 
probe the pulsatile TCPC hemodynamics. The objective of this study was two folds: 1) 
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compare the TCPC hemodynamics across different templates, including one intra-atrial 
TCPC, one extra-cardiac TCPC, and one patient with an abnormal systemic venous return 
and highly pulsatile hepatic flow; and 2) assess the error introduced when neglecting the 
pulsatility of the in vivo TCPC flows, depending on the level of pulsatility.  
The motivation for the first aspect of this study was to further the understanding 
of the pros and cons of extra-cardiac and intra-atrial TCPC implementations. Comparing 
the results across patients, the connection type had little impact on the reported power 
losses, which mostly depended upon the vessel cross-sectional areas. On the other hand, 
the intra-atrial anatomy was found to favor both: (i) IVC-SVC mixing at the center of the 
connection, due to the bulgier geometry of an intra-atrial tunnel compared to an extra-
cardiac graft; and (ii) long particle residence times due to local irregularities in the baffle 
geometry. While the former point might be beneficial as a means to ensure a more 
balanced hepatic flow distribution, the latter might on the opposite be detrimental as 
longer particle residence times will in turn favor cell-to-cell contacts, and increase the 
risk of thromboembolic events. A larger connection area as is seen in intra-atrial 
connections could thus be a desirable feature, but such designs should be carefully 
reviewed to avoid sudden variations in the baffle cross-sectional area, minimize regions 
of flow separation, and ultimately minimize the risks of thrombus formation. 
With the constant refinement and increasing complexity of numerical tools 
available today, one pragmatic question that arises is where to set the trade-off between 
the added accuracy and the added computational cost. This question is of critical 
importance for surgical planning applications which typically require the investigation of 
a large number of options for a given patient, and are subjected to stringent time-
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constraints in order to provide the results between the time of diagnosis and the time of 
surgery. Accordingly the second aspect of the pulsatile study sought to determine when 
pulsatility might be neglected in favor of faster simulations, while still predicting the 
TCPC efficiency with reasonable accuracy.  
Across the different cases considered, flow pulsatility was found to yield higher 
mean power losses than the predicted non-pulsatile value; and, in cases where IVC-SVC 
mixing was already observed under non-pulsatile conditions, improve the hepatic flow 
distribution by further enhancing the natural flow unsteadiness and mixing. This being 
said, the differences between the non-pulsatile performances and the mean pulsatile 
values remained very slight for the three cases with moderate pulsatility levels (falling 
below 80%). On the other hand, the non-pulsatile assumption failed to capture even the 
mean flow characteristics and efficiency metrics for the patient with the highest 
pulsatility levels, which reached up to 361% in the hepatic veins. Pulsatile losses for that 
patient were more than twice the predicted non-pulsatile value; the amount of flow 
unsteadiness and mixing in the hepatic baffle under pulsatile conditions had no common 
measure with their non pulsatile counterpart; and, due to the increased HepV-SVC 
mixing, the pulsatile residence times were significantly shorter than under non-pulsatile 
conditions.  
Although limited to a very small sample size, these results indicate that there is a 
threshold below which non-pulsatile simulations might provide satisfactory results, but 
above which pulsatility ought to be included in the numerical model for accurate clinical 
recommendations. The precise definition of this threshold, however, would require a 
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larger sample size, with a better characterization of pulsatility levels falling between our 
lower and higher values, namely between 80% and 360%.  
 
11.3 Patient Specific Surgical Planning 
Finally, in the last arm of our study, we combined our numerical framework with 
the virtual surgery interface developed by Pekkan and Rossignac [101] to conduct 
prospective surgical planning investigations for six failing Fontan patients with severe 
pulmonary artero-venous malformations (PAVMs). The palliative strategy for correction 
of PAVMs typically involves a Fontan revision where attempts are made to redirect the 
hepatic effluent to the affected lung. However, as the complexity of the underlying 
anatomy increases, the amount of control that can be exercised decreases. This difficulty 
is clearly illustrated in patients having an interrupted inferior vena cava with azygous 
continuation (such as the six patients enrolled in our study) who represent one of the most 
complex forms of single ventricle heart defects, and in whom the incidence of PAVMs 
can be as high as 21%[69]. 
Clearly, the wide variety of patient anatomies makes it difficult to design a 
general procedure that fits all patients, while the complexity of in vivo anatomies poses 
significant challenges to identify the surgical option that best distributes hepatic flow for 
a given patient. This thesis introduces a whole new paradigm for addressing this problem 
using an image-based surgical planning approach that can be used to optimize Fontan 
procedures on a patient-specific basis. Different virtual operation scenarios can be 
investigated for each patient, allowing clinicians to conduct a multi-factorial risk/benefit 
analysis (balancing power losses against hepatic flow distribution and ease of completion, 
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for example), and thereby empowering them with the option to select the best treatment 
for an individual patient, which may prove beneficial and cost effective to both the 
hospital and the patient in the long-term.  
While such individualized investigation provides a direct benefit to the patient 
under consideration, its impact for the global patient community is more limited, as most 
clinical centers to date do not have access to patient-specific surgical planning interfaces. 
Taking advantage of the experience gained from the six patient-specific surgical planning 
studies, the final arm of this study provides general surgical guidelines for Fontan 
patients with an interrupted IVC, and identifies cases for which individualized surgical 
planning remains the only viable approach. A characteristic of patients with an 
interrupted IVC is that most of the lower systemic venous return reaches the SVC 
through the azygous vein, while the TCPC baffle only carries the hepatic blood flow, 
resulting in a low energy blood stream that cannot compete against the superior venous 
returns. Consequently, all six patients demonstrated a very high sensitivity to the location 
of the baffle anastomosis with respect to the superior venous returns.  
The recommended approach depends on whether the patient has: 1) a normal 
superior venous return with a single superior vena cava (SVC); or 2) a persistent left 
superior vena (LSVC). For patients with an interrupted IVC and a single SVC, “classic” 
intra-atrial or extra-cardiac options are for the most part not recommended, as even a 
small offset with respect to the superior inflow directions leads to a complete shift in the 
observed hepatic flow distribution. Hepatic-to-azygous shunts, on the other hand, are 
systematically among the best performers in terms of hepatic flow distribution, leading to 
a vigorous mixing of all systemic venous returns in the Kawashima connection, and 
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thereby ensuring that the hepatic flow distributions closely followed the global flow 
distribution to the two lungs, as would be the case in a normal circulation. However, this 
design also systematically comes at higher energy expenses than any other option. 
Accordingly, while hepatic-to-azygous shunts might be considered as a good fall-back 
option for patients with a single SVC, other TCPC implementations should be pursued, 
whenever possible, to achieve similar hepatic flow distribution but at lower energy 
expenses.  
For patients with a persistent LSVC, the separation of the left and right superior 
inflows provides a natural solution to the difficulty of identifying the optimal baffle 
anastomosis location. Connecting the hepatic baffle anywhere along the mid-PA segment 
is a simple yet extremely efficient approach, provided that the following conditions are 
met: (i) almost equal contribution of the left and right superior inflows to the total 
systemic venous return; (ii) high enough hepatic flow rate; and (iii) a well-defined mid-
PA segment (i.e. clear separation between the SVC and LSVC anastomosis sites). Under 
those circumstances, the exact baffle design and anastomosis location along the mid-PA 
segment have little impact on the hepatic performance, allowing surgeons to freely adjust 
the TCPC design to the surrounding anatomical constraints. When the superior venous 
returns are highly biased towards the azygous side, or when the hepatic flow is too low, 
an alternate solution is to first re-route the azygous blood flow into the hepatic baffle, and 
then connect the baffle to the mid-PA segment. Patients for whom the two SVCs are 
connected close to one another present a more challenging configuration, lying in 
between the single and bilateral SVC scenarios, and are thus better addressed using an 
individualized surgical planning approach. 
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In conclusion, all these studies  clearly demonstrate that hemodynamics play a 
significant role in the Fontan physiology. While optimizing hemodynamics based on 
anatomical considerations alone used to represent a challenge, the framework developed 
as part of this thesis now allows bioengineers and clinicians to envision multiple different 
surgical scenarios, quantify their hemodynamic performance and identify the better 
performing one. This presents a novel approach to better understand and treat rare forms 
of SVHDs, providing a framework to isolate the impact of different flow or geometric 
variations, which would otherwise not be possible due to too small a patient population. 
However, while this framework allows for the optimization of the TCPC design for better 
hemodynamics, the link between hemodynamics and long-term patient outcome still 
remains vague. The next critical step would thus be to conduct a large clinical study, 
correlating the hemodynamic patterns with parameters of clinical outcome, to better 
optimize the care and management of single ventricle patients. 
- 435 -  
CHAPTER 12 
LIMITATIONS AND FUTURE DIRECTIONS 
 
In this thesis, a novel unstructured immersed-boundary method was developed for 
the characterization of the in vivo TCPC hemodynamics. This flow solver was designed 
with the specific goal of capturing the complexity of patient-specific anatomies and 
pulsatile flows, and allowing for the easy performance of patient-specific surgical 
planning studies. There are several opportunities for taking these technologies one step 
further, and more importantly re-enforcing the link between the proposed hemodynamic 
optimization framework and the ultimate patient outcome. These avenues are outlined in 
the forthcoming sections. 
 
12.1 Larger Sample Size Studies 
While the current thesis work allowed for the identification of apparent trends 
across the different patient groups, would it be in the pulsatile investigation or in the 
surgical planning studies, these analyses were conducted on very small patient 
populations and need to be further confirmed on a larger patient pool. The pulsatile 
investigation in particular, demonstrated that there is a threshold below which the impact 
of pulsatility might be neglected in favor of shorter computational times, but above which 
the inflow pulsatility should be included in order to appropriately capture the efficiency 
of different TCPC options. This finding could have significant implications for surgical 
planning applications, and as such it might be critical to: 1) conduct a larger sample size 
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study to better define the range of validity of the non-pulsatile assumption, and 2) to 
assess whether there is a threshold above which including or neglecting flow pulsatility 
alters the efficiency ranking of virtual surgery options. 
Along the same lines, from the surgical planning study, it is apparent that the 
formulation of any surgical guideline will require a very detailed classification of the 
Fontan patients based on both anatomical and flow considerations. While the current 
study allowed for the establishment of detailed guidelines for patients with an interrupted 
IVC and bilateral SVCs, the procedure to follow for patients with a single SVC remains 
less clear. While the most complex cases will always be best addressed with an 
individualized surgical planning approach, it is believed that increasing the number of 
patients enrolled in the surgical planning study will ultimately allow for the definition of 
detailed “pathology templates”, and associated better performing surgical approaches.  
 
12.2 Characterizing the Uncertainty in the Surgical Planning 
Predictions 
From the results described in the surgical planning investigations, it is apparent 
that the hemodynamic performance (i.e. the hepatic flow distribution and power losses) is 
not only a function of the TCPC geometry, but also of the inflow and outflow rates. 
Accordingly, the relevance and accuracy of the surgical planning recommendations will 
be greatly impacted by our ability to predict the post-operative flow conditions.  
The global flow distribution to the LPA and RPA will be dictated by the evolution 
of the left and right pulmonary vascular resistances, which will in turn depend on the 
amount of hepatic effluents distributed to these two lungs and the presence or absence of 
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pulmonary artero-venous malformations. In this thesis, we tried to best predict the 
temporal evolution of the global flow distribution to the RPA and LPA, by characterizing 
the hemodynamic performance of each TCPC design over a broad range of LPA/RPA 
flow splits, thus providing a potential evolution curve for each option. 
The inflow conditions on the other hand were imposed based on the pre-operative 
flow rate measurements. However, the caval flow rates are expected to change after the 
3rd stage of the TCPC surgery or as the patient grows, and could potentially evolve 
depending on the resistance of the TCPC connection and remodeling of the systemic 
vasculature. There is thus a need to: 1) better understand the temporal evolution of the 
caval flow rates before and after surgery, in healthy and failing Fontan patients; and 2) 
characterize how the uncertainty in the inflow boundary conditions propagates to the 
ranking of different surgical planning options and the final recommendation for the 
TCPC surgery.  
 
12.3 Linking TCPC Hemodynamics to Patient Outcome 
The current thesis proposes a novel framework for the optimization of the TCPC 
design based on a finite set of hemodynamic efficiency metrics, namely power losses and 
hepatic flow distribution. While both metrics have been clinically or theoretically shown 
to impact patient outcome, these links remain weak and very imprecise. There is a critical 
need for more clinical information in order to help prioritize between different 
hemodynamic metrics. Questions to be answered include, among others:  
1) What is the sensitivity of the pulmonary vasculature to the hepatic effluent 
concentration? Is there a range of clinically acceptable hepatic flow distributions for 
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which both lungs will be healthy, even these distributions slightly depart from a 50/50 
LPA/RPA balance? 
2) What is the exact impact of the TCPC hemodynamic resistance on ventricular 
function? Are some patients more sensitive to the TCPC efficiency than others? 
3) What is the exact role of the TCPC pressure drops or flow reversal in the development 
of gastro-intestinal track disorders such as protein losing enteropathy (PLE)?  
Answers to the above questions would require both clinical and bioengineering 
analyses, as well as both cross-sectional and longitudinal studies, quantifying the changes 
in TCPC hemodynamics and patient outcomes and assessing whether any correlation can 
be made between them. 
 
12.4 Realism of the Virtual Surgery Interface 
In the course of the pulsatile investigation, the bulgy aspect of the intra-atrial 
TCPC was observed to favor the mixing of the systemic venous returns, which may help 
achieve a more balanced hepatic flow distribution. However, this geometric characteristic 
was not modeled in the virtual intra-atrial options considered for the surgical planning 
studies. There is thus a need to further refine the realism of the virtual surgery interface. 
A first step to determine the critical geometrical parameters to model might be to acquire 
post-operative MRI data and confront the TCPC performed to the corresponding virtual 
option, seeking to understand the causes of the differences and their impact on the 
predicted performances.  
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12.5 Combining the Unstructured Cartesian Paradigm with Local Mesh 
Refinement Strategies 
A major characteristic of real-life anatomical flows is the fact that due to their 
relatively low Reynolds number the emergence of dynamically rich flow patterns can be 
localized only in a certain region of the overall flow domain, which makes their 
numerical resolution particularly challenging. Typical examples of such configurations 
are provided by Patient 3 in Chapter 8 and Patient A1 in Chapter 9. In the case of Patient 
3, a fine computational mesh was required to properly characterize the flow through the 
severely stenosed mid-PA segment. Similarly, in Patient A1, the presence of a severe 
LPA stenosis led to important flow instabilities downstream of the stenosis characterized 
by chaotic mixing and small random vortical structures, which are the hallmark of 
transitional flow regimes and early signs of turbulence, and required a fine spatial 
discretization. A mesh refinement study for Patient A1 demonstrated that the grid 
employed in this thesis (h = 0.022DIVC, yielding 1.82 million active nodes) is adequate for 
obtaining grid insensitive results in most of the anatomy, but it is clearly not fine enough 
to fully resolve the length scales that emerge in the flow downstream of the LPA 
constriction.  
Future work should thus focus on combining the unstructured Cartesian paradigm 
with local grid embedding strategies in order to be able to carry out fully resolved 
simulations at a reasonable computational cost. The unstructured immersed-boundary 
approach developed as part of this thesis provides the basis for developing such methods 
and for implementing them efficiently for complex anatomical simulations. 
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12.6 Further Refinements of the Computational Model 
Inlet Velocity Profiles: As was discussed when comparing the numerical results to either 
controlled in vitro experiments in Chapter 7 or against the in vivo PC MRI measurements 
in Chapter 8, the flow structures at the center of the TCPC can be very dependent upon 
the choice of inlet velocity profiles. Potential avenues to further refine the realism of the 
CFD simulations include: 1) interpolating the in vivo PC MRI measurements onto the 
inlet cross-sections of the numerical model; or 2) expanding the computational domain 
further upstream, to model the merging of the hepatic and IVC flows on the inferior side, 
and of the innominate and SVC flows on the superior side. A potential difficulty 
associated with the latter approach might be an increasing PC MRI measurement error as 
the dimensions of the vessels of interest decrease from the IVC and SVC to the upstream 
branches. 
 
Outlet Boundary Conditions: All simulations reported in this thesis were conducted 
using prescribed mass flow splits at the outlets. While this approach is reasonable for 
non-pulsatile simulations, or for pulsatile simulations for which the dynamic flow split 
variations can be obtained from PC MRI, it may be more questionable if surgical 
planning studies were to be conducted under pulsatile conditions or using moving walls. 
For either of these cases, it might be better suited to change the outflow boundary 
conditions to resistance or impedance boundary conditions, allowing for the LPA/RPA 
flow splits to dynamically adapt to the inlet flow curves.  
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Rigid Walls: All simulations and in vitro experiments reported in this thesis were 
conducted neglecting wall motion, and focusing on the impact of the TCPC flow 
pulsatility. This simplification was deemed reasonable in view of the in vivo MR images, 
where the in vivo motion of the TCPC wall appeared to be of small magnitude, even in 
intra-atrial cases. However, under pulsatile conditions, wall compliance might play an 
important role in the transmission and absorption of the pulsatile pressure waves.  
It should be kept in mind that both of the above numerical refinements might 
significantly increase the computational complexity and costs. There might thus be a 
need to quantify the gain achieved by including wall motion and weigh it against the 
added computational cost, following a similar process as the pulsatile sensitivity analysis 
performed in this thesis. 
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APPENDIX A. STEP-BY-STEP GENERATION OF 
PATIENT-SPECIFIC COMPUTATIONAL MESHES 
 
This section describes the steps leading from the point clouds description of an in 
vivo anatomy obtained from the reconstruction of the magnetic resonance images (MRI) 
to the unstructured Cartesian mesh that will be used in the computational fluid dynamic 
simulations. An overview of the entire process is provided in Figure A-1. 
 
 
Point cloud representation of the in vivo 
anatomy obtained from the segmentation of 
the MRI or CT images
Smooth surface with planar inlet/outlet 
cross-sections
Unstructured triangular surface mesh with 
vessel extensions
Unstructured Cartesian volume mesh
GeomagicsStudio 
(Section A.1)
Gambit
(Section A.2)
In-House 
Preprocessing Code
(Section A.3)
 
Figure A-1: Mesh generation overview 
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A.1 Surface Preparation, Geomagic Studio 11 (Geomagic Inc., NC, USA) 
1. Import the point cloud data obtained from the MRI segmentation and 3D 
reconstruction (Go to File/Import) 
 
2. Fit surface:  
a. Surface Wrap: Go to Points/Wrap, the default settings should work. 
b. Fill the holes left after the surface wrapping (Go to Polygons/Fill holes or select 
). Use the default settings first.  
i) If filling some of the holes yield to the formation of artificial bumps, change 
the “Fill type” from “Curvature” to “Flat” 
ii) Another option might be to create a bridge ( ) across the center of the hole 
and then fill the smaller holes independently 
 
3. Remove the local surface irregularities: 
a. If the geometry is very irregular the first step might be to apply smoothing the the 
entire geometry (Polygons/Smooth/Relax or Polygons/Smooth/ Reduce Noise)  
b. If the irregularities are more limited in space, then the two best performing 
options are either: 
i) To apply a local smoothing with Polygons/Smooth/Sandpaper 
ii) To delete the local irregularity and fill back the hole using the curvature-based 
filling 
c. Attention should be paid to delete all inverted surface elements and fill back the 
corresponding holes (Figure A-2) 
i) The inverted surface elements can easily be visualized as they will appear in 
yellow, whereas the rest of the surface should appear in blue. 
ii) Rotating the anatomy helps detect the inverted elements as the surface 
rendering used by Geomagic Studio will lead these yellow triangles to “shine” 
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Inverted 
Element
Delete 
Zone
Fill 
Hole
 
Figure A-2: Detection and removal of an inverted surface element in Geomagic Studio. 
 
4. Create the inlet/outlet cross-sections (Figure A-3) 
a. Select the vessel to be cut  
i) Right click on the mouse and choose “Select Through”. In the same menu, go 
to “Selection Tools” and pick the method of choice. “Lasso” typically is the 
easiest to use 
b. Cut the vessel 
i) Go to Polygons/Trim/Trim with Plane or select the  icon 
ii) Change the plane orientation method from “System Plane” to “Three Points” 
and select three points on the vessel surface such that the plane is visually 
perpendicular to the vessel axis. Click “Align” to align the plane with the 
selected points. 
iii) “Intersect Plane” 
 
 
Trim by Plane using Three Points After the creation of a 
planar vessel cross-
section
 
Figure A-3: Creation of a planar outlet cross-section. 
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iv)  “Delete Selection”. The section that will be deleted is the section highlighted 
in red after the plane intersection. If this section is not that has to be removed 
first select “Reverse Selection” and then “Delete Selection” 
v) “Close Intersection” to create a water-tight geometry 
vi) “OK” to accept the thus created vessel cross-section 
c. Repeat the operation for each inlet and outlet 
 
5. Convert the surface from its triangular structure to a format that can easily be 
imported into other computer aided design (CAD) or meshing software by creating a 
limited number of B-spline patches rather than the large number of surface triangles. 
a. Switch from the polygon to the shape phase: Go to Edit/Phase/Shape Phase 
b. Create Patches: Go to Patches/Construct Patches. Use “Auto-estimate” for the 
number of patches required. The default options work for most geometries 
c. If the defaults fail to adequately describe the geometry 
i) Go to Contours/Detect Curvature 
ii) Go to Contours/Shuffle Curvature Lines. Modify the main curvature lines (in 
orange) so as to provide proper guidelines for the patch generation. As a 
general rule, two curvature lines should run along the sides of each vessel, 
diametrically opposite to one another. Another curvature line should run all 
along the base of each vessel when two vessels merge together. 
iii) Go to Contours/Construct Patches. The patches will be defined using the 
curvature lines defined above. 
d. Go to Patches/Repair Patches and check the quality of the patch layout. The most 
important point is to avoid patch overlap. The easiest option to use is to edit 
patches ( ) and move the patch corners until no patches overlap any longer. 
6. Construct the grid (Grids/Construct Grids). The defaults should work. 
a. If they fail, the faulty patches will be highlighted in red and the user should cancel 
the operation and correct these patches accordingly 
7. Fit surface 
a. Go to Grids/Specify Planar Region. Select all the patches on a given inlet or outlet 
and click “Next”. Repeat until the operation is completed.  
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b. Go to NURBS/Fit Surface. A baseline tension of 0.7 should provide a smooth 
geometry. The user may adjust that value until a satisfying rendering is achieved 
8. Export as an .igs file format 
 
 
A.2 Surface Mesh Generation, Gambit 2.4 (ANSYS Inc., PA, USA) 
1. Import the .igs file exported from Geomagic Studio (File/Import/IGES) 
a. The default import settings should be fine 
b. If the import operation takes longer than normal, the most likely cause is a faulty 
surface generation in Geomagic Studio and the user should go back to the 
previous step 
2. Merge patches: after the surface preparation in Geomagic Studio 11.0, the TCPC 
surface is typically discretized with hundreds of patches, which is inadequate for the 
prescription of the inlet/outlet boundary conditions. The patches should thus be 
merged into larger surfaces by boundary type (Figure A-4). 
a. Under “Operation”, select the Geometry mode ( ) 
b. Under “Geometry”, select the faces ( ) 
c. Under the “Face” options, select “Merge Surfaces” ( ) 
d. Select all the patches that belong to the same boundary (e.g. all IVC surfaces), 
and apply 
 
 
Select “Merge Surfaces” Inlet surface with 
multiple patches
Inlet surface after 
merging the patches
 
Figure A-4: Merge the patches belonging to the same boundary type 
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3. Extend the inlet/outlet entrance lengths 
a. In the geometry/vertex menu, select “create vertex on edge” and create N number 
of points such that each edge has at least 3 distinct points (Figure A-5).  
 
“Create Vertex on Edge” Create 2 new vertices on 
each inlet/outlet boundary
 
Figure A-5: Create N independent points on each inlet/outlet boundary to ensure that 
each one of them has at least three distinct, unaligned points. 
 
 
b. Under Operation, choose the “Toolbox” menu ( ), select “Axis” ( ) and 
then “Create Coordinate System” ( ). Check the box “Vertices” to define the 
coordinate system using the vertices created in the previous step. Select three 
distinct vertices on a given edge, and accept (Figure A-6). 
 
“Create Coordinate System”
Define a coordinate system for each 
inlet/outlet using three independent 
vertices
 
Figure A-6: Create a new coordinate system for each inlet/outlet 
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c. Extend the inlet and outlet vessel lengths in the direction normal to the cross-
sectional plane (Figure A-7). 
i) Go to the “Geometry/Volume” menu and select “Sweep surface” 
ii) Select the cross-section of the inlet/outlet to be extended 
iii) For the “Path” option, check the “Vector” box and then click “Define” to 
define the extension direction 
iv) Select the coordinates axis defined on the inlet/outlet to be extended. The z-
axis will be oriented normally to the surface. If the z-axis is pointing towards 
the inside of the TCPC choose the “negative” direction, otherwise “positive”.  
v) Set the extension length and accept 
For the cases studied in this thesis, the inlet vessels were typically extended by 
10mm, while the outlets were typically extended by 50mm. 
 
“Sweep Surface”
Sweep the surface along the Z-direction (here 
negative) of the associated coordinate system
 
Figure A-7: Inlet/outlet extension 
 
 
4. Unstructured Surface Mesh Generation 
a. Mesh all edges (Figure A-8). Using the edges to define the mesh resolution allows 
for an easy control over the surface mesh spacing. If a finer resolution is needed 
along one the pulmonary arteries for example, then this can be ensured by simply 
defining a finer mesh spacing along the corresponding edges.  
i) Go to the mesh/edges menu 
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ii) Select all edges and set your mesh spacing (typically 1 or 1.5mm).  
iii) In cases where one vessel is significantly smaller than the others, the 
corresponding edge may be meshed independently with a finer setting. 
 
“Mesh Edges”
 
Figure A-8: Edge mesh generation. Meshing the edges first allows for a detailed control 
over the surface mesh resolution, allowing for finer resolutions in regions where it is 
needed. 
 
 
b. Mesh surfaces (Figure A-9) 
i) Select the TCPC wall, the extension walls and the outer inlet/outlet cross-
sections (do not select the cross-section lying at the interface between the 
TCPC and the extensions) 
ii) Change the mesh type to “Tri”, uncheck “Spacing” and “Apply” 
 
“Mesh Surfaces”
Uncheck box to use 
edge spacing
Do not mesh the 
interfacial surfaces
 
Figure A-9: Surface mesh generation 
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5. Label the inlet/outlet cross-sections (Figure A-10) 
This operation will ease the prescription of the inlet and outlet boundary conditions 
with the in-house code.  
a. Change solver type to FIDAP 
b. In operation select “Zones” ( ), and then select “Specify Continuum Type” 
( ) 
c. The default setting for the continuum types to be select is “Volume”, change to 
“Faces” 
d. Select one inlet or outlet, name it (e.g. IVC or LPA) and apply 
e. Repeat the operation for all inlets and outlets 
The advantage of labeling the inlets and outlets is that Gambit will export the mesh 
surfaces in the order in which they are labeled. Controlling the order in which the 
surfaces are labeled allows for an easier prescription of the boundary conditions.  
 
6. Export the mesh (File/Export/Mesh) “mesh_name.FDNEUT” 
 
 
 
Specify Boundary Name
Define as LPA
 
Figure A-10: Label each inlet and outlet, in the same order as the one that will be used for 
the boundary condition prescription in the in-house code. 
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A.3 Volume Mesh Generation, In-House Code 
All settings for the volume mesh generation are controlled from the text file 
input_MPI.txt. This file includes parameters that pertain both to the flow solver and to the 
pre-processor. We will only present the parameters associated with the mesh generation. 
The input_MPI.txt file is divided into sections with specific instructions, which are here 
listed, with examples of parameter settings. 
 
1. General information 
a. NAME_PROBLEM: This can be any word or short sentence helping the user 
remember characteristics of the simulation. NAME_PROBLEM will appear on 
the top of the screen output. 
b. REST_Q_UH and REST_GEOM: these are the numbers associated with the 
geometric and flow restart files.  
i. For the pre-processor REST_Q_UH does not come into play.  
ii. Setting REST_GEOM = 0 means that the pre-processing should be started 
from scratch 
iii. Setting REST_GEOM > 0 means that the pre-processing has already been 
done, but that the user wants to associate the volume mesh with a finer surface 
mesh for example. 
 
2. Parameters to read the immersed boundary 
a. F_FDNEUT: The name of the .FDNEUT file with the unstructured triangular 
surface mesh 
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b.  (N)PT_TO_REMOVE, (N)NC_TO_REMOVE, (N)NC_TO_ADD, NC_TO_ADD, and 
are options allowing the user to correct selected surface elements if there are a 
few defects after the Gambit mesh generation steps. If there are too many holes or 
inverted elements, then it is simpler to go back to Gambit or Geomagics. 
i. If there are no defects in the surface mesh, all these parameters should be set 
to 0 
c. NINVERT_NORMAL allows the user to invert the normal directions over an entire 
boundary so to ensure that all normals are pointing towards the fluid.  
i. For most cases Gambit exports the mesh with all normals not pointing towards the 
fluid domain. For these cases. Set NINVERT_NORMAL to any value larger than the 
number of boundaries in your surface mesh.  
ii. If only some boundaries but not all, say two, have inverted normals, then set 
NINVERT_NORMAL=2, and then list the corresponding zone numbers as 
GROUPS_TO_INVERT(1:2)=7,11 if the two zones with inverted normals were 
zones number 7 and 11 in your surface mesh.  
 
3. Scaling of the physical dimensions 
The in-house code is written using the non-dimensional form of the Navier-Stokes equations. 
A first step is thus to normalize the geometry by a characteristic length.  
a. IJK_BODY_LENGTH offers a number of pre-set options, including the maximum x, y, 
or z dimensions (IJK_BODY_LENGTH = 1 to 3) or using the equivalent hydraulic 
diameter of a given inlet or outlet (IJK_BODY_LENGTH > 100) 
b. For all other characteristic lengths set IJK_BODY_LENGTH = 0 and type in the 
normalization parameter to use as L_REF.  
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4. Spatial resolution of the Cartesian volume mesh 
Two options are offered to define the spatial resolution: 
a. If GRID_OPTION = 1, then the user fixes the number of grid cells in each direction 
(IMG, JMG, KMG) and the code adjusts the mesh resolution to cover the entire geometry 
b. If GRID_OPTION = 2, then the user fixes the mesh spacing (GRID_DX) after non-
dimensionalization and the code adjusts the number of grid cells in each directions to 
cover the entire geometry. 
In this thesis the geometries were discretized using option 2, and the mesh spacing was 
typically set to be isotropic and equal to 0.02 non-dimensional units (i.e. h = 0.02 DIVC) 
 
5. IB-node detection parameter 
a. In order to sort the Cartesian grid nodes between those that fall inside or outside of the 
fluid domain, a preliminary search is performed that only takes into consideration the 
Cartesian cell centers that fall within a certain search radius of the immersed boundary 
nodes (see Figure A-11). This search radius is defined as R = COEFF_DSMAX . Δx 
b. COEFF_DSMAX should be set to a large enough value for none of the IB cell centers to 
be overlooked, but kept small enough to minimize computational time. The typical 
steting used in this thesis was COEFF_DSMAX = 9.0. 
c. EPS_VEC is the tolerance for points to be considered as being within the fluid domain or 
outside of it. This parameter was typically set to EPS_VEC=0.001. 
 
With all these parameters in place, the preprocessing code will automatically generate the 
desired unstructured Cartesian grid. All geometric information will be written in the 
geometric restart file Rest_Geom0000. It is advised to change the restart file name to any 
number other than the default value of 0000. 
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R = 1.5 Δx
R = 3Δx
Immersed 
boundary
Cartesian grid 
cell center
Body node
Search radius
n
 
Figure A-11: IB-detection. In the preliminary search, only the Cartesian grid cell centers 
that fall within a certain distance R of the immersed boundary node are differentiated 
between those that fall inside or outside of the fluid domain. If R is too small (e.g. R= 
1.5Δx), then some IB cell centers may be overlooked. 
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APPENDIX B.  
SIMULATION SET-UP 
 
In order to help in the data organization and clean-up, all code inputs are provided 
as *.txt files, while the code outputs are either in binary format (for the flow restart files, 
Rest_Q_Uh_XXXX) or in Tecplot readable *.dat format. The three following files are 
required to start any simulation: 
1. The binary restart file with all geometric information obtained from the pre-
processor (Rest_GeomXXXX) 
2. The general input file: input_MPI.txt 
3. The settings to use for the Poisson solver: control.txt 
Additional files (optional) may be provided to further specify the inlet and outlet 
boundary conditions: 
4. For pulsatile simulations, list the time-varying cardiac output and inlet/outlet 
flow splits in BC.txt 
5. Specific inlet velocity profiles 
The different input parameters are described in details in the following sections. 
 
B.1 General information (in input_MPI.txt) 
 NAME_PROBLEM: This can be any word or short sentence helping the user 
remember characteristics of the simulation. NAME_PROBLEM will appear on the 
top of the screen output. 
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 REST_GEOM: index for the geometric restart file, ought to be > 0 
 REST_Q_UH: index for the flow restart file.  
o REST_Q_UH = 0: the flow simulations will be started from scratch 
o REST_Q_UH > 0: the flow simulations will be initialized with the flow 
information contained in the associated Rest_Q_Uh_XXXX file (where XXXX is 
equal to REST_Q_UH).  
- If Rest_Q_Uh_XXXX cannot be found, the simulations will be initialized 
with zero velocities and pressures and started from scratch. 
- If MONITOR_RESET < 0, the running average will keep building upon the 
values stored in the restart file, otherwise it will be reset.  
 DELTI: physical time-step (in non-dimensional time units) 
 NT2: maximum number of physical time-steps to be done 
 ITMAX_PPROJ: number of inner iterations to be done in the momentum step 
(typically set to 10) 
 ERR_TOL: tolerance threshold below which a value should be considered as a 
machine 0 (typically set to 1E-15) 
 
B.2 Code outputs (in input_MPI.txt) 
 Frequency at which the flow fields should be outputted 
o NWOUT: instantaneous pressure and velocity fields in Tecplot format 
o NWAVE: running-average (velocity and pressure) in Tecplot format 
o NWDUMP: flow restart file in binary format 
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o DUMP_OVERWRITE: if this is set to F (false) then each output will be written to 
a new file, indexed by the time-step number. If it is set to T (true) the restart files 
will be overwritten, in order to save space. For pulsatile simulations this value is 
automatically switched to F within the code itself.  
 Monitoring the simulations and convergence: The user can specify a series of points 
for which he wants the time-history of the pressure and velocity components. For 
each one of these points the code will output a Tecplot-compatible file containing the 
time-series of the instantaneous pressure and velocity components (P,U,V,W) and the 
corresponding running averages (PM,UM,VM,WM) 
o MONITOR_FILE: file header  
o MONITOR_NUM_POINTS: number of points to track 
o MONITOR_XYZ(N,1:3) = X,Y,Z: coordinates of the Nth point monitor 
  Checks for debugging: Unless the user wants to debug a specific problem, these 
checks should be set to F (false) as they will result in a large number of screen and 
file outputs that will drastically slow down the simulations. Check information will be 
outputted to the files MPIYYY_output_ZZZ.dat where YYY is the number of 
processors and ZZZ is the processor identification number. 
o CHECK and CHECK_P = T or F: general information for the momentum and 
pressure projection step, respectively 
o CHECK2_INPUT = F or T: track the computation at a specific grid cell of index 
L_TO_PRN_INPUT. This cell index is the global cell index, the code will then 
identify which processor it is associated with and its local index. 
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B.3 Boundary conditions (in input_MPI.txt) 
 REN: Reynolds Number 
 BC_STEADY = T or F: If this value is set to T (true) then the code will use the 
constant boundary conditions and boundary types prescribed below, otherwise it will 
look for a time-varying input prescribed in BC.txt 
B.3.1.1 Non-Pulsatile boundary conditions  
 BC_NUM: number of boundaries for which the boundary conditions will be 
specified. This number should be at least equal to the number of inlets and outlets.  
 BC_NGROUP: index of the BC_NUM boundaries for which the boundary conditions 
will be specified 
 BC_TYPE(1:BC_NUM): type of boundary condition to use 
o BC_TYPE(N) > 0: inlet. 1=flat velocity profile, 2=parabolic velocity profile 
based on the inlet equivalent diameter, 3=prescribed velocity profile to be 
specified in text files stored in a folder named BC_N_profiles 
o BC_TYPE(N) = -3: outlet 
o BC_TYPE(N) ≤ -100: wall. -100: IB velocity set to 0, -101: no slip wall with the 
IB velocity reconstructed using a bi-quadratic interpolation, -102: slip wall 
 BC_SPLIT: portion of the flow coming or exiting through a given boundary. This 
value should be 0 for walls, >0 for an inlet and <0 for an outlet. The sum of the inlet 
ratios should be 1 and the sum of the outlet ratios should be -1 
Note: If nothing is specified for a given boundary, the default setting will be BC_SPLIT 
= 0 (i.e. no flow) and BC_TYPE = -101 (i.e. no slip wall). 
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 The total flow rate or cardiac output coming in and out of the geometry may be set in 
one of two ways: 
o If the Reynolds number was computed using the mean velocity through inlet N as 
a characteristic velocity then, set NORM_VEL = N. The total flow rate, DVOL_0, 
will be computed as the ratio of the cross-sectional are of inlet N and 
BC_SPLIT(N). This will ensure a mean non-dimensional velocity of 1 through 
the inlet taken as a reference. 
o Otherwise, set NORM_VEL =0 and DVOL_0 to the desired value. Ensure that 
DVOL_0 is consistent with the characteristic distances and velocities chosen to 
compute the Reynolds number REN.  
B.3.1.2 Pulsatile boundary conditions (in BC.txt) 
For pulsatile simulations, the two following parameters should be set in 
input_MPI.txt: REN and BC_STEADY=F. The time-dependent cardiac output, flow 
splits and boundary types should be specified in BC.txt according to the format 
exemplified in Figure B-1 and detailed below: 
 NT_UNSTBC_MAX: number of time-points for which the boundary conditions are 
specified  
 List of the non-dimensional time-points 
 List of the total non-dimension flow rate for each time point 
 For each boundary (indexed by NBC= N), the lists of 
o BC_TYPE for each time-point 
o BC_SPLIT for each time point  
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NT_UNSTBC_MAX= 4 
Non-dimensional time  
0.00  0.25  0.50 0.75  
 
Total Non-Dimensional Flow Rate  
1.23  1.45  1.01  0.60 
 
NBC= 1 
 1  1  -3  -3   
0.01  0.1 -0.01 -0.1 
 
NBC= 2 
1 1 1 1 
0.99 0.9 1.0 1.0 
 
NBC= 3 
-3 -3 -3 -3  
-1.00 -1.00 -0.99 -0.90  
 
Figure B-1: Example of a BC.txt file with 4 time-steps and three different types of 
inlet/outlet boundary conditions. 
 
 
Any boundary not listed in BC.txt will be considered as a no-slip wall for all time-
steps (i.e. BC_TYPE = -101 and BC_SPLIT = 0). Similarly to the non-pulsatile settings 
the sum of the inflow splits should be equal to 1 at every time-step, while the sum of the 
outflow splits should be equal to -1. If the temporal resolution used in the simulations is 
finer than that used in BC.txt, the intermediate velocity and flow split values are 
reconstructed by quadratic interpolation. 
Attention should be paid to ensure that the time-varying non-dimensional total 
flow rate is consistent with the characteristic distance and velocity retained to compute 
the Reynolds number. For the simulations conducted in this thesis, the characteristic 
distance was chosen to be the equivalent hydraulic diameter of the IVC inlet cross-
section, DIVC, and the characteristic velocity to be the mean IVC velocity averaged both 
over the cardiac cycle and the inlet cross-section, IVCU . With these notations the time- 
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varying non-dimensional flow rate, CO*, is given by: 
 ( ) ( ) 2**
IVCIVC DU
tCOtCO
⋅
=  (B-1) 
where CO is the measured time varying flow rate, t is the physical time, and t* is the 
corresponding non-dimensional time-instant given by IVCIVC DUtt ⋅=
* . 
 
B.4 Flow Solver Parameters 
These parameters should for the most part be left to their default values. Their 
significance is given below. The parameters pertaining to the momentum step are listed in 
input_MPI.txt, while the parameters pertaining to the pressure projection step are listed in 
control.txt in a format readable by the PetSc libraries. 
B.4.1.1 Momentum step (in input_MPI.txt) 
 IRK and ALPHA: order of accuracy for the Runge-Kutta iterations in the momentum 
step, and associated ALPHA coefficients. Unless debugging, these values should be 
set to IRK = 4 and ALPHA(1:4) = 0.25, 0.33, 0.5, 1.0 
 On and off switches for the different subroutines. Unless debugging these values 
should be set to 1 (0 will turn off the subroutines) 
o IUNST: unsteady term ( t∂∂ur )  
o IVISC: viscous terms ( ur21Re ∇− )  
o ICONV: convective term ( uu rr ∇⋅ )  
o APPLY_BCOND: apply boundary conditions for all boundary types, including 
inlets, outlets and walls 
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o APPLY_IBM_INTERPOL: velocity interpolation for the wall boundary 
conditions 
 CONVEC_ORDER = 1 or 2: Order of accuracy for computation of the spatial 
derivatives in the convective term. Unless debugging this value should be set to 2. 
B.4.1.2 Pressure Projection Step (in Control.txt)  
 Main solver 
o ps_ksp_type: type of solver to use, this was always set to fgmres.  
- For the FGMRES approach an additional parameter to set is 
ps_ksp_gmres_restart. The FGMRES method iteratively builds a Krylov 
subspace refining the solution towards its exact value. This, however, may 
pose memory limitations. The solver can thus be restarted at regular intervals 
to reset the memory. For most cases ps_ksp_gmres_restart was set to 20 or 30. 
In cases where the simulations ran out of memory, the value was decreased 
further.  
o Convergence criteria: the Poisson solver exits when either one of the following 
conditions is met: 
- When the absolute error is less than ps_ksp_atol (typically set to 1.e-8) 
- When the relative error is  less than ps_ksp_rtol (typically set to 1.e-5) 
- When the number of FGMRES iterations exceeds ps_ksp_max_it (set to 200, 
although the other criteria were typically met in less than 50 iterations)  
 Preconditioner 
o mypc_type: type of preconditioner to use, typically set to either mg or bjacobi, for 
the multi-grid or biJacobi approaches, respectively. 
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o For the multi-grid approach a few additional parameters need to be set 
- ps_mg_level: number of multigrid levels to use (1 is the equivalent of no 
multi-grid approach). This parameter was typically set to 2 or 3. 
- ps_mg_refine: directions in which the grid should be coarsened for the multi-
grid approach. 111 means in all directions, 100 means in the X direction only, 
010 in the Y direction only, 110 in the X and Y directions only, etc. 
- after_mg: whether to perform a post-smoothing step after the multi-grid. 
Typically set to no. 
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APPENDIX C.  
IMPLEMENTATION DETAILS 
 
C.1 Flow Solver Implementation Overview 
The mathematical formulation of the fractional step method used in this thesis is 
presented in Chapter 5. Its practical implementation is described in Figure C-1, as a 
pseudo-code. This pseudo-code breaks down the solver into its individual steps, lists the 
subroutine performing each step as well as the files where these subroutines may be 
found.  
All initialization and time-integration steps are orchestrated from the main 
program file in main.F90. Subroutines specific to the momentum step can be found in 
rk4_solver.F90, while the subroutines pertaining to the pressure projection step are given 
in poisson_solver.F90.All boundary condition types are provided in bcond.F90 and 
ibm_interpol.F90 for the velocity interpolation along the wall boundaries. Finally, the 
different options for the flow field outputs are provided in plot_picture.F90 for the 
outputs in tecplot format and in rest_dmp.F90 for the binary restart files. 
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Initialize the simulation 
- read the input text files: input_MPI.txt, control.txt and BC.txt 
- allocate the structures associated with all grid levels 
ALLOCATE( XMG(MG_LMIN:MG_LMAX)) 
- split the computational domain among the different processors for parallel simulations with 
MPI (in split_domain.F90). This operation is done by one processor only (IAM=0) 
CALL SPLIT_DOMAIN(REST_GEOM) 
- read the flow and geometry restart files for the finest grid level, MG_LMAX (in 
rest_dmp.F90): 
o CALL REST_DMP(REST_GEOM,0): read the array sizes and allocate all arrays 
o CALL REST_DMP(REST_GEOM,-1): read the geometry (Rest_GeomXXXX where 
XXXX= REST_GEOM) 
o CALL REST_DMP(REST_Q_UH,-2): read the flow restart file (Rest_Q_Uh_XXXX 
where XXXX=REST_Q_UH) 
 
 
Iterate in time for NTIME = NT1 to NT2 
- Store previous time steps (U_HNM1=U_HN and U_HN =U_H) 
- Apply boundary conditions for the new time step (in bcond.F90) 
CALL BCOND 
- If NTIME = NT1 compute the discrete 3D Laplacian operator (LHS) for all grid levels, and 
store it for all subsequent time iteration 
- Advance in time using the fractional step method (in mg_fs_implicit_RK4.f90) 
o Momentum step: compute the intermediate velocity field with an explicit Runge-Kutta 
formulation (in rk4_solver.F90) 
DO IT = 1, ITMAX_PPROJ 
     CALL SOLVER_RK 
END DO  
o Pressure projection step: solve the Poisson equation for the incremental pressure (in 
poisson_solver.F90) 
CALL POISSON_SOLVER 
 Compute the divergence of the intermediate velocity field on the finest grid level  
CALL POISSON_RHS(MG_LMAX) 
 Initialize the Krylov-Subspace solver using the PetSc libraries 
• use GMRES on the finest level MG_LMAX 
• set-up the preconditioner (which is set in control.txt, and was typically 
chosen to be either a multi-grid or a BiJacobi preconditioner) 
 solve the system to establish the incremental pressure PHI, such that 
LHS*PHI=RHS  
 destroy the PetSc environment 
o Pressure and velocity corrections on the finest level (in mg_fs_implicit.F90) 
CALL UPDATE_PRES_VEL 
 U_H = U_H + grad(PHI) 
 P = P+PHI 
 Apply boundary conditions (in bcond.F90) 
- Outputs 
o Tecplot files at the following frequencies (in plot_picture.F90) 
 NWOUT for the instantaneous velocity and pressure fields 
 NWAVE for the running average of the velocity and pressure fields 
o Flow restart file at the frequency NWDUMP (in rest_dmp.F90) 
 If DUMP_OVERWRITE = TRUE then every even output will be written to 
Rest_Q_Uh_1000 and every odd output to Rest_Q_Uh_1001 
 
Figure C-1: Pseudo-code depicting the general organization of the in-house flow solver. 
Calls to the specific subroutines are provided in blue to guide the reader through the 
solver. The files were these subroutines may be found are given in parenthesis. 
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C.2 Multi-Linear Interpolation Operators for the Multi-Grid Poisson Solver 
The multi-grid implementation retained for the pressure correction step makes use 
of two multi-linear interpolation operators to communicate the computed residuals and 
solutions between a fine level 1+l  and a coarse level l . These operators are constructed 
by performing a linear interpolation along each grid direction. This might be better 
visualized in two dimensions as shown in Figure C-2. Let us consider a variable 1+lθ , 
available at level 1+l . The restriction of 1+lθ  onto a cell center, C, of level l  will be 
obtained by interpolating between the four closest fine grid cells (F1, F2, F3 and F4 in 
Figure C-2) in the following manner: 
( ){ } ( ) ( ){ }134134112112 4321 111 ++++ ⋅−+⋅−+⋅−+⋅= lllll FFFFC θαθαβθαθαβθ  (C-1) 
where 
2121212 FFF
ddδα = , 4343434 FFF ddδα = , 341234 δδδβ ddC= and XZd  is the distance 
between the corresponding points. Since the Cartesian grid is uniform, each of these 
coefficients is in practice constant throughout the domain and equal to 21 . The 2D 
multi-linear interpolation operator would thus simplify into: 
 
4
1111
4321
++++ +++
=
llll
l FFFF
C
θθθθ
θ  (C-2) 
Applying the same reasoning for the restriction procedure, the 2D formulation of the 
multi-linear operator 1+→llR  would read as: 
 
16
1339
43211
llll
l CCCC
F
θθθθ
θ
⋅+⋅+⋅+⋅
=+  (C-3) 
where the fine grid nodes are numbered in order of proximity to node F as in Figure C-2.  
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Figure C-2: Multi-linear interpolation and restriction operators exemplified on a 2D grid. 
δ12 and δ34 depict the intermediate interpolation points. The coefficients indicated in red 
indicate the weight attributed to each point on the interpolation/restriction stencil. 
 
 
The generalization of these operators in three dimensions is illustrated in Figure 
C-3 and reads as: 
( )θll →+1R :    ∑
=
+=
8
1
1
8
1
j
FC j
ll θθ   (C-4) 
( )θ1+→llR :   64
133399927
876543211
llllllll
l CCCCCCCC
F
θθθθθθθθ
θ
⋅+⋅+⋅+⋅+⋅+⋅+⋅+⋅
=+  (C-5) 
 where jF  with { }8,1∈j  denote the eight fine grid cell centers closest to the coarse cell 
center C, and jC  with { }8,1∈j  denote the eight coarse grid cell centers closest to the fine 
cell center F ordered by proximity.  
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Figure C-3: Trilinear interpolation operator exemplified for 3D grid. It should be noted 
that in order to simplify the display, the black lines do not represent the edges of the grid 
cells, but rather the connections between adjacent cell centers. The coefficients indicated 
in red indicate the weight attributed to each point on the interpolation/restriction stencil.  
- 469 - 
APPENDIX D.  
SURGICAL PLANNING DATA 
 
This appendix provides all the data used to create the plots shown in the patient-
specific surgical planning study (Chapter 9). For each Patient, we provide the cardiac 
output and inflow distribution. The outflow distributions tested for each one of the 
different options are listed in the associated tables in terms of global flow distribution to 
the RPA (GFDRPA). The tables also provide the associated efficiency metrics in terms of  
- The hepatic flow distribution to the RPA (HFDRPA) 
- The pressures at each inlet and outlet cross-sections, which is to say in the 
hepatic veins (HepV), azygous vein (AZ), superior vena cava (SVC), and 
innominate vein (IV) or left superior vena cava (LSVC) for the inlets, and at 
the outlet cross-sections of the left and right pulmonary arteries (LPA and 
RPA, respectively). The pressure at the HepV inlet cross-section is taken as a 
reference to express all the other pressures. 
- The control volume power losses. 
 
D.1 Patient A1 (CHOP M1) 
Patient A1 was a 4 year-old female, with a completed extra-cardiac TCPC 
(denoted as Pre-Op.) and left lung pulmonary arterovenous malformations (PAVMs). The 
cardiac output was 3.43 L/min, 21%, 22%, 24% and 33% of which came in through the 
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HepV, IV, AZ and SVC, respectively. The pre-operative outflow distribution was 
GFDRPA = 30%. The results are discussed in Section 9.2.1. 
 
Table D-1: Efficiency metrics associated with Patient A1’s pre-operative TCPC anatomy 
and the four surgical planning options, for varying outflow conditions. 
Option 
Number 
GFDRPA 
(%) 
HFDRPA 
(%) 
Pressure (mmHg) Power Loss 
(mW) HepV AZ IV SVC LPA RPA 
Pre-Op 30 90.7 0.000 -0.048 -0.103 -0.100 -8.543 -0.317 44.78 
Option 
1 
30 0.5 0.000 0.029 -0.046 -0.064 -5.829 -0.347 30.35 
50 4.4 0.000 -0.074 -0.128 -0.150 -3.318 -1.001 14.35 
Option  
2 30 93.9 0.000 -0.025 -0.069 -0.063 -7.400 -0.395 38.63 
Option  
3 
20 41.8 0.000 0.159 -0.124 -0.121 -8.217 -0.179 48.57 
30 62.7 0.000 0.158 -0.122 -0.134 -6.402 -0.264 33.40 
50 79.2 0.000 0.168 -0.117 -0.130 -3.387 -0.644 13.84 
Option  
4 
30 31.8 0.000 -0.030 -0.463 -0.448 -6.624 -0.723 33.97 
50 56.7 0.000 -0.040 -0.521 -0.534 -3.621 -1.232 14.95 
 
 
 
D.2 Patient A2 (CHOA M1) 
Patient A2 was a 6 year old male, with a completed intra-atrial TCPC (denoted as 
Pre-Op.) and right lung PAVMs. The inflow and outflow conditions were not available 
for that patient and were determined based on the data available for previous patients. 
The cardiac output was set to 3.43 L/min distributed as follows: 21%, 22%, 24% and 
33% coming through the HepV, IV, AZ and SVC, respectively. The pre-operative 
outflow distribution was unavailable as well, but based on the presence of right PAVMs 
it might be assumed that it corresponded to a GFDRPA greater than 50%. The results are 
discussed in Section 9.2.2. 
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Table D-2: Efficiency metrics associated with Patient A2’s pre-operative TCPC anatomy 
and the eight surgical planning options, for varying outflow conditions. 
Option 
Number 
GFDRPA 
(%) 
HFDRPA 
(%) 
Pressure (mmHg) Power Loss 
(mW) HepV AZ IV SVC LPA RPA 
Pre-Op 
80 13.3 0.000 0.090 0.004 0.017 -0.196 -0.314 1.78 
70 1.8 0.000 0.083 -0.007 0.006 -0.369 -0.269 1.79 
60 0.0 0.000 0.088 -0.008 0.007 -0.644 -0.184 1.99 
50 0.0 0.000 0.089 -0.009 0.011 -0.884 -0.148 2.36 
Option 
1 
60 100.0 0.000 0.062 -0.024 -0.002 -0.576 -0.222 1.85 
50 100.0 0.000 0.066 -0.017 0.006 -0.837 -0.168 2.19 
30 93.7 0.000 0.079 -0.007 0.017 -1.530 -0.090 3.67 
20 75.2 0.000 0.101 0.015 0.040 -1.959 -0.050 4.93 
Option 
2 
30 53.3 0.000 0.087 -0.003 0.021 -1.524 -0.094 3.77 
40 63.5 0.000 0.078 -0.012 0.013 -1.143 -0.134 2.82 
50 81.3 0.000 0.078 -0.015 0.000 -0.659 -0.145 1.46 
Option 
3 
50 31.3 0.000 0.087 -0.009 0.012 -0.846 -0.160 2.31 
40 19.1 0.000 0.089 -0.002 0.019 -1.179 -0.112 3.00 
30 9.7 0.000 0.088 -0.003 0.019 -1.546 -0.080 3.90 
Option 
4 
50 77.5 0.000 0.087 -0.005 0.017 -0.815 -0.154 2.12 
40 64.1 0.000 0.091 -0.001 0.022 -1.151 -0.117 2.79 
30 29.8 0.000 0.089 -0.006 0.017 -1.539 -0.090 3.68 
Option 
5 50 49.7 0.000 0.095 -0.001 0.015 -0.615 -0.124 1.28 
Option 
6 50 45.9 0.000 0.067 0.000 0.015 -0.634 -0.116 1.28 
Option 
7 
70 28.8 0.000 0.005 -0.026 -0.019 -0.357 -0.256 1.45 
60 23.7 0.000 0.005 -0.031 -0.024 -0.511 -0.190 1.33 
50 12.4 0.000 0.009 -0.067 -0.061 -0.791 -0.206 1.80 
Option 
8 
50 33.2 0.000 -0.016 -0.407 -0.397 -1.294 -0.593 3.74 
40 35.1 0.000 -0.017 -0.408 -0.398 -1.652 -0.554 4.52 
30 34.4 0.000 -0.018 -0.408 -0.399 -2.016 -0.522 5.37 
 
 
D.3 Patient A3 (CHOP M4) 
Patient A3 was a 3 year old female who had not yet undergone the final stage of 
the TCPC surgery, and was diagnosed with bilateral PAVMs. The cardiac output was 
3.86 L/min, 32%, 17%, and 51% of which came through the HepV, AZ and SVC, 
respectively. The pre-operative GFDRPA was 51%. The results are discussed in Section 
9.2.3. 
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Table D-3: Efficiency metrics associated with the eight surgical planning options 
implemented for Patient A3, under varying outflow conditions. 
Option 
Number 
GFDRPA 
(%) 
HFDRPA 
(%) 
Pressure (mmHg) Power Loss 
(mW) HepV AZ SVC LPA RPA 
Option 
1 
30 70.6 0.000 0.008 -0.060 -4.216 -0.613 19.59 
40 75.8 0.000 -0.025 -0.133 -2.981 -0.799 12.99 
51 84.3 0.000 0.038 -0.072 -2.139 -1.053 10.39 
Option 
2 
40 49.5 0.000 0.095 -0.036 -3.854 -0.670 18.20 
51 66.9 0.000 0.081 -0.056 -2.591 -0.909 12.62 
60 83.5 0.000 0.069 -0.079 -1.728 -1.154 10.21 
Option 
3 
20 29.9 0.000 0.108 -0.145 -5.141 -0.384 24.84 
30 48.6 0.000 0.111 -0.117 -3.998 -0.704 18.66 
40 40.9 0.000 0.234 -0.047 -2.913 -0.560 12.96 
51 59.9 0.000 0.027 -0.068 -2.336 -0.890 11.21 
60 73.4 0.000 0.016 -0.083 -1.574 -1.123 9.31 
Option 
4 
0 0.0 0.000 0.000 0.000 0.000 0.000 0.00 
40 29.7 0.000 0.029 -0.107 -3.349 -0.841 15.60 
51 40.4 0.000 0.008 -0.105 -2.227 -1.119 9.72 
60 50.6 0.000 0.003 -0.106 -1.551 -1.412 6.90 
Option 
5 
40 6.3 0.000 0.041 -0.091 -2.433 -0.864 11.07 
51 9.8 0.000 0.028 -0.094 -1.690 -1.162 7.73 
60 14.2 0.000 0.011 -0.075 -1.088 -1.460 5.70 
70 21.5 0.000 0.027 -0.085 -0.631 -1.887 4.87 
Option 
6 
40 0.0 0.000 -0.173 -0.306 -3.215 -1.167 14.87 
51 7.7 0.000 -0.069 -0.202 -2.387 -1.387 11.03 
60 10.1 0.000 0.002 -0.146 -1.680 -1.617 8.22 
70 12.1 0.000 0.097 -0.043 -0.975 -1.910 6.20 
80 48.4 0.000 0.146 0.003 -0.440 -3.961 16.54 
90 69.6 0.000 0.286 0.141 -0.122 -5.021 23.01 
Option 
7 
40 65.0 0.000 0.098 -0.176 -2.876 -0.581 12.11 
51 82.6 0.000 0.098 -0.156 -1.973 -0.839 7.36 
Option 
8 
30 24.6 0.000 0.023 -2.515 -7.748 -4.581 40.03 
40 30.2 0.000 0.019 -2.444 -6.209 -4.479 32.21 
51 59.3 0.000 0.013 -2.341 -4.616 -4.039 24.38 
60 65.5 0.000 0.017 -2.408 -4.056 -4.552 25.13 
 
 
D.4 Patient B1 (CHOP M3) 
Patient B1 was a 12 year old female, with a completed extra-cardiac TCPC and 
left-sided PAVMs. The cardiac output was 3.25 L/min. Inflow distributions were not 
available and determined based on the data available for the earlier surgical planning 
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cases, resulting in 21%, 22%, 24% and 33% of the cardiac output coming in through the 
HepV, LSVC, AZ and SVC, respectively. The pre-operative GFDRPA was 28%. The 
associated results are discussed in Section 9.3.1. 
 
 
Table D-4: Efficiency metrics associated with Patient B1’s pre-operative anatomy and the 
nine surgical planning options, under varying outflow conditions. 
Option 
Number 
GFDRPA 
(%) 
HFDRPA 
(%) 
Pressure (mmHg) Power Loss 
(mW) HepV AZ LSVC SVC LPA RPA 
Pre-Op 28 85.3 0.000 -0.224 -0.256 0.040 -0.393 -0.047 1.25 
Option 
1 
28 9.0 0.000 -0.068 -0.097 -0.008 -0.248 -0.103 1.02 
40 33.7 0.000 -0.036 -0.021 -0.009 -0.127 -0.119 0.76 
50 90.0 0.000 0.000 -0.029 -0.048 -0.102 -0.156 0.82 
Option 
2 
28 7.0 0.000 -0.077 -0.103 0.055 -0.265 -0.061 1.13 
40 36.5 0.000 -0.028 -0.052 0.000 -0.176 -0.130 0.98 
45 65.9 0.000 -0.026 -0.012 -0.013 -0.105 -0.131 0.76 
50 82.5 0.000 -0.007 -0.034 -0.018 -0.126 -0.150 0.93 
Option 
3 
28 7.4 0.000 -0.083 -0.113 0.020 -0.289 -0.081 1.22 
40 52.0 0.000 -0.037 -0.021 0.001 -0.132 -0.121 0.82 
50 92.7 0.000 -0.003 -0.035 0.020 -0.112 -0.164 1.04 
Option 
4 
28 1.2 0.000 -0.073 -0.089 0.013 -0.266 -0.084 1.13 
40 39.2 0.000 -0.029 -0.015 -0.001 -0.132 -0.121 0.82 
50 100.0 0.000 -0.001 -0.031 0.019 -0.110 -0.199 1.16 
Option 
5 
28 0.0 0.000 -0.008 -0.034 0.021 -0.214 -0.072 1.06 
50 25.8 0.000 -0.004 -0.041 -0.168 -0.139 -0.314 1.21 
60 35.2 0.000 0.002 -0.038 -0.398 -0.120 -0.532 1.71 
Option 
6 
28 0.0 0.000 -0.046 -0.199 -0.162 -0.450 -0.261 1.89 
50 2.4 0.000 -0.048 -0.209 -0.343 -0.448 -0.503 2.25 
60 18.7 0.000 -0.042 -0.204 -0.575 -0.462 -0.777 2.99 
Option 
7 
28 25.0 0.000 0.089 -0.714 0.004 -0.845 -0.085 3.42 
40 53.7 0.000 0.065 -0.365 -0.065 -0.465 -0.140 1.78 
50 65.3 0.000 0.084 -0.329 -0.003 -0.377 -0.147 1.56 
60 75.2 0.000 0.084 -0.192 -0.006 -0.213 -0.168 1.23 
Option 
8 
28 2.6 0.000 0.054 -0.304 -0.149 -0.395 -0.227 1.60 
40 15.9 0.000 0.053 -0.198 -0.133 -0.257 -0.262 1.32 
50 41.9 0.000 0.054 -0.139 -0.170 -0.181 -0.304 1.27 
Option 
9 
20 20.9 0.000 -0.031 -0.077 0.001 -0.319 -0.056 1.38 
28 58.7 0.000 -0.018 -0.097 0.045 -0.264 -0.041 1.18 
50 93.4 0.000 0.001 -0.041 0.028 -0.140 -0.109 0.94 
60 100.0 0.000 0.006 -0.019 0.025 -0.068 -0.150 0.94 
 
- 474 - 
D.5 Patient B2 (CHOP M7) 
Patient B2 was an 11 year old male, with a completed extra-cardiac TCPC and 
right-sided PAVMs. The cardiac output was 4.01 L/min, distributed as follows: 10%, 
19%, 31%, 40% coming in through the HepV, LSVC, AZ and SVC, respectively. The 
pre-operative GFDRPA was 35%. The corresponding results are discussed in Section 9.3.2. 
 
 Table D-5: Efficiency metrics associated with Patient B2’s pre-operative anatomy and 
the seven surgical planning options, under varying outflow conditions. 
 GFDRPA (%) 
HFDRPA 
(%) 
Pressure (mmHg) Power Loss 
(mW) HepV AZ LSVC SVC LPA RPA 
Pre-Op 
40 0.0 0.000 0.066 0.268 0.079 -0.606 -0.681 5.64 
50 0.0 0.000 -0.011 0.289 0.006 -0.454 -1.028 5.61 
60 0.0 0.000 -0.101 0.339 -0.086 -0.360 -1.337 5.80 
70 0.0 0.000 -0.206 0.294 -0.173 -0.318 -1.823 7.06 
Option 
1 
40 10.3 0.000 -0.080 0.024 -0.068 -0.841 -0.849 6.15 
50 0.4 0.000 -0.118 0.122 -0.109 -0.705 -1.111 6.04 
60 0.6 0.000 -0.077 0.311 -0.066 -0.411 -1.385 6.14 
70 0.3 0.000 -0.104 0.357 -0.073 -0.247 -1.791 7.07 
Option 
2 
40 0.0 0.000 -0.047 0.188 -0.030 -0.605 -0.793 5.12 
50 0.7 0.000 -0.095 0.218 -0.073 -0.498 -1.068 5.19 
60 3.6 0.000 -0.105 0.305 -0.079 -0.339 -1.353 5.46 
70 12.6 0.000 -0.144 0.306 -0.096 -0.239 -1.753 6.36 
Option 
3 
40 33.6 0.000 0.024 0.278 0.037 -0.511 -0.711 4.95 
50 45.7 0.000 -0.009 0.273 0.002 -0.424 -1.047 5.41 
55 37.4 0.000 -0.122 0.242 -0.098 -0.400 -1.266 5.39 
60 24.9 0.000 -0.082 0.304 -0.071 -0.374 -1.388 5.92 
70 22.7 0.000 -0.127 0.294 -0.103 -0.256 -1.789 6.72 
Option 
4 
40 99.5 0.000 -0.003 -0.031 -0.110 -0.785 -0.945 6.10 
50 100.0 0.000 -0.001 0.152 -0.091 -0.566 -1.220 6.28 
60 100.0 0.000 -0.001 0.274 -0.086 -0.402 -1.573 7.10 
70 100.0 0.000 -0.005 0.344 -0.068 -0.220 -1.864 7.60 
Option 
5 
30 0.4 0.000 0.040 -0.048 -0.172 -0.923 -0.499 5.47 
40 2.2 0.000 0.058 0.066 -0.149 -0.743 -0.750 5.32 
50 5.5 0.000 0.057 0.117 -0.165 -0.596 -1.017 5.21 
60 16.1 0.000 0.057 0.150 -0.234 -0.502 -1.464 6.11 
Option 
6 
40 0.0 0.000 0.021 0.314 0.061 -0.641 -0.801 6.13 
50 71.0 0.000 0.000 0.270 -0.039 -0.469 -1.235 6.37 
60 100.0 0.000 -0.007 0.263 -0.091 -0.356 -1.738 7.85 
Option 
7 
40 22.5 0.000 0.042 0.210 -0.112 -0.650 -0.739 5.14 
50 34.6 0.000 0.029 0.208 -0.142 -0.534 -1.079 5.43 
60 61.4 0.000 0.047 0.258 -0.088 -0.452 -1.400 6.34 
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D.6 Patient B3 (CHOP M2) 
Patient B3 was 4 year old female whose hepatic baffle had been taken down, such 
the connection was equivalent to a second-stage Kawashima connection. She was 
diagnosed with bilateral PAVMs. The cardiac output was 2.93 L/min, 21%, 26%, 15%, 
38% of which came through the HepV, LSVC, AZ and SVC. The pre-operative GFDRPA 
was 39%. The corresponding results are discussed in Section 9.3.3. 
 
Table D-6: Efficiency metrics associated with the fourteen surgical planning options 
implemented for Patient B3, under varying outflow conditions. 
Option 
Number 
GFDRPA 
(%) 
HFDRPA 
(%) 
Pressure (mmHg) Power Loss 
(mW) HepV AZ LSVC SVC LPA RPA 
Option 
1 
30 93.6 0.006 -1.658 -1.565 -0.064 -2.334 -0.372 5.69 
40 100.0 0.006 -0.754 -0.645 -0.075 -1.249 -0.602 3.38 
50 100.0 0.007 -0.206 -0.114 -0.052 -0.554 -0.855 2.88 
61 100.0 0.007 -0.025 0.062 -0.013 -0.264 -1.214 3.78 
Option 
2 
30 100.0 0.007 -1.604 -1.521 -0.071 -2.329 -0.414 5.88 
40 100.0 0.007 -0.725 -0.618 -0.083 -1.213 -0.695 3.58 
50 100.0 0.007 -0.233 -0.141 -0.077 -0.579 -0.991 3.33 
61 100.0 0.007 -0.051 0.035 -0.045 -0.292 -1.350 4.35 
Option 
3 
30 36.3 0.007 -1.624 -1.673 -0.060 -2.494 -0.363 6.30 
40 49.3 0.007 -0.801 -0.693 -0.055 -1.313 -0.596 3.59 
50 72.5 0.007 -0.185 -0.090 -0.047 -0.536 -0.910 3.14 
61 100.0 0.007 -0.033 0.056 -0.024 -0.275 -1.304 4.24 
Option 
4 
30 2.2 0.007 -1.388 -1.284 -0.069 -2.028 -0.391 5.08 
40 24.6 0.005 -0.655 -0.543 -0.062 -1.103 -0.630 3.22 
50 52.6 0.007 -0.185 -0.092 -0.029 -0.531 -0.908 3.15 
61 100.0 0.007 -0.057 0.032 -0.029 -0.293 -1.318 4.25 
Option 
5 
40 5.8 0.009 -0.310 -0.476 -0.064 -1.014 -0.617 3.22 
50 62.1 0.009 -0.097 -0.005 -0.158 -0.517 -1.264 4.04 
Option 
6 
40 8.0 0.009 -0.135 -0.047 -0.052 -0.614 -0.631 2.61 
50 72.7 0.009 -0.097 -0.005 -0.158 -0.435 -1.145 3.42 
61 94.7 0.009 -0.095 -0.007 -0.379 -0.325 -1.779 5.05 
Option 
7 
30 0.0 0.007 -0.303 -0.184 0.070 -0.898 -0.247 2.96 
40 21.5 0.007 -0.158 -0.059 -0.026 -0.607 -0.583 2.59 
50 64.1 0.007 -0.051 0.041 -0.344 -0.415 -1.233 3.46 
61 100.0 0.007 -0.031 0.058 -1.127 -0.275 -2.449 6.15 
Option 
8 
40 20.4 0.007 -0.035 0.057 -0.061 -0.585 -0.614 2.80 
50 67.3 0.007 -0.046 0.048 -0.419 -0.425 -1.293 3.49 
61 90.4 0.007 -0.095 -0.004 -1.223 -0.352 -2.443 5.87 
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Table D-6 continued: Efficiency metrics associated with the fourteen surgical planning 
options implemented for Patient B3, under varying outflow conditions. 
Option 
9 
40 10.0 0.007 -0.029 0.054 -0.086 -0.566 -0.638 2.72 
50 50.2 0.007 -0.076 0.009 -0.510 -0.475 -1.396 3.67 
61 64.3 0.007 -0.084 0.000 -1.436 -0.383 -2.649 6.26 
Option 
10 
40 0.0 0.007 -0.083 -0.227 -0.345 -1.001 -0.890 4.94 
50 3.4 0.007 -0.080 -0.238 -0.756 -0.889 -1.607 5.82 
61 10.4 0.007 -0.083 -0.266 -1.878 -0.864 -3.090 7.70 
70 23.5 0.007 -0.077 -0.244 -2.702 -0.760 -4.097 13.10 
Option 
11 
40 9.8 0.008 0.016 -1.366 -0.180 -1.851 -0.742 5.35 
50 48.0 0.011 0.012 -1.940 -0.522 -2.521 -1.378 6.93 
60 56.2 0.008 0.018 -0.356 -0.667 -0.566 -2.057 5.56 
Option 
12 
50 20.4 0.009 -0.030 -0.170 -0.199 -0.603 -1.008 3.17 
61 43.8 0.009 -0.029 -0.108 -0.330 -0.411 -1.493 4.13 
70 62.9 0.008 1.041 -0.097 -0.508 -0.306 -1.959 6.45 
Option 
13 
30 0.2 0.009 -0.032 -0.077 -0.058 -0.959 -0.449 3.65 
40 26.2 0.009 -0.015 -0.026 -0.055 -0.699 -0.748 3.41 
50 61.2 0.009 -0.005 0.028 -0.056 -0.454 -1.066 3.59 
61 100.0 0.009 0.003 0.088 -0.059 -0.209 -1.558 4.91 
Option 
14 
30 7.0 0.010 -0.168 -0.072 -0.079 -0.774 -0.463 2.65 
40 26.5 0.010 -0.105 -0.010 -0.060 -0.583 -0.719 2.80 
50 62.1 0.010 -0.069 0.027 -0.050 -0.406 -1.055 3.34 
61 95.2 0.010 -0.042 0.049 -0.060 -0.273 -1.551 4.94 
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